<chapter label="CHAPTER 6" id="ch0006"><title><emphasis role="strong">Metabolic and Endocrine Disorders</emphasis></title>
<sect1 id="ch0006s0179"><title><emphasis role="strong">EATING DISORDERS: ANOREXIA NERVOSA/BULIMIA NERVOSA</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis>&mdash;Eating disorders encompass a spectrum of psychological problems that involve insufficient or excessive food intake, resulting in significant health problems across the life span. The cause of eating disorders is thought to stem from a mixture of social, psychological, and biological factors. How much each factor contributes to the development of these disorders is a matter of debate.</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Physiological factors</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Genetic factors</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Some studies suggest that genetics contribute to about 50% of the variance for eating disorders.</para></listitem>
<listitem><para>Clinical depression also has a genetic risk with anorexia.</para></listitem>
<listitem><para>Genes seem to influence eating regulation, personality, and emotion and may be factors in these disorders.</para></listitem>
</orderedlist>
</listitem>
<listitem><para>Neurobiological factors</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>The neurotransmitter serotonin has a correlation with mood, sleep, emesis, sexuality, and appetite.</para></listitem>
<listitem><para>Anorexia may be linked to a disturbed serotonin system.</para></listitem>
<listitem><para>Cause and effect are not easily separated, as other factors, such as starvation, may be involved.</para></listitem>
<listitem><para>After recovery, personality characteristics, anxiety, and perfectionism remain, suggesting that they may be causal factors.</para>
</listitem></orderedlist>
</listitem>
<listitem><para>Nutritional factors</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Zinc deficiency is known to cause a decrease in appetite and has been recommended for the treatment of anorexia.</para></listitem>
<listitem><para>Other nutrients, such as tyrosine and tryptophan, as well as vitamin B<subscript>1</subscript> may also be deficient and contribute to malnutrition.</para></listitem>
</orderedlist>
</listitem></orderedlist>
</listitem>
<listitem><para>Psychological factors</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Biases in thinking and perception are believed to maintain and contribute to developing anorexia.</para></listitem>
<listitem><para>Feelings of fatness and unattractiveness are overestimated, perceived, and evaluated by the affected persons as being true, regardless of reality of their body, food, and eating.</para></listitem>
<listitem><para>A &ldquo;transdiagnostic model&rdquo; (Fairburn et al, 2009) proposes that all major eating disorders (with the exception of obesity) share some core types of psychopathology that help maintain the eating disorder behavior. These core psychopathologies include clinical perfectionism, chronic low self-esteem, mood intolerance, and interpersonal difficulties.</para>
</listitem></orderedlist></listitem>
<listitem><para>Social and environmental factors</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>The media, which have promoted the concept of thinness as the ideal female form, are believed to contribute to the development of eating disorders.</para></listitem>
<listitem><para>Those in professions where there is pressure to be thin (e.g., models, dancers, and athletes) may develop anorexia.</para></listitem>
<listitem><para>Below-median annual household income was associated with increased prevalence rates from 1998 to 2008 in binge eating, extreme dieting, and purging (Mitchison et al, 2014).</para></listitem>
<listitem><para>Environmental eating disorder triggers (e.g., fad dieting, excessive exercise, or medical illness) are examples of negative energy states that can bring about behavioral changes (e.g., restricting food intake, binging), <emphasis>triggering preexisting genetic drivers</emphasis> for eating disorders (Lutter &amp; Ramsay, 2017).</para>
</listitem>
<listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> A subset of adolescents who are temperamentally incapable of dealing with age-appropriate challenges without extreme reward-seeking behavior (thinness) may be susceptible to anorexia nervosa (AN) (Bernstein, 2017).</para></listitem>
<listitem><para>Child sexual abuse is noted in people with anorexia, and while it is not a specific risk factor, it is for mental illness in general.</para></listitem>
<listitem><para>The Internet has become a source of contact and communication for those with eating disorders and may or may not be helpful for them (Gibson, 2017).</para></listitem>
</orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Characteristics</emphasis>&mdash;<emphasis>Note:</emphasis> The fifth edition of the <emphasis>Diagnostic and Statistical Manual of Mental Disorders</emphasis> (<emphasis>DSM-5</emphasis>) separates anorexia nervosa and bulimia nervosa as two separate disorders, and there continues to be consideration that these two disorders may be part of a unified eating disorder (Bernstein, 2017).</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Anorexia nervosa (AN)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Serious, chronic illness of starvation associated with a severe disturbance of body image and a morbid fear of obesity</para></listitem>
<listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Disorder is primarily a phenomenon of puberty and early adulthood, but has been observed in both the very young and very old (Swanson et al, 2011). Increasing numbers of women over age 30 (with 13% of American women over age 50) experiencing some form of eating disorder (Trace et al, 2013).</para></listitem>
<listitem><para>Constellation of factors involved include an individual&rsquo;s genetic makeup, personality, and psychological and emotional challenges.</para></listitem>
<listitem><para>Predisposing factors include female sex, family history of eating disorders, perfectionistic personality, low self-esteem, difficulty communicating negative emotions and resolving conflicts. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Maternal issues (e.g., negative expressed emotions, maternal encouragement or insistence of weight loss) are risk factors for childhood onset.</para></listitem>
<listitem><para>May be divided into stages or may be viewed as a continuum of self-starvation, malnutrition, severe weight loss, and extreme weight loss</para></listitem>
<listitem><para>Divided into two subtypes (Bernstein, 2017)</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Restricting (AN-R): Severe limitation of food as primary means to weight loss. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Recent research suggests that youths with AN-R followed a more regular eating pattern but consumed insufficient amounts of food during meals (Bernstein, 2017).</para></listitem>
<listitem><para>Binge eating/purging (AN-BE/P): Periods of food intake compensated by self-induced vomiting, laxative or diuretic abuse, and/or excessive exercise. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Research also suggests youths with AN-BE/P tended to have more irregular eating patterns than those with AN-R (Bernstein, 2017).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para>Bulimia nervosa (BN)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Chronic cycle involving binge eating and purging</para></listitem>
<listitem><para>Characterized by binges of overeating, which may be extreme, followed by self-induced vomiting, purging, and misuse of laxatives, diuretics, or enemas; may also involve nonpurging behaviors such as excessive exercise and fasting</para></listitem>
<listitem><para>Fear of gaining weight motivates purging or compensatory behaviors.</para></listitem>
<listitem><para>Often seen in persons of normal weight but may be seen in overweight clients</para></listitem>
<listitem><para>More common among persons whose occupations, vocations, or hobbies require rapidly gaining and/or losing weight (e.g., wrestlers, body builders; jockeys, runners, gymnasts, actors, models)</para></listitem>
<listitem><para>Does not occur specifically with episodes of AN, although up to 60% of persons with BN report prior histories of AN (Randhawa et al, 2016)</para></listitem>
<listitem><para>Severity of conditions is characterized by frequency of inappropriate behaviors, from mild (average of 1&ndash;3 episodes/week) to extreme (14 or more episodes/week).</para></listitem>
<listitem><para>Often present with co-concurring conditions, such as self-injury (cutting and other forms of self-harm without suicidal intent), substance abuse, and impulsivity (e.g., risky sexual behaviors, shoplifting) (National Eating Disorders Association [NEDA], 2016).</para></listitem>
<listitem><para>More than half of persons with bulimia suffer from anxiety disorders (Ulfvebrand et al, 2015).</para></listitem>
<listitem><para>Often not diagnosed for months or years after onset because of person&rsquo;s secretiveness, usually associated with shame.</para>
</listitem></orderedlist></listitem>
<listitem><para>Binge eating disorder (BED)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Most common eating disorder overall with lifetime prevalence of 2.8% and most common eating disorder in men (2%) (Randhawa et al, 2016)</para></listitem>
<listitem><para>Characterized by binge eating (gorging behavior) without inappropriate compensatory behaviors such as purging or fasting</para></listitem>
<listitem><para>Ingestion of a large amount of food (in a discrete period of time [e.g., 2 hours]) with a sense of loss of control; frequent dieting without weight loss</para></listitem>
<listitem><para>Binge eating may be as high as 25% in postbariatric surgical persons (Berkman et al, 2015).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>The hypothalamus, which regulates appetite by signaling hunger and satiety, may not release balanced amounts of neurotransmitters, such as serotonin or pancreatic polypeptides.</para></listitem>
<listitem><para>Occurs in people of any age, gender, race, sexual orientation, religion, or social stratum. A study of college students suggests transgender and nontransgender lesbian, gay, and bisexual students appear to be at the highest risk for eating disorders (Diemer et al, 2015) while a common profile of an individual with an eating disorder is a female between the ages of 30 and 40 (Trace et al, 2013).</para></listitem>
<listitem><para>Both AN and BN can be present in the same individual.</para></listitem>
<listitem><para>Risk factors</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Personal characteristics: low self-esteem and feelings of helplessness</para></listitem>
<listitem><para>Social factors: popular cultural preferences, media images, peer pressure, occupational expectations, for example, model, dancer, athlete</para></listitem>
<listitem><para>Family structure: Theory suggests that girls who live in families that highly value perfection are at a greater risk for developing an eating disorder.</para></listitem>
<listitem><para>Presence of psychiatric comorbidities: anxiety, depression, addictive behavior, or impulse control disorders</para></listitem>
<listitem><para>Genetics: Family and twin studies reveal that addictive genetic factors account for approximately 40% to 60% of liability to anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED) (Trace et al, 2013). A newer study supports previous findings that the risk of developing an eating disorder may have a 50% to 80% genetic component (supporting data, Castellini et al, 2017).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>All disorders</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: At least up to 30 million Americans suffer from an eating disorder during their lifetime; 1 in 10 individuals with an eating disorder receives treatment (Anorexia Nervosa and Associated Disorders [ANAD], 2017).</para></listitem>
<listitem><para>Mortality: Eating disorders have the highest mortality rate of any mental illness with approximately one in five deaths being suicide (ANAD, 2017).</para></listitem>
<listitem><para>Cost: Inpatient treatment can range anywhere from $500 to $2000 a day, and the average cost for a 30-day stay in a treatment facility is $30,000. Patients often need from 3 to 6 months of inpatient care. Outpatient care, including medical monitoring and continuing therapy, can reach upward of $100,000 (<ulink url="PsychGuides.com">PsychGuides.com</ulink>, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para>AN</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: More common in girls and women, with a female-to-male ratio of 10 to 20:1 in developed countries (Bernstein, 2017); only about 50% of those affected will recover (Bernstein, 2017). Recovery also depends on the patient&rsquo;s body mass index (BMI) and his or her weight loss at presentation, as well as the duration of symptoms, duration of inpatient care, and state of family relationships (Kaplan et al, 2009).</para></listitem>
<listitem><para>Mortality: AN has the highest mortality rate among all psychological disorders with 20% of deaths attributed to suicide. Analysis of 36 quantitative studies published in 2011 reported that the standard mortality ratio (SMR) for AN is 5.86 (see <link linkend="ch0006s0179note0424">Glossary</link>) (ANAD, 2017; Arcelus et al, 2011). A recent study found that mortality was higher if psychiatric comorbidities were present (Kask et al, 2016). Cardiac complications are the most common physiological cause of death (about 10%) (Bernstein, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para>BN</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Recent studies suggest a female-to-male ratio of 10:1. In some populations (e.g., active duty military), body dissatisfaction and subclinical eating disorder rates among males have been reported to be in excess of 20% (Randhawa et al, 2016). A national study concluded that the lifetime comorbidity of BN with any psychiatric disorder (e.g., affective and anxiety disorders, substance abuse; impulse control disorders) is 94.5% (reported in Randhawa et al, 2016, with 14 accompanying relevant citations).</para></listitem>
<listitem><para>Mortality: Up to 3% eventually die of complications from the disease. The leading cause of death is suicide, which is more common in persons with BN than those with AN. SMR for BN is 1.93 (ANAD, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para>BED</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Most common eating disorder in the United States; 30% to 40% of those seeking weight loss treatments can be clinically diagnosed with binge eating disorder (Binge Eating Disorder Association [BEDA], 2016).</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0179note0424"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Abnormal involuntary movement scale (AIMS): </emphasis>System used to assess abnormal involuntary movements, such as hand tremors or rhythmic movements of the tongue and jaw, which may result from the long-term administration of psychotropic drugs.</para>
<para><emphasis role="strong">Electroconvulsive therapy (ECT): </emphasis>Use of an electric shock to produce convulsions and thereby treat drug-resistant psychiatric disorders, such as some cases of major depression, bipolar disorder, suicidal ideation, and schizophrenia.</para>
<para><emphasis role="strong">Family therapy: </emphasis>Focuses on the interdependent relationships within the family as a whole.</para>
<para><emphasis role="strong">Obsessive-compulsive disorder (OCD): </emphasis>Chronic anxiety disorder most commonly characterized by obsessive, distressing, intrusive thoughts and related compulsions.</para>
<para><emphasis role="strong">Osteopenia: </emphasis>Reduced bone mass of lesser severity than osteoporosis.</para>
<para><emphasis role="strong">Recovery environment: </emphasis>The individual in treatment and the supportive family members work together to create an environment in which all feel safe to express their feelings without judgment, criticism, or guilt.</para>
<para><emphasis role="strong">Refeeding syndrome (RFS): </emphasis>Severe electrolyte imbalances (principally potassium, magnesium, and phosphate) and metabolic abnormalities in undernourished individuals undergoing refeeding therapy, whether orally, enterally, or parenterally. RFS reflects the change from catabolic to anabolic metabolism (Crook, 2014).</para>
<para><emphasis role="strong">Standard mortality ratio (SMR): </emphasis>The ratio of observed deaths in the study group to expected deaths in the general population. Example: SMR for anorexia nervosa (AN) in 2011 was 5.86, where death occurred almost 60% more often in the study population with AN than the reference population without AN (Arcelus et al, 2011).</para>
<para><emphasis role="strong">Total parenteral nutrition (TPN): </emphasis>Nutritional therapy specifically designed to prevent or correct protein-calorie malnutrition, which is administered via an enteral or parenteral route.</para>
</note>
<sect2 id="ch0006s0180"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Acute care is provided through inpatient stay on a medical or behavioral unit and for correction of severe nutritional deficits and electrolyte imbalances or initial psychiatric stabilization. Individuals who are medically stable may begin therapy in a residential program. Long-term care is provided in an outpatient or day treatment program (partial hospitalization) or in the community.</para>
</sect2>
<sect2 id="ch0006s0181"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0047">Dysrhythmias</link></para>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para>Metabolic alkalosis&mdash;primary base bicarbonate excess (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0006s0219">Total nutritional support: parenteral/enteral feeding</link></para>
<table frame="top" id="ch0006s0179ta0241"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Disturbed sleep patterns&mdash;early morning insomnia, fatigue</para></listitem>
<listitem><para>Feeling &ldquo;hyper&rdquo; or anxious</para></listitem>
<listitem><para>Increased activity, avid exerciser, participation in high-energy sports</para></listitem>
<listitem><para>Employment in positions or professions that emphasize and require strict weight control, such as gymnasts, bodybuilders, and other athletes, jockeys, models, dancers, skaters, actors, wrestlers, flight attendants, and others for whom thinness is emphasized and overly rewarded</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Periods of hyperactivity, constant vigorous exercising (AN)</para></listitem>
<listitem><para>Psychomotor retardation (slowing of physical movement due to a slowing of brain activity [late-stage AN])</para></listitem>
<listitem><para>Generalized muscle weakness (most common neurologic symptom in AN) (Bernstein, 2017)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Feeling cold even when room is warm</para></listitem>
<listitem><para>Dizziness, lightheadedness (BN)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Low blood pressure (BP), orthostatic changes in BP or heart rate</para></listitem>
<listitem><para>Cold hands and feet (acrocyanosis)</para></listitem>
<listitem><para>Tachycardia, bradycardia, dysrhythmias</para></listitem>
<listitem><para>Resting heart rate often 30 to 40 bpm (severe AN) (Bernstein, 2017)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Lack of control over eating, for example, cannot stop eating or cannot control what or how much is eaten (BN)</para></listitem>
<listitem><para>Feeling disgusted with self, depressed, or very guilty because of overeating</para></listitem>
<listitem><para>Suppression of angry feelings</para></listitem>
<listitem><para>Distorted or unrealistic body image; reports self as fat regardless of weight (denial) and sees thin body as fat</para></listitem>
<listitem><para>Persistent overconcern with body shape and weight</para></listitem>
<listitem><para>Unrealistic pleasure in weight loss, while denying oneself pleasure in other areas</para></listitem>
<listitem><para>High self-expectations</para></listitem>
<listitem><para>Stress factors&mdash;family move, divorce, onset of puberty</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Emotional states of depression, withdrawal, anger, anxiety, pessimistic outlook</para></listitem>
<listitem><para>Flat affect</para></listitem>
<listitem><para>Psychiatric conditions, such as depression, anxiety, bipolar disorder, OCD</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Diarrhea or constipation</para></listitem>
<listitem><para>Laxative and diuretic abuse</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Constant hunger or denial of hunger; normal or exaggerated appetite that rarely vanishes until late in the disorder (AN)</para></listitem>
<listitem><para>Intense fear of gaining weight (females); may have prior history of being overweight (particularly males)</para></listitem>
<listitem><para>Preoccupation with food, such as calorie counting, gourmet cooking</para></listitem>
<listitem><para>Recurrent episodes of binge eating, a feeling of lack of control over behavior during eating binges, a minimum average of two binge-eating episodes a week for at least 3 months (BN)</para></listitem>
<listitem><para>Sore throat (BN)</para></listitem>
<listitem><para>Regularly engages in self-induced vomiting either independently or as a complication of anorexia, or strict dieting or fasting</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight loss and maintenance of body weight 15% or more below that expected; refusal to maintain body weight over minimal norm for age and height (AN)</para></listitem>
<listitem><para>No medical illness evident to account for weight loss</para></listitem>
<listitem><para>Cachectic appearance, skin may be dry, yellowish, pale, with poor turgor (AN)</para></listitem>
<listitem><para>Loss of muscle mass (AN)</para></listitem>
<listitem><para>Peripheral edema (AN, BN)</para></listitem>
<listitem><para>Preoccupation with food&mdash;calorie counting, hiding food, cutting food into small pieces, rearranging food on plate</para></listitem>
<listitem><para>Irrational thinking about eating, food, and weight</para></listitem>
<listitem><para>Weight may be normal or slightly above or below normal (BN)</para></listitem>
<listitem><para>Swollen salivary glands; sore, inflamed buccal cavity; swollen parotid and submandibular glands (AN, BN)</para></listitem>
<listitem><para>Vomiting, bloody vomitus (BN) (may indicate esophageal tearing&mdash;Mallory-Weiss syndrome)</para></listitem>
<listitem><para>Diminished intestinal motility</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">HYGIENE</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased hair growth on body (lanugo), hair thinning or loss (axillary, pubic), hair is dull, not shiny</para></listitem>
<listitem><para>Brittle nails</para></listitem>
<listitem><para>Erosion of tooth enamel, gums in poor condition, ulcerations of mucosa</para></listitem>
<listitem><para>Enlarged salivary glands; dry mouth; reddened, dry, cracked lips</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Appropriate affect (except in regard to body and eating) or depressive affect</para></listitem>
<listitem><para>Hysterical or obsessive personality style; absence of other psychiatric illness or thought disorder&mdash;although a significant number may show evidence of an affective disorder</para></listitem>
<listitem><para><emphasis role="bi">Mental changes:</emphasis> Apathy, confusion, memory impairment brought on by malnutrition or starvation</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Headaches</para></listitem>
<listitem><para>Sore throat or mouth</para></listitem>
<listitem><para>Vague abdominal pain and distress (more common in those who self-induce vomiting)</para></listitem>
<listitem><para>Bloating</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Body temperature below normal</para></listitem>
<listitem><para>Skin abrasions or scars (e.g., cutting, burning); other self-induced trauma</para></listitem>
<listitem><para>Eczema and other skin rashes; calluses on back of hands from sticking finger down throat to induce vomiting (BN)</para></listitem>
<listitem><para>Recurrent infectious processes (indicative of depressed immune system)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Absence of at least three consecutive menstrual cycles due to decreased levels of estrogen in response to malnutrition (AN)</para></listitem>
<listitem><para>Promiscuity or loss of sexual interest</para></listitem>
<listitem><para>History of sexual abuse</para></listitem>
<listitem><para>Heterosexual or member of LGBT community</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Amenorrhea occurs in up to 50% of women with BN (Randhawa et al, 2016)</para></listitem>
<listitem><para>Irregular periods; scanty periods</para></listitem>
<listitem><para>Breast atrophy</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SOCIAL INTERACTION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Middle-class or upper-class family background but increasingly noted in lower-income families</para></listitem>
<listitem><para>History of being a quiet, cooperative child/individual</para></listitem>
<listitem><para>Problems of control issues in relationships, difficult communications with others, especially authority figures</para></listitem>
<listitem><para>Poor communication within family of origin</para></listitem>
<listitem><para>Engagement in power struggles</para></listitem>
<listitem><para>An emotional crisis of some sort, such as divorce/separation, menopause, the onset of puberty, or an unwanted family move</para></listitem>
<listitem><para>Altered relationships or problems with relationships, withdrawal from friends and social contacts</para></listitem>
<listitem><para>Abusive family relationships</para></listitem>
<listitem><para>Sense of helplessness</para></listitem>
<listitem><para>History of legal difficulties&mdash;shoplifting, drug use</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Passive father, dominant mother</para></listitem>
<listitem><para>Family members closely fused</para></listitem>
<listitem><para>Togetherness prized</para></listitem>
<listitem><para>Personal boundaries not respected</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of higher than normal incidence of depression</para></listitem>
<listitem><para>Other family members with eating disorders (genetic predisposition)</para></listitem>
<listitem><para>Health beliefs and practice&mdash;certain foods have &ldquo;too many&rdquo; calories, use of &ldquo;health&rdquo; foods, and so forth</para></listitem>
<listitem><para>Substance abuse</para></listitem>
<listitem><para>Use of herbal or over-the-counter (OTC) preparations to control weight gain, such as bitter orange, green tea extract, guarana, rhodiola, laxatives (bisacodyl, cascara, senna), high-fiber supplements</para></listitem>
<listitem><para>Use of prescription diet medications&mdash;Meridia, phenteramine, Xenical (often obtained without prescription via Internet)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Assistance with maintenance of treatment plan</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0179ta0242"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests that typically include hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; white blood cell (WBC) count and differential.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines presence of anemia (not due to blood loss). WBCs are reduced (leukopenia) due to margination; lymphocytes are increased (lymphocytosis). Platelets show significantly less than normal activity (thrombocytopenia). Hgb may be elevated in extreme dehydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Basic metabolic profile (BMP):</emphasis> Provides baseline data and can be used to evaluate and monitor fluid and electrolyte balance.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolyte imbalances are secondary to vomiting and potassium is most often affected. Other imbalances include disturbances of sodium, chloride, calcium, magnesium, and phosphorus (AN). Hypokalemia and hypochloremic metabolic alkalosis are observed with vomiting; metabolic acidosis is possible in cases of laxative abuse (BN). Hyponatremia may be a result of excess water intake (AN). May show elevated bicarbonate levels. In AN, hypoglycemia is often present because of lack of carbohydrates in the diet or low glycogen levels in the liver. Blood urea nitrogen (BUN) and creatinine (Cr) may be normal or low. BUN may be elevated (AN) or if severe dehydration is present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Erythrocyte sedimentation rate (ESR):</emphasis> Helps exclude unrecognized chronic medical conditions.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>ESR is normal in AN; therefore, elevations may indicate anorexia associated with an organic condition (e.g., steroid-induced anorexia nervosa in adolescent with systemic lupus erythematosus [SLE]) (Bernstein, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Amylase:</emphasis> Digestive enzyme primarily located in pancreas and salivary glands.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated in up to 30% of clients in presence of significant vomiting; reflects hypersecretion of the salivary glands (Randhawa et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Aspartate aminotransferase/alanine aminotransferase (AST/ALT), aluminum phosphide (ALP), total bilirubin, and direct bilirubin:</emphasis> Liver function tests to determine associated impairment or damage and gallbladder involvement.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Liver function studies may be minimally elevated (AN). In severe starvation states, AST/ALT levels are elevated. In BN, liver function tests are usually normal, although amylase may be elevated because of vomiting (Randhawa et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides:</emphasis> Types of lipids.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dramatic elevations in cholesterol are observed in cases of AN starvation. This elevation may be secondary to (1) decrease in triiodothyronine (T<subscript>3</subscript>) levels, (2) low cholesterol-binding globulin, and (3) leakage of intrahepatic cholesterol.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">T<subscript>3</subscript>, thyroxine (T<subscript>4</subscript>), and reverse T<subscript>3</subscript>:</emphasis> Thyroid function tests.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>T<subscript>4</subscript> and T<subscript>3</subscript> levels may be low; reverse T<subscript>3</subscript> increased, in AN, reflecting euthyroid sick syndrome.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Pituitary function:</emphasis> Propranolol-glucagon stimulation test studies the response of human growth hormone (hGH).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Depressed in AN. Gonadotropic hypofunction is noted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Estrogen and luteinizing hormone (LH) secretions test: </emphasis>Produced by the anterior lobe of the pituitary gland that stimulates ovulation and the development of the corpus luteum in females and the production of testosterone by the interstitial cells of the testis in males.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pattern often resembles those of prepubertal girls.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ASSOCIATED STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urinalysis</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ketones in the urine represent starvation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Fecal occult blood:</emphasis> Identifies associated gastrointestinal (GI) complications.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positive result may indicate esophagitis, gastritis (BN), or repeated colon irritation from laxative use (AN, BN).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> Record of the electrical activity of the heart.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abnormal tracing with low-voltage, T-wave inversion, prolonged QT interval, bradycardia, and dysrhythmias may be present, reflecting electrolyte imbalances. <emphasis>Note:</emphasis> In AN (and severe BN), frequency of rhythm disturbances is concerning, especially Q-T interval prolongation that may be an indication for risk of cardiac dysrhythmias and sudden death (Bernstein, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray or computed tomography (CT) scan:</emphasis> Determine presence of associated complications.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reveal rib fractures associated with repeated vomiting in presence of hypocalcemia and/or osteopenia. Heart size may be decreased.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Bone density scans, e.g., DEXA (dual-energy x-ray absorptiometry) scan:</emphasis> Measures bone density and is used to assess risk for fracture.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May reveal osteopenia (see <link linkend="ch0006s0179note0424">Glossary</link>) associated with lack of/malabsorption of nutrients, vitamins, minerals.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0182"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Obtain client&rsquo;s cooperation for treatment.</para></listitem>
<listitem><para>Reestablish adequate, appropriate nutritional intake.</para></listitem>
<listitem><para>Correct fluid and electrolyte imbalance.</para></listitem>
<listitem><para>Assist client to develop realistic body image and improve self-esteem.</para></listitem>
<listitem><para>Provide support and involve significant other (SO), if available, in treatment program.</para></listitem>
<listitem><para>Coordinate total treatment program with other disciplines.</para></listitem>
<listitem><para>Provide information about disease, prognosis, and treatment to client and SO.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0183"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Adequate nutrition and fluid intake maintained.</para></listitem>
<listitem><para>Maladaptive coping behaviors and stressors that precipitate anxiety recognized.</para></listitem>
<listitem><para>Adaptive coping strategies and techniques for anxiety reduction and self-control implemented.</para></listitem>
<listitem><para>Self-esteem increased.</para></listitem>
<listitem><para>Disease process, prognosis, and treatment regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<para>*** Because this condition spans a wide age range from children to the elderly, interventions presented here need to be adjusted for age-appropriateness.</para>
<note id="ch0006s0179note0425">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective child/adolescent Eating Dynamics</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Disordered eating habits; eating in isolation; eating disorder</para>
<para>Ineffective coping strategies; anxious/insecure parent-child relationship; abuse</para>
<para>Changes to self-esteem upon entering puberty</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Poor appetite/under eating; avoids participation in regular mealtimes; food refusal (AN)</para>
<para>Overeating; frequently eating processed/poor quality food (BN)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Eating Disorder-Self Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Eat regularly scheduled meals with family.</para>
<para><emphasis role="strong">Knowledge: Eating Disorder Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Follow dietary plan.</para>
<para>Acknowledge significance of health status appropriate for age and developmental level.</para>
</note>
<note role="none" id="ch0006s0179note0426">
<table frame="top" id="ch0006s0179ta0243"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Eating Disorders Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish a minimum weight goal and daily nutritional/metabolic requirements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides comparative baseline for effectiveness of therapy. <emphasis>Note:</emphasis> Malnutrition is a mood-altering condition, leading to depression and affecting cognitive function and decision making. Improved nutritional status enhances thinking ability, allowing initiation of psychological work.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Implement structured meal plans and schedule times for eating. Involve child in menu planning.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Like medication, nutrition prescriptions include a minimum of three meals and two to three snacks per day. Sets clear expectations parent and child while encouraging child to participate in decision-making process (Ekern, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide food choices within reason (e.g., apple with peanut butter, cheese and crackers).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides some sense of control for the child while still meeting nutrition needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review parents&rsquo; eating and exercise habits and provide nutritional education as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Parents need to set good example with healthy eating and exercise patterns.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate with registered dietitian to create a focused nutritional prescription and educational plan for client/family.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in developing medical nutritional therapeutic plan with goal of stabilizing medical condition and promoting self-management training (Ekern, 2012). (Refer to ND, <link linkend="ch0006s0179note0427">imbalanced Nutrition: less than body</link> requirements following.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide dietary supplements or tube feedings as indicated during acute/intensive treatment programs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Child&rsquo;s refusal to eat solids necessitates liquid supplement diet while refusal of food and supplements requires NG tube feedings (Ekern, 2014).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Engage in family-based therapy (FBT).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Family-based interventions are most effective in younger children with parents taking charge of nutrition decisions and gaining skills in meal support, management of food avoidant behaviors, and anxiety (Ekern, 2014). FBT also empowers parents to renegotiate the relationship with their child, focusing on issues other than food and assisting the child to resume normal adolescent development (Lock et al, 2005).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0427">
<title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient dietary intake; inability to digest food or absorb nutrients (self-induced vomiting)</para>
<para>Psychological disorder (distorted view of body&mdash;see&rsquo;s self as fat [AN/BN], fear of gaining weight; deceptive behaviors relating to food; frequent trips to bathroom after eating [BN])</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Food intake less than recommended daily allowance; food aversion; insufficient interest in food; satiety immediately upon ingesting food (AN)</para>
<para>Body weight 20% or more below ideal weight range (AN); [fluctuations in weight] (BN)</para>
<para>Capillary fragility; pale mucous membranes, insufficient muscle tone; excessive hair loss (AN)</para>
<para>Sore buccal cavity (BN)</para>
<para>Diarrhea (AN/BN)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Eating Disorder-Self Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of nutritional needs.</para>
<para>Establish a dietary pattern with caloric intake adequate to regain or maintain appropriate weight.</para>
<para>Demonstrate weight gain toward individually expected range.</para>
</note>
<note role="none" id="ch0006s0179note0428">
<table frame="top" id="ch0006s0179ta0244"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Eating Disorders Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Establish a minimum weight goal and daily nutritional/metabolic requirements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides comparative baseline for effectiveness of therapy. <emphasis>Note:</emphasis> Malnutrition is a mood-altering condition, leading to depression and affecting cognitive function and decision making. Improved nutritional status enhances thinking ability, allowing initiation of psychological work.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Contract with client regarding commitment to therapeutic program and meeting specific dietary needs and goals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individual success is enhanced when client commits to a contract.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Use a consistent approach. Sit with client while eating; present and remove food without persuasion or comment. Promote pleasant environment and record intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client detects urgency and may react to pressure. Any comment that might be seen as coercion provides focus on food. When staff responds in a consistent manner, client can begin to trust staff responses. The single area in which client has exercised power and control is food and eating, and she or he may experience guilt or rebellion if forced to eat. Structuring meals and decreasing discussions about food will decrease power struggles with client and avoid manipulative games.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide small, frequent, and nutritionally dense meals and supplemental snacks, as appropriate. Attempt to increase daily caloric intake slowly by 200 to 300 kcal every 3 to 5 days.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gastric dilation may occur if refeeding is too rapid following a period of starvation dieting. Client may feel bloated for weeks while body adjusts to increased food intake. <emphasis>Note: </emphasis>Client is at risk for developing refeeding syndrome (RFS). Research suggests that introducing more calories more quickly with a goal of weight gain 2 to 3 lb/wk has better results (Krans, 2013; MacCormick, 2013; Redgrave et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Make selective menu available, and allow client to control choices as much as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client who gains confidence in self and feels in control of environment is more likely to eat preferred foods.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be alert to choices of low-calorie foods and beverages, hoarding food, and disposing of food in various places, such as pockets or wastebaskets.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client will try to avoid taking in what is viewed as excessive calories and may go to great lengths to avoid eating.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain a regular weighing schedule, such as Monday and Friday before breakfast in same attire, and graph results.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides accurate ongoing record of weight loss or gain. Also diminishes obsessing about changes in weight.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh with back to scale, depending on program protocols.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although some programs prefer that client does not see the results of the weighing, this can force the issue of trust in client who usually does not trust others.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Avoid room checks and other control devices whenever possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>External control reinforces feelings of powerlessness and therefore is usually not helpful.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide one-to-one supervision and have client with bulimia remain in the day room area or in sight with no bathroom privileges for a specified period, such as 2 to 3 hours, following eating if contracting is unsuccessful.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents vomiting during or immediately after eating. Client may desire food and eating but uses a binge-purge syndrome to control weight. <emphasis>Note:</emphasis> Some clients purge for the first time in response to establishment of a weight-gain program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor exercise program and set limits on physical activities. Chart activity and level of work&mdash;pacing and so on.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Moderate exercise helps in maintaining muscle tone and combating depression; however, client may exercise excessively to burn calories.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain matter-of-fact, nonjudgmental attitude if giving tube feedings, parenteral fluids, and so on.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Perception of punishment is counterproductive to client&rsquo;s self-confidence and faith in own ability to control destiny.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be alert to possibility of client disconnecting feeding tube and emptying enteral or parenteral fluids if used. Check measurements and tape tubing snugly.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sabotage behavior is common in attempt to prevent weight gain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor for signs of refeeding syndrome reflecting fluid and electrolyte disorders, increased cardiac workload, and oxygen consumption.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refeeding syndrome and congestive heart failure can occur because of too rapid an increase in oral intake. Heart size diminishes because of malnutrition and may have a difficult time compensating for an increase in circulating volume (Redgrave et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Perform a comprehensive nutritional assessment at the earliest possible time after emergency conditions are resolved.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assessing nutritional intake for all patients (even those with &ldquo;normal&rdquo; body weight BMI) is important because weight per se does not always correlate with appropriate nutritional intake or normal body composition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide nutritional therapy within a hospital treatment program, as indicated when condition is life-threatening.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cure of the underlying problem cannot happen without improved nutritional status. Hospitalization provides a controlled environment in which food intake, vomiting, elimination, medications, and activities can be monitored. It also separates client from SO, who may be a contributing factor, and provides exposure to others with the same problem, creating an atmosphere for sharing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Involve client in setting up and carrying out program of behavior modification. Provide reward for weight gain as individually determined; ignore loss.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides structured eating situation while allowing client some control in choices. Behavior modification may be effective in mild cases or for short-term weight gain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer nutritional diet by prescribed means&mdash;regular food with supplements, high-calorie liquid diet, or tube feedings if needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When caloric intake is insufficient to sustain metabolic needs, nutritional support can be used to prevent malnutrition and death while therapy is continuing. Tube feeding is most often initiated on an inpatient basis when the person with anorexia&rsquo;s weight is at or less than 85% of expected weight and/or less than the third percentile for BMI (Bernstein, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Blenderize anything left on the tray after a given period of time and tube-feed, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This method of feeding may be used as part of a behavior modification program to provide total intake of needed calories.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer enteral or parenteral nutrition, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>TPN, or hyperalimentation, may be required for life-threatening situations; however, enteral feedings are preferred because they preserve GI function and reduce atrophy of the gut.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Avoid giving laxatives.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use is counterproductive because they may be used by client to rid body of food or calories.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medication, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vitamins, minerals, electrolytes</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In AN, medication is usually limited to use in managing medical complications, such as calcium and vitamin D for osteopenia (which can be severe), potassium, magnesium, and phosphorus. Restoring electrolytes before refeeding reduces the risk of refeeding syndrome (Bernstein, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serotonin and histamine antagonist, such as cyproheptadine (Periactin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>While there are no drugs formulated to treat anorexia (Krans, 2013), some drugs may be used for client with severe anorexia without binging and purging. A serotonin and histamine antagonist may be used in high doses to stimulate the appetite, decrease preoccupation with food, and combat depression. Does not appear to have serious side effects, although decreased mental alertness may occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine (Prozac) and other antidepressants, such as tricyclics, for example, amitriptyline (Elavil) and imipramine (Tofranil); dopamine reuptake blocker, such as bupropion (Wellbutrin); 5-HT2 blocker, such as trazadone (Desryel)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Various antidepressants may be used to lift depression, stimulate appetite, and stabilize AN. Many of these same drugs are also found to be useful in reducing binge-purge cycles in BN.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monoamine oxidase inhibitors (MAOIs), such as phenelzine (Nardil) and tranylcypromine sulfate (Parnate)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used to treat depression when other drug therapy is ineffective; decreases urge to binge in BN.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antipsychotic drugs, such as risperadone (Risperdal), olanzapine (Zyprexa), chlorpromazine (Thorazine), and lithium (Eskalith, Lithane, Lithobid)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Newer antipsychotic drugs, such as Risperdal or Zyprexa, are being used to manage eating disorders, especially in the presence of dual disorder, such as with bulimia and bipolar disorder. These drugs can reduce tension, anxiety, and nervousness and increase cooperation with psychotherapeutic program. However, some antipsychotic drugs are used only when absolutely necessary for severely delusional, overactive, hospitalized client as a last resort (e.g., Thorazine). Possibility of extrapyramidal side effects is a concern.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor electrolytes, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refeeding syndrome may develop with rapid decrease in potassium, magnesium, and phosphate levels.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for or assist with electroconvulsive therapy (ECT), if indicated. Discuss reasons for use and help client understand this is not punishment.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>In rare and difficult cases in which malnutrition is severe or life-threatening, a short-term ECT series may enable client to begin eating and become accessible to psychotherapy.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0429">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient intake; insufficient knowledge about fluid needs</para>
<para>Extremes of weight</para>
<para>Excessive fluid loss through normal route (vomiting)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Hydration</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain fluid balance at a functional level, as evidenced by adequate urine output, stable vital signs, moist mucous membranes, and good skin turgor.</para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of causative factors and behaviors necessary to maintain or correct fluid balance.</para>
</note>
<note role="none" id="ch0006s0179note0430">
<table frame="top" id="ch0006s0179ta0245"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs, capillary refill, status of mucous membranes, and skin turgor.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of adequacy of circulating volume. Orthostatic hypotension may occur with risk of falls and injury following sudden changes in position.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor amount and types of fluid intake. Measure urine output accurately.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may abstain from all intake, with resulting dehydration, or substitute fluids for caloric intake, disturbing electrolyte balance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss strategies to stop vomiting and laxative or diuretic use.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helping client deal with the feelings that lead to vomiting and laxative or diuretic use will prevent continued fluid loss. <emphasis>Note:</emphasis> Client with bulimia has learned that vomiting provides a release of anxiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify actions necessary to regain or maintain optimal fluid balance, such as specific fluid intake schedule.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involving client in plan to correct fluid imbalances improves chances for success.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review electrolyte and renal function test results.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid and electrolyte shifts or depressed renal function can adversely affect cerebral function and client&rsquo;s recovery, requiring correction before therapeutic interventions can begin.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer intravenous (IV) fluids and electrolytes, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Used to correct fluid and electrolyte imbalances and prevent cardiac dysrhythmias.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0431">
<title><emphasis role="strong">NURSING DIAGNOSIS: disturbed Body Image</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Alteration in self-perception (morbid fear of obesity)</para>
<para>Alteration in cognitive functioning (perceived loss of control in some aspect of life)</para>
<para>Impaired psychosocial functioning</para>
<para>Cultural incongruence</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Behavior of monitoring one&rsquo;s body; refusal to acknowledge change</para>
<para>Alteration in view of one&rsquo;s body; negative feeling about body</para>
<para>Change in social involvement; fear of rejection by others</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Body Image</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Establish a more realistic internal picture of self.</para>
<para>Engage in strategies to enhance appearance.</para>
<para>Verbalize acceptance of positive feedback about self.</para>
</note>
<note role="none" id="ch0006s0179note0432">
<table frame="top" id="ch0006s0179ta0246"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Body Image Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Have client draw picture of self.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity to discuss client&rsquo;s perception of self and body image, and realities of individual situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Listen to but avoid challenging irrational or illogical thinking. Present reality concisely and briefly.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is difficult to respond logically when thinking ability is physiologically impaired. Client needs to hear reality, but challenging client leads to distrust and frustration. <emphasis>Note:</emphasis> Even though client may gain weight, she or he may continue to struggle with attitudes and behaviors typical of eating disorders, major depression, and substance dependence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involve in personal development program, preferably in a group setting. Provide information about proper application of makeup and grooming.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Learning about methods to enhance personal appearance may be helpful to long-range sense of self-esteem and image. Feedback from others can promote feelings of self-worth.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend consultation with an image consultant.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positive image enhances sense of self-esteem.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest disposing of &ldquo;thin&rdquo; clothes as weight gain occurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides incentive to at least maintain and not lose weight. Not seeing &ldquo;thin&rdquo; clothes removes visual reminder of thinner self.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Assist client to confront changes associated with puberty and sexual fears. Provide sex education as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Major physical and psychological changes in adolescence can contribute to development of eating disorders. Feelings of powerlessness and loss of control of feelings, in particular sexual sensations, can lead to an unconscious desire to desexualize self. Client often believes that these fears can be overcome by taking control of bodily appearance, development, and function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note athletic activities, as well as excessive/compulsive exercise. Discuss menstrual problems (e.g., amenorrhea).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>There is a similar risk for eating disorders in athletes as in nonathletes (Greenleaf et al, 2010; Petrie et al, 2007), but there is a higher level of menstrual dysfunction in athletes (Coelho et al, 2014; Sundgot-Borgen &amp; Torstveit, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note body image concerns in men such as muscle dysmorphia, drive for masculinity, low testosterone, and bone loss. Encourage client to take control of activities, avoid overtraining/excessive exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Males may be preoccupied with increased muscle mass, be dissatisfied with body, and need to learn to focus on a healthy body image without the need to be muscle-bound or a super-athlete (Ekern, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Encourage age-appropriate responsibilities and social behaviors for adolescent males.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists client in developing age-appropriate autonomy and transitioning from boyhood to adulthood in ways other than focusing on food (Ekern, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage participation in directed activities such as group hiking, bicycle tours, and wilderness adventures, such as the Outward Bound program.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although exercise is often used negatively by these clients, participation in directed activities provides an opportunity to learn self-reliance, enhance self-concept, and realize that food is the fuel required by the body to do its work. Athletes, especially, may need to moderate their exercise in order to maintain their training levels, while avoiding overtraining.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to therapist trained in dealing with sexuality, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May need professional assistance to deal with sexuality issues and accept self as a sexual individual.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0433">
<title><emphasis role="strong">NURSING DIAGNOSIS: chronic low Self-Esteem</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inadequate group membership/belonging; receiving insufficient respect/approval from others</para>
<para>Cultural incongruence</para>
<para>Repeated negative reinforcement</para>
<para>Psychiatric disorder; depression</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dependent on others&rsquo; opinions</para>
<para>Exaggerates negative feedback about self; rejection of positive feedback</para>
<para>Indecisive behavior; overly conforming; passivity</para>
<para>Guilt, shame</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Esteem</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Acknowledge self as an individual.</para>
<para>Accept responsibility for own actions.</para>
<para>Verbalize positive feelings about own self-worth.</para>
</note>
<note role="none" id="ch0006s0179note0434">
<table frame="top" id="ch0006s0179ta0247"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Self-Esteem Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish a therapeutic nurse-client relationship.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Within a helping relationship, client can begin to trust and try out new thinking and behaviors.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Listen with regard when client speaks.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sets an example and provides a sense of competence and self-worth in that client has been heard and attended to.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be aware of client&rsquo;s distorted thinking ability.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows care providers to have more realistic expectations of client and provide appropriate information and support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote self-concept without moral judgment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client sees self as weak-willed even though part of person may feel sense of power and control, for example, through dieting and weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>State rules clearly regarding weighing schedule, remaining in sight during medication and eating times, and consequences of not following the rules. Involve client in establishing rules and consequences.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consistency is important in establishing trust. Client is invested in decisions and as part of the behavior modification program, knows risks involved in not following established rules (e.g., decrease in privileges). Failure to follow rules is viewed as client&rsquo;s choice and accepted by staff in matter-of-fact manner so as not to provide reinforcement for the undesirable behavior.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Without undue comment, be consistent in carrying out rules.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may be denying the psychological aspects of own situation and is often expressing a sense of inadequacy and depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Confront denial and respond with reality when client makes unrealistic statements such as &ldquo;I&rsquo;m gaining weight, so there&rsquo;s nothing really wrong with me.&rdquo;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Feelings of disgust, hostility, and infuriation are not uncommon when caring for these clients. Prognosis often remains poor even with a gain in weight because other problems may remain. Many clients continue to see themselves as fat, and there is also a high incidence of affective disorders, social phobias, obsessive-compulsive symptoms, drug abuse, and psychosexual dysfunction. Nurse needs to deal with own feelings so they do not interfere with care of client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be aware of own reaction to client&rsquo;s behavior. Avoid arguing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Feelings of personal ineffectiveness, low self-esteem, and perfectionism are often part of the problem. Client feels helpless to change and requires assistance to problem-solve methods of control in life situations.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client to assume control in areas other than dieting and weight loss, such as management of own daily activities and work and leisure choices.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client needs to recognize ability to control other areas in life and may need to learn problem-solving skills to achieve this control. Setting realistic goals fosters success.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help client formulate goals for self not related to eating and create a manageable plan for reaching those goals, one at a time, progressing from simple to more complex.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May have feelings of isolation and fear of rejection and judgment by others.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note client&rsquo;s withdrawal from or discomfort in social settings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoidance of social situations and contact with others can compound feelings of worthlessness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to take charge of own life in a more healthful way by making own decisions and accepting self as she or he is at this moment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client often does not know what she or he may want for self. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Parents, generally mother, often make decisions for client. Client may also believe she or he has to be the best in everything and holds self responsible for being perfect.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Let client know that it is acceptable to be different from family, particularly mother.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Developing a sense of identity separate from family and maintaining sense of control in other ways besides dieting and weight loss is a desirable goal of therapy and program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to express anger and acknowledge when it is verbalized.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Important to know that anger is part of self and as such is acceptable. Expressing anger may need to be taught to client because anger is generally considered unacceptable in the family, and therefore client does not express it.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client to learn strategies other than eating for dealing with feelings. Have client keep a diary of feelings, particularly when thinking about food.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Feelings are the underlying issue, and client often uses food instead of dealing with feelings appropriately. Client needs to learn to recognize feelings and how to express them clearly.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess feelings of helplessness and hopelessness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lack of control is a common and underlying problem for this client and may be accompanied by more serious emotional disorders.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be alert to suicidal ideation and behavior.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Intense anxiety and panic about weight gain, depression, and hopeless feelings may lead to suicidal attempts, particularly if client is impulsive.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use cognitive-behavioral or interpersonal psychotherapy approach rather than interpretive therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although both therapies have similar results, cognitive-behavioral seems to work more quickly. Interaction between individuals is more helpful for client to discover feelings, impulses, and needs from within own self. Client has not learned this internal control as a child and may not be able to interpret or attach meaning to behavior.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involve in group therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides an opportunity to talk about feelings and try out new behaviors. Also helpful to hear what other participants say about their problems in dealing with illness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refer to occupational and recreational therapy, including animal/equine activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can develop interest and skills to fill time that has been occupied by obsession with eating. Involvement in recreational activities encourages social interactions with others and promotes fun and relaxation. Animal therapy assists client to develop self-awareness, better relationships, and improve nonverbal communication skills.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Engage in eye movement desensitization and reprocessing (EMDR) therapy as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some clients have a history of traumatic event/abuse and controlling eating behavior has become an unhealthy coping mechanism. Recovery can be delayed or unsuccessful if underlying trauma not addressed. EMDR was originally developed to treat posttraumatic stress disorder (PTSD) but has also been found to be effective in the treatment of anxiety disorders, depression, and addictive behavior problems (Ekern, 2016).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to therapist trained in dealing with sexuality, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Adult may need help to address life changes (e.g., divorce, menopause), <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> and adolescent may need professional assistance to deal with sexuality issues and accept self as a sexual adult.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0435">
<title><emphasis role="strong">NURSING DIAGNOSIS: readiness for enhanced family Coping</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Expresses desire to acknowledge growth impact of crisis</para>
<para>Expresses desire to enhance health promotion</para>
<para>Expresses desire to choose experiences that optimize wellness</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Family Will</emphasis></para>
<para><emphasis role="strong">Family Coping</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate individual involvement in problem-solving process directed at encouraging client well-being.</para>
<para>Express feelings and emotions appropriately among members.</para>
<para>Demonstrate acceptance and loving toward client.</para>
<para><emphasis role="strong">Family Support During Treatment</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Collaborate with client in determining care/health goals.</para>
<para>Use available resources appropriately.</para>
<para>Report feelings of self-confidence and satisfaction with plan developed.</para>
</note>
<note role="none" id="ch0006s0179note0436">
<table frame="top" id="ch0006s0179ta0248"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Family Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe communication among family members/with SO and identify patterns of interaction. Encourage each family member to speak for self, preventing two members discussing a third without that member&rsquo;s participation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides clues to difficulties that individuals may have in expressing themselves effectively. <emphasis>Note:</emphasis> In the enmeshed, overinvolved family members often speak for each other and need to learn to be responsible for their own words and actions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Listen to expression of hope, planning, and effect on relationships and life.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beginning to plan for future with hope promotes changes in relationships that can support growth.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify cultural or religious practices/health beliefs and expectations that may impact family members&rsquo; interactions with client and dealing with condition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Preconceived biases may interfere with treatment efforts toward positive growth and resolution of condition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discourage members from asking for approval from each other. Be alert to verbal or nonverbal checking with others for approval. Acknowledge competent actions of client and family members/SO.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Each individual needs to develop own internal sense of self-esteem. Client often is living up to others&rsquo; (family&rsquo;s/SO&rsquo;s) expectations rather than making own choices. Acknowledgment provides recognition of self in positive ways.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Communicate message of separation&mdash;that it is acceptable for family members to be different from each other.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individuation needs reinforcement. Such a message confronts rigidity and opens options for different behaviors.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage and allow expression of feelings, such as crying or anger by individuals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Often these families have not allowed free expression of feelings and need help and permission to learn and accept this. In adult clients, this provides the SO/partner opportunity to express how condition is affecting their relationship and begin healing process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Reinforce importance of parents as a couple who have rights of their own.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The focus on the child with anorexia is very intense and often is the only area around which the couple interacts. The couple needs to explore their own relationship and restore the balance within relationship to help prevent its disintegration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Prevent client from intervening in conflicts between parents. Assist parents in identifying and solving their issues.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Triangulation occurs in which a parent-child coalition exists. Sometimes the child is openly pressed to ally self with one parent against the other. The symptom (anorexia) is the regulator in the family system, and the parents deny their own conflicts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be aware and confront sabotage behavior on the part of family members/SO.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Feelings of blame, shame, and helplessness may lead to unconscious behavior designed to maintain the status quo.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to community resources, such as:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Age-appropriate family therapy (e.g., family-based therapy [FBT], Uniting Couples Against Anorexia Nervosa) [UCAN]) (Trace et al, 2013)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Eating disorders are not caused by families but are a family problem. Family therapy such as FBT for adolescents or UCAN for adults focuses on developing a recovery environment in which family members work together to create a safe, growth-promoting environment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Parents&rsquo; groups, parent effectiveness classes</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May help reduce overprotectiveness, and support and facilitate the process of dealing with unresolved conflicts and change.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Family therapy groups, as indicated</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide a forum for families to talk about their concerns and misconceptions, learning from others. As family members gain knowledge, they can use it to learn new skills of communication and encouragement, instead of using emotion.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0437">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Skin Integrity</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inadequate nutrition [e.g., emaciation; obesity]; alteration in fluid volume [including presence of edema]; alteration in metabolism</para>
<para>Alteration in skin turgor; impaired circulation; pressure over bony prominences</para>
<para>[Immunological factors]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of causative factors and absence of itching.</para>
<para>Identify and demonstrate behaviors to maintain soft, supple, intact skin.</para>
</note>
<note role="none" id="ch0006s0179note0438">
<table frame="top" id="ch0006s0179ta0249"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Skin Surveillance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for reddened, blanched, and excoriated areas.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of increased risk of breakdown, requiring more intensive treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage bathing every other day instead of daily if this is an area of concern.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Frequent baths contribute to dryness of the skin.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use skin cream twice a day and after bathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lubricates skin and decreases itching.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Massage skin gently.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves circulation to the skin and enhances skin tone.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss importance of frequent position changes and need for remaining active.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances circulation and perfusion to skin by preventing prolonged pressure on tissues.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of adequate nutrition and fluid intake. (Refer to ND: <link linkend="ch0006s0179note0427">imbalanced Nutrition: less than body requirements</link>.)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Improved nutrition and hydration will improve skin condition.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0439">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Decisional conflict; powerlessness; family conflict</para>
<para>Difficulty managing complex treatment regimen</para>
<para>Insufficient knowledge; perceived seriousness of condition/benefits</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Failure to include treatment regimen in daily living</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>[Absence of interest in improving health behaviors]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Eating Disorder Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize plan for lifestyle changes to maintain healthy weight.</para>
<para>Identify relationship of signs and symptoms, such as weight loss and tooth decay, to behaviors of not eating or binging-purging.</para>
<para>Identify strategies to prevent relapse.</para>
<para>Establish realistic exercise/activity program.</para>
<para>Assume responsibility for own learning.</para>
<para>Seek out sources and resources to assist with making identified changes.</para>
</note>
<note role="none" id="ch0006s0179note0440">
<table frame="top" id="ch0006s0179ta0250"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Learning Facilitation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine level of knowledge and readiness to learn.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Learning is easier when it begins where the learner is.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note blocks to learning, including physical, intellectual, and emotional issues.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Malnutrition, family problems, drug abuse, affective disorders, and obsessive-compulsive symptoms can be blocks to learning requiring resolution before effective learning can occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss familial tendencies and genetic risk for eating disorder.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recent research supports the findings suggesting that anorexia and bulimia are disorders that occur in families; for example, this client is more likely to have an immediate family member or even a more distant relative with either disorder. The disease may be inheritable with single or multiple genes combined with environmental factors and traits such as perfectionism, maturity fears, and low self-esteem (Balik et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide written information for client and SOs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helpful as reminder of and reinforcement for learning.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss consequences of behavior and potential for recovery and relapse.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sudden death can occur because of electrolyte imbalances and suppression of the immune system. Liver damage may result from protein deficiency, or gastric rupture may follow binge eating and vomiting.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review dietary needs, answering questions as indicated. Encourage inclusion of high-fiber foods and adequate fluid intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client and family may need assistance with planning for new way of eating. Constipation may occur when laxative use is curtailed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage the use of relaxation and other stress management techniques, such as visualization, guided imagery, and biofeedback.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>New ways of coping with feelings of anxiety and fear help client manage these feelings in more effective ways, assisting in giving up maladaptive behaviors of not eating or binging-purging.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with establishing a sensible exercise program. Caution regarding overexercise. Modify sports workouts if necessary and use coach-athletic relationship.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Exercise can assist with developing a positive body image and combats depression&mdash;release of endorphins in the brain enhances sense of well-being. However, client may use excessive exercise as a way to control weight. <emphasis>Note:</emphasis> It may not be helpful to remove from sports, especially if there is a positive coach-athlete relationship. Sports might be individual&rsquo;s identity and can be maintained unless client is noncompliant with treatment regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss need for information about sex and sexuality.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because avoidance of own sexuality is an issue for this client, realistic information can be helpful in beginning to deal with self as a sexual being.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to National Association of Anorexia Nervosa and Associated Disorders, Overeaters Anonymous, and other local resources, as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be a helpful source of support and information for client and SO.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0179note0441">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for imbalanced Nutrition: less than body requirements</emphasis>&mdash;psychological factors (dysfunctional eating patterns)</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, perceived seriousness/benefits, excessive demands made on individual, family conflict</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0184"><title><emphasis role="strong">OBESITY</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>A chronic accumulation of excess body fat, at least 20% over average desired weight for age, sex, and height, or a body mass index (BMI) greater than 30 for persons of either sex</para></listitem>
<listitem><para>Negatively impacts all body systems and increases risk of multiple physical and psychological pathologies, including hypertension, heart disease, stroke, diabetes, chronic kidney disease, cancers, arthritis, sleep apnea, depression and anxiety disorders, difficulty maintaining personal relationships, prejudice and discrimination, and limited access to public conveniences</para></listitem>
<listitem><para>Considered a chronic relapsing progressive disease process by the World Obesity Federation (2017), emphasizing need for immediate action for prevention and control of the global epidemic</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Causes are multiple, complex, and cannot be attributed simply to a disorder of willpower or the result of insufficient exercise</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Variations in metabolism, body fat distribution, and appetite regulation can be attributed to genetic factors.</para>
</listitem></orderedlist></listitem>
<listitem><para>Physiological factors</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Lesions in the hypothalamus&mdash;appetite and satiety centers</para></listitem>
<listitem><para>Hypothyroidism&mdash;may interfere with basal metabolism</para></listitem>
<listitem><para>Diabetes mellitus&mdash;decreased insulin production or utilization</para></listitem>
<listitem><para>Cushing&rsquo;s disease&mdash;increased cortisone production</para>
</listitem></orderedlist></listitem>
<listitem><para>Environmental influences, behavioral and societal issues: includes availability of high-fat, calorie-dense convenience foods, large portions, incessant and unavoidable media advertisements influencing desire to eat; marketing of unhealthy foods and drinks; and sedentary lifestyle</para></listitem>
<listitem><para>Psychosocial influences: possibility of unresolved dependency needs with individual fixed in the oral stage of psychosexual development, with food believed to be a coping mechanism for dealing with life&rsquo;s problems</para></listitem>
<listitem><para>Medications: Certain medications in each of these classes can cause weight gain: antidepressants, antihistamines, antipsychotics, beta blockers, corticosteroids, diabetes medications, antileptics, mood stabilizers (Anderson, 2014; Budd &amp; Peterson, 2015).</para></listitem>
<listitem><para>Societal distribution: Obesity disproportionately affects racial and ethnic minorities as well as people at lower income and educational levels, although it is prevalent among men and women of every segment of society (Mitchell et al, 2011).</para></listitem>
<listitem><para>Physical distribution: Accumulating data suggest that regional fat distribution (e.g., abdominal, visceral, subcutaneous) substantially affects the incidence of comorbidities associated with obesity (Wijga et al, 2010).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Classifications</emphasis>&mdash;Although several classifications and definitions for degrees of obesity are accepted, the two most widely accepted classifications are those from the World Health Organization (WHO, 2017c) and surgical practice (Hamdy et al, 2017):</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Grade 1 overweight (commonly called <emphasis role="strong">overweight</emphasis>)&mdash;BMI of 25 or greater</para></listitem>
<listitem><para>Grade 2 overweight (commonly called <emphasis role="strong">obesity</emphasis>)&mdash;BMI of 30 or greater</para></listitem>
<listitem><para>Obesity subcategories</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Class 1 BMI of 30 to &lt;35</para></listitem>
<listitem><para>Class 2: BMI of 35 to &lt;40</para></listitem>
<listitem><para>Class 3 BMI of 40 or higher (sometimes called &ldquo;extreme, severe, or morbid obesity&rdquo;) (CDC, 2016a)</para></listitem>
</orderedlist>
</listitem><listitem><para>Surgical literature often uses a different classification to recognize particularly severe obesity (Hamdy et al, 2017):</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Severe obesity&mdash;BMI greater than 40 kg/m<superscript>2</superscript></para></listitem>
<listitem><para>Morbid obesity&mdash;BMI of 40 to 50 kg/m<superscript>2</superscript></para></listitem>
<listitem><para>Super obese&mdash;BMI greater than 50 kg/m<superscript>2</superscript></para>
</listitem></orderedlist></listitem>
<listitem><para>Most likely influenced by multiple factors as demonstrated by the transactional model of stress/adaptation (Townsend, 2015).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: According to the Centers for Disease Control and Prevention (CDC) for the statistical collection years of 2000 to 2014, 38% of adults over 20 were obese and 71% overweight in the United States. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> In children (ages 2&ndash;5), the obesity rate decreased during 2000 to 2014 to 8.9% and remained stable in children ages 6 to 11 (at 17.5%) and in children ages 12 to 19 (at 20.5%) (CDC/NCHS, 2015). In 2015, worldwide prevalence of obesity was estimated to be 603.7 million adults and 107.7 million children (The GBD 2015 Obesity Collaborators, 2017).</para></listitem>
<listitem><para>Mortality: Many methodological and conceptual difficulties arise in attempting to estimate the number of deaths in the United States that are attributable to obesity. In a study published in 2013 (from data covering 1986&ndash;2006), the estimated percentage of adult deaths associated with overweight and obesity was 5.0% overall, with 15.6% for black and white men and 26.8% and 21.7% for black and white women, respectively (Masters et al, 2013).</para></listitem>
<listitem><para>Cost: In 2008, more than $190 billion was spent to manage obesity in the United States (Cawley &amp; Meyerhoefer, 2012).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0184note0442"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Anthropometric measurements: </emphasis>Body measurements, including height, weight, body mass index (BMI), waist-to-hip ratio, and percentage of body fat.</para>
<para><emphasis role="strong">Appestat: </emphasis>Control mechanism in the brain that signals either hunger or fullness.</para>
<para><emphasis role="strong">Body mass index (BMI): </emphasis>Number calculated from an individual&rsquo;s weight and height, measured in kilograms divided by height in square meters, correlating to direct measures of body fat.</para>
<para><emphasis role="strong">Circadian rhythm: </emphasis>Internal body clock that regulates the 24-hour cycle of biological processes, including sleep, wakefulness, and hunger.</para>
<para><emphasis role="strong">Cushing&rsquo;s syndrome: </emphasis>Endocrine (hormonal) disorder resulting from excessive exposure to or production of the hormone cortisol.</para>
<para><emphasis role="strong">Endomorphic body type: </emphasis>Descriptive of a type of body that is soft and round or pear-shaped with disposition of fat predominantly in the abdomen, hips, thighs, and buttocks.</para>
<para><emphasis role="strong">Energy balance: </emphasis>Weight is balanced by the amount of energy calories obtained from food equating to the energy the body uses.</para>
<para><emphasis role="strong">Hyperlipidemia: </emphasis>Elevated high levels of total cholesterol and triglycerides, normal or elevated low-density lipoprotein (LDL, &ldquo;bad cholesterol&rdquo;), and low high-density lipoprotein (HDL, &ldquo;good cholesterol&rdquo;).</para>
<para><emphasis role="strong">Obesity: </emphasis>Having a high amount of extra body fat, with BMI greater than 30.</para>
<para><emphasis role="strong">Overweight: </emphasis>Having extra body weight from muscle, bone, fat, and/or water, with BMI between 25 and 29.9.</para>
<para><emphasis role="strong">Pickwickian syndrome: </emphasis>Extreme obesity along with shallow breathing, sleep apnea, excessive sleepiness, and heart failure.</para>
<para><emphasis role="strong">Polycythemia: </emphasis>Excess number of red blood cells in circulating blood, which can contribute to blood clots.</para>
<para><emphasis role="strong">Sarcopenic obesity: </emphasis>Process characterized by loss of lean muscle and concomitant increase in body fat as a person ages. It is often seen in the sedentary individual, whether or not the person is overweight.</para>
<para><emphasis role="strong">Transactional model of stress/adaptation: </emphasis>Begins with the precipitating event, leading to predisposing factors, cognitive appraisal, primary and secondary responses, and quality of individual&rsquo;s response, resulting in adaptive (effective) or maladaptive (refusal to eat and other ineffective behaviors).</para>
<para><emphasis role="strong">Yo-yo dieting: </emphasis>Repeatedly losing weight by dieting and subsequently regaining it.</para>
</note>
<sect2 id="ch0006s0185"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Community level unless morbid obesity requires brief inpatient stay.</para>
</sect2>
<sect2 id="ch0006s0186"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0004s0114">Cerebrovascular accident (CVA)/stroke</link></para>
<para><link linkend="ch0005s0169">Cholecystitis with cholelithiasis</link></para>
<para><link linkend="ch0006s0209">Cirrhosis of the liver</link></para>
<para><link linkend="ch0006s0194">Diabetes mellitus/diabetic ketoacidosis</link></para>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0002s0022">Hypertension: severe</link></para>
<para><link linkend="ch0002s0042">Myocardial infarction</link></para>
<para><link linkend="ch0006s0189">Bariatric surgery</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0002s0064">Venous thromboembolism (VTE) disease including deep vein thrombosis (DVT) and pulmonary embolism (PE)</link></para>
<table frame="top" id="ch0006s0184ta0251"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fatigue, constant drowsiness</para></listitem>
<listitem><para>Dyspnea with exertion</para></listitem>
<listitem><para>Inability or lack of desire to be active or engage in regular exercise, sedentary lifestyle</para></listitem>
<listitem><para>Work schedules that leave little time for exercise</para></listitem>
<listitem><para>Environmental problems such as lack of sidewalks, safe places to walk</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased heart rate or respirations with activity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hypertension</para></listitem>
<listitem><para>Edema</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Cultural and lifestyle factors affecting food choices</para></listitem>
<listitem><para>Weight may or may not be perceived as a problem</para></listitem>
<listitem><para>Eating relieves unpleasant feelings&mdash;loneliness, frustration, boredom</para></listitem>
<listitem><para>Perception of body image as undesirable</para></listitem>
<listitem><para>Significant other&rsquo;s (SO&rsquo;s) resistance to weight loss (may sabotage client&rsquo;s efforts)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Reluctant to engage in social activities</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Normal and excessive ingestion of food</para></listitem>
<listitem><para>Experimentation with numerous types of diets (yo-yo dieting) with varied or short-lived results</para></listitem>
<listitem><para>History of recurrent weight loss and gain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight disproportionate to height</para></listitem>
<listitem><para>Endomorphic body type</para></listitem>
<listitem><para>Failure to adjust food intake to diminishing requirements&mdash;change in lifestyle from active to sedentary, aging</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pain or discomfort on weight-bearing joints or spine</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulty with movement, negotiating stairs, long walks</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dyspnea</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Cyanosis, respiratory distress if Pickwickian syndrome is present</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Menstrual disturbances, amenorrhea</para></listitem>
<listitem><para>Pregnancy(ies)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hormone regulation problems</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Menopause</para></listitem>
<listitem><para>Problems with relationships</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Problem may be lifelong or related to life event</para></listitem>
<listitem><para>Family history of obesity</para></listitem>
<listitem><para>Concomitant health problems may include hypertension, diabetes, gallbladder and cardiovascular disease, hypothyroidism</para></listitem>
<listitem><para><inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Pediatric comorbidities are common</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require support with therapeutic regimen; home modifications, assistive devices and equipment</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0184ta0252"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS (MAY INCLUDE, NOT LIMITED TO, THE FOLLOWING)</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Lipid profile:</emphasis> Total cholesterol, triglycerides, and HDL and LDL: fats circulating in the blood.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obesity is often associated with hyperlipidemia, which is defined as high total cholesterol, elevated triglycerides, normal or elevated LDL, and low HDL. HDL cholesterol &lt;40 mg/dL in men or &lt;50 mg/dL and/or triglycerides &ge;150 mg/dL has been shown to be associated with metabolic syndrome and increased risk of cardiovascular disease (American Heart Association [AHA], 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Endocrine function (thyroid, pituitary, growth hormone, pancreas, etc.):</emphasis> Determines which gland(s) are involved and may determine the cause of obesity. May involve measuring hormone levels and their metabolites in the blood and urine.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The goal of testing is to identify the hormone(s) that are being under- or overproduced, which may be negatively affecting client&rsquo;s weight. Examples of conditions may include hypothyroidism, hypopituitarism, hypogonadism, hyperglycemia and hyperinsulinemia, and elevated cortisol.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Anthropometric measurements (including and not limited to the following):</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Body mass index (BMI) calculation, waist circumference, and waist/hip ratio are the common measures of the degree of body fat used in routine clinical practice (Hamdy et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Body mass index (BMI):</emphasis> Measures relative body fat. Typically calculated as weight (kg) &divide; height (m<superscript>2</superscript>).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BMI is a weight-for-height index commonly used to classify overweight and obesity in adults. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> For children and teens, BMI is age and gender specific and weight to stature specific (ages 2&ndash;20 years), expressed in percentiles (CDC, 2017b). In a study, the authors concluded that &ldquo;there were more than five times as many deaths among participants in the highest obesity categories (BMI of 35.0 to 39.9 and 40.0 to 49.9) than in previous studies because severe obesity had become more common&rdquo; (Aune et al, 2016). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note:</emphasis> Childhood BMI has been found to be an indicator for adult hypertension (University of Surrey, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Waist-to-hip ratio (WHR):</emphasis> Based on waist and hip measurements.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A WHR &gt;1.0 in men and &gt;0.85 in women indicates abdominal fat accumulation and is considered the strongest anthropometric measure associated with myocardial infarction risk and is a better predictor than BMI alone.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Waist circumference (WC):</emphasis> Used to assess abdominal (visceral) fat.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Considered a better measure of visceral fat than the WHR. Increased WC is associated with risk of type 2 diabetes, hypertension, dyslipidemia, and cardiovascular disease across all categories of overweight and obesity. Cardiovascular risk is considered high in men with WC greater than 37 inches and in women with WC greater than 31 inches (Hamdy et al, 2017).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Standard skin thicknesses (i.e., subscapular, triceps, biceps, suprailiac)</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Skinfold measurements are the least accurate means by which to assess obesity but can be used to estimate the degree and distribution of obesity (Hamdy et al, 2017).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0187"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Assist client to identify a workable method of weight control, incorporating healthful foods and activity.</para></listitem>
<listitem><para>Promote improved self-concept, including body image and self-esteem.</para></listitem>
<listitem><para>Encourage healthy practices to provide for weight control throughout life.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0188"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Healthy patterns for eating and weight control identified.</para></listitem>
<listitem><para>Weight loss toward desired goal established.</para></listitem>
<listitem><para>Positive perception of self-verbalized.</para></listitem>
<listitem><para>Plans developed for future weight control.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0184note0443">
<title><emphasis role="strong">NURSING DIAGNOSIS: Obesity</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Energy expenditure below energy intake based on standard assessment; average daily physical activity is less than recommended for gender and age; sedentary behavior occurring for 2 or more hr/d</para>
<para>Frequent snacking; portion sizes larger than recommended; disordered eating behaviors</para>
<para>Economically disadvantaged</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Adult: BMI of &gt;30 kg/m<superscript>2</superscript>; child 2 to 18 years: BMI of &gt;30 kg/m<superscript>2</superscript> or &gt;95th percentile for age and gender</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Eating Disorder Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify inappropriate behaviors and consequences associated with overeating or weight gain.</para>
<para>Demonstrate appropriate change in lifestyle and behaviors, including eating patterns and food quantity and quality, and exercise program.</para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display weight loss with optimal maintenance of health.</para>
</note>
<note role="none" id="ch0006s0184note0444">
<table frame="top" id="ch0006s0184ta0253"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Weight-Reduction Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review individual cause for obesity (e.g., excess intake vs metabolic or disease condition).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies and influences choice of some interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain previous dieting history. Determine which diets and strategies have been used, results, and individual frustrations and factors interfering with success.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may have tried multiple diets, with little lasting change in body weight and feel negatively about embarking on another plan.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Implement and review daily food diary, for example, total caloric intake, types and amounts of food, and eating habits and associated feelings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides the opportunity for the individual to focus on a realistic picture of the amount of food ingested and corresponding eating habits and feelings. Identifies patterns requiring change and a base on which to tailor the dietary program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage client to use technology (e.g., smartphone, computer) applications for tracking, if available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helpful applications are those that contain a large database of foods with nutritional information for various serving sizes; a calorie tracker, nutrient tracker (e.g., carbs, protein, fats).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine client&rsquo;s motivation for weight loss, for instance, health issues, own satisfaction, or to gain approval from others.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps to clarify client&rsquo;s motivation and potential for success in weight reduction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss client&rsquo;s and SO&rsquo;s view of self, including familial and cultural influences.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client&rsquo;s family and cultural practices greatly influence client&rsquo;s self-view regarding food and body image.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Notice occurrence of negative feedback from SO(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Feedback from family may reveal control issues impacting motivation for change.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Formulate an eating plan with the client, using knowledge of individual&rsquo;s height, body build, age, gender, and individual patterns of eating, as well as energy and nutrient requirements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An important factor in the success of any weight-loss program is adherence to a sound nutritional plan. Although there is little basis for recommending one commercial diet plan over another, a good reducing diet should contain foods from all basic food groups, with a focus on low-fat intake and adequate protein intake to prevent loss of lean muscle mass. It is helpful to keep the plan as similar to client&rsquo;s usual eating pattern as possible. A plan developed with and agreed to by the client is more likely to be successful.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize the importance of avoiding fad diets.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elimination of needed components can lead to metabolic imbalances; for example, excessive reduction of carbohydrates can lead to fatigue, headache, instability, weakness, and metabolic acidosis (ketosis), thus interfering with effectiveness of weight-loss program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss need to give self permission to include desired or craved food items in dietary plan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Denying self by always excluding favorite foods results in a sense of deprivation and feelings of guilt and failure when individual &ldquo;succumbs to temptation.&rdquo; These feelings can sabotage weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be alert to binge eating and develop strategies for dealing with these episodes, such as substituting other actions for eating.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The client who binges experiences guilt about it, which is also counterproductive because negative feelings may sabotage further weight-loss efforts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify realistic incremental goals for weekly weight loss.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reasonable weight loss of 1 to 2 lb/wk results in longer-lasting effects. Excessive or rapid loss may result in fatigue and irritability and ultimately lead to failure in meeting goals for weight loss. Motivation is more easily sustained by meeting &ldquo;stair-step&rdquo; goals.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh periodically as individually indicated, and obtain appropriate body measurements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about effectiveness of therapeutic regimen and visual evidence of success of client&rsquo;s efforts. During hospitalization for controlled fasting, daily weighing may be required. Weekly weighing is more appropriate after discharge.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine current physical activity level. Discuss implementation of long-term exercise program.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physical activity promotes weight loss by reducing appetite and burning fat, while improving lean muscle mass and strength.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Promote whole family strategies (e.g., discuss implementation of &ldquo;5-2-1-0 Every Day&rdquo; plan to prevent/fight obesity).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The Foundation for Healthy Communities (FHC) promotes &ldquo;5 (or more) vegetables and fruits; 2 (or fewer) hours of recreational screen time (TV, computer); 1 (or more) hours of physical activity; and 0 sugary drinks every day&rdquo; (FHC Staff, 2007). These are helpful guidelines in promoting a healthy lifestyle.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Develop an appetite reeducation plan with client (e.g., avoiding sugary snacks, increasing protein foods, drinking water throughout day, brushing teeth or using mouthwash, eating something that takes up a lot of room in stomach but has few calories, such as soup).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Appetite is both a psychological and physical phenomenon, requiring thoughtful attention and preparedness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Limit high-calorie, fatty, or sugary foods available in the home; keep a large variety of cut-up fruits and vegetables in refrigerator.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes healthy snacking habits in both adults and children.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize the importance of avoiding tension at mealtimes and not eating too quickly.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reducing tension provides a more relaxed eating atmosphere and encourages leisurely eating patterns. This is important because a period of time is required for the appestat mechanism to know the stomach is full.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage client to eat only at a designated eating place (e.g., kitchen, dining room) and to avoid standing while eating.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Techniques that modify eating behaviors may be helpful in avoiding diet failure. Supports a more relaxed/leisurely mealtime.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss restriction of salt intake and diuretic drugs if used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Water retention may be a problem because of increased fluid intake and fat metabolism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reassess caloric requirements every 2 to 4 weeks; provide additional support when plateaus occur.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in weight and exercise necessitate changes in plan. As weight is lost, changes in metabolism occur, resulting in plateaus when weight remains stable for periods of time. This can create distrust and lead to accusations of &ldquo;cheating&rdquo; on caloric intake, which are not helpful. Client may need additional support at this time.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Perform comprehensive nutritional assessment to determine calorie, nutrient, and vitamin and supplement requirements for individual.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Intake can be calculated by several different formulas, but weight reduction is based on the basal caloric requirement for 24 hours depending on client&rsquo;s sex, age, current or desired weight, and length of time estimated to achieve desired weight. <emphasis>Note:</emphasis> Standard tables are subject to error when applied to individual situations, and circadian rhythms and lifestyle patterns need to be considered.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide medications, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Currently, there are three major groups of drugs used to manage obesity: (1) centrally acting medications that impair dietary intake (such as appetite suppressants), (2) medications that act peripherally to impair dietary absorption (such as lipase inhibitors), and (3) medications that increase energy expenditure (such as caffeine and other stimulants) (Hamdy et al, 2017). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note:</emphasis> It is currently recommended that the use of weight-loss medications during childhood and adolescence be restricted to clinical trials (Styne et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Appetite-suppressant drugs, such as: Bupropion (Wellbutrin) and naltrexone (Contrave, Revia)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used with caution and supervision at the beginning of a weight-loss program to reduce appetite and increase energy expenditure. They are effective for only a few weeks and may cause problems of dependence in some people.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lipase inhibitors, such as orlistat (Xenical, Alli)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs induce weight loss by inhibiting fat absorption. <emphasis>Note:</emphasis> Use of lipase inhibitors may reduce absorption of some fat-soluble vitamins (A, D, E, K) and beta-carotene. Vitamin supplement should be given at least 2 hours before or after Xenical.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>CNS stimulants, such as phenteramine/topiramate (Qsymia), phentermine (Lomaira), and phendimetrazine (Bontril, PDM)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adrenergic agonists that release tissue stores of epinephrine, causing subsequent alpha- and/or beta-adrenergic stimulation, have provided benefits to individuals with severe obesity who are under physician-supervised weight-loss programs. They are approved for short-term use (8&ndash;12 weeks) in adults.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Hospitalize for fasting regimen or stabilization of medical problems, when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aggressive therapy and support may be necessary to initiate weight loss, although fasting is not generally a treatment of choice. Client can be monitored more effectively in a controlled setting to minimize complications such as orthostatic hypotension, anemia, and cardiac irregularities.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for bariatric surgical interventions, such as gastric banding or bypass, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>These interventions may be necessary to help the client lose weight when obesity is life-threatening. (Refer to CP: <link linkend="ch0006s0189">Bariatric Surgery</link>.)</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0184note0445">
<title><emphasis role="strong">NURSING DIAGNOSIS: sedentary Lifestyle</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient interest, motivation, or resources [e.g., time, money, companionship, facilities] for physical activities</para>
<para>Insufficient knowledge of health benefits associated with physical exercise</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Chooses daily routine lacking physical exercise</para>
<para>Average daily physical activity is less than recommended for gender and age</para>
<para>Demonstrates physical deconditioning</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Exercise Participation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of importance of regular exercise to weight loss and general well-being.</para>
<para>Identify necessary precautions and safety concerns and self-monitoring techniques.</para>
<para>Formulate realistic exercise program with gradual increase in activity.</para>
</note>
<note role="none" id="ch0006s0184note0446">
<table frame="top" id="ch0006s0184ta0254"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Exercise Promotion</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review necessity for and benefits of regular exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Exercise promotes weight loss by reducing appetite, increasing energy, toning muscles, and enhancing cardiac fitness and sense of well-being and accomplishment. In addition, exercise (even when performed at lower than recommended levels) has been found to influence risk factors associated with obesity (e.g., hypertension, glucose intolerance, insulin resistance, hyperlipidemia and inflammation) (Garber et al, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine current activity level and plan progressive exercise program tailored to the individual&rsquo;s physical condition, goals, and choice.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Commitment on the part of the client enables the setting of more realistic goals and adherence to the plan.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify perceived and actual barriers to exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lack of resources, including proper apparel such as supportive shoes and comfortable clothing, a safe place to walk, or facility membership for water aerobics, reduces the likelihood of individual adhering to specific program. In addition, fear of discrimination or ridicule by others may limit client&rsquo;s willingness to exercise in public.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss appropriate warm-up exercises, cool-down activities, and specific techniques to avoid injury.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Preventing muscle injuries allows client to stay active. Time spent recuperating from exercise-induced injuries may result in relapse to sedentary habits.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine optimal exercise heart rate. Demonstrate proper technique to monitor pulse and discuss signs and symptoms requiring modification of activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes safety as client exercises to tolerance, not peer pressure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify alternatives to chosen activity program to accommodate weather, travel, and so forth.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes continuation of program by reducing reasons/excuses to refrain from activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss use of mechanical devices or equipment for weight reduction.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fat loss occurs on a generalized overall basis, and there is no evidence that spot reducing or mechanical devices aid in weight loss in specific areas; however, specific types of exercise or equipment may be useful in toning specific body parts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend keeping a graph of activity as exercise program advances.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides visual record of progress and positive reinforcement for efforts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest client identify an exercise buddy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides support and companionship, increasing likelihood of adherence to program.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage involvement in social activities that are not centered on food&mdash;bike ride or nature hike, attending musical event, and group sporting activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides opportunity for pleasure and relaxation not associated with food as well as additional physical activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Involve physical therapist or exercise physiologist in developing progressive program.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Facilitates development of an appropriate program of activities that are geared to obese individual and considers impact of client&rsquo;s weight on ability to perform specific activities and safety concerns.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0184note0447">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for disturbed Body Image</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in view of one&rsquo;s body; nonverbal response to actual or perceived changes in body</para>
<para>Negative feelings about body (e.g., hopelessness, powerlessness); change in social involvement; fear of reaction by other</para>
<para>Preoccupation with change&mdash;attempts to lose weight</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Body Image</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize a more realistic self-image.</para>
<para>Demonstrate some acceptance of self as is rather than an idealized image.</para>
<para><emphasis role="strong">Self-Esteem</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Seek information and actively pursue appropriate weight loss.</para>
<para>Acknowledge self as an individual who has responsibility for self.</para>
</note>
<note role="none" id="ch0006s0184note0448">
<table frame="top" id="ch0006s0184ta0255"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Body Image Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s view of being overweight or &ldquo;fat&rdquo; and what it does for the individual.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mental image includes our ideal and is usually not up-to-date. Fat and compulsive eating behaviors may have deep-rooted psychological implications, such as compensation for lack of love and nurturing or a defense against intimacy. In addition, chronically obese client may report long-term discrimination in family, social, and professional settings. She or he may experience mixed feelings of fear and shame or compensate for psychological trauma by developing a strong or &ldquo;big&rdquo; personality.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client perception of threat to self.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client&rsquo;s perception of what problem weight poses is more important than what the threat really is and needs to be dealt with before reality can be addressed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify basic sense of self-worth and image client has of existential, physical, and psychological self. Determine locus of control.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides insight into view of self as fat and own ability to control weight. Information necessary to determine individual needs and treatment plan.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote open communication, avoiding criticism or judgment about client&rsquo;s behavior.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Supports client&rsquo;s own responsibility for weight loss, enhances sense of control, and promotes willingness to discuss difficulties and setbacks and to problem-solve. <emphasis>Note: </emphasis>Distrust and accusations of &ldquo;cheating&rdquo; on caloric intake are not helpful.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client to identify feelings that lead to compulsive eating. Encourage journaling.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>People often eat because of depression, anger, and guilt. Awareness of emotions that lead to overeating can be the first step in changing behavior.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Have client recall coping patterns related to food in family of origin and explore how these may affect current situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Parents act as role models for the child. Maladaptive coping patterns, such as overeating, are learned within the family system and are supported through positive reinforcement. Food may be substituted by the parent for affection and love, and eating is associated with a feeling of satisfaction, becoming the primary defense.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Develop strategies for doing something besides eating for dealing with dysfunctional eating, such as talking with a friend.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replacing eating with other activities helps retrain old patterns and establish new ways to deal with feelings.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify client&rsquo;s motivation for weight loss and assist with goal setting.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The individual may harbor repressed feeling of hostility, which may be expressed inward on the self. Because of a poor self-concept, the person often has difficulty with relationships. <emphasis>Note:</emphasis> When losing weight to please or attract someone else, the client is less likely to be successful or maintain weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Outline and clearly state responsibilities of client and nurse.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is helpful for each individual to understand area of own responsibility in the program so that misunderstandings do not arise.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Graph weight on a weekly basis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides ongoing visual evidence of weight changes, reinforcing reality.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to use imagery to visualize self at desired weight and to practice handling of new behaviors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mental rehearsal is very useful in helping the client plan for and deal with anticipated change in self-image or occasions that may arise, such as family gatherings or special dinners, where constant decisions about eating many foods will occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest client enhance current self through the application of makeup, current hairstyles, and dressing to maximize figure assets.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances feelings of self-esteem and promotes improved body image.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage buying clothes instead of food treats as a reward for weight loss and life successes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Properly fitting clothes enhance the body image as small losses are made and the individual feels more positive. Waiting until the desired weight loss is reached can become discouraging.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest the client dispose of &ldquo;fat clothes&rdquo; as weight loss occurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Removes the &ldquo;safety valve&rdquo; of having clothes available &ldquo;in case&rdquo; the weight is regained. Retaining fat clothes can convey the message that the weight loss will not occur or be maintained.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be alert to myths the client and SO may have about weight and weight loss.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beliefs about what an ideal body looks like or unconscious motivations can sabotage efforts to lose weight. Some of these include the feminine thought of &ldquo;If I become thin, men will view me as a sexual object&rdquo;; the masculine counterpart, &ldquo;I don&rsquo;t trust myself to stay in control of my sexual feelings&rdquo;; as well as issues of strength, power, or the &ldquo;good cook&rdquo; image.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine relationship history and possibility of sexual abuse.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May contribute to current issues of self-esteem and patterns of coping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ensure availability of properly sized equipment, including gowns and other apparel; blood pressure cuff; wider and strong wheelchair, bed, commode, scales, and transfer devices, when providing inpatient care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Healthcare providers have a moral and legal obligation to meet the client&rsquo;s needs for dignity, comfort, and safety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide privacy during care activities. Assist with personal care, as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Individual knows size makes it hard to care for her or him and usually is sensitive and self-conscious about body.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help staff be aware of and deal with own feelings when caring for client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Judgmental attitudes, feelings of disgust, anger, and weariness can interfere with care and be transmitted to client, reinforcing negative self-concept and image.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to community support and/or therapy group.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Weight-loss groups can provide companionship, enhance motivation, decrease loneliness and social ostracism, and give practical solutions to common problems. Group therapy can be helpful in dealing with underlying psychological concerns.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0184note0449">
<title><emphasis role="strong">NURSING DIAGNOSIS: Social Isolation</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inability to engage in satisfying personal relationships; [self-concept disturbance]</para>
<para>Insufficient personal resources</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Desire to be alone; feeling different from others; withdrawn</para>
<para>History of rejection; insecurity in public; absence of support system</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Social Involvement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize awareness of feelings that lead to poor social interactions.</para>
<para>Express sense of self-worth.</para>
<para>Become involved in achieving positive changes in social behaviors and interpersonal relationships.</para>
</note>
<note role="none" id="ch0006s0184note0450">
<table frame="top" id="ch0006s0184ta0256"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Socialization Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review family patterns of relating and social behaviors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Social interaction is primarily learned within the family of origin. When inadequate patterns are identified, actions for change can be instituted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to express feelings and perceptions of problems.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps identify and clarify reasons for difficulties in interacting with others, such as feeling unloved or unlovable and insecure about sexuality.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client&rsquo;s use of coping skills and defense mechanisms.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May have coping skills that will be useful in the process of weight loss. Defense mechanisms used to protect the individual may contribute to feelings of aloneness or isolation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Have client list behaviors that cause discomfort.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies specific concerns and suggests actions that can be taken to effect change.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Involve in role-playing new ways to deal with identified behaviors or situations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Practicing these new behaviors enables the individual to become comfortable with them in a safe situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss negative self-concepts and self-talk, such as, &ldquo;No one wants to be with a fat person,&rdquo; &ldquo;Who would be interested in talking to me?&rdquo;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be impeding positive social interactions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage use of positive self-talk such as telling oneself &ldquo;I am OK&rdquo; or &ldquo;I can enjoy social activities and do not need to be controlled by what others think or say.&rdquo;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positive strategies enhance feelings of comfort and support efforts for change.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer for ongoing family or individual therapy, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client benefits from involvement of SO to provide support and encouragement.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0184note0451">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Difficulty managing complex treatment regimen; insufficient knowledge of therapeutic regimen</para>
<para>Decisional conflicts; family pattern of healthcare</para>
<para>Perceived seriousness of condition/barriers</para>
<para>Insufficient social support</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Difficulty with prescribed regimen</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>Failure to include treatment regimen in daily living or to take action to reduce risk factors</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Eating Disorder Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of need for lifestyle changes to maintain or control weight.</para>
<para>Establish individual goal and plan for attaining that goal.</para>
<para>Begin to look for information about nutrition and ways to manage weight.</para>
</note>
<note role="none" id="ch0006s0184note0452">
<table frame="top" id="ch0006s0184ta0257"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Prescribed Diet</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine level of nutritional knowledge and what client believes is most urgent need.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Necessary to know what additional information to provide. When client&rsquo;s views are listened to, trust is enhanced.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify individual long-term goals for health, such as lowering blood pressure, controlling serum lipid and glucose levels.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A high relapse rate at 5-year follow-up suggests obesity cannot be reliably reversed. Shifting the focus from initial weight loss and percentage of body fat to overall management of wellness may enhance rehabilitation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide information about ways to maintain satisfactory food intake in settings away from home.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>&ldquo;Smart&rdquo; eating when dining out or when traveling helps individual manage weight while still enjoying social outlets.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify other sources of information&mdash;quality Internet sites, books, community classes, and groups.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Using different avenues of accessing information furthers client&rsquo;s learning. Involvement with others who are also losing weight can provide support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Individual</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize necessity of continued follow-up care or counseling, especially when plateaus occur.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>As weight is lost, changes in metabolism occur, interfering with further loss by creating a plateau as the body activates a survival mechanism, attempting to prevent &ldquo;starvation.&rdquo; This requires new strategies and aggressive support to continue weight loss and to maintain reduced weight. <emphasis>Note:</emphasis> The National Weight Control Registry (NWCR) members must have maintained at least a 30-pound weight loss for 1 year or longer. Most report continuing to maintain a low-calorie, low-fat diet and doing high levels of activity (e.g., 90% exercise, on average, about 1 hour per day) (NWCR, n.d.). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note:</emphasis> Because pediatric comorbidities are common, long-term health complications (e.g., prediabetes, arterial damage) often result and both client and parents need age-appropriate information and ongoing support (Styne et al, 2017; University of Surrey, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss use of medications; advise client to discuss with physician and pharmacist any additions to regimen such as over-the-counter (OTC) medications, antibiotics, and herbal supplements.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obesity can alter the pharmacokinetic properties of medications. Changes in dosages may be needed based on the degree to which drugs are absorbed, resulting in subtherapeutic or toxic drug levels or dangerous side effects and interactions that might occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client about risk of deep vein thrombosis (DVT) and self-care including ankle exercises, walking to limit of ability, and reporting any unusual discomfort in legs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The very obese client is at higher risk for DVT and pulmonary embolism than the general population because of immobility, stasis, and polycythemia related to chronic respiratory insufficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss necessity of good skin care, especially in skinfolds, such as pendulous abdomen, breasts, groin, perineal areas, during hot weather and times of immobility or following exercise.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client is at risk for developing pressure injuries/ulcers and can be prone to yeast infections. Frequent skin care such as cleansing and drying the tissues and using antifungal creams in skinfolds, as appropriate, can prevent skin breakdown.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identify alternative ways to &ldquo;reward&rdquo; self and family for accomplishments or to provide solace.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Reduces likelihood of relying on food to deal with feelings (emotional eating).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0184note0453">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities in addition to above nursing diagnoses)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, perceived seriousness and benefits, excessive demands made on individual; family conflict</para></listitem>
<listitem><para><emphasis role="strong">Oher nursing diagnoses associated with comorbidities/complications of condition</emphasis></para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0189"><title><emphasis role="strong">BARIATRIC SURGERY</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Indications</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Weight and health of extremely obese persons can be favorably changed by bariatric surgery.</para></listitem>
<listitem><para>Benefits are being reported in improvement in comorbid conditions associated with morbid obesity such as hypertension, hyperlipidemia, back pain, and sleep apnea. Studies are supporting that bariatric surgery is effective in remitting type 2 diabetes in 50% to 85% of individuals (Dixon et al, 2009).</para></listitem>
<listitem><para>Surgery recommended for clients with type 2 diabetes and BMI &ge;40 kg/m<superscript>2</superscript> regardless of glycemic control and for clients with BMI 30 to 34.9 kg/m<superscript>2</superscript> who have inadequately controlled hyperglycemia despite optimal medical management. <emphasis>Note:</emphasis> BMI thresholds should be reduced by 2.5 kg/m<superscript>2</superscript> for clients of Asian descent (Cohen at al, 2016).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Procedures</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Laparoscopy is the most common surgical approach used, preferred because of improved recovery and lower morbidity (Lim, 2016). <emphasis>Note:</emphasis> Although the procedure can be limited by patient size, as well as instrument and trocar length, even extremely large patients have been successfully completed laparoscopically (Lim, 2016).</para></listitem>
<listitem><para>Those with previous abdominal surgery or complicating medical problems may require an open-abdomen approach.</para></listitem>
<listitem><para>Basic concepts for bariatric surgery (Saber &amp; El-Ghazaly, 2017)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="bi">Restriction</emphasis></para>
<para>Restrictive procedures limit caloric intake by reducing the stomach&rsquo;s reservoir capacity by means of resection, bypass, or creation of a proximal gastric outlet.</para>
<para>Most common procedure:</para>
<para>Adjustable gastric banding (AGB, also may be called &ldquo;the band&rdquo; or Lap-Band): This laparoscopic procedure is reversible and adjustable. The gastric band can be adjusted, resulting in an increased degree of restriction. Digestion is slowed by allowing smaller-than-normal amounts of food through to the remainder of the gastrointestinal tract. The absorption function of the small intestine is intact, resulting in the lowest risk for vitamin and mineral deficiencies. Weight loss is slower and less immediate than with other procedures but over 2 years is about 50% to 60% of excess body weight (Saber &amp; El-Ghazaly, 2017). Because of its many advantages, ABG has replaced the vertical banded gastroplasty (VGB) as the main restrictive procedure (Lim, 2016).</para>
</listitem>
<listitem><para><emphasis role="bi">Combined restriction and malabsorption</emphasis></para>
<para>Most common procedures:</para>
<para>Laparoscopic sleeve gastrectomy (SG): This restrictive, irreversible procedure, usually performed laparoscopically, removes 80% to 90% of the stomach, leaving only a gastric &ldquo;sleeve.&rdquo; This operation is believed to be safer than the RYGB procedure, due to the fact that the natural anatomy of the gastrointestinal tract is not changed and therefore has no true malabsorptive component (Lim, 2016; Saber &amp; El-Gahazly, 2017). <emphasis>Note:</emphasis> In 2015, SG was the most commonly performed bariatric procedure in the world and in the United States (American Society for Metabolic and Bariatric Surgery [ASMBS], 2016).</para>
<para>Roux-en-Y gastric bypass (RYGB): Involves creating a small stomach pouch and attaching it directly to the small intestine using a Y-shaped limb of the small bowel; the larger stomach portion and the duodenum are bypassed. The procedure is irreversible, is usually performed by laparoscopy, and works both by restricting intake and by slowing the digestion and absorption. Weight loss usually exceeds 100 lb or about 65% to 75% of excess body weight (Saber &amp; El-Ghazaly, 2017). <emphasis>Note:</emphasis> An updated Cochrane review from 2014 stated that RYGB and sleeve gastrectomy had comparable outcomes, and both had better outcomes than adjustable gastric banding (Colquitt et al, 2014).</para>
</listitem>
<listitem><para><emphasis role="bi">Primarily malabsorptive procedures with some restriction</emphasis></para>
<para>Biliopancreatic diversion with duodenal switch (BPD-DS): Considered for individuals with severe obesity, this procedure is performed at only a few centers in the United States (Lim, 2016). The surgery involves removing 65% to 70% of the stomach, leaving the pyloric valve intact. The remaining portion of the stomach is then connected to the proximal portion of the ileum, and a large portion of the small intestine is bypassed. Early weight loss is from restriction and malabsorption and later is mostly from malabsorption (Saber &amp; El-Ghazaly, 2017). The surgery reduces fat absorption by over 70% and causes favorable changes in gut hormones to reduce appetite and improve satiety (ASMBS, n.d.); however, it has a greater potential to cause long-term protein, vitamin, and mineral deficiencies. Most people lose 75% to 85% of their excess weight and stay at their new weight (Colquitt et al, 2014).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Complications</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Complications of bariatric surgery are specific to the performed procedure.</para></listitem>
<listitem><para>Early complications of gastric bypass can include bleeding (0.5% to 2%) and anastomotic leaks (1% to 3%) (Saber &amp; El-Ghazaly, 2017).</para></listitem>
<listitem><para>Late complications: Cholelithiasis (occurs in about 38% of <emphasis role="bi">gastric bypass</emphasis> patients [Ellsmere, 2017]); stomal stenosis, gastric remnant distention, ulceration at margins, hernias (all relatively uncommon). <emphasis>Note:</emphasis> Common late complications of <emphasis>gastric banding</emphasis> include gastroesophageal reflux disease, port problems, and band slippage (Kodner &amp; Hartman, 2014).</para></listitem>
<listitem><para>Wound infections: Open-abdomen procedures have been associated with higher risk of infection (10% to 16%) than laparoscopic procedures (3% to 4%) (Chopra et al, 2010).</para></listitem>
<listitem><para>Nutritional side effects: Malabsorptive effects include risk for deficiencies (e.g., iron, calcium, thiamine, folate, and vitamin B<subscript>12</subscript>); deficiencies can occur early or late and are long term.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Recent numbers of bariatric surgeries vary, but the American Society for Metabolic and Bariatric Surgery (ASMBS) reports a figure of 196,000 for all procedures for 2015 (ASMBS, 2017).</para></listitem>
<listitem><para>Mortality: Rates vary somewhat by procedures but are generally low. Data involving nearly 60,000 bariatric patients show that the risk of death within the 30 days following bariatric surgery averages 0.13%, or approximately one out of 1000 patients (ASMBS, 2017).</para></listitem>
<listitem><para>Cost: According to Obesity Coverage, the average costs in 2015 were $25,600 for gastric bypass surgery, $14,500 for Lap-Band surgery, and $14,900 for gastric sleeve (Obesity Coverage, 2017).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0189note0454"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Bariatric surgery: </emphasis>Term is synonymous with &ldquo;obesity surgery&rdquo; or &ldquo;weight-loss surgery.&rdquo;</para>
<para><emphasis role="strong">Body mass index (BMI): </emphasis>Uses individual&rsquo;s weight in kilograms divided by height in meters squared to produce a unit of measure for classifying body composition.</para>
<para><emphasis role="strong">Comorbidities: </emphasis>In the context of obesity, means medical conditions that a client may have that are either caused or exacerbated by obesity. Examples include diabetes type 2, hypertension, cardiopulmonary disease, sleep apnea, gastroesophageal reflux disease (GERD), and musculoskeletal problems.</para>
<para><emphasis role="strong">Dumping syndrome: </emphasis>A group of symptoms that result from the quick &ldquo;dumping&rdquo; of food into the small intestine. The most typical forms may occur after gastric bypass, although not all individuals develop dumping syndrome. Early dumping occurs shortly after a meal and consists of any combination of lightheadedness, flushing, diarrhea, and extreme weakness. Delayed dumping may occur an hour or later after a meal and is believed to be a result of hypoglycemia.</para>
<para><emphasis role="strong">Intertriginous dermatitis (ITD): </emphasis>An inflammatory condition of opposing skin surfaces caused by moisture. People with more skinfolds, especially the obese, often have ITD under the abdominal or pubic panniculi. Following weight-loss surgery, surplus skin remains and is also a site for the development of ITD.</para>
<para><emphasis role="strong">Laparoscopic surgery: </emphasis>A way of performing various bariatric surgical procedures through multiple small holes or incisions in the abdomen.</para>
<para><emphasis role="strong">Malabsorptive surgery: </emphasis>A type of bariatric surgery that causes weight loss by bypassing a portion of the small intestine, where almost all of the absorption of nutrients takes place.</para>
<para><emphasis role="strong">Panniculus: </emphasis>Term used to describe an excess fold or layer (apron) of skin and tissue that hangs dependently. Abdominal panniculi can grow over and beyond the abdomen, eventually covering the genitals and potentially extending even further, passing the knees. This can cause considerable discomfort and disability. Other areas of the body that may develop panniculi include the neck, upper back, flank, upper-medial thigh, posterior legs and ankles.</para>
<para><emphasis role="strong">Restrictive surgery: </emphasis>A type of bariatric surgery that induces weight loss by making only a small portion of the stomach (the pouch or, in the case of sleeve gastrectomy, a tube) available to receive food from the esophagus.</para>
<para><emphasis role="strong">Skinfolds: </emphasis>Areas where one skin layer rests on or against another. These folds tend to be dark, moist, and warm, making them an ideal breeding ground for organisms like bacteria and fungi. Individuals can develop severe skin infections and may experience large ulcerations and lesions from unchecked growth of microorganisms.</para>
</note>
<sect2 id="ch0006s0190"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Care is provided in an inpatient acute surgical unit.</para>
</sect2>
<sect2 id="ch0006s0191"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0006s0184">Obesity</link></para>
<para><link linkend="ch0005s0164">Peritonitis</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<para><link linkend="ch0002s0064">Venous thromboembolism (VTE) disease including deep vein thrombosis (DVT) and pulmonary embolism (PE)</link></para>
<table frame="top" id="ch0006s0189ta0258"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>****Refer to <link linkend="ch0006">Metabolic and Endocrine Disorders</link>: <link linkend="ch0006s0184">Obesity</link> Database for additional assessment information.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Exertional discomfort, inability to participate in desired activity or sports</para></listitem>
<listitem><para>Difficulty sleeping</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Exertional dyspnea</para></listitem>
<listitem><para>Slow to move, inability to participate in desired activity</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Motivated to lose weight for oneself (or for gratification of others)</para></listitem>
<listitem><para>Embarrassment that they&rsquo;ve been unable to lose weight by other means</para></listitem>
<listitem><para>Worry that even after surgery will fail to lose weight</para></listitem>
<listitem><para>Fear or anxiety about procedure and ability to deal with postoperative adjustments</para></listitem>
<listitem><para>Feels lonely, isolated, disconnected from others</para></listitem>
<listitem><para>History of psychiatric illness or treatment</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Anxiety, depression</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Urinary stress incontinence</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of yo-yo dieting, years of failed dieting; weight fluctuations; dysfunctional eating patterns</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight exceeding ideal body weight by 100 lb, or BMI more than 40 (morbid obesity) or BMI of 25 to 40 with comorbid conditions, such as diabetes, sleep apnea, or heart disease</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">HYGIENE</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulty with dressing, bathing, toileting, perineal care, or other self-care activities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Poor general hygiene, or constant attention to hygiene practices</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Incisional pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding behavior</para></listitem>
<listitem><para>Positioning to avoid pain</para></listitem>
<listitem><para>Restlessness, moaning, irritability</para></listitem>
<listitem><para>Facial mask, grimacing</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of chronic respiratory diseases; use of respiratory aids (including oxygen, medications)</para></listitem>
<listitem><para>Heavy snoring, daytime sleepiness, morning headaches</para></listitem>
<listitem><para>Sleep apnea (may use continuous positive airway pressure [CPAP])</para></listitem>
<listitem><para>History of/current smoking</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath with activity or rest</para></listitem>
<listitem><para>Breath sounds may be distant (chest depth and shallow respirations)</para></listitem>
<listitem><para>Obesity hypoventilation syndrome (OHS)</para></listitem>
<listitem><para>Nighttime hypoventilation, sleep-disordered breathing, and daytime hypercapnia and hypoxemia</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of falls/other accidental injuries due to unstable gait, arthritis, joint problems</para></listitem>
<listitem><para>Use of ambulatory or other assistive devices for transportation (e.g., walker, cane, wheelchair)</para></listitem>
<listitem><para>Skin injuries, dermatitis, and other skin problems associated with skinfolds and hanging fat and tissue deposits (panniculi)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Areas of skin breakdown, including breast, abdominal, and other body skinfolds</para></listitem>
<listitem><para>Intertrigonous dermatitis, pressure ulcers, candidiasis, incontinence-associated dermatitis, lower leg ulcers (Blackett et al, 2011)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY/SOCIAL INTERACTIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Problems with menstruation, fertility, and/or childbearing</para></listitem>
<listitem><para>Problems with relationships that client perceives is related to condition</para></listitem>
<listitem><para>History of bullying, discrimination, and abuse</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May or may not have support people present</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Presence of chronic conditions&mdash;hypertension, diabetes, heart failure, arthritis, sleep apnea, Pickwickian syndrome, infertility</para></listitem>
<listitem><para>Learning about lifelong healthy eating and physical activity habits, medical follow-up, and vitamin and mineral supplementation</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require support with therapeutic regimen and weight loss, assistance with self-care, homemaker and maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<para><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></para>
<para>Studies depend on individual situation and are used to rule out underlying disease and provide a preoperative workup, including psychiatric evaluation.</para>
</sect2>
<sect2 id="ch0006s0192"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Support respiratory function.</para></listitem>
<listitem><para>Prevent or minimize complications.</para></listitem>
<listitem><para>Provide appropriate nutritional intake.</para></listitem>
<listitem><para>Provide information regarding surgical procedure, postoperative expectations, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0193"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Ventilation and oxygenation adequate for individual needs.</para></listitem>
<listitem><para>Complications prevented or controlled.</para></listitem>
<listitem><para>Nutritional intake modified for specific procedure.</para></listitem>
<listitem><para>Procedure, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0189note0455">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Breathing Pattern</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Obesity; body position that inhibits lung expansion</para>
<para>Pain, anxiety</para>
<para>Fatigue</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Feeling breathless; dyspnea</para>
<para>Tachypnea, alteration in depth of breathing; decreased vital capacity</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Ventilation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate ventilation.</para>
<para>Experience no cyanosis or other signs of hypoxia, with ABGs within acceptable range.</para>
</note>
<note role="none" id="ch0006s0189note0456">
<table frame="top" id="ch0006s0189ta0259"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Ventilation Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be aware of presurgical history of respiratory conditions (e.g., obstructive sleep apnea, use of nighttime CPAP).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Continuous positive airway pressure (CPAP) may be used postoperatively to maintain adequate tidal volumes, to clear anesthesia, and to maintain a wakeful state.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor respiratory rate and depth. Auscultate breath sounds. Investigate presence of pallor and cyanosis, increased restlessness, or confusion.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respirations may be shallow because of incisional pain, analgesia, immobility, and obesity itself, causing hypoventilation and potentiating risk of atelectasis and hypoxia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevate head of bed 30 to 45 degrees.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourages optimal diaphragmatic excursion and lung expansion and minimizes pressure of abdominal contents on the thoracic cavity. <emphasis>Note:</emphasis> When kept recumbent, obese clients are at high risk for severe hypoventilation (Dambaugh &amp; Eckland, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage deep-breathing exercises. Assist with coughing and splint incision.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes maximal lung expansion and aids in clearing airways, thus reducing risk of atelectasis and pneumonia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Turn periodically and ambulate as early as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes aeration of all segments of the lung, mobilizing and aiding movement of secretions. <emphasis>Note:</emphasis> If client was a good candidate for bariatric surgery, she or he was probably relatively healthy before operation and is usually able to turn self, walk, and transfer to chair within 8 hours of surgery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pad side rails and teach client to use them as armrests.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Using the side rail as an armrest allows for greater chest expansion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use small pillow under head, when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many obese clients have large, thick necks, and use of large, fluffy pillows may obstruct the airway.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maximizes available O<subscript>2</subscript> for exchange and reduces work of breathing. <emphasis>Note:</emphasis> Some clients may require noninvasive mechanical ventilation, which necessitates a proper-fitting interface (Dambaugh &amp; Eckland, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist in use of blow bottle or incentive spirometer, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances lung expansion; reduces potential for atelectasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor continuous pulse oximetry, or ABGs, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reflects ventilation, oxygenation, and acid-base status. Used as a basis for evaluating need for and effectiveness of respiratory therapies.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor patient-controlled analgesia (PCA) and administer analgesics, as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Maintenance of comfort enhances participation in respiratory therapy and promotes increased lung expansion. <emphasis>Note:</emphasis> For the first 48 hours after the procedure, intravenous (IV) PCA is the method of choice. (Refer to CP: <link linkend="ch0014s0348">Surgical Intervention</link>, ND <link linkend="ch0014s0348note0561">acute Pain</link> for pain control interventions.)</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0457">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for ineffective Tissue Perfusion [specify]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge of disease process, risk factors, or aggravating factors (e.g., obesity, smoking sedentary lifestyle, immobility)</para>
<para>Hypertension; diabetes mellitus</para>
<para>Sedentary lifestyle</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Circulation Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain perfusion as individually appropriate&mdash;skin warm and dry, peripheral pulses present and strong, and vital signs within acceptable range.</para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify causative or risk factors.</para>
<para>Demonstrate behaviors to improve or maintain circulation.</para>
</note>
<note role="none" id="ch0006s0189note0458">
<table frame="top" id="ch0006s0189ta0260"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Surveillance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs, palpate peripheral pulses routinely, and evaluate capillary refill and changes in mentation. Note 24-hour fluid balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of circulatory adequacy. (Refer to ND: <link linkend="ch0006s0189note0459">risk for deficient Fluid Volume</link>, below.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage frequent range-of-motion (ROM) exercises for legs and ankles. Maintain schedule of sequential compression devices (SCD) on lower extremities when used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stimulates circulation in the lower extremities, reduces high-risk complications associated with venous stasis, such as DVT and pulmonary embolus (PE).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess for redness, edema, and discomfort in calf.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of thrombus formation, but warning signs may not always be present in obese individuals.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage early ambulation; discourage sitting and dangling legs at the bedside.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sitting constricts venous flow, whereas walking encourages venous return. <emphasis>Note:</emphasis> Feelings of dyspnea may result in decreased exercise tolerance and decreased mobility (Dambaugh &amp; Eckland, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate for complications, such as rigid abdomen, nonincisional abdominal pain, fever, tachycardia, and low blood pressure.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although rare, client can develop abdominal complications, such as abdominal compartment syndrome, sepsis, or septic shock secondary to anastomotic leak or wound infection, requiring intensive interventions or return to surgery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer heparin therapy, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used prophylactically to reduce risk of thrombus formation or to treat thromboemboli.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor hemoglobin (Hgb), hematocrit (Hct), and coagulation studies, such as prothrombin time (PT) and international normalized ratio (INR).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provides information about circulatory volume and alterations in coagulation and indicates therapy needs and effectiveness.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0459">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Extremes of weight</para>
<para>Active fluid volume loss [e.g., hemorrhage, nasogastric suction, diarrhea]</para>
<para>Deviations affecting intake&mdash;limited oral intake</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Hydration</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate fluid volume with balanced intake and output (I&amp;O) and be free of signs reflecting dehydration.</para>
</note>
<note role="none" id="ch0006s0189note0460">
<table frame="top" id="ch0006s0189ta0261"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess vital signs, noting changes in blood pressure (BP), such as orthostatic hypotension, tachycardia, and fever. Assess skin turgor, capillary refill, and moisture of mucous membranes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of dehydration and hypovolemia and adequacy of current fluid replacement. <emphasis>Note:</emphasis> Adequately sized cuff must be used to ensure factual measurement of BP. If cuff is too small, reading will be falsely elevated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor I&amp;O, including nasogastric (NG) suction losses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in gastric capacity and intestinal motility and nausea greatly influence intake and fluid needs, increasing risk of dehydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish individual needs and replacement schedule.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determined by amount of measured losses and estimated insensible losses and dependent on gastric capacity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage increased oral intake when able, beginning with clear liquids and advancing to full liquids. Encourage frequent small sips of fluids.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Intake capacity is drastically reduced (to as little as 15 to 30 mL), so client may need IV fluid support for a while, but once oral fluids are resumed, client must drink frequently in order to be hydrated. Small sips will reduce nausea.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer IV fluids, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replaces fluid losses and restores fluid balance in immediate postoperative phase until client is able to take sufficient oral fluids.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor electrolyte levels and replace, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Use of NG tube and changes in GI function can deplete electrolytes, affecting organ function.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0461">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">Risk Factors May Include</emphasis></para>
<para>Inability to ingest food&mdash;restricted intake, early satiety</para>
<para>Inability to absorb nutrients&mdash;malabsorption of nutrients and impaired absorption of vitamins</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Eating Disorder Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify individual nutritional needs.</para>
<para>Display behaviors to maintain adequate nutritional intake.</para>
<para>Demonstrate appropriate weight loss with normalization of laboratory values.</para>
</note>
<note role="none" id="ch0006s0189note0462">
<table frame="top" id="ch0006s0189ta0262"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Diet Staging: Weight-Loss Surgery</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s type of bariatric procedure and early postoperative dietary plan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The diet after surgery is based on the type of bariatric procedure and client&rsquo;s comorbid conditions (e.g., diabetes) and is a staged approach (e.g., clear liquid to full liquids, to pureed foods, to healthy solid foods). Dietary advancement is based on nutritional needs and increasing tolerance for dietary texture (Kushner et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establish hourly intake schedule. Measure and provide food and fluids in amount specified.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>After gastric restriction procedures, stomach capacity is reduced to approximately 30 to 50 mL, necessitating frequent, small feedings.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct in how to eat slowly. Take small bites, using a baby spoon. Chew food thoroughly. Take 30 to 60 minutes to eat meal, then refrain from eating until next scheduled mealtime.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases satiety and reduces risk of overeating. <emphasis>Note</emphasis>: Chewing food to mush-like consistency prevents complications (such as blocking the new opening from the stomach into the intestine [gastric bypass] or putting too much strain on gastric band [Lap-Band]). Blockages prevent food from leaving the stomach, causing vomiting, nausea, and abdominal pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid taking fluids with meals and for 30 minutes before or 45 minutes after meals. Encourage almost constant sipping of fluids between scheduled eating times.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although fluids are a necessary part of the client&rsquo;s intake, the stomach is too small to hold food and fluids at the same time.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid high-calorie fluids&mdash;milkshakes, sodas, and alcoholic beverages.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These can sabotage weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of recognizing satiety and stopping intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Overeating may cause nausea and vomiting, as well as having the potential to damage surgical anastomosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Require that client sit up to drink and eat.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces possibility of aspiration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine foods that are gas forming and eliminate them from diet.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May cause nausea and bloating, interfering with digestion and causing client to restrict nutritional intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss food preferences with client and include those foods in pur&eacute;ed diet when possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May enhance intake and promote sense of participation and control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weigh on regular schedule.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitors losses and aids in assessing nutritional needs and effectiveness of therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refer to dietitian or multidisciplinary team.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides assistance in planning a diet specifically geared toward client&rsquo;s type of bariatric surgery (e.g., gastric bypass, Lap-Band) that meets client&rsquo;s nutritional needs as well as offering individualized treatment and support. <emphasis>Note:</emphasis> Because quantity is strictly limited, foods should be nutrient dense, low in fat and sugars, and high in protein.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer vitamin supplements (may use chewable vitamins) and vitamin B<subscript>12</subscript> injections, folate, and calcium, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>When absorption is impaired, supplements will be needed for life to prevent complications associated with vitamin deficiencies. Increased intestinal motility following bypass procedure lowers calcium level and increases absorption of oxalates, which can lead to urinary stone formation.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0463">
<title><emphasis role="strong">NURSING DIAGNOSIS: impaired Skin/Tissue Integrity</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Mechanical factors (e.g., shearing forces, pressure, surgical procedure)</para>
<para>Impaired circulation</para>
<para>Imbalanced nutritional state&mdash;obesity</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in skin integrity [i.e., disruption of skin surface/skin layers; invasion of body structures]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Wound Healing: Primary Intention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display timely wound healing without complications.</para>
<para><emphasis role="strong">Tissue Integrity: Skin and Mucous Membranes</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display intact skin free of signs of pressure or breakdown.</para>
</note>
<note role="none" id="ch0006s0189note0464">
<table frame="top" id="ch0006s0189ta0263"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Incision Site Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe incisions periodically, noting approximation of wound edges, hematoma formation and resolution, and presence of redness, bleeding, and drainage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Verifies status of healing, provides for early detection of developing complications requiring prompt evaluation and influencing choice of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide routine incisional care, being careful to keep dressing dry and sterile. Assess and maintain patency of drains (if used).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes healing. Accumulation of serosanguineous drainage in subcutaneous layers increases tension on suture line, may delay wound healing, and serves as a medium for bacterial growth.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct client/provide incisional support when turning, coughing, deep breathing, and ambulating.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces possibility of dehiscence and incisional hernia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Pressure Ulcer Prevention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage/assist with frequent positional change. Inspect pressure points, and massage gently, as indicated. Apply transparent skin barrier to elbows and heels, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces pressure on skin, promoting peripheral circulation and reducing risk of skin breakdown. Skin barrier reduces risk of shearing injury. <emphasis>Note:</emphasis> Obese clients may be unable/have difficulty repositioning themselves (Dambaugh &amp; Eckland, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Skinfold management:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Inspect all skin surfaces, paying particular attention to multiple skinfolds (e.g., under breasts, abdomen, perineal and gluteal folds, posterior neck, lumbar and midback areas) common in the obese client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may have intertriginous dermatitis (ITD), thought to arise from skin-on-skin friction that initially leads to mild erythema and may progress to more intense inflammation with erosion, oozing, exudation, maceration, and crusting. Moisture or excoriation enhances growth of yeast and bacteria that can lead to chronic skin infections and raise the risk of postoperative wound infection from local contamination (Black et al, 2011; Dambaugh &amp; Eckland, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bathe/cleanse skin carefully, using a mild skin cleanser instead of ordinary soap.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gentle mechanical actions should be used when cleansing the skin, and scrubbing should be avoided. The cleanser should be free of perfumes or potential irritants, and its pH should be similar to that of normal skin. One option is pH-balanced disposable cleansing cloths or soft baby washcloths, since regular washcloths can be abrasive. <emphasis>Note:</emphasis> The pH of ordinary soap is usually due to alkaline, which may increase skin irritation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Apply skin moisturizers, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be needed to keep skin supple if at risk for cracking or fissuring from excessive dryness.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use absorptive fabric/padding and loose-fitting clothing, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obese clients tend to sweat profusely. The combination of increased perspiration and larger skinfolds increases the risk for maceration and for friction damage. Use of absorptive materials in skinfolds helps keep them dry and reduces risk of skin rashes and breakdown. Client should be encouraged to wear loose-fitting, lightweight clothing made from natural fibers to absorb moisture from skinfolds. Other options include athletic clothing specifically designed to draw moisture away from the skin.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Utilize draw sheets to form sling to lift or shift large tissue areas (e.g., abdominal panniculus) when moving client in bed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of friction and shear injuries and pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide foam, water, or air mattress, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces skin pressure and enhances circulation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to skin/wound specialist nurse if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be desired/needed in client with severe skin and/or tissue conditions. Management strategies must focus on elimination of skin-to-skin contact without causing harm to friable tissue, as well as education of client/SO in skin care.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0465">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inadequate primary defenses&mdash;broken skin, traumatized tissues, decreased ciliary action, stasis of body fluids</para>
<para>[Invasive procedures; malnutrition associated with obesity]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of healthcare-acquired infection.</para>
<para>Achieve timely wound healing free of signs of local or generalized infectious process.</para>
</note>
<note role="none" id="ch0006s0189note0466">
<table frame="top" id="ch0006s0189ta0264"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recognize client&rsquo;s risks for postoperative infections (e.g., obesity with possible preoperative malnutrition, as well as the increased need for protein and micronutrients for normal surgical wound healing in setting of restricted intake and possible malabsorption issues).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The nature of gastric bypass surgery leaves clients in a state of &ldquo;deliberate malnutrition,&rdquo; possibly exacerbating the altered metabolic response and nutritional deficiencies already present in the obese client. In addition, it is known that obesity is often associated with preoperative malnutrition. Nutritional deficits and stress of surgery can affect early wound healing in current situation, as well as increase the risk of other complications (Pierpont et al, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize and model proper handwashing technique.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents spread of bacteria and cross-contamination.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain aseptic technique in dressing changes and invasive procedures.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of healthcare-associated infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect surgical incisions and invasive line sites for erythema and purulent drainage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection of developing infection provides for prevention of more serious complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage frequent position changes, deep breathing, coughing, and use of respiratory adjuncts, such as incentive spirometer.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes mobilization of secretions, reducing risk of pneumonia associated with hypoventilation and atelectasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide routine catheter care (when used) and provide or assist with good perineal care. Remove catheter as early as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents ascending bladder infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to drink acid-ash juices, such as cranberry.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintains urine acidity and prevents bacteria from adhering to the bladder wall to retard bacterial growth.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for reports of abdominal pain, especially after third postoperative day; elevated temperature; and increased white blood cell (WBC) count.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggests possibility of anastomotic leak, developing peritonitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer IV antibiotics, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A prophylactic antibiotic regimen is usually standard in these clients to reduce risk of perioperative contamination and peritonitis.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Obtain specimen of purulent drainage or sputum for culture and sensitivity.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Identifies infectious agent; aids in choice of appropriate therapy.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0467">
<title><emphasis role="strong">NURSING DIAGNOSIS: Diarrhea</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Treatment regimen: inflammation; irritation; malabsorption</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Loose, liquid stools</para>
<para>Hyperactive bowel sounds; bowel urgency, cramping</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of causative factors and rationale of treatment regimen.</para>
<para>Follow through with treatment recommendations.</para>
<para><emphasis role="strong">Gastrointestinal Function</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Regain near-normal bowel function.</para>
</note>
<note role="none" id="ch0006s0189note0468">
<table frame="top" id="ch0006s0189ta0265"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Diarrhea Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss potential for diarrhea as indicated (e.g., after gastric bypass). Observe and record stool frequency, characteristics, and accompanying symptoms.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gastric bypass surgery may cause &ldquo;dumping syndrome&rdquo; where food moves too quickly from the stomach to the small intestine. Symptoms include nausea, weakness, sweating, fainting, and, occasionally, diarrhea after eating. This condition is usually self-limiting but can cause discomfort and social difficulties when persistent.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage diet high in fiber and bulk within dietary limitations, with moderate fluid intake as diet resumes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases consistency of the effluent. Although fluid is necessary for optimal body function, excessive amounts contribute to diarrhea.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Restrict fat intake, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low-fat diet reduces risk of steatorrhea and limits laxative effect of decreased fat absorption.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications such as diphenoxylate with atropine (Lomotil), if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antidiarrheals may be desired to control frequency of stools; however, drug absorption issues may prevent their use.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor serum electrolytes.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Large gastric losses potentiate the risk of electrolyte imbalance, which can lead to more serious or life-threatening complications.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0469">
<title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information; insufficient knowledge of resources</para>
<para>Misinformation presented by others</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions; development of preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of surgical procedure, potential complications, and postoperative expectations.</para>
<para><emphasis role="strong">Knowledge: Treatment Regimen</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of therapeutic needs and rationale for actions.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>
<note role="none" id="ch0006s0189note0470">
<table frame="top" id="ch0006s0189ta0266"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Individual</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review specific surgical procedure and postoperative expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which informed choices can be made and goals formulated. Initial weight loss is rapid, with client often losing half of the total weight loss during the first 6 months. Weight loss then gradually stabilizes over a 2-year period.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Address concerns about altered body size and image.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Anticipation of problems can be helpful in dealing with situations that arise. (Refer to CP: <link linkend="ch0006s0184">Obesity</link>; ND: <link linkend="ch0006s0184note0447">disturbed Body Image</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review medication regimen, dosage, and side effects.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge may enhance client&rsquo;s involvement with therapeutic regimen. <emphasis>Note:</emphasis> As client loses weight, the dosages of many medications may need to be recalculated because body fat alters the pharmacokinetics of many medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend avoidance of alcohol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High caloric count contributes to slowed weight loss as well as liver and pancreatic dysfunction. <emphasis>Note:</emphasis> Recent studies found that the Roux-en-Y and sleeve gastrectomy procedures more than doubled the association to alcohol problems. It is believed alcohol is metabolized differently after these procedures, which may lead to loss of sensitivity to the effects of alcohol at the time of drinking and thus increase risk of overuse and abuse (King et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss responsibility for self-care with client and significant other (SO).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Full involvement in weight-loss program is important for successful outcome after procedure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of regular medical follow-up, including laboratory studies, and discuss possible health problems.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Periodic assessment and evaluation, for example, over 3 to 12 months, promotes early recognition of such complications as liver dysfunction, malnutrition, electrolyte imbalances, and kidney stones, which may develop following bypass procedure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Diet Staging: Weight Loss Surgery</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage progressive exercise and activity program balanced with adequate rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes weight loss, enhances muscle tone, and minimizes postoperative complications while preventing undue fatigue.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review proper eating habits; for example, eat small amounts of food slowly and chew well; sit at table in calm, relaxed environment; eat only at prescribed times; avoid between-meal snacking; and do not &ldquo;make up&rdquo; skipped feedings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Focuses attention on eating, increasing awareness of intake and feelings of satiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify signs of hypokalemia, for example, diarrhea, muscle cramps, weakness of lower extremities, weak or irregular pulse, and dizziness with position changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increasing dietary intake of potassium (e.g., milk, coffee, potatoes, carrots, bananas, oranges) may correct deficit, preventing serious respiratory or cardiac complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss symptoms that may indicate dumping syndrome: weakness, profuse perspiration, nausea, vomiting, faintness, flushing, and epigastric discomfort or palpitations occurring during or immediately following meals. Problem-solve solutions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Generally occurring in early postoperative period (1 to 3 weeks), syndrome is usually self-limiting but may become chronic and require medical intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review symptoms requiring medical evaluation, including persistent nausea or vomiting, abdominal distention or tenderness, change in pattern of bowel elimination, fever, purulent wound drainage, excessive weight loss, plateauing, or weight gain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early recognition of developing complications allows for prompt intervention, preventing serious outcome.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to bariatric postoperative program or community support groups.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Involvement with others who have dealt with same problems enhances coping; may promote cooperation with therapeutic regimen and long-term positive recovery.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0189note0471">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for imbalanced Nutrition: less than body requirements</emphasis>&mdash;inability to ingest food&mdash;restricted intake, early satiety; inability to absorb nutrients&mdash;malabsorption of nutrients and impaired absorption of vitamins</para></listitem>
<listitem><para><emphasis role="bi">risk for delayed Surgical Recovery</emphasis>&mdash;obesity; pain; excessive surgical procedure</para></listitem>
<listitem><para><emphasis role="bi">risk for ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen; family patterns of healthcare; perceived benefit/barriers; social support deficit</para></listitem>
<listitem><para><emphasis role="bi">risk for [recurrent] Overweight</emphasis>&mdash;disordered eating behavior, frequent snacking, consumption of sugar-sweetened beverages, average daily physical activity less than recommended</para></listitem></itemizedlist>
</note>
<para><emphasis role="strong">***Refer to <link linkend="ch0014s0343note0550">Potential Considerations</link> in <link linkend="ch0014s0348">Surgical Intervention</link> plan of care.</emphasis></para>
</sect2></sect1>
<sect1 id="ch0006s0194"><title><emphasis role="strong">DIABETES MELLITUS AND DIABETIC KETOACIDOSIS</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Diabetes mellitus (DM, also called diabetes) is a chronic metabolic disorder characterized by high blood glucose levels, in which the body cannot metabolize carbohydrates, fats, and proteins because of a lack of, or ineffective use of, the hormone insulin.</para></listitem>
<listitem><para>Diabetes is the leading cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness as well as a major cause of heart disease and stroke among adults in the United States (American Diabetes Association [ADA], 2017).</para></listitem>
<listitem><para>Diabetic ketoacidosis (DKA) is a life-threatening emergency caused by a relative or absolute deficiency of insulin. DKA is a complex disturbed metabolic state, characterized by hyperglycemia, ketoacidosis, and ketonuria. Although DKA occurs mainly in type 1 diabetes mellitus (T1DM), it can occur in people with type 2 DM (T2DM) (Hamdy, 2014).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Classifications of Diabetes Mellitus</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>The ADA classifies diabetes into four main categories, based on underlying mechanisms (ADA, 2017; Tashko, 2017).</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Type 1 diabetes mellitus (T1DM)&mdash;formerly called <emphasis>juvenile-onset</emphasis> or <emphasis>insulin-dependent diabetes</emphasis> is due to autoimmune beta-cell destruction in the pancreas, resulting in an absolute insulin deficiency.</para></listitem>
<listitem><para>Type 2 diabetes mellitus (T2DM)&mdash;formerly known as <emphasis>adult onset</emphasis> or <emphasis>non-insulin-dependent diabetes</emphasis> is due to a progressive loss of beta-cell insulin secretion and mounting insulin resistance.</para></listitem>
<listitem><para>Gestational diabetes (GD) applies to women in whom glucose intolerance develops or is first discovered during pregnancy. GD develops in 2% to 18% of all pregnant women, typically develops in the second or third trimester, but disappears after delivery (ADA, 2017; Tashko, 2017). However, up to 10% of women with GD go on to develop T2DM, anywhere from weeks after delivery to months (or even years) later (Dansinger, 2017).</para></listitem>
<listitem><para>Other cause diabetes: Less commonly known forms include disease of the exocrine pancreas (such as occurs with cystic fibrosis), drug- or chemical-induced diabetes (such as occurs with glucocorticoid use or after organ transplantation), ketosis-prone diabetes (KPD), and latent autoimmune diabetes in adults (LADA) (Giese, 2016; Tashko, 2017).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology of Diabetes</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Type 1 Diabetes</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>An autoimmune disease possibly triggered by genetic and environmental factors</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Destroys beta-cells in the pancreas</para></listitem>
<listitem><para>When 80% to 90% of the beta-cells are destroyed, overt symptoms occur.</para></listitem>
<listitem><para>Abrupt onset of signs and symptoms of hyperglycemia</para></listitem>
<listitem><para>Totally insulin deficient; clients require exogenous insulin to survive.</para>
</listitem></orderedlist></listitem>
<listitem><para>Other characteristics</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Five percent of people with diabetes have this type (ADA, 2017).</para></listitem>
<listitem><para>Usually occurs before 30 years of age, with peak onset during puberty, but can occur at any age. <emphasis>Note:</emphasis> A Swedish study in 2008 reported that 25% of T1DM cases are diagnosed as adults (Thunander et al, 2008).</para></listitem>
<listitem><para>Common complications: ketoacidosis, kidney disease, heart disease, neuropathy, foot problems, eye disease (retinopathy); skin infections, gum disease (Dansinger, 2017).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Type 2 Diabetes</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Involves a decreased ability to use the insulin produced in the pancreas</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Decreased insulin secretion in response to glucose levels</para></listitem>
<listitem><para>Insulin resistance blocking cells from absorbing glucose</para></listitem>
<listitem><para>Excess production of glucose because of defective insulin secretory response</para>
</listitem></orderedlist></listitem>
<listitem><para>Other characteristics</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Accounts for approximately 90% of all diabetes in the United States (Centers for Disease Control and Prevention [CDC], 2014).</para></listitem>
<listitem><para>Usually occurs after 30 years of age but is now occurring in children and adolescents. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note: </emphasis>T2DM now represents 8% to 45% of all new cases of diabetes reported among children and adolescents, primarily in minority populations (Dabelea et al, 2007; Morales Pozzo, 2017).</para></listitem>
<listitem><para>Increased prevalence in some ethnic groups&mdash;African Americans (13.2% of all African Americans age 20 or older have diagnosed diabetes) (ADA, 2014), Hispanic/Latino, Native Americans, Asian Americans, and Pacific Islanders</para></listitem>
<listitem><para>Strong genetic predisposition</para></listitem>
<listitem><para>Frequently associated with obesity</para></listitem>
<listitem><para>Common complications: <emphasis role="bi">Short term:</emphasis> hypoglycemia, HHNS (see <link linkend="ch0006s0194note0472">Glossary</link>). <emphasis role="bi">Long term:</emphasis> microvascular complications affecting eyes (cataracts and/or retinopathy); kidneys (nephropathy with impaired kidney function or failure); nerves (peripheral neuropathy is the most common form, often affecting the feet and hands). Macrovascular complications can affect the large blood vessels over time, causing heart attack, stroke, and peripheral vascular disease (Leontis &amp; Hess-Fischl, 2017). <emphasis>Note:</emphasis> Person with T2DM is not typically prone to ketoacidosis.</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology of DKA (Hamdy, 2014)</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Previously undiagnosed or newly diagnosed type 1 diabetes</para></listitem>
<listitem><para>Brittle diabetes</para></listitem>
<listitem><para>Underlying infection (40%)</para></listitem>
<listitem><para>Missed or disrupted insulin treatments; acute insulin deficiency (25%)</para></listitem>
<listitem><para>Stress associated with illness, infection, trauma, or emotional distress</para></listitem>
<listitem><para>Biochemical changes, including blood glucose greater than 250 mg/dL (usually much higher) with acidity demonstrated by increased serum ketones, and arterial pH &lt;7</para></listitem>
<listitem><para>DKA is much more common in young children and adolescents than it is in adults. However, it may occur in patients with diabetes at any age.</para></listitem>
<listitem><para>Cerebral edema is the most severe complication of DKA. It occurs in 0.5% to 1% of all DKA cases (Lawrence et al, 2005) and carries a mortality rate of 21% to 24%. Survivors are at risk of residual neurologic problems (Wolfsdorf et al, 2007).</para></listitem>
</orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: In 2015, an estimated 30.3 million Americans had diabetes, with approximately 1.25 million children and adults having type 1. <emphasis>Note:</emphasis> These figures include both diagnosed and undiagnosed diabetes (which includes persons who were unaware of or did not report having diabetes). Both fasting glucose and hemoglobin A1C (A1C) levels were used to derive estimates for undiagnosed diabetes and prediabetes (ADA, 2017; CDC, 2017a). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> In 2015, approximately 193,000 American children and adolescents (under the age of 20) were estimated to have diagnosed diabetes, with most of those being T1DM (ADA, 2017; CDC, 2017a). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Research shows that the initial presentation of T1DM is ketoacidosis in about one-third of children (Klingensmith et al, 2013).</para>
</listitem>
<listitem><para>Mortality: In 2016, diabetes was reported to be the seventh leading cause of death. This ranking is based on 76,488 death certificates in 2014, in which diabetes was the underlying cause of death (CDC, 2016b). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Children aged 1 to 4 years are particularly at risk and may die due to diabetic ketoacidosis (DKA) at the time of diagnosis. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Most deaths in adolescents result from delayed diagnosis or neglected treatment and subsequent cerebral edema during treatment for DKA, although untreated hypoglycemia also causes some deaths (Lamb, 2017).</para></listitem>
<listitem><para>Cost: Estimated direct medical care costs of $176 billion annually with an additional $69 billion of indirect costs (CDC, 2016b).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0194note0472"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">A1C test: </emphasis>(also known as HbA1c, glycated hemoglobin, or glycosylated hemoglobin) is a blood test that correlates with a person&rsquo;s average blood glucose level over a span of a few months.</para>
<para><emphasis role="strong">Acetone: </emphasis>Chemical formed in the blood when the body uses fat instead of glucose for energy. Acetone passes through the body into the urine. Someone with high levels of acetone can have breath that smells fruity and is called &ldquo;acetone breath.&rdquo;</para>
<para><emphasis role="strong">Beta-cells: </emphasis>Cells that make insulin found in areas of the pancreas called the islets of Langerhans.</para>
<para><emphasis role="strong">Blood glucose: </emphasis>The main sugar that the body makes from food. Glucose is carried through the bloodstream to provide energy to all of the body&rsquo;s living cells.</para>
<para><emphasis role="strong">Counterregulatory hormone: </emphasis>A hormone that opposes the action of another or others. For example, the action of <emphasis role="strong">insulin </emphasis>is counterregulated by hormones <emphasis role="strong">glucagon, epinephrine (adrenaline), norepinephrine (noradrenaline), cortisol, </emphasis>and <emphasis role="strong">growth hormone.</emphasis></para>
<para><emphasis role="strong">Dawn phenomenon: </emphasis>An abrupt increase in fasting levels of serum glucose concentrations between the hours of 5 a.m. and 9 a.m., without preceding hypoglycemia, especially in diabetic patients receiving insulin therapy.</para>
<para><emphasis role="strong">Diabetic ketoacidosis (DKA): </emphasis>A life-threatening complication of T1DM in which very high blood sugar levels (along with a very low level of insulin) result in a dangerous accumulation of ketones (acids) in the blood and urine. Coma or death can result if condition is not treated. <emphasis>Note:</emphasis> Although persons with DKA typically have a history of diabetes, 27% to 37% are newly diagnosed with diabetes (especially young children), and it is the most common cause of mortality in people under 40 with T1DM. DKA is more common in young people and in certain groups of people (e.g., those with eating disorders or mental disorders) (Mills &amp; Stamper, 2014; Westerberg, 2013).</para>
<para><emphasis role="strong">Diabetic neuropathy: </emphasis>Family of nerve disorders caused by diabetes, causing numbness, pain, and weakness in the hands, arms, feet, and legs. About half of all diabetics have some form of neuropathy.</para>
<para><emphasis role="strong">Hyperglycemia: </emphasis>High blood glucose.</para>
<para><emphasis role="strong">Hyperosmolar hyperglycemic nonketotic syndrome (HHNS): </emphasis>A rare complication of diabetes (<emphasis role="bi">most commonly, T2DM</emphasis>), where diabetes is uncontrolled (e.g., blood glucose level is very high, often greater than 600). HHNS is most likely to occur in conjunction with an illness, and elderly people are most likely to develop it. When blood glucose level starts to climb, the body will try to get rid of the excess glucose through frequent urination, resulting in dehydration. If HHNS continues, the severe dehydration will lead to seizures, coma, and eventually death.</para>
<para><emphasis role="strong">Hypoglycemia: </emphasis>Low blood glucose.</para>
<para><emphasis role="strong">Impaired fasting glucose: </emphasis>Person has elevated fasting blood glucose because the liver is resistant to the action of insulin, allowing it to release too much glucose into the bloodstream. Also, the early burst of insulin (that normally occurs within 30 minutes of a meal) is absent. The late insulin response after the meal is normal, so blood glucose returns to its usual (but elevated) level 2 hours after the meal.</para>
<para><emphasis role="strong">Impaired glucose tolerance: </emphasis>Some people have trouble producing late-phase insulin. Glucose level is normal after fasting overnight and between meals but rises progressively after meals or after eating carbs and remains elevated 2 hours.</para>
<para><emphasis role="strong">Insulin: </emphasis>Hormone produced by the pancreas that helps the body use blood glucose for energy. A person lacking this hormone is dependent on supplemental, outside (exogenous) sources.</para>
<para><emphasis role="strong">Insulin analogue: </emphasis>An altered form of insulin, different from any occurring in nature, but still available to the human body for performing the same action as human insulin in terms of glycemic control.</para>
<para><emphasis role="strong">Insulin release: </emphasis>Following a meal, insulin is released in <emphasis role="bi">two phases:</emphasis> (1) an early burst that occurs 30 minutes after eating and a (2) late phase that happens a half hour to 2 hours after a meal.</para>
<para><emphasis role="strong">Insulin resistance: </emphasis>Body is unable to use the insulin that it makes because of cell-receptor defect resulting in inability of cells to absorb glucose.</para>
<para><emphasis role="strong">Ketones: </emphasis>Chemical substances produced when the body breaks down fat for energy. When ketones build up in the body over a long period of time, serious illness or coma can result.</para>
<para><emphasis role="strong">Kussmaul respirations: </emphasis>Abnormal respiratory pattern characterized by rapid, deep breathing, often seen in client with metabolic acidosis.</para>
<para><emphasis role="strong">Lactic acidosis: </emphasis>The buildup of lactic acid in the body. Cells make lactic acid when they use glucose for energy. If too much lactic acid stays in the body, the balance tips and the person begins to feel ill. Lactic acidosis may be caused by DKA or liver or kidney disease.</para>
<para><emphasis role="strong">Metabolic acidosis: </emphasis>A pH imbalance in which the body has accumulated too much acid and does not have enough bicarbonate to effectively neutralize the effects of the acid. It can be brought on by a lack of insulin, a starvation diet, a gastrointestinal (GI) disorder, or a major organ dysfunction. For a person with diabetes, this can lead to diabetic ketoacidosis.</para>
</note>
<sect2 id="ch0006s0195"><title><emphasis role="strong">CARE SETTINGS</emphasis></title>
<para>Diabetes is managed throughout life in the community setting.</para>
<para>Diabetic ketoacidosis (DKA) may be encountered in any setting, with mild DKA managed at the community level; however, severe metabolic imbalance requires inpatient acute care on a medical unit.</para>
</sect2>
<sect2 id="ch0006s0196"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para>Metabolic acidosis&mdash;primary base bicarbonate deficiency (see Davis <emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0014s0384">Pediatric considerations</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><emphasis role="strong">***The hospitalized client with DKA is the focus of this care plan.</emphasis></para>
<table frame="top" id="ch0006s0194ta0267"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE (DKA)</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>****Data depend on the severity and duration of metabolic imbalance, length and stage of diabetic process, and effects on other organ function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Sleep and rest disturbances</para></listitem>
<listitem><para>Weakness, fatigue, difficulty walking and moving</para></listitem>
<listitem><para>Muscle cramps, decreased muscle strength</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachycardia and tachypnea at rest or with activity</para></listitem>
<listitem><para>Lethargy, disorientation, coma</para></listitem>
<listitem><para>Decreased muscle strength and tone</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of hypertension; acute myocardial infarction (MI)</para></listitem>
<listitem><para>Leg ulcers, slow healing</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Confusion, disorientation (hypoglycemia); coma (in severe DKA)</para></listitem>
<listitem><para>Tachycardia; dysrhythmias</para></listitem>
<listitem><para>Postural blood pressure (BP) changes; hypertension</para></listitem>
<listitem><para>Crackles; jugular vein distention (JVD)&mdash;if heart failure present</para></listitem>
<listitem><para>Decreased or absent pulses</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Life stressors, including financial concerns related to condition</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Anxiety, irritability</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Change in usual voiding pattern</para></listitem>
<listitem><para>Excessive urination (polyuria)</para></listitem>
<listitem><para>Nocturia</para></listitem>
<listitem><para>Pain and burning, difficulty voiding (infection neurogenic bladder)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Pale, yellow, dilute urine</para></listitem>
<listitem><para>Polyuria may progress to oliguria and anuria if severe hypovolemia occurs</para></listitem>
<listitem><para>Glycosuria</para></listitem>
<listitem><para>Cloudy, odorous urine (infection)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent and recurrent urinary tract infections (UTIs) (often a precipitator of DKA)</para></listitem>
<listitem><para>Abdominal tenderness, bloating, diarrhea</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal rigidity and distention</para></listitem>
<listitem><para>Bowel sounds diminished or hyperactive (diarrhea)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Not following prescribed diet if diabetic (e.g., increased intake of glucose and carbohydrates)</para></listitem>
<listitem><para>No diet followed (e.g., unknown diabetes)</para></listitem>
<listitem><para>Loss of appetite, nausea, and vomiting</para></listitem>
<listitem><para>Unexplained or rapid weight loss over a period of days or weeks</para></listitem>
<listitem><para>Overweight or obesity (common in adults and <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> strongly associated with children and adolescents with T2DM)</para></listitem>
<listitem><para>Thirst; abnormally great thirst</para></listitem>
<listitem><para>Use of medications exacerbating dehydration, such as diuretics</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Halitosis and sweet, fruity breath odor</para></listitem>
<listitem><para>Hot, dry, flushed skin (if fever present)</para></listitem>
<listitem><para>Dry and cracked skin, poor skin turgor; sunken eyeballs&mdash;if dehydration is severe in DKA</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fainting spells, dizziness</para></listitem>
<listitem><para>Headaches</para></listitem>
<listitem><para>Visual disturbances</para></listitem>
<listitem><para>Tingling, numbness, weakness in muscles</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Confusion, disorientation</para></listitem>
<listitem><para>Drowsiness, lethargy, stupor, and coma (later stages DKA or hypoglycemia)</para></listitem>
<listitem><para>Seizure activity (late stages of DKA or hypoglycemia)</para></listitem>
<listitem><para>Deep tendon reflexes (DTRs) may be decreased</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal bloating and pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Facial grimacing with abdominal palpation, guarding</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Air hunger (late stages of DKA)</para></listitem>
<listitem><para>Cough, with and without purulent sputum (infection)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachypnea</para></listitem>
<listitem><para>Kussmaul&rsquo;s respiration (metabolic acidosis)</para></listitem>
<listitem><para>Rhonchi, wheezes</para></listitem>
<listitem><para>Yellow or green sputum (infection)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dry, itching skin, skin ulcerations</para></listitem>
<listitem><para>Paresthesia (diabetic neuropathy)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Skin breakdown, lesions, and ulcerations</para></listitem>
<listitem><para>Weakness and paralysis of muscles, including respiratory musculature&mdash;if potassium levels are markedly decreased</para></listitem>
<listitem><para>Decreased general strength and range of motion (ROM)</para></listitem>
<listitem><para>Fever, diaphoresis, other signs of infection <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> (especially in children presenting in DKA as an initial presentation of T1DM)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Vaginal discharge (prone to infection)</para></listitem>
<listitem><para>Problems with impotence (men), orgasmic difficulty (women)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Familial risk factors, such as diabetes mellitus, heart disease, stroke, hypertension</para></listitem>
<listitem><para>Slow and delayed healing</para></listitem>
<listitem><para>History of failure to comply with insulin or oral diabetes medications prescriptions</para></listitem>
<listitem><para>Use of drugs, such as steroids, thiazide diuretics, phenytoin (Dilantin), and phenobarbital (can increase glucose levels)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May need assistance with dietary regimen, glucose monitoring, medication administration, supplies, and self-care</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0194ta0268"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Glucose:</emphasis> The gold standard for diagnosing diabetes is an elevated plasma glucose level after an overnight fast.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Diabetes diagnosis (type 1):</emphasis> This person typically presents with symptoms of uncontrolled hyperglycemia (e.g., polyuria, polydipsia, polyphagia). In such cases, the diagnosis of DM can be confirmed with a random (nonfasting) plasma glucose concentration of 200 mg/dL or a fasting plasma glucose concentration of 126 mg/dL or higher (Khardori, 2017). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note:</emphasis> A1C is not typically measured when person presents with overt symptoms of uncontrolled hyperglycemia, as often occurs in children (Vehik et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Hemoglobin A1c test, also called A1C, or HbA1c, or glycated hemoglobin test:</emphasis> Levels provide an estimate of plasma glucose levels during the preceding 1 to 3 months. The normal range is between 4% and 5.6%. Target level for diabetics is &lt;7%.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Diabetes diagnosis (type 2):</emphasis> A fasting plasma glucose (FPG) value above 126 mg/dL, a 2-hour plasma glucose above 200 mg/dL after an oral glucose challenge, or A1C greater than 6.5% establishes a diagnosis of diabetes. <emphasis>Note:</emphasis> Use of the A1C test is recommended for persons with T2DM. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Since more children/youth are now being diagnosed with T2DM, this test may be used as a screening tool in children.</para>
<para><emphasis role="bi">DKA diagnosis:</emphasis> Is defined as glucose greater than 250 mg/dL in association with an arterial pH of less than 7.30, or serum bicarbonate of less than 15 mEq/L, and ketonemia (serum ketones) and ketonuria (abnormally large amounts of ketones in urine) (Hamdy, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Total serum ketones:</emphasis> Types of naturally occurring and synthetic lipid compounds.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>When insulin levels are too low or there is not enough glucose to use for energy, the body burns fat for energy. The body then makes ketone bodies (waste products) that cause the acid level in the blood to become too high. Ketones may also be present in the urine as levels reach threshold and &ldquo;spill&rdquo; over into the urine.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum osmolality:</emphasis> Measures the concentration of particles found in the fluid part of blood to help evaluate the body&rsquo;s water balance. Normal calculated values range from 280 to 303 mOsm/K.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Osmolality increases with dehydration and decreases with overhydration. In DKA, osmolality is elevated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Glucogon:</emphasis> Hormone that raises the blood glucose level.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated level is associated with conditions that produce (1) actual hypoglycemia; (2) relative lack of glucose, such as trauma or infection; or (3) lack of insulin. Therefore, glucagon may be elevated with severe DKA despite hyperglycemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum insulin:</emphasis> Peptide hormone that enables the body to metabolize and use glucose.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be decreased or absent (type 1) or normal to high (type 2), indicating absolute or relative deficiency of body&rsquo;s insulin (endogenous), or improper use of insulin preparations (exogenous).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Islet cell autoantibodies:</emphasis> Partial listing may include such tests as islet cell cytoplasmic autoantibodies (ICAs), glutamic acid decarboxylase-65 autoantibody (GAD-65A), insulioma-assoicated-2 autoantibody (IA-2A), and insulin autoantibodies (IAAs).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These tests may be helpful in diagnosing autoimmune diabetes such as latent autoimmune diabetes (LADA) or slowly progressing T1DM (Kawasaki et al, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrolytes:</emphasis> Substances that dissociate into ions in solution and acquire the capacity to conduct electricity. Common electrolytes include sodium, potassium, chloride, calcium, and phosphate.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sodium may be low, normal, or high (with total body depletion). Initial potassium level may be high, normal, or low (total body depletion). Potassium may be falsely elevated, reflecting cellular shifts, then markedly decrease with treatment of the DKA. Phosphate may be normal or low; chloride may be high. Levels are determined by amount of solute and water loss, which is not always equal.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Arterial blood gases (ABGs):</emphasis> Assessment of ABG levels of oxygen (PaO<subscript>2</subscript>), carbon dioxide (PaCO<subscript>2</subscript>), bicarbonate (HCO<subscript>3</subscript><superscript>&minus;</superscript>), and pH.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually reflect low pH and decreased HCO<subscript>3</subscript><superscript>&minus;</superscript> (metabolic acidosis) with compensatory respiratory alkalosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests, which typically includes Hgb; hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; white blood cell (WBC) count and differential.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hct may be elevated, reflecting dehydration; increased WBCs or leukocytosis suggests hemoconcentration, response to stress, or infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urine:</emphasis> Urine glucose correlates poorly with blood glucose, being dependent on renal glucose threshold (150 to 300 mg/dL) and should be used only if measuring of blood glucose is not possible or as a confirmatory test. Ketones should be self-monitored during febrile illness or when DKA symptoms are present.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In DKA, urine tests are positive for glucose and ketones. Specific gravity and osmolality may be elevated if dehydration is present.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Cultures and sensitivities:</emphasis> Specimens may include urine, sputum, or wound drainage.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reveal source of infection and identify effective antimicrobial agent.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">CT scan or MRI of head</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>These imaging studies can detect early cerebral edema and may be used in children with altered mental status and DKA (Hamdy, 2014).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0197"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Restore fluid, electrolyte, and acid-base balance.</para></listitem>
<listitem><para>Correct or reverse metabolic abnormalities.</para></listitem>
<listitem><para>Identify and assist with management of underlying cause or disease process.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, self-care, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0198"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Homeostasis achieved.</para></listitem>
<listitem><para>Causative and precipitating factors corrected or controlled.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Disease process, prognosis, self-care needs, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0194note0473">
<title><emphasis role="strong">NURSING DIAGNOSIS: deficient Fluid Volume [specify]</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Active fluid losses&mdash;diarrhea, vomiting, osmotic diuresis</para>
<para>Barrier to accessing fluid; insufficient fluid intake&mdash;nausea, vomiting, anorexia, mental status changes</para>
<para>Factors influencing fluid needs [e.g., hypermetabolic state; compromised regulatory mechanisms]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Increased urine output (hyperglycemia); decreased urine output, increased urine concentration (dehydration)</para>
<para>Weakness, thirst, sudden weight loss</para>
<para>Dry skin and mucous membranes, poor skin turgor</para>
<para>Decreased blood pressure, increased pulse rate, decreased pulse pressure</para>
<para>Alteration in mental status</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate adequate hydration as evidenced by stable vital signs, palpable peripheral pulses, good skin turgor and capillary refill, individually appropriate urinary output, and electrolyte levels within normal range.</para>
</note>
<note role="none" id="ch0006s0194note0474">
<table frame="top" id="ch0006s0194ta0269"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Obtain history from client and significant other (SO) related to duration and intensity of symptoms, such as vomiting and excessive urination.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps estimate total volume depletion. Symptoms may have been present for varying amounts of time&mdash;hours to days. Presence of infectious process results in fever and hypermetabolic state, increasing insensible fluid losses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note orthostatic BP changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypovolemia may be manifested by hypotension and tachycardia. Estimates of severity of hypovolemia may be made when client&rsquo;s systolic BP drops more than 10 mm Hg from a recumbent to a sitting or standing position.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respiratory pattern, such as Kussmaul&rsquo;s respirations, acetone breath</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lungs remove carbonic acid through respirations, producing a compensatory respiratory alkalosis or ketoacidosis. Acetone breath is due to breakdown of acetoacetic acid and should diminish as ketosis is corrected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Respiratory rate and quality; use of accessory muscles, periods of apnea, and appearance of cyanosis</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Correction of hyperglycemia and acidosis will cause the respiratory rate and pattern to approach normal. In contrast, increased work of breathing&mdash;shallow, rapid respirations&mdash;and presence of cyanosis may indicate respiratory fatigue and that client is losing ability to compensate for acidosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Temperature, skin color, and moisture</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although fever, chills, and diaphoresis are common with infectious process, fever with flushed, dry skin may reflect dehydration. <emphasis>Note:</emphasis> Although infection is a common precipitating factor for DKA, client may be normothermic, feverish, or hypothermic (because of peripheral vasodilation).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess peripheral pulses, capillary refill, skin turgor, and mucous membranes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of level of hydration and adequacy of circulating volume.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor intake and output (I&amp;O); note urine-specific gravity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides ongoing estimate of volume replacement needs, kidney function, and effectiveness of therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides the best assessment of current fluid status and adequacy of fluid replacement.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Promote comfortable environment. Cover client with light sheets.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoids overheating, which could promote further fluid loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate changes in mentation and sensorium.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in mentation can be due to abnormally high or low glucose, electrolyte abnormalities, acidosis, decreased cerebral perfusion, or developing hypoxia. Regardless of the cause, impaired consciousness can predispose client to aspiration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer fluids, as indicated such as:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Intravenous solutions replace extravascular and intravascular fluids and replenish electrolyte losses. They also dilute both the levels of glucose and circulating counterregulatory hormones (see <link linkend="ch0006s0194note0472">Glossary</link>) (Hamdy, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Isotonic (0.9%) or lactated Ringer&rsquo;s solution without additives. (Type of solution may be changed after initial stabilization according to physician orders or DKA protocol.)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Type and amount of fluid depends on degree of deficit and individual client response. <emphasis>Note:</emphasis> Client with DKA is often severely dehydrated due to active fluid losses and fluid shifts within the body, because of metabolic influences. Recent fluid replacement recommendations include 1 to 3 liters (L) of isotonic saline or lactated Ringer&rsquo;s during the first hour of treatment, followed by 1 L during the second hour, 1 L during the following 2 hours, and then 1 L every 4 hours (Hamdy, 2014). <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> The International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus Guidelines suggest that initial fluid replacement in pediatric patients should be 10 to 20 mL/kg of 0.9% saline during the first 1 to 2 hours (Wolfsdorf et al, 2007).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Albumin, plasma, dextran</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Plasma expanders may occasionally be needed if the deficit is life-threatening and BP does not normalize with rehydration efforts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Insert and maintain indwelling urinary catheter, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides for accurate and ongoing measurement of urinary output, especially if autonomic neuropathies result in neurogenic bladder with urinary retention and overflow incontinence. May be removed when client is stable to reduce risk of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hct</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses level of hydration; Hct is often elevated because of hemoconcentration associated with osmotic diuresis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blood urea nitrogen (BUN)/creatinine (Cr)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated values may reflect cellular breakdown from dehydration or signal the onset of renal failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum osmolality</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated because of hyperglycemia and dehydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sodium</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be decreased, reflecting shift of fluids from the intracellular compartment as with osmotic diuresis. High sodium values reflect severe fluid loss and dehydration or sodium reabsorption in response to aldosterone secretion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Initially, hyperkalemia occurs in response to metabolic acidosis, but as this potassium is lost in the urine, the absolute potassium level in the body is depleted. As insulin is replaced and acidosis is corrected, serum potassium deficit becomes apparent.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer potassium and other electrolytes intravenously (IV) or by oral route, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium should be added to the IV as soon as urinary flow is adequate, to prevent hypokalemia. <emphasis>Note:</emphasis> Potassium phosphate may be drug of choice when IV fluids contain sodium chloride in order to prevent chloride overload. Phosphate concentrations tend to decrease with insulin therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer bicarbonate, if indicated, for example, if pH is less than 7.1.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Not routinely necessary and given with caution to help correct acidosis in the presence of hypotension or shock, lactic acidosis, or severe hyperkalemia.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Insert nasogastric (NG) tube and attach to suction, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Decompresses stomach and may relieve vomiting.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0194note0475">
<title><emphasis role="strong">NURSING DIAGNOSIS: unstable Blood Glucose Level</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient diabetes management or adherence to diabetes management plan; inadequate blood glucose monitoring or ineffective medication management</para>
<para>Insufficient dietary intake; excessive weight gain or loss; rapid growth period; pregnancy</para>
<para>Compromised physical health status; excessive stress; [infectious process]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inadequate/inappropriate food intake, lack of interest in food</para>
<para>Weakness, fatigue, poor muscle tone</para>
<para>Altered level of consciousness (LOC)</para>
<para>Increased urinary output, dilute urine</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Blood Glucose Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Achieve and maintain glucose in satisfactory range.</para>
<para><emphasis role="strong">Self-Management: Diabetes</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Acknowledge factors that lead to unstable glucose and DKA.</para>
<para>Verbalize understanding of body and energy needs.</para>
<para>Verbalize plan for modifying factors to prevent or minimize complications.</para>
</note>
<note role="none" id="ch0006s0194note0476">
<table frame="top" id="ch0006s0194ta0270"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hyperglycemia Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine individual factors that may have contributed to current situation. Note client&rsquo;s age, developmental level, and awareness of needs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Occasionally, client with &ldquo;no known diabetes&rdquo; will present with DKA, especially a young person with some type of precipitating infection. However, many times DKA is precipitated by failure of diabetes management, possibly related to dietary factors, activity, or medications. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Because DKA presents more frequently in the young client with known T1DM, there has been a failure to account for developmental changes, such as a growth spurt or adolescent pregnancy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Perform blood glucose testing. Ascertain whether client and SO(s) are adept at blood glucose monitoring and are testing according to plan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>All available glucose monitors will provide satisfactory readings if properly used and maintained and routinely calibrated. <emphasis>Note:</emphasis> Unstable blood glucose is often associated with failure to perform testing on a regular schedule. Frequent glucose monitoring at home makes DKA less likely, as it allows client/caregiver to promptly search for reasons for unexpectedly high glucose levels before condition progresses to DKA (Bradley &amp; Tobias, 2008).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>For client on oral diabetes medications, review medications and ask about client&rsquo;s adherence to treatment plan.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A client presenting in DKA may not have been on either oral drugs or insulin prior to this incident, client may not have followed therapeutic regimen, or glucose may not be well controlled on current meds. (For additional information about oral diabetes medication refer to ND; <link linkend="ch0006s0194note0483">ineffective Health Maintenance</link>, end of this care plan.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>For client receiving insulin:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Physiologic insulin replacement is the standard of care in persons with advanced insulin deficiency. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject>&nbsp;<emphasis>Note: </emphasis>Children with diabetes usually have type 1 and thus a lifetime dependence on exogenous insulin. Most young children require two or more injections of insulin daily, with doses adjusted on the basis of intermittent monitoring of blood glucose levels. Typically, they receive around 50% of the basal requirement in the morning; the remainder is given as food-related boluses. Older children and adolescents may receive insulin via a programmable pump, over time, and in two ways: (1) a steady measured and continuous dose (&ldquo;basal&rdquo; insulin) and (2) a surge (&ldquo;bolus&rdquo;) dose, at client&rsquo;s direction, around mealtime (ADA, 2015; Lamb, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review type(s) of insulin used, such as ultra-short acting (e.g., lispro, aspart), short acting (e.g., regular), intermediate (e.g., NPH), and long acting (e.g., glargine, ultralente). Note delivery method&mdash;inhaled, subcutaneous injections, premixed pen injector, insulin infuser, or pump. Note times when short-acting, intermediate-acting, and long-acting insulins are administered, duration, and when they peak.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These factors affect timing of effects and provide clues to potential timing of glucose instability. Insulin products have differing onset, peak, and duration of action, ranging from ultra-short acting to ultra-long acting. The use of longer-acting insulin preparations and the continuous delivery of insulin via pump can produce near-normal glycemia (Meneghini, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Check injection sites.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Insulin absorption can vary from day to day in healthy sites and is even less absorbable in lypohypertrophic (lumpy) tissues.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review client&rsquo;s dietary program and usual pattern; compare with recent intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies deficits and deviations from therapeutic plan, which may precipitate unstable glucose and uncontrolled hyperglycemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily or as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assesses adequacy of nutritional intake&mdash;both absorption and utilization. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Note: Eating disorders are a contributing factor in 20% of recurrent DKA in young clients (Polin, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate bowel sounds. Note reports of abdominal pain and bloating, nausea, or vomiting. Maintain nothing by mouth (NPO) status, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyperglycemia and fluid and electrolyte disturbances decrease gastric motility and function resulting in gastroparesis, affecting choice of interventions. <emphasis>Note: </emphasis>Long-term difficulties with gastroparesis and poor intestinal motility suggest autonomic neuropathies affecting the GI tract and requiring symptomatic treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide liquids containing nutrients and electrolytes as soon as client can tolerate oral fluids; progress to more solid food as tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oral route is preferred when client is alert and bowel function is restored.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify food preferences, including ethnic and cultural needs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Incorporating as many of the client&rsquo;s food preferences into the meal plan as possible increases cooperation with dietary guidelines after discharge.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Include SO in meal planning, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes sense of involvement; provides information for SO to understand nutritional needs of client. <emphasis>Note:</emphasis> Various methods available for dietary planning include carbohydrate counting, exchange list, point system, or preselected menus.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for signs of hypoglycemia&mdash;changes in LOC, cool and clammy skin, rapid pulse, hunger, irritability, anxiety, headache, lightheadedness, and shakiness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Once carbohydrate metabolism resumes, blood glucose level will fall, and as insulin is being adjusted, hypoglycemia may occur. Unless client is comatose, hypoglycemia can occur without notable change in LOC. This potentially life-threatening emergency should be assessed and treated quickly per protocol. <emphasis>Note:</emphasis> Type 1 diabetics of long standing may not display usual signs of hypoglycemia because normal response to low blood sugar may be diminished.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as serum glucose, acetone, pH, and HCO<subscript>3</subscript><superscript>&minus;</superscript>.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blood glucose will decrease slowly with controlled fluid replacement and insulin therapy. With the administration of optimal insulin dosages, glucose can then enter the cells and be used for energy. When this happens, acetone levels decrease and acidosis is corrected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate in treatment of hyperglycemia in DKA:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment is focused on correction of metabolic imbalances and includes (1) correction of fluid loss with intravenous fluids; (2) correction of hyperglycemia with insulin; (3) correction of electrolyte disturbances, particularly potassium loss; (4) correction of acid-base balance; and (5) treatment of concurrent infection, if present (Hamdy, 2014).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer rapid (short)-acting insulin, such as regular (Humulin R), lispro (Humalog), or aspart (Novalog) by intermittent or continuous IV method, for example, IV bolus followed by a continuous drip via pump of approximately 5 to 10 units/hr so that glucose is reduced by 50 to 75 mg/dL/hr.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid-acting insulin is used in hyperglycemic crisis. The IV route is the initial route of choice because absorption from subcutaneous tissues may be erratic. Many believe the continuous method is the optimal way to facilitate transition to carbohydrate metabolism and reduce incidence of hypoglycemia. <emphasis>Note:</emphasis> Intermediate insulin, such as NPH, Humulin N, Lente, and long-acting insulin, such as Ultralente, protamine zinc insulin (PZI), and glargine (Lantus), may be part of the client&rsquo;s usual or added insulins but are not part of crisis hyperglycemic treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer glucose solutions, for example, 5% dextrose and half-normal saline.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Glucose solutions may be added after insulin and fluids have brought the blood glucose to approximately 180 mg/dL (Hamdy, 2014). As carbohydrate metabolism approaches normal, care must be taken to avoid hypoglycemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Consult with nutritionist or dietitian for resumption of oral intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in calculating and adjusting diet to meet client&rsquo;s specific needs; answer questions and assist client and SO in developing meal plans.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide diet of approximately 60% carbohydrates, 20% proteins, and 20% fats in designated number of meals and snacks.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Complex carbohydrates help to maintain more stable glucose levels, reduce serum cholesterol levels, and promote satiation. Food intake is scheduled according to specific insulin characteristics, such as peak effect and individual client response. <emphasis>Note:</emphasis> A snack of complex carbohydrates at bedtime is especially important if insulin is given in divided doses to prevent hypoglycemia during sleep and potential Somogyi response.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0194note0477">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Chronic disease&mdash;diabetes mellitus [hyperglycemia, metabolic disorder; poor tissue perfusion]</para>
<para>Alteration in skin integrity; invasive procedures/devises</para>
<para>Leukopenia; decrease in ciliary action</para>
<para>Increased environmental exposure to pathogens; [preexisting respiratory or urinary tract infection]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of infection(s).</para>
<para>Identify interventions to prevent or reduce risk of infection.</para>
<para>Demonstrate techniques and lifestyle changes to prevent development of infection.</para>
</note>
<note role="none" id="ch0006s0194note0478">
<table frame="top" id="ch0006s0194ta0271"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Prevention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe for signs of infection and inflammation&mdash;fever, flushed appearance, wound drainage, purulent sputum, and cloudy urine.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may be admitted with infection, which could have precipitated the ketoacidotic state, or can develop a hospital-acquired infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Model and promote good handwashing by staff and client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of cross-contamination.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain aseptic technique for IV insertion procedure, administration of medications, and providing site care. Rotate IV sites, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High glucose in the blood creates an excellent medium for bacterial growth.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide catheter and perineal care, where indicated. Teach the female client to clean from front to back after elimination.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes risk of UTI. Comatose client may be at particular risk if urinary retention occurred before hospitalization. <emphasis>Note:</emphasis> Elderly female diabetic clients are especially prone to UTIs and vaginal yeast infections. Many UTIs are asymptomatic, possibly related to neurogenic bladder.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide conscientious skin care, keep the skin dry, and keep linens dry and wrinkle-free.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Peripheral circulation may be impaired, placing client at increased risk for skin irritation and breakdown and infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect client&rsquo;s feet, noting presence of ulcers, infected ingrown toenails, or other problems requiring medical or nursing intervention.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Foot injuries, sensory neuropathy, and impaired circulation are associated with many complications in diabetics, including skin and soft tissue infections (cellulitis) with potential for amputations. These infections can affect any skin surface but most commonly involve the feet (Khardori, 2015). <emphasis>Note:</emphasis> Cellulitis can precipitate DKA.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rhonchi indicate accumulation of secretions possibly related to pneumonia or bronchitis that may have precipitated the DKA.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Place in semi-Fowler&rsquo;s position.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates lung expansion and reduces risk of aspiration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reposition and encourage coughing and deep breathing if client is alert and cooperative. Otherwise, suction airway, using sterile technique, as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in ventilating all lung areas and mobilizing secretions. Prevents stasis of secretions with increased risk of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide tissues and trash bag in a convenient location for sputum and other secretions. Instruct client in proper handling of secretions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes spread of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and assist with oral hygiene.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of oral and gum disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage adequate dietary and fluid intake (at least 2500 mL/d if not contraindicated by cardiac or renal dysfunction), including 8 oz of cranberry juice per day, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases susceptibility to infection. Increased urinary flow prevents stasis and aids in maintaining urine acidity, reducing bacteria growth and flushing organisms out of system. <emphasis>Note:</emphasis> Use of cranberry juice can help prevent bacteria from adhering to the bladder wall, reducing the risk of recurrent UTI.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obtain specimens for culture and sensitivities, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies organism(s) so that most appropriate drug therapy can be instituted.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer antibiotics, as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Early treatment may help prevent sepsis.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0194note0479">
<title><emphasis role="strong">NURSING DIAGNOSIS: [risk for disturbed Sensory Perception, (specify)]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>[Biochemical imbalance (e.g., glucose, insulin, electrolyte; insulin resistance, dehydration)]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Neurological Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Regain/maintain usual level of mentation.</para>
<para>Recognize and compensate for existing sensory impairments.</para>
</note>
<note role="none" id="ch0006s0194note0480">
<table frame="top" id="ch0006s0194ta0272"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Neurologic Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs and mental status.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides a baseline from which to compare abnormal findings; for instance, fever may affect mentation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Address client by name; reorient as needed to place, person, time, and situation. Give short explanations, speaking slowly and enunciating clearly.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases confusion and helps maintain contact with reality.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Schedule nursing activities to provide for uninterrupted rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes restful sleep, reduces fatigue, and may improve cognition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep client&rsquo;s routine as consistent as possible. Encourage participation in activities of daily living (ADLs) as able.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps keep client in touch with reality and maintain orientation to the environment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Protect client from injury&mdash;avoid or limit use of restraints as able, place bed in low position when cognition is impaired or seizures occur. Pad bed rails if client is prone to seizures.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Disoriented client is prone to injury, especially at night, and precautions need to be taken as indicated. Seizure precautions reduce risk of physical injury.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate visual acuity, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Retinal edema or detachment, hemorrhage, presence of cataracts, or temporary paralysis of extraocular muscles may impair vision, requiring corrective therapy or supportive care. <emphasis>Note:</emphasis> Retinopathy is a very common microvascular complication associated with diabetes and is the cause of approximately 8000 new cases of blindness annually (Bhavsar et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of hyperesthesia, pain, or sensory loss in the feet and legs. Determine issue client may have with walking. Ascertain if client has (or needs) mobility aids.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Peripheral neuropathies may result in severe discomfort and absent or distorted tactile sensation, potentiating risk of impaired balance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep hands and feet warm, avoiding exposure to cool drafts, hot water, or heating pad.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces discomfort and potential for dermal injury. <emphasis>Note: </emphasis>Sudden development of cold hands and feet may reflect hypoglycemia, suggesting need to evaluate serum glucose level.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist with ambulation or position changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes client safety, especially when sense of balance is affected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Carry out prescribed regimen for correcting DKA, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alteration in thought processes and potential for seizure activity is usually alleviated once hyperosmolar state is corrected.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory values, such as blood glucose, serum osmolality, Hgb/Hct, and BUN/Cr.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Imbalances can impair mentation. <emphasis>Note:</emphasis> If fluid is replaced too quickly, water intoxication can occur&mdash;sodium concentration falls, water enters brain cells, and confusion, disorientation, or coma may develop.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0194note0481">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Coping</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Situational or maturational crisis [long-term, progressive illness that is not curable]; inadequate opportunity to prepare for stressor</para>
<para>High degree of threat; inaccurate threat appraisal</para>
<para>Inadequate confidence in ability to deal with situation; inadequate level of perception of control</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Inability to deal with situation or ask for help</para>
<para>Insufficient goal-directed behavior, problem-solving, or problem resolution</para>
<para>Ineffective coping strategies; risk-taking behavior</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Health Beliefs: Perceived Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Assess the current situation accurately; identify ineffective coping behaviors and consequences.</para>
<para>Verbalize awareness of own coping abilities and sense of control.</para>
<para>Meet psychological needs as evidenced by appropriate expression of feels, identification of options, and use of resources.</para>
</note>
<note role="none" id="ch0006s0194note0482">
<table frame="top" id="ch0006s0194ta0273"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Coping Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine client&rsquo;s developmental level of functioning and client/care provider/significant other (SO) ability to understand events.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A client and/or family experiencing a new diagnosis of diabetes, a first-time DKA, or failure of diabetes management can be vulnerable and upset. <inlinemediaobject><imageobject><imagedata fileref="pp.jpg"/></imageobject></inlinemediaobject> Because the onset of T1DM is typically in childhood or adolescence, developmental issues are certainly in play.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine individual stressors (e.g., family issues, school, work, and social issues; finances).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A new diagnosis of diabetes or a crisis of diabetes management frequently adds more stressors than the client or family feels able to deal with.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine (if possible) changes that may occur (or have occurred) as a result of diabetes (e.g., in relationship or role with SO; client is involved in risk-taking behavior [e.g., alcohol/other drug use, child&rsquo;s eating disorder is escalating, or client is refusing to take diabetes meds]).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The client and SOs may have significant distress and turmoil in their lives. Complications and setbacks occur, people act out, and changes occur that affect the lives of everyone involved. Even those who are highly motivated to adhere to treatment may struggle adapting to a lifelong condition and need external supports.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain disease process, current procedures, and expectations in a simple, concise manner.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May help client/SO to express emotions, grasp the situation, and feel more in control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client and SO to express feelings about current crisis/hospitalization and diabetes in general.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies concerns and facilitates problem-solving.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Active-listen to concerns. Acknowledge normality of feelings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recognition that these reactions are normal can help client problem-solve and seek help as needed. Diabetic control is a full-time job that serves as a constant reminder of both presence of condition and threat to client&rsquo;s health and life.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess how client has handled problems in the past; identify locus of control.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge of individual&rsquo;s style helps determine needs for treatment goals. Client whose locus of control is internal usually looks at ways to gain control over own treatment program. Client who operates with an external locus of control wants to be cared for by others and may project blame for circumstances onto external factors.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide opportunity for SO to express concerns and discuss ways in which he or she can be helpful to client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances sense of being involved and gives SO a chance to problem-solve solutions to help client prevent recurrence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain expectations and goals of client and SO.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Unrealistic expectations and pressure from others or self may result in feelings of frustration or loss of control and may impair coping abilities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Support participation in self-care and give positive feedback for efforts. Provide for gradual implementation and continuation of necessary behaviors and lifestyle changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes feeling of control over situation and can enhance commitment to plan.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate in management of underlying condition(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>As diabetes control is reestablished and other contributing conditions are treated, client&rsquo;s/SO&rsquo;s sense of optimism and coping abilities may be restored/enhanced.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to diabetes educator, nutrition team, medical equipment, home-care providers, other outside resources, and/or professional therapy as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Education and support (people and other resources) are important in assisting the client/SO to understand that they can live life in a normal way but within their given limitations.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0194note0483">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient knowledge of and complexity of healthcare regimen</para>
<para>Decisional conflicts; family conflict; family pattern of healthcare; insufficient social support</para>
<para>Perceived seriousness of condition, susceptibility, benefit or barrier</para>
<para>Economically disadvantaged</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Difficulty with prescribed regimen</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>Failure to include treatment regimen in daily living or take actions to reduce risk factors</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Diabetes Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process and potential complications.</para>
<para>Identify relationship of signs and symptoms to the disease process and correlate symptoms with causative factors.</para>
<para><emphasis role="strong">Self-Management: Diabetes</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize acceptance of need and desire to change actions to achieve agreed-upon health goals.</para>
<para>Correctly perform necessary procedures and explain reasons for the actions.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>
<note role="none" id="ch0006s0194note0484">
<table frame="top" id="ch0006s0194ta0274"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Learning Facilitation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Create an environment of trust by listening to concerns and being available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapport and respect need to be established before client will be willing to take part in the learning process.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Work with client in setting mutual goals for learning.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Participation in the planning promotes enthusiasm and cooperation with the principles learned.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Select a variety of teaching strategies, such as demonstrating needed skills and having client do return demonstration, incorporating new skills into the hospital routine.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of different means of accessing information promotes information retention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss essential elements, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain the normal blood glucose range and how it compares with client&rsquo;s level, the type of diabetes the client has, and the relationship between insulin deficiency and a high glucose level.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed lifestyle choices.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reasons for the DKA (or other diabetes crisis) episode.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Knowledge of the precipitating factors may help avoid recurrences.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acute and chronic complications of the disease, including visual disturbances, neurosensory and cardiovascular changes, renal impairment, and hypertension.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Awareness helps client be more consistent with care and may prevent or delay onset of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Demonstrate client&rsquo;s glucose self-monitoring system, including fingerstick testing. Have client and SO return demonstration of obtaining sample and operating glucose meter until proficient.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Frequent (up to six to eight times daily) self-monitoring of blood glucose (SMBG) is the foundation of intensive T1DM management. There are many different blood glucose monitors available. The client/SO may desire recommendations for a meter that best meets the client&rsquo;s needs (e.g., large numbers on the screen because of poor eyesight or client needs a simple meter rather than one that is complex). <emphasis>Note:</emphasis> A just-released study suggests that blood glucose testing does not offer a significant advantage in blood sugar control for people with T2DM who are not treated with insulin (Young et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain that client/caregiver know client&rsquo;s desired glucose range and appropriate insulin coverage.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Desired blood glucose ranges are based on each individual&rsquo;s needs, but frequent testing promotes tighter control of serum levels.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review client&rsquo;s particular dietary plan. In general, plan should include avoiding sugar and limiting intake of fat, salt, and alcohol; eating complex carbohydrates, especially those high in fiber such as fruits, vegetables, and whole grains.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Medical nutrition therapy for diabetes encourages client to make meal choices based on unique needs and preferences. Awareness of importance of dietary control aids client in planning meals and sticking to regimen. Fiber can slow glucose absorption, decreasing fluctuations in serum levels but may cause GI discomfort, increase flatus, and affect vitamin and mineral absorption.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review medication regimen (e.g., oral medication or insulin):</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine type of agent(s) the client with T2DM may be using (e.g., (1) <emphasis role="strong">sulfonylureas </emphasis>such as chlorpropamide [Diabinese], empagliflozin [Jardiance], and glipizide [Glucotrol]; (2) <emphasis role="strong">biguanides </emphasis>such as metformin [Glucophage, Glumetza]; (3) <emphasis role="strong">meglitinides </emphasis>such as repaglinide [Prandin] and nateglinide [Sarlix]; (4) <emphasis role="strong">thiazolidinediones, </emphasis>such as rosiglitazone [Avandia] and pioglitazone [Actos]; (5) <emphasis role="strong">alpha-glucosidase inhibitors, </emphasis>such as acarbose [Precose] and miglitol [Glyset]; (6) <emphasis role="strong">DPP-IV inhibitors, </emphasis>such as sitagliptin [Januvia], linagliptin [Tradjenta], and exenatide [Byetta]; (7) <emphasis role="strong">SBLT2 inhibitors, </emphasis>such as dapagliflozin [Farxiga] and canagliflozin (Invokana); and (8) <emphasis role="strong">combination agents </emphasis>such as alogliptin and metformin [Kazano], rosiglitazone and glimepiride [Avandaryl]). Ascertain client&rsquo;s compliance with therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drugs for type 2 diabetes work in different ways to bring blood sugar levels back to normal. They include (1) drugs that increase insulin production (e.g., Diabinese, Prandin), (2) drugs that improve body&rsquo;s use of insulin (e.g., Actos, Avandia), (3) drugs that reduce sugar absorption in the intestines (e.g., Precose, Glyset), (4) drugs that decrease sugar production by the liver and improve insulin resistance (e.g., metformin), (5) drugs that increase insulin production by the pancreas and reduce sugar production by the liver (e.g., Januvia, Byetta), and (6) drugs that block reabsorption of glucose by the kidneys and increase glucose excretion (e.g., Farxiga, Invokana). Combination drugs contain more than one type of diabetes medication such as one to block reabsorption of glucose by the kidneys while also helping the pancreas produce more insulin and the liver to produce less glucose (Dansinger, 2016; Grams et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review type and timing of client&rsquo;s insulin(s), as indicated: both (1) <emphasis role="bi">basal</emphasis> (for long-term coverage) such as detemir (Levemir) and glargine (Lantus) and (2) <emphasis role="bi">bolus</emphasis> (for rapid-action coverage) such as aspart (NovoLog), glulisine (Apidra), lispro (HumaLog), and human insulin inhaled powder (Afrezza).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Long-acting <emphasis role="bi">basal</emphasis> insulins work to provide around-the-clock blood sugar control for both types of diabetes (and is likely the first type of insulin given for T2DM). Fast-acting <emphasis role="bi">bolus</emphasis> insulin(s) (injected or inhaled) may be given near mealtimes in both types of diabetes. Mixed insulins are available in either a vial or insulin pen. If multiple daily injections are required, combinations of types (e.g., rapid-acting plus short-acting, intermediate, and long-acting insulin) are used. If the pump method is used, only rapid-acting insulin is used, and client programs own basal and bolus settings (Vallerand et al, 2017). <emphasis>Note:</emphasis> DKA is rare among pump users who perform SMBG adequately but can develop quickly because of the short half-life of rapid-acting insulin analogues commonly used in pumps.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review and obtain return demonstration of self-administration of insulin, either injection or pump, and care of equipment. Have client demonstrate procedure: drawing up and injecting insulin, insulin pen technique, or use of continuous pump.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Confirms that client is proficient in skills or will require assistance or full care in managing procedures and equipment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of maintaining diary of glucose testing, medication dose and time, dietary intake, activity, feelings, sensations, and life events.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in creating overall picture of client situation to achieve better disease control and promotes self-care and independence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss factors that play a part in diabetic control such as aerobic versus isometric exercise, stress, surgery, and illness. Review &ldquo;sick day&rdquo; rules.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This information promotes diabetic control and can greatly reduce the occurrence of ketoacidosis. <emphasis>Note:</emphasis> Aerobic exercise such as walking and swimming promotes effective use of insulin, lowering glucose levels, and strengthens the cardiovascular system. A &ldquo;sick day&rdquo; management plan helps maintain equilibrium during illness, minor surgery, severe emotional stress, exogenous steroids (as with spinal or joint injections or any oral treatment for asthma and arthritis), or any condition that might send glucose spiraling upward.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review effects of smoking. Encourage cessation of smoking.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nicotine constricts the small blood vessels, and insulin absorption is delayed for as long as these vessels remain constricted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Establish regular exercise or activity schedule and identify corresponding insulin concerns.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Exercise times should not coincide with the peak action of insulin. A snack should be ingested before or during exercise as needed, and rotation of injection sites should avoid the muscle group that will be used in the activity (e.g., abdominal site is preferred over thigh or arm before jogging or swimming) to prevent accelerated uptake of insulin.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify the symptoms of hypoglycemia&mdash;weakness, dizziness, lethargy, hunger, irritability, diaphoresis, pallor, tachycardia, tremors, headache, and changes in mentation&mdash;and explain causes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client/caregiver must be made aware of the signs and symptoms of hypoglycemia and educated about ways to manage it. It has been shown that hypoglycemia is often the result of diabetes management errors (i.e., incorrect dosing or timing of insulin, failure to eat when needed, failure to keep blood glucose as close to normal levels as possible). Early detection and treatment of hypoglycemia can limit its effects and help prevent recurrence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct SO in emergency use of glucagon.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Given for treatment of severe hypoglycemia when client is unable to take oral carbohydrates. Prompt intervention may prevent more serious complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of using medical alert ID bracelet or necklace.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can promote quick entry into the health system and appropriate care with fewer resultant complications in the event of an emergency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Instruct in importance of routine daily examination of the feet and proper foot care. Demonstrate ways to examine feet, inspect shoes for fit, and care for toenails, calluses, and corns. Encourage use of natural-fiber stockings and refraining from going barefoot.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents or delays complications associated with peripheral neuropathies and circulatory impairment, especially cellulitis, gangrene, and amputation. Studies show that diabetic foot ulcers are responsible for more hospitalizations than any other complication of diabetes (Rice et al, 2014) and are associated with reduced quality of life and higher risk for early mortality (Hingorani et al, 2016). Also, diabetes is the leading cause of nontraumatic lower extremity amputations in the United States. In fact, every year, approximately 5% of diabetics develop foot ulcers and 1% of those require amputation (Rowe, 2017). Prevention and early treatment of diabetic foot injuries/ulcers are therefore critical. <emphasis>Note:</emphasis> High-risk individuals such as those with significant neuropathy, foot deformities, or previous amputations may benefit from custom therapeutic footwear (Hingorani et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of seeking medical attention promptly if foot injuries occur or ulcerations develop.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clients with plantar foot ulcers may require off-loading with use of a contact cast or irremovable fixed ankle walking boot. Individuals with nonplantar wounds or healed ulcers may benefit from specific types of pressure-relieving footwear such as surgical sandal or a heal relief shoe (Hingorani et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Emphasize importance of regular eye examinations, especially for clients who have had T1DM for 5 years or more.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in vision may be gradual and are more pronounced in persons with poorly controlled DM and BP. Problems include changes in visual acuity and may progress to retinopathy and blindness. <emphasis>Note:</emphasis> Retinopathy is the most frequent cause of new blindness among adults 20 to 74 years of age (National Eye Institute [NEI], 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Arrange for vision aids when needed, such as magnifying sleeve for insulin syringe, prefilled insulin pens, large-print instructions, and one-touch or talking glucose meters.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adaptive aids have been developed in recent years to help the visually impaired manage their own DM more effectively.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss sexual functioning and answer questions client and SO may have.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Impotence may be first symptom of onset of DM. <emphasis>Note: </emphasis>Counseling and use of penile prosthesis may be of benefit.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend reading product labels and avoidance of over-the-counter (OTC) drugs without prior discussion with healthcare provider.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These products may contain sugars and interact with prescribed medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss importance of follow-up care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps maintain tighter control of disease process and may prevent exacerbations of DM, retarding development of systemic complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review signs and symptoms requiring medical evaluation&mdash;fever, cold, or flu symptoms; cloudy, odorous urine; painful urination; delayed healing of cuts or sores; sensory changes with pain or tingling of lower extremities; changes in blood sugar level; and presence of ketones in urine.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prompt intervention may prevent development of more serious or life-threatening complications.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify community resources such as the American Diabetes Association, Internet resources, and online diabetes bulletin boards, visiting nurse, weight-loss or smoking cessation clinics, contact person, or diabetic instructor.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Continued support is usually necessary to sustain lifestyle changes and promote well-being.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0194note0485">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for unstable Blood Glucose Level</emphasis>&mdash;lack of acceptance of diagnosis, inadequate blood glucose monitoring, average daily activity less than recommended, excessive stress</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economically disadvantaged, perceived susceptibility (recurrence of problem)</para></listitem>
<listitem><para><emphasis role="bi">risk for Trauma</emphasis>&mdash;alteration in sensation; insufficient vision</para></listitem>
<listitem><para><emphasis role="bi">risk for Sexual Dysfunction</emphasis>&mdash;altered body function (disease process)</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0199"><title><emphasis role="strong">HYPERTHYROIDISM, THYROTOXICOSIS, AND THYROID STORM</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis>&mdash;Hyperthyroidism is the result of inappropriately elevated thyroid function. The term <emphasis>thyrotoxicosis </emphasis>refers to an excessive amount of circulating thyroid hormones from any source. Thyroid storm (also referred to as thyrotoxic crisis) occurs when a large amount of thyroid hormone is released in a short period of time. A diagnosis of thyroid storm is based on the presence of severe and life-threatening symptoms (high fever, cardiovascular dysfunction, and altered mentation) in the setting of biochemical evidence of hyperthyroidism. Approximately 1% to 2% of patients with hyperthyroidism progress to thyroid storm (Ross, 2017).</para></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Metabolic imbalance resulting from overproduction of the thyroid hormones triiodothyronine (T<subscript>3</subscript>) and thyroxine (T<subscript>4</subscript>), creating a life-threatening emergency.</para></listitem>
<listitem><para>Thyroid storm is extreme thyrotoxicosis, which can occur with or without preexisting hyperthyroidism (Leung, 2016), but is usually associated with untreated (or inadequately treated) hyperthyroidism.</para></listitem>
<listitem><para>Genetic factors appear to influence the incidence of thyroid disorders. For example, Hashimoto&rsquo;s hypothyroidism and Graves&rsquo; disease often occur in multiple members of the same family.</para></listitem>
<listitem><para>Varied causation of hyperthyroidism:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Toxic diffuse goiter (also called Graves&rsquo; disease) is the most common form of hyperthyroidism, accounting for 80% of hyperthyroidism diagnoses; it predominantly affects those aged 20 to 40 years (Lee &amp; Ananthakrishnan, 2017; Schraga, 2017).</para></listitem>
<listitem><para>Chronic, subacute, and &ldquo;silent&rdquo; thyroiditis (Hashimoto&rsquo;s thyroiditis). <emphasis>Note</emphasis>: Although subacute thyroiditis is the primary cause of hypothyroidism, it can initially present (in 15%&ndash;20% of cases) with thyrotoxicosis (Lee &amp; Ananthakrishnan, 2017; Schraga, 2017).</para></listitem>
<listitem><para>Toxic nodular goiter (TNG): TNG is a spectrum of the disease ranging from a single hyperfunctioning nodule (toxic adenoma) within a multinodular thyroid to one gland with multiple areas of hyperfunction. Toxic multinodular goiter (TMG) accounts for 15% to 20% of thyrotoxicosis but primarily in world regions of iodine deficiency. Toxic adenoma is the cause of 3% to 5% of thyrotoxicosis (Lee &amp; Ananthakrishnan, 2017; Orlander et al, 2016).</para></listitem>
<listitem><para>Pituitary tumors (e.g., thyroid-stimulating hormone-secreting [TSH] tumors) can cause thyroid to make too much thyroxine. Although this type of tumor is rare, it can cause hyperthyroidism (Toft, n.d.).</para></listitem>
<listitem><para>Thyroid cancers: Graves&rsquo; disease appears to be linked with larger, multifocal, and potentially more aggressive thyroid cancers when compared with single or multinodular toxic goiter. In one study, thyroid cancers were found in 22.2% of patients with thyroid nodules in Graves&rsquo; goiters compared with 2.9% of patients with diffuse toxic goiter with no nodules (Vole, 2016).</para></listitem>
<listitem><para>Pregnancy: Hyperthyroidism affects 0.1% to 0.4% of pregnancies (Ogunyemi, 2016). The most common cause of hyperthyroidism in women of childbearing age is autoimmune Grave&rsquo;s diseases (GD) occurring before pregnancy in 0.4% to 1.0% of women and in approximately 0.2% during pregnancy. These women are at higher risk of preeclampsia, early labor, and thyroid storm (Alexander et al, 2017; Ogunyemi, 2016).</para></listitem>
<listitem><para>Antineoplastic agents may cause thyroid dysfunction in 20% to 50% of patients (Schraga, 2017).</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Triggers for thyroid storm:</emphasis></para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Surgery: thyroid (or other) surgery</para></listitem>
<listitem><para>Infections</para></listitem>
<listitem><para>Trauma</para></listitem>
<listitem><para>Exposure to excess iodine (e.g., iodinated contrast medium for radiographic scan)</para></listitem>
<listitem><para>Cardiovascular events; diabetic ketoacidosis or hyperosmolar coma; insulin-induced hypoglycemia</para></listitem>
<listitem><para>Toxemia of pregnancy</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics:</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: The overall incidence of hyperthyroidism in the United States is estimated between 0.05% and 1.2% (Endocrine Society, 2017; Leung, 2016). Hyperthyroidism from toxic multinodular goiter and toxic adenoma is permanent. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation (A-fib) (Dahl et al, 2008).</para></listitem>
<listitem><para>Mortality: Adult mortality rate from thyroid storm is variable (according to multiple sources, including the United States, Japan, and Malaysia) and ranged from 8%, 10%, and 25% (respectively) in hospitalized patients (Ross, 2017).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0199note0486"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Ablation: </emphasis>Removal of thyroid gland usually carried out surgically but may be done chemically with radioactive iodine.</para>
<para><emphasis role="strong">Endocrine gland: </emphasis>Gland that releases a chemical messenger, known as a hormone, directly into the bloodstream, which will affect other parts of the body. The thyroid is an endocrine gland.</para>
<para><emphasis role="strong">Euthyroid: </emphasis>Situation where thyroid-stimulating hormone (TSH) test values are in the normal range and the thyroid is neither hyperthyroid nor hypothyroid.</para>
<para><emphasis role="strong">Exophthalmos: </emphasis>Abnormal bulging of the eyeball, often with resulting difficulty or inability to close eyelid. Most often caused by thyroid-related eye disease.</para>
<para><emphasis role="strong">Goiter: </emphasis>Enlargement of the thyroid gland.</para>
<para><emphasis role="strong">Graves&rsquo; disease: </emphasis>A condition caused by excessive production of thyroid hormone and characterized by an enlarged thyroid gland, protrusion of the eyeballs, a rapid heartbeat, and nervous excitability. Also called toxic goiter or exophthalmic goiter.</para>
<para><emphasis role="strong">Nodule: </emphasis>A small, solid collection of tissue that is palpable.</para>
<para><emphasis role="strong">Pretibial myxedema: </emphasis>A skin condition associated with Graves&rsquo; disease characterized by swollen, itchy patches of skin on the front of the lower legs or shins.</para>
<para><emphasis role="strong">Radioactive iodine (RAI): </emphasis>An isotope of the chemical element iodine that is radioactive. Used in diagnostic tests as well as in radiotherapy of a hyperactive thyroid gland, most often due to Graves&rsquo; disease.</para>
<para><emphasis role="strong">Subclinical hyperthyroidism: </emphasis>Mild form of hyperthyroidism, characterized by low TSH and normal T<subscript>3</subscript> and T<subscript>4</subscript>. The client may have no symptoms at all or mild symptoms (e.g., weight loss, anxiety) and possibly experience heart and bone problems.</para>
<para><emphasis role="strong">Thyroidectomy: </emphasis>Surgical removal of all or a portion of the gland (amount varies). In a subtotal thyroidectomy, a lobe or portion of thyroid tissue remains to produce thyroid hormone.</para>
<para><emphasis role="strong">Thyroid storm (severe thyrotoxicosis): </emphasis>A state of thyroid hormone excess, arising from either overproduction from the thyroid gland (hyperthyroidism) or exogenous sources (e.g., oral thyroid replacement drugs).</para>
</note>
<sect2 id="ch0006s0200"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Most people with classic hyperthyroidism rarely need hospitalization. Critically ill clients and those with extreme manifestations of thyrotoxicosis, plus a significant concurrent illness, require inpatient acute care on a medical unit.</para>
</sect2>
<sect2 id="ch0006s0201"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0002s0027">Heart failure: chronic</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para>Thyroidectomy (see Davis<emphasis>Plus</emphasis>)</para>
<table frame="top" id="ch0006s0199ta0275"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Data depend on the severity and duration of hormone imbalance and involvement of other organs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Extreme fatigue</para></listitem>
<listitem><para>Nervousness, irritability</para></listitem>
<listitem><para>Insomnia</para></listitem>
<listitem><para>Muscle weakness</para></listitem>
<listitem><para>Incoordination</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Palpitations</para></listitem>
<listitem><para>Chest pain (angina)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dysrhythmias&mdash;atrial fibrillation, gallop rhythm</para></listitem>
<listitem><para>Murmurs</para></listitem>
<listitem><para>Tachycardia out of proportion to fever, e.g., exceeding 140 bpm (thyroid storm)</para></listitem>
<listitem><para>High systolic blood pressure, low diastolic blood pressure (widened pulse pressure)</para></listitem>
<listitem><para>Congestive heart failure; circulatory collapse, shock (thyroid storm)</para></listitem>
<listitem><para>Diaphoresis (may be profuse with thyroid storm)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Urinating in large amounts</para></listitem>
<listitem><para>Stool changes; diarrhea</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">EGO INTEGRITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent stressful experience&mdash;emotional and physical</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Emotional lability&mdash;mild euphoria to delirium</para></listitem>
<listitem><para>Anxiety and depression</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent and sudden weight loss</para></listitem>
<listitem><para>Nausea and vomiting</para></listitem>
<listitem><para>Thirst</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dehydration (due to GI losses and diaphoresis)</para></listitem>
<listitem><para>Nonpitting edema, especially in front of the shinbone</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Mental status and behavior alterations&mdash;confusion, disorientation, nervousness, irritability, delirium, frank psychosis, stupor, coma</para></listitem>
<listitem><para>Hyperactive deep tendon reflexes (DTRs)</para></listitem>
<listitem><para>Fine tremor in hands; purposeless, quick, jerky movements of body parts</para></listitem>
<listitem><para>Rapid and hoarse speech</para></listitem>
<listitem><para>Paralysis (thyrotoxic hypokalemia)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Eye pain, sensitivity to light</para></listitem>
<listitem><para>Chest pain (often occurs in the absence of cardiovascular disease)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulty breathing</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased respiratory rate, tachypnea</para></listitem>
<listitem><para>Breath sounds: crackles, wheezes</para></listitem>
<listitem><para>Pulmonary edema (thyrotoxic crisis)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Heat intolerance, excessive sweating</para></listitem>
<listitem><para>Itching skin</para></listitem>
<listitem><para>Visual disturbance; dry eye; problems closing eyes</para></listitem>
<listitem><para>Allergy to iodine (may be used in testing or potentially in treatment)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Elevated temperature</para></listitem>
<listitem><para>Fever (104&deg;F to 106&deg;F [40&ndash;44&deg;C] common in thyroid storm)</para></listitem>
<listitem><para>Skin smooth, warm, and flushed (fever)</para></listitem>
<listitem><para>Pruritic, erythematous lesions&mdash;often in pretibial area&mdash;that become brawny</para></listitem>
<listitem><para>Exophthalmos, lid retraction, conjunctival irritation, tearing; stare</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Menstrual irregularity; hypomenorrhea, amenorrhea (long-term hyperthyroidism)</para></listitem>
<listitem><para>Toxemia of pregnancy</para></listitem>
<listitem><para>Decreased libido</para></listitem>
<listitem><para>Impotence</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of thyroid problems</para></listitem>
<listitem><para>History of hypothyroidism, thyroid hormone replacement therapy or antithyroid therapy, premature withdrawal of antithyroid drugs, recent partial thyroidectomy</para></listitem>
<listitem><para>History of insulin-induced hypoglycemia, cardiac disorders or surgery, recent illness (e.g., pneumonia), trauma, x-ray contrast studies</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with treatment regimen, self-care activities, homemaker and maintenance tasks</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0199ta0276"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Thyroid function tests:</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis>Note:</emphasis> Thyroid function studies do not distinguish thyrotoxicosis from thyroid storm (that diagnosis is made on basis of clinical evaluation).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">TSH:</emphasis> Measures the amount of TSH in the blood; it is done first to evaluate thyroid function.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>TSH is suppressed in hyperthyroidism and suppressed to unmeasurable levels in thyrotoxicosis (except when etiology is a TSH-secreting pituitary tumor or pituitary resistant to thyroid hormone).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Thyroxine (T<subscript>4</subscript>):</emphasis> Produced by the thyroid gland when the pituitary gland releases TSH. Free T<subscript>4</subscript> can be measured directly (FT<subscript>4</subscript>) or calculated by index (FTI). Total T<subscript>4</subscript> measures both bound and free T<subscript>4</subscript>. Free T<subscript>4</subscript> affects tissue function, whereas bound T<subscript>4</subscript> does not.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Total T<subscript>4</subscript>, FT<subscript>4</subscript>, and FTI are elevated in hyperthyroidism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Triiodothyronine (T<subscript>3</subscript>):</emphasis> Small amount produced directly by thyroid gland. Most T<subscript>3</subscript> is made by other tissues that convert T<subscript>4</subscript> into T<subscript>3</subscript>. T<subscript>4</subscript> has a greater effect on metabolism than T<subscript>3</subscript> even though T<subscript>3</subscript> is normally present in lower amounts than T<subscript>4</subscript>. Total T<subscript>3</subscript> measures both bound and free T<subscript>3</subscript> (FT<subscript>3</subscript>).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Both T<subscript>3</subscript> and T<subscript>4</subscript> are increased in hyperthyroidism; however, T<subscript>3</subscript> appears to be the more accurate diagnostic indicator of hyperthyroidism than T<subscript>4</subscript>. T<subscript>3</subscript> becomes abnormal earlier than T<subscript>4</subscript> and returns to normal later than T<subscript>4</subscript> in hyperthyroidism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Triiodothyronine uptake (T<subscript>3</subscript>U):</emphasis> An indirect measurement of the amount of the protein thyroxine-binding globulin (TBG) that can bind T<subscript>3</subscript> and T<subscript>4</subscript>.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A high T<subscript>4</subscript> value combined with a high T<subscript>3</subscript>U value usually confirms the presence of hyperthyroidism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Thyroid antibodies:</emphasis> May include antithyroid peroxidase (anti-TPO) antibody, thyroid-stimulating antibody (TSAb) (also known as thyroid-stimulating immunoglobulin [TSI]), long-acting thyroid stimulator (LATS), or TSH-receptor antibody (TRAb)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Autoantibody titers in hyperthyroidism are as follows: (1) Graves&rsquo; disease&mdash;significantly elevated anti-TPO, elevated TSAb; (2) toxic multinodular goiter&mdash;low or absent anti-TPO and TSAb; and (3) toxic adenoma&mdash;low or absent anti-TPO and TSAb (Lee &amp; Ananthakrishnan, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Thyroid ultrasound:</emphasis> Uses high-frequency sound waves to obtain an image of the thyroid gland, obtain accurate measurements, and identify nodules.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Differentiates a &ldquo;solid&rdquo; nodule from a fluid-filled cyst; however, it does not differentiate as to whether a nodule is benign or malignant. Determines if a nodule is getting smaller or is growing larger during treatment. Also aids in performing thyroid needle biopsy by improving accuracy if the nodule cannot be felt easily on examination.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">CT or radioactive iodine uptake (RAIU) thyroid scan:</emphasis> During this procedure, the amount of iodine &ldquo;taken up&rdquo; by the thyroid is measured and images are taken. A gamma camera scan views the entire thyroid gland at once. A computerized rectilinear thyroid (CRT) scan uses computer technology to enhance thyroid nodules.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Measures both thyroid function and thyroid size. A CT scan may be done with or without contrast for screening, often followed by RAUI scan. Uptake of radioactive iodine occurs in Graves&rsquo; disease toxic multinodular goiter and toxic adenoma (the more common forms of hyperthyroidism and thyrotoxicosis).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0202"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Reduce metabolic demands and support cardiovascular function.</para></listitem>
<listitem><para>Provide psychological support.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and therapy needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0203"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Homeostasis achieved.</para></listitem>
<listitem><para>Current situation being dealt with effectively.</para></listitem>
<listitem><para>Complications prevented and minimized.</para></listitem>
<listitem><para>Disease process, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0199note0487">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for decreased Cardiac Output</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Altered preload [e.g., decreased venous return]</para>
<para>Altered afterload [e.g., systemic vascular resistance]</para>
<para>Alteration in heart rate or rhythm</para>
<para>[Hypermetabolic state]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Circulation Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate cardiac output for tissue needs as evidenced by stable vital signs, palpable peripheral pulses, good capillary refill, usual mentation, and absence of dysrhythmias.</para>
</note>
<note role="none" id="ch0006s0199note0488">
<table frame="top" id="ch0006s0199ta0277"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Hemodynamic Regulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Note: Intensive care admission is recommended for management of thyroid storm.</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP lying, sitting, and standing, if able. Note widened pulse pressure.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>General and orthostatic hypotension may occur as a result of excessive peripheral vasodilation and decreased circulating volume. Widened pulse pressure reflects compensatory increase in stroke volume and decreased systemic vascular resistance (SVR).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor central venous pressure (CVP), or other hemodynamic pressures, if available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides more direct measure of circulating volume and cardiac function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate reports of chest pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May reflect increased myocardial oxygen demands and ischemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess pulse and heart rate while client is sleeping.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides a more accurate assessment of tachycardia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate heart sounds, noting extra heart sounds and development of gallops and systolic murmurs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prominent S<subscript>1</subscript> and murmurs are associated with forceful cardiac output of hypermetabolic state. Development of S<subscript>3</subscript> may warn of impending cardiac failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor ECG, noting rate and rhythm. Document dysrhythmias.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tachycardia (greater than normally expected, with fever) and increased circulatory demand may reflect direct myocardial stimulation by thyroid hormone. Dysrhythmias (especially A-Fib) often occur and may compromise cardiac function and output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate breath sounds, noting adventitious sounds such as crackles.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early sign of pulmonary congestion, reflecting developing cardiac failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor temperature, provide cool environment, limit bed linens and clothes, and administer tepid sponge baths.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever, which may exceed 104&deg;F (40.0&deg;C), can occur as a result of excessive hormone levels increasing diuresis and dehydration, causing increased peripheral vasodilation, venous pooling, and hypotension.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for dry mucous membranes, weak and thready pulse, poor capillary refill, decreased urinary output, and hypotension.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid dehydration can occur with thyroid storm often due to gastrointestinal losses and excessive diaphoresis, which reduces circulating volume and compromises cardiac output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Record intake and output (I&amp;O). Note urine-specific gravity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Significant fluid losses through vomiting, diarrhea, diuresis, or diaphoresis can lead to profound dehydration, concentrated urine, and weight loss.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily. Encourage chair rest and bedrest; limit nonessential activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Activity increases metabolic and circulatory demands, which may potentiate cardiac failure.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note history of asthma and bronchoconstrictive disease, sinus bradycardia and heart blocks, advanced heart failure (HF), or current pregnancy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence and potential recurrence of these conditions affects choice of therapy; for example, use of beta-adrenergic blocking agents may be contraindicated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer intravenous (IV) fluids, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid fluid replacement may be necessary to improve circulating volume but must be balanced against signs of cardiac failure and need for inotropic support.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, such as:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Generally, drugs used to treat thyroid storm are those used for uncomplicated hyperthyroidism (at higher doses and more frequently) with additional drugs such as glucocorticoids and iodine solution (Leung, 2016; Ross, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers, for example, propranolol (Inderal), atenolol (Tenormin), nadolol (Corgard), and pindolol (Visken)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta blockers are for relief of neurologic and cardiovascular symptoms. However, their onset is slow and benefit is limited in reducing T<subscript>3</subscript>, so they are typically given along with a thioamide (Leung, 2016; Ross, 2017; Schraga, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thioamides (also called thyroid hormone antagonists), for example, methimazole (Tapazole) and propylthiouracil (PTU)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs block thyroid hormone synthesis and inhibit conversion of T<subscript>4</subscript> to T<subscript>3</subscript> and are used both for long-term control of hyperthyroidism and for thyroid storm (at higher doses). PTU is often now reserved for acute and rapid treatment of thyroid storm (i.e., given every 4 hours in monitored patient in ICU). Tapazole is more potent and longer acting than PTU. IV tapazole may be preferred for thyroid storm, as well as severe (but not life-threating) hyperthyroidism because of its longer duration of action. <emphasis>Caution:</emphasis> The U.S. Food and Drug Administration (FDA) has added a black box warning regarding potential liver injury with PTU (Leung, 2016; Ross, 2017; Schraga, 2017). <emphasis>Note:</emphasis> Thyroid storm has been reported in patients with Graves&rsquo; disease after discontinuation of thioamides because of liver failure. In such patients who require urgent treatment of hyperthyroidism, thyroidectomy is the treatment of choice (Kandil et al, 2011; Ross, 2017; Schraga, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oral iodide-iodine solution (Lugol&rsquo;s solution) or supersaturated potassium iodide (SSKI, PIMA)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Used to rapidly block the release of T<subscript>4</subscript> and T<subscript>3</subscript> thyroid hormone in thyroid storm and/or short-term use in hyperthyroidism (e.g., preoperative preparation for thyroidectomy in Graves&rsquo; disease) (Lee &amp; Ananthakrishnan, 2017). <emphasis>Note:</emphasis> Should be started 1 to 3 hours after initiation of antithyroid drug therapy to minimize hormone formation from the iodine (Leung, 2016; Ross, 2017; Schraga, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corticosteroids, for example, dexamethasone (Decadron)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides glucocorticol support, decreases hyperthermia, relieves relative adrenal insufficiency, inhibits calcium absorption, and reduces peripheral conversion of T<subscript>4</subscript> to T<subscript>3</subscript>.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Digoxin (Lanoxin)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be required in clients with HF before beta-adrenergic blocking therapy can be considered and safely initiated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Furosemide (Lasix)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuresis may be necessary if HF occurs. <emphasis>Note:</emphasis> It also may be effective in reducing calcium level if neuromuscular function is impaired.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium (KCl, K-Lyte)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased losses of K<superscript>+</superscript> through intestinal and renal routes may result in dysrhythmias if not corrected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Acetaminophen (Tylenol)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Drug of choice to reduce temperature and associated metabolic demands. Aspirin is contraindicated because it actually increases level of circulating thyroid hormones by blocking binding of T<subscript>3</subscript> and T<subscript>4</subscript> with thyroid-binding proteins.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory and diagnostic studies, as indicated:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum potassium</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypokalemia resulting from intestinal losses, altered intake, or diuretic therapy may cause dysrhythmias and compromise cardiac function and output.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum calcium</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevation may alter cardiac contractility.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sputum culture</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pulmonary infection is most frequent precipitating factor of crisis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Obtain serial ECGs and other cardiac diagnostic studies (e.g., echocardiogram, myocardial perfusion studies), if indicated after thyroid storm is abated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May demonstrate effects of electrolyte imbalance and/or ischemic changes reflecting inadequate myocardial oxygen supply in the presence of increased metabolic demands or dysrhythmias. <emphasis>Note:</emphasis> Studies have associated subclinical hyperthyroidism with a higher prevalence of atrial fibrillation (AF) in older clients, confirmed by ECG, than those with normal serum TSH (Ross, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chest x-rays</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac enlargement may occur in response to increased circulatory demands. Pulmonary congestion may be noted with cardiac decompensation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental oxygen (O<subscript>2</subscript>), as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be necessary to support increased metabolic demands and O<subscript>2</subscript> consumption.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide hypothermia blanket, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Occasionally used to lower uncontrolled hyperthermia (104&deg;F [40.0&deg;C] and higher) to reduce metabolic demands, O<subscript>2</subscript> consumption, and cardiac workload.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for radioactive iodine ablation (RAI) or surgical intervention.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>RAI is often the treatment of choice for hyperthyroidism, with the purpose of reversing the overactivity. This is referred to as radioactive iodine ablation, or chemical ablation. Peak results take 6 to 12 weeks, and occasionally a second treatment may be necessary; however, a single dose controls hyperthyroidism in about 90% of clients. <emphasis>Note:</emphasis> This therapy is contraindicated during pregnancy and breastfeeding (Ross, 2017). In patients with Graves&rsquo; disease, definitive therapy with radioactive iodine or thyroidectomy is important to prevent a recurrence of severe thyrotoxicosis. Thyroidectomy may be performed once euthyroid state is achieved in individuals who are intolerant of antithyroid medications or who refuse RAI therapy (Schraga, 2017).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0199note0489">
<title><emphasis role="strong">NURSING DIAGNOSIS: Fatigue</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Illness (e.g., hyperthyroidism)</para>
<para>Altered body chemistry&mdash;hypermetabolic state, medications</para>
<para>Stressors; anxiety; sleep deprivation</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient energy, impaired ability to maintain usual routine or physical activity</para>
<para>Tiredness; nonrestorative sleep pattern</para>
<para>Alteration in concentration</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fatigue: Disruptive Effects</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report improved sense of energy.</para>
<para>Display improved ability to participate in desired activities.</para>
<para>Identify basis of fatigue and individual areas of control.</para>
</note>
<note role="none" id="ch0006s0199note0490">
<table frame="top" id="ch0006s0199ta0278"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Energy Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor vital signs, noting pulse rate at rest and when active.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pulse is typically elevated, and even at rest tachycardia may be noted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note presence of/development of tachypnea, dyspnea, pallor, and cyanosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>O<subscript>2</subscript> demand and consumption are increased in hypermetabolic state, potentiating risk of hypoxia with activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide quiet environment, cool room, decreased sensory stimuli, soothing colors, and quiet music.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces stimuli that may aggravate agitation, hyperactivity, and insomnia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to restrict activity and rest in bed as much as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps counteract effects of increased metabolism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide comfort measures&mdash;judicious touch and massage and cool showers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May decrease nervous energy, promoting relaxation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide for calming diversional activities (e.g., reading, computer games, television).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows for use of nervous energy in a constructive manner, serves as a distraction, and may reduce anxiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid topics that irritate or upset client. Discuss ways to respond to these feelings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased irritability of the CNS may cause client to be easily excited, agitated, and prone to emotional outbursts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss with SO reasons for fatigue and emotional lability.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding that fatigue and emotional lability is caused by the hyperthyroid state may enhance client&rsquo;s/SO&rsquo;s coping with situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, such as sedatives and antianxiety agents.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be prescribed to help combat nervousness, hyperactivity, and insomnia.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0199note0491">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Biological factors&mdash;metabolic demands; fever</para>
<para>Insufficient dietary intake or inability to absorb nutrients (nausea, vomiting, diarrhea)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stable weight with normal laboratory values and be free of signs of malnutrition.</para>
</note>
<note role="none" id="ch0006s0199note0492">
<table frame="top" id="ch0006s0199ta0279"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Nutrition Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor daily food intake once client resumes eating. Weigh daily and report losses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Continued weight loss in face of adequate caloric intake may indicate failure of antithyroid therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to eat and increase number of meals and snacks, using high-calorie foods that are easily digested.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in keeping caloric intake high enough to keep up with rapid expenditure of calories caused by hypermetabolic state.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid foods that increase peristalsis, such as tea, coffee, fibrous and highly seasoned foods, and fluids that cause diarrhea&mdash;apple and prune juice.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased motility of gastrointestinal (GI) tract may result in diarrhea and impair absorption of needed nutrients.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Consult with dietitian to provide diet high in calories, protein, carbohydrates, and vitamins.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May need assistance to ensure adequate intake of nutrients, identify appropriate supplements.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, such as glucose and vitamin B complex.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Given to meet energy requirements and prevent or correct hypoglycemia associated with hypermetabolic state in thyrotoxicosis.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0199note0493">
<title><emphasis role="strong">NURSING DIAGNOSIS: Anxiety [specify level]</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Stressors; situational crisis (e.g., stimulation, pseudo-catecholamine effect of thyroid hormones); change in health status</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Apprehensive; jittery; shakiness; distressed</para>
<para>Difficulty concentrating</para>
<para>Focus on self; restlessness; tremors</para>
<para>Sleep disturbance</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Anxiety Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Appear relaxed.</para>
<para>Report anxiety reduced to a manageable level.</para>
<para><emphasis role="strong">Anxiety Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Recognize changes in thinking and behavior and causative factors.</para>
</note>
<note role="none" id="ch0006s0199note0494">
<table frame="top" id="ch0006s0199ta0280"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Anxiety Reduction</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor changes in behavior. Note behavior indicative of level of anxiety.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be hypervigilant, restless, extremely sensitive, or crying, or may develop frank psychosis. Mild anxiety may be displayed by irritability and insomnia. Severe anxiety progressing to panic state may produce feelings of impending doom, terror, inability to speak or move, shouting, and swearing. <emphasis>Note:</emphasis> It has been reported that pseudo-psychiatric symptoms were a first sign of hyperthyroidism in 2% to 12% of cases (Formica, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess thinking processes, such as memory; attention span; and orientation to person, place, time, and situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines extent of interference with sensory processing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor physical responses, noting palpitations, repetitive movements, hyperventilation, and insomnia.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased number of beta-adrenergic receptor sites, coupled with effects of excess thyroid hormones, produces clinical manifestations of catecholamine excess even when normal levels of norepinephrine and epinephrine exist.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stay with client, maintaining calm manner. Acknowledge feelings and allow client&rsquo;s behavior to belong to client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Affirms to client and SO that although client feels out of control, environment is safe. Avoiding personal responses to inappropriate remarks or actions prevents conflicts and overreaction to stressful situation and client behavior.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Describe and explain procedures, surrounding environment, or sounds that may be heard by client. Present reality concisely and briefly without challenging illogical thinking.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides accurate information, which reduces distortions and misinterpretations that can contribute to anxiety and fear reactions. Avoiding challenging of distorted thinking limits defensive reaction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Speak in brief statements, using simple words.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Attention span may be shortened and concentration reduced, limiting ability to assimilate information.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduce external stimuli. Place in quiet, cool room; provide soft, soothing music; reduce bright lights; limit procedures and reduce number of persons interacting with client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Creates a therapeutic environment, shows recognition that unit activity and personnel may increase client&rsquo;s anxiety. May decrease hyperactivity and CNS irritability.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide safety measures, such as padded side rails, close supervision, or use of soft restraints as last resort, as necessary.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents injury to client who may be hallucinating and disoriented.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss with client and SO reasons for emotional lability or psychotic reaction.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding that behavior is physically based enhances acceptance of situation and encourages different responses and approaches.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforce expectation that emotional control should return as drug therapy progresses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information and reassures client that the situation is temporary and will improve with treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications as indicated (e.g., antianxiety agents or sedatives), and monitor effects.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be used in conjunction with medical regimen to reduce effects of hyperthyroid secretion. Promotes relaxation and reduces CNS hyperactivity and agitation, enhancing thinking ability and sense of control.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to support systems, as needed, including counseling, social services, and pastoral care.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Ongoing therapy support may be desired and required by client and SO if crisis precipitates lifestyle alterations. <emphasis>Note:</emphasis> When psychiatric symptoms remain after restoration of euthyroidism, specific treatment with psychotropic drugs may be indicated.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0199note0495">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Dry Eye</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Autoimmune disease: (Grave&rsquo;s disease/hyperthyroidism-related symptoms, i.e., lack of moisture, inflammation and irritation; bulging of eyeball due to tissue swelling, lid retraction)</para>
<para>Altered protective mechanisms of eye&mdash;reduced ability to blink, eye dryness</para>
<para>Periorbital edema</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Dry Eye Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain moist eye membranes, free of ulcerations, corneal scarring, and eroded vision.</para>
<para><emphasis role="strong">Risk Control: Dry Eye</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Identify measures to provide protection for eyes and prevent complications.</para>
</note>
<note role="none" id="ch0006s0199note0496">
<table frame="top" id="ch0006s0199ta0281"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Dry Eye Prevention</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note presence of thyroid condition(s) that can cause and/or worsen dry eye symptoms in current situation, and determine severity of symptoms.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Thyroid eye disease (TED) may or may not be a factor in the care of client with thyroid storm. However, its presence impacts client needs and influences nursing interventions during facility care. Although 50% of patients with Graves&rsquo; disease have TED, only 5% develop severe ophthalmopathy (e.g., diplopia, visual-field deficits, or blurred vision) (Bahn Chair et al, 2011). Milder symptoms include light sensitivity (photophobia), constant eye irritation, or blurred vision associated with eye drops or gels to reduce dryness. In severe Graves&rsquo; disease, the eyes may be protruding, the eyelids may not close all of the way during sleep or normal blinking, causing corneal irritation and (rarely) increased ocular pressure (glaucoma).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Keep head of bed raised when client is sleeping.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A great deal of swelling can accompany TED (e.g., demonstrated by bags under the eyes, bulging of the eyes, swelling of the tissue coating the eyes). Sleeping with head raised can allow fluid to settle out of face.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage use of wrap-around dark glasses when awake and goggles or taping of eyelids shut during sleep as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Protects exposed cornea if client is unable to close eyelids completely and helps to maintain eye moisture.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide opportunity for client to discuss feelings about altered appearance and measures to enhance self-image.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Protruding eyes may be viewed as unattractive. Appearance can be enhanced with proper use of makeup, overall grooming, and use of shaded glasses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate in treatment of underlying thyroid condition (ongoing) as well as interventions to manage thyroid eye disease (TED), such as:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment during the active phase of the TED focuses on preserving sight and the integrity of the cornea, as well as promoting client&rsquo;s comfort (e.g., reducing congestion, redness, pain, and eyeball exposure).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Eye drops, ointments, and artificial tears or corticosteroids, along with antithyroid drugs</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To minimize eye irritation, artificial tears may be used several times per day and gel ointments may be applied at night to prevent the eyes from drying out. Cyclosporine (Restasis) and lifitegrast (Xiidra) are the only prescription medications currently approved by the U.S. Food and Drug Administration for treating dry eye (National Eye Institute [NEI], 2017). Corticosteroid eye drops also may be prescribed short term to reduce eye inflammation (Lee &amp; Ananthakrishnan, 2017; Douglas, n.d.).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgery, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Surgical treatment of TED will not be considered during acute thyrotoxic crisis but in stable client can be done over time in several procedures. Surgery can release pressure on the optic nerve (to improve vision), reduce exposure of the surface of the eye, improve eyelid closing, reduce bulging appearance, and reduce pressure pain.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0199note0497">
<title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information; insufficient knowledge of resources</para>
<para>Misinformation presented by others</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Acute Illness Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process and potential complications.</para>
<para>Identify relationship of signs and symptoms to the disease process and correlate symptoms with causative factors.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Participate in treatment regimen.</para>
<para>Initiate necessary lifestyle changes.</para>
</note>
<note role="none" id="ch0006s0199note0498">
<table frame="top" id="ch0006s0199ta0282"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review disease process and future expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed choices.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide information appropriate to individual situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Severity of condition, cause, age, and concurrent complications determine course of treatment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify stressors and discuss precipitators to thyroid crises&mdash;personal, social, and job concerns; infection; failure of antithyroid drugs or failure to take medications; and pregnancy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Psychogenic factors are often of prime importance in the occurrence and exacerbation of this disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss drug therapy, including need for adhering to regimen and expected therapeutic and side effects.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antithyroid medication, either as primary therapy or in preparation for thyroidectomy, requires adherence to a medical regimen over an extended period to inhibit hormone production.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify signs and symptoms requiring medical evaluation, such as fever, sore throat, and skin eruptions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early identification of toxic reactions (thiourea therapy) and prompt intervention are important in preventing development of agranulocytosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain need to check with physician and pharmacist before taking other prescribed or over-the-counter (OTC) drugs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antithyroid medications can affect or be affected by numerous other medications, requiring monitoring of medication levels, side effects, and interactions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of planned rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents undue fatigue and reduces metabolic demands. As euthyroid state is achieved, stamina and activity level will improve.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review need for nutritious diet and periodic review of nutrient needs; avoid caffeine, red and yellow food dyes, and artificial preservatives.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides adequate nutrients to support hypermetabolic state. As hormonal imbalance is corrected, diet will need to be readjusted to prevent excessive weight gain. Irritants and stimulants should be limited to avoid cumulative systemic effects.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Emphasize necessity of continued medical follow-up.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Required to monitor effectiveness of therapy and for prevention of potentially fatal complications.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0199note0499">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">risk for ineffective Health Management</emphasis>&mdash;perceived susceptibility/seriousness of condition; perceived barrier; difficulty managing complex treatment regimen</para></listitem>
<listitem><para><emphasis role="bi">risk for Overweight</emphasis>&mdash;decrease in metabolic rate [if hypothyroidism occurs after thyrotoxic crisis or in overmedication with antithyroid agents)], excessive intake in relation to metabolic needs</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0204"><title><emphasis role="strong">HEPATITIS</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Hepatitis (inflammation of the liver) can damage liver cells (hepatocytes) and impair liver function either directly (from the inflammation) or indirectly (from an autoimmune response).</para></listitem>
<listitem><para>May be acute or chronic:</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Acute: Swelling of hepatocytes reduces ability to detoxify drugs; produce clotting factors, plasma proteins, bile, and glycogen; and store fat-soluble vitamins. Adults with acute hepatitis A or B are usually asymptomatic. Persons with acute hepatitis C may or may not have symptoms.</para></listitem>
<listitem><para>Chronic: Inflammation of the liver of more than 6 months&rsquo; duration. Not all viral infections progress from acute to chronic; however, some do. For example, chronic hepatitis C infection develops in 75% to 85% of infected persons (Chen &amp; Morgan, 2006). Chronic hepatitis B (CHB) has been characterized into four phases, reflecting the relationship between viral replication and the host immune response (e.g., phases are from mild liver to fibrosis). These phases are of variable duration, and not every person infected with CHB will go through all phases (Terrault et al, 2016).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Infectious causes: viral, bacterial, fungal, or other</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Viruses are primarily designated by letters (e.g., A, B, C, D, E), with terms used interchangeably, for example, hepatitis B is also known as HBV or HepB.</para></listitem>
<listitem><para>In the United States, viral hepatitis is most commonly caused by HAV, HBV, and HCV (Samji et al, 2017).</para></listitem>
<listitem><para>HAV is spread primarily through the fecal-oral route, either through exposure to contaminated food or water (poor sanitation and hygiene) or from person to person (e.g., living with/sexual partner of infected person; anal-oral sexual contact) (Westbrook &amp; Dusheiko, 2014; World Health Organization [WHO], 2017a). HAV causes only acute infection and typically gets better without treatment after a few weeks. Hepatitis A infection does not cause chronic liver disease, but it can (rarely) cause debilitating symptoms and fulminant hepatitis (acute liver failure), which is often fatal.</para></listitem>
<listitem><para>HVB is transmitted by exposure to body fluids (saliva, serum, semen) of an infected person (e.g., birth to infected mother; sexual contact with infected person; injection drug use with shared needles; shared equipment such as glucose monitor) (Centers for Disease Control and Prevention [CDC], 2016c; Weinbaum et al, 2008).</para></listitem>
<listitem><para>HCV is transmitted by injection drug use with shared needles, receiving blood transfusion or organ transplant before 1992, and (less frequently) through poor infection control practices during healthcare procedures or outbreaks in healthcare facilities (CDC, 2016c). Sexual transmission occurs, but rarely, although the likelihood of sexual transmission rises with number of sex partners (CDC, 2010).</para></listitem>
<listitem><para>HDV is transmitted percutaneously (through the skin) through contact with infected blood or blood products. The HepD virus cannot replicate without the HepB virus; therefore, it does not occur in the absence of HBV. Prevalence is low in North America (WHO, 2017b).</para></listitem>
<listitem><para>HEV is transmitted primarily through the fecal-oral route, with contaminated water being the most common means. Person-to-person transmission is rare. The disease is common in countries with limited access to essential water, sanitation, hygiene, and health services (WHO, 2017b).</para></listitem>
<listitem><para>Other viruses: Cytomegalovirus (CMV), Epstein-Barr virus (EBV), <emphasis>Mycobacterium avium</emphasis> complex (MAC), herpes simplex, varicella-zoster, toxoplasmosis, and histoplasmosis may also cause inflammation of the liver, but they do not target the liver.</para>
</listitem></orderedlist></listitem>
<listitem><para>Noninfectious causes: physical or toxic chemical agents, autoimmune</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Toxic agents: carbon tetrachloride, vinyl chloride; alcohol, cocaine, acetaminophen, isoniazid, anabolic steroids, methyldopa, erythromycin; poisonous mushrooms</para></listitem>
<listitem><para>Autoimmune: no identifiable etiology; several types, with type 1 most common form in North America more often affecting (70%) and associated with other autoimmune diseases. Type 2 occurs most often in children, generally affects girls age 2 to 14 (American Liver Foundation, 2017; National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2014).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Between 2000 and 2015, the reported incidence of HepA and HepB declined significantly by 88% and 64%, respectively. By contrast, HepC has increased by 75% since 2010 (Dan et al, 2015). The CDC reported 1390 new cases of acute HAV in 2015 and estimated that the number of new infections in the United States would be around 2800 in that year (CDC, 2015).</para></listitem>
<listitem><para>After adjusting for underascertainment and underreporting, the estimated number of new HBV infections in 2015 was 21,900. Using most recent national prevalence data, the CDC estimates that approximately 850,000 persons are living with HBV in the United States, although other studies have estimated this number to be much higher (CDC, 2017d).</para></listitem>
<listitem><para>Approximately 8% to 20% of patients with chronic hepatitis B and 15% to 30% with hepatitis C eventually develop cirrhosis, as evidenced by the histologic changes of severe fibrosis and nodular regeneration (Samji et al, 2017).</para></listitem>
<listitem><para>After adjusting for underascertainment and underreporting, the CDC estimated that 33,900 new HCV infections occurred in 2015 and further estimates that approximately 3.5 million persons are currently living with HCV (CDC, 2017d).</para>
</listitem></orderedlist></listitem>
<listitem><para>Mortality: Total deaths reported by National Vital Statistics to be directly related to hepatitis (per mortality/death certificates) for the year 2014 were 8081 (CDC, 2017e), although it believed that HCV deaths are underreported. Chronic HCV infection is the leading cause of liver-related death and hepatocellular cancer in the Western world (Westbrook &amp; Dusheiko, 2014).</para></listitem>
<listitem><para>Cost: According to estimates published by the National Viral Hepatitis Roundtable (NVHR), HBV infections result in an estimated $658 million in medical costs and lost wages annually, while the projected direct and indirect costs of the current HCV epidemic, if left unchecked, will be over $85 billion for the years 2010 through 2019 (NVHR, 2016).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0204note0500"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Acute hepatitis: </emphasis>Often self-limiting, although approximately 5% to 10% of clients with HBV and 80% to 85% of clients with HCV progress to a chronic state (Samji et al, 2017).</para>
<para><emphasis role="strong">Anorexia: </emphasis>Loss of appetite as result of disease.</para>
<para><emphasis role="strong">Ascites: </emphasis>Buildup of fluid in the abdomen due to a number of conditions, including severe liver disease.</para>
<para><emphasis role="strong">Autoimmune: </emphasis>Persistent inflammation and necrosis with hypergammaglobulinemia and autoantibodies without other common causes of hepatitis.</para>
<para><emphasis role="strong">Chronic hepatitis: </emphasis>Persistent inflammation and necrosis lasting more than 6 months, commonly due to hepatitis B, C, or D virus.</para>
<para><emphasis role="strong">Fulminant hepatitis: </emphasis>Occurs suddenly and with great intensity or severity, progressing to encephalopathy within 8 weeks of onset and death if liver transplant is not performed.</para>
<para><emphasis role="strong">Hepatic encephalopathy: </emphasis>Brain dysfunction directly due to the liver dysfunction most often seen in advanced cirrhosis. Encephalopathy may cause disturbances of consciousness and progress to coma.</para>
<para><emphasis role="strong">Hepatocyte: </emphasis>Parenchymal liver cell.</para>
<para><emphasis role="strong">Jaundice: </emphasis>Yellow staining of the skin and sclera (and sometimes other tissues and body fluids) by abnormally high blood levels of the bile pigment bilirubin.</para>
<para><emphasis role="strong">Pruritus: </emphasis>Severe itching of the skin.</para>
<para><emphasis role="strong">Right upper quadrant (RUQ): </emphasis>Anatomic location of the liver.</para>
<para><emphasis role="strong">Toxic hepatitis: </emphasis>Liver inflammation often due to common drugs used to treat disease or chemicals found in the workplace.</para>
</note>
<sect2 id="ch0006s0205"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Care is most often provided in the outpatient setting or at the community level. In states of acute hepatic inflammation, inpatient acute care on a medical unit may be required to monitor and treat hepatic failure or hepatic encephalopathy.</para>
<para><emphasis role="strong">****NOTE: This care plan focuses on care of the client with viral hepatitis.</emphasis></para>
</sect2>
<sect2 id="ch0006s0206"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0014s0360">Alcohol: acute withdrawal</link></para>
<para><link linkend="ch0006s0209">Cirrhosis of the liver</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0008s0254">Renal dialysis&mdash;general considerations</link></para>
<para><link linkend="ch0014s0365">Substance use disorders</link></para>
<table frame="top" id="ch0006s0204ta0283"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Data depend on the cause (type of hepatitis) and severity of liver involvement and damage.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fatigue</para></listitem>
<listitem><para>Weakness, general malaise, muscle aches</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Bradycardia&mdash;in severe hyperbilirubinemia</para></listitem>
<listitem><para>Jaundiced sclera, skin, mucous membranes</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Dark urine, clay-colored stools</para></listitem>
<listitem><para>Diarrhea, constipation</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Nausea, vomiting</para></listitem>
<listitem><para>Loss of appetite, weight loss</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight gain&mdash;edema, ascites</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal distention due to liver enlargement</para></listitem>
<listitem><para>Ascites</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Irritability, drowsiness, lethargy</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal cramping, RUQ tenderness</para></listitem>
<listitem><para>Headache</para></listitem>
<listitem><para>Joint pain</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Muscle guarding, restlessness</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever&mdash;usually low grade (viral)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Itching (pruritus)</para></listitem>
<listitem><para>Skin rashes</para></listitem>
<listitem><para>Tattoos, piercings (possible equipment source)</para></listitem>
<listitem><para>History of blood transfusions or organ transplant received prior to viral screening tests</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Urticaria, maculopapular lesions, irregular patches of erythema</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Lifestyle or behaviors increasing risk of exposure&mdash;unprotected sexual intercourse with infected person</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of known or possible exposure to virus, bacteria, or toxins&mdash;from contaminated food, water, needles, surgical equipment, or blood; hepatitis virus carriers (symptomatic or asymptomatic); exposure to toxic chemicals, such as carbon tetrachloride, vinyl chloride</para></listitem>
<listitem><para>History of known or possible exposure to hepatotoxic prescription, such as sulfonamides, phenothiazines, isoniazid, or over-the-counter (OTC) drug use, such as acetaminophen</para></listitem>
<listitem><para>Use of herbal supplements associated with hepatotoxicity, such as chaparral, Jin Bu Huan, germander, comfrey, mistletoe, skullcap, margosa oil, pennyroyal</para></listitem>
<listitem><para>Use of street injection drugs or alcohol</para></listitem>
<listitem><para>Travel to or immigration from Central and East Asia, North Africa, the Middle East, India, Malaysia, Japan (HCV)</para></listitem>
<listitem><para>Concurrent diabetes, heart failure (HF), malignancy, or renal disease</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with homemaking, maintenance tasks, shopping, transportation</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0204ta0284"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Acute viral hepatitis panel:</emphasis> Used to help detect and/or diagnose an acute liver infection due to one of the three most common hepatitis viruses: hepatitis A virus (HAV), hepatitis B virus (HBV), or hepatitis C virus (HCV).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These tests are used to determine if symptoms are due to a current infection with a virus and to identify which virus in particular is causing the disease. These tests may also help determine if someone has been exposed to one of the viruses even before symptoms develop. An acute hepatitis panel typically consists of the following tests (Van Leeuwen &amp; Bladh, 2015):</para>
<itemizedlist mark="&bull;"><listitem><para>Hepatitis A antibody, IgM&mdash;body produces antibodies early after exposure so positive hepatitis A IgM test is usually considered diagnostic for acute hepatitis A.</para></listitem>
<listitem><para>Hepatitis B core antibody, IgM&mdash;the first antibody produced in response to a hepatitis B infection and, when detected, may indicate an acute infection. It may also be present in people with chronic hepatitis B when flares occur.</para></listitem>
<listitem><para>Hepatitis B surface Ag&mdash;earliest indicator of acute infection but may also be present in blood of person chronically infected.</para></listitem>
<listitem><para>Hepatitis C antibody&mdash;test detects antibodies produced in response to HCV infection. It cannot distinguish between an active and a previous infection. If positive, it is typically followed up with other tests to determine if the infection is a current one.</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Liver enzymes/isoenzymes:</emphasis> Of limited value in differentiating viral from nonviral hepatitis.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abnormal&mdash;may be 4 to 10 times normal values.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Alanine aminotransferase (ALT):</emphasis> Considered best liver enzyme test for detecting hepatitis.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevation usually occurs before other symptoms, such as jaundice, are noted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests that typically includes hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; white blood cell (WBC) count and differential&mdash;the percentage of each of the five types of mature WBCs: neutrophils, lymphocytes (B cells and T cells), monocytes, eosinophils, and basophils.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>RBCs are decreased because of shortened life span of RBCs&mdash;liver enzyme alterations or hemorrhage. WBCs may be abnormally low (leukopenia) or high (leukocytosis); monocytes may be increased (monocytosis), and lymphocytes may be increased and atypical in appearance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum albumin:</emphasis> Measures the main body protein manufactured by the liver.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Level is decreased.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Prothrombin time (PT):</emphasis> One of several clotting factors that is produced by the liver. Evaluates the body&rsquo;s ability to produce a clot in a reasonable amount of time.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be prolonged&mdash;liver dysfunction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum bilirubin:</emphasis> Yellow-red substance that results from the breakdown of Hgb, a normal process of the liver, then excreted via the intestines.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High level indicates the liver is incapable of adequately removing bilirubin in a timely manner due to blockage of bile ducts or liver disease, such as acute hepatitis. Accumulation of bilirubin is responsible for jaundice of the skin and mucous membranes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ASSOCIATED TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Liver biopsy:</emphasis> Considered if diagnosis is uncertain or if clinical course is atypical or unduly prolonged.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides initial assessment of disease severity in client with chronic HBV or chronic HVC.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Urinalysis:</emphasis> Checks the urine for bilirubin in the nonjaundiced client with suspected viral hepatitis.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Elevated bilirubin levels and proteinuria and hematuria may occur.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0207"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Reduce demands on liver while promoting physical well-being.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Enhance self-concept and acceptance of situation.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0208"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Homeostasis achieved.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Dealing with reality of current situation.</para></listitem>
<listitem><para>Disease process, prognosis, transmission, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0204note0501">
<title><emphasis role="strong">NURSING DIAGNOSIS: impaired Liver Function</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Viral infection (e.g., viruses A, B, C, D), Epstein-Barr</para>
<para>HIV coinfection</para>
<para>Hepatotoxic medications (e.g., acetaminophen, statins)</para>
<para>Substance abuse (e.g., alcohol, cocaine)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Presence of virus or antibodies, abnormal liver function tests</para>
<para>Presence of jaundice, hepatic enlargement</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Acute Illness Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate behaviors or lifestyle changes to limit effects of condition.</para>
<para><emphasis role="strong">Liver Function</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of signs of liver failure as evidenced by liver function studies within acceptable range and absence of jaundice, hepatic enlargement, or altered mental status.</para>
</note>
<note role="none" id="ch0006s0204note0502">
<table frame="top" id="ch0006s0204ta0285"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Infection Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine presence of condition(s), as listed above. Note whether problem is acute&mdash;viral hepatitis or acetaminophen overdose&mdash;or chronic&mdash;longstanding alcoholic or viral hepatitis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Influences choice of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review usual and/or occasional use medications&mdash;sulfonamides, phenothiazines, isoniazid&mdash;for hepatotoxic drugs or OTC drug use such as acetaminophen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May require changes in usual medication regimen and client education about hepatic effects of OTC drugs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Ascertain if client works in high-risk occupation; for example, performs tasks that involve contact with blood, blood-contaminated body fluids, other body fluids, or sharps or needles.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps in identifying source of infection&mdash;occupational high risk for exposure to HBV and HCV.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for exposure to contaminated food or untreated drinking water or for evidence of poor sanitation practices by food service workers if source is known.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps in identifying source of infection&mdash;risk for exposure to enteric viruses, such as HAV and HEV.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review results of laboratory tests, such as hepatitis viral titers, liver function, and other diagnostic studies.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies cause of hepatitis, influences choice of interventions, and monitors response to therapies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with treatment of underlying condition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Supports organ function and minimizes liver damage and risk of organ failure. For chronic HBV and HCV infections, in particular, the goals of therapy are to reduce liver inflammation and fibrosis and to prevent progression to cirrhosis and the associated complications</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The goal of antiviral therapy (in general) is to decrease viral replication, thus preventing progression of the disease; reduce the prevalence of cirrhosis; and treat distressing symptoms (e.g., fatigue, vomiting, joint pain). The particular or combination of medication used depends on the type and chronicity of the infection, as well as the status of liver function. Because treatment regimens for hepatitis are being actively researched, medication recommendations, indications, and dosages are all subject to change.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antivirals, such as ribavirin (Rebetol, Virazol), boceprevir (Victrelis), famciclovir (Famvir), and entecavir (Baraclude)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment of hepatitis depends on its type and the client&rsquo;s liver function and general health. For HBV and HCV, drugs with general antiviral properties are used to inhibit viral reproduction. They are sometimes used in conjunction with interferons or NRTIs to improve their effectiveness (Samji et al, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nucleoside reverse transcriptase inhibitors (NRTIs), such as entecavir (Baraclude), lamivudine (Epivir-HBV), adefovir (Hespera), telbivudine (Tyzeka), and tenofovir (Viread)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>NRTIs may be used to help reduce HBV viral load and treat chronic, active hepatitis B. These drugs are often used in combinations and usually require a long-term (e.g., a year or more) treatment regimen. NRTIs may be an alternative choice for individuals unable or unwilling to use interferons, or in the presence of impaired immune function such as coinfection with HIV.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Interferons such as IFN alpha-2a (Roferon A) and IFN alpha-2b (Intron A)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Interferons lead to temporary improvement in liver function in chronic HVB and HCV infections (Dhawan, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pegylated interferons, such as PEG-IFN alpha-2a (Pegasys) and PEG-IFN alpha-2b (Peg-Intron)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These agents have largely replaced standard interferons in the treatment of HCV and may be used in combination therapy with antivirals such as ribavirin (Rebetol), boceprevir (Victrelis), and protease inhibitor such as TVR (Incivek) (Yee et al, 2012).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Newer direct anti-antiviral agents (e.g., daclatasvir [Daklinza], elbasvir and grazoprevir [Zepatier], glecaprevir and pibrentasvir [Myvyret], simeprevir [Olysio], sofosbuvir [Solvadi], sofosbuvir-velpatasvir [Epclusa])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These drugs (not a complete listing) are proving highly useful in weakening the HepC virus. <emphasis>Note:</emphasis> There is no one-size-fits-all treatment option for HepC, because to date, 6 different types or genotypes of HCV and more than 50 subtypes have been identified. The goal of treatment is complete viral clearance (Rantini, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Steroid therapy, such as prednisone (Deltasone), alone or in combination with azathioprine (Imuran)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Steroids may be contraindicated because they can increase risk of relapse or development of chronic hepatitis in clients with viral hepatitis; however, anti-inflammatory effect may be useful in chronic active hepatitis to reduce nausea and vomiting and to enable client to retain food and fluids. Steroids may decrease serum aminotransferase and bilirubin levels, but they do not affect liver necrosis or regeneration. Combination therapy has fewer steroid-related side effects.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to specialist or liver treatment center for consideration of other treatment options, for example, transplantation, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Liver transplants may be deemed necessary for liver failure associated with viral (B, C, and D) and autoimmune hepatitis. Currently, almost one-half of all liver transplants in the United States are performed for end-stage HCV. However, HCV reinfection posttransplant is nearly universal and if left untreated negatively affects patient and graft survival (Taylor et al, 2016).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0503">
<title><emphasis role="strong">NURSING DIAGNOSIS: Fatigue</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Illness, anemia, malnutrition, physical deconditioning</para>
<para>Stressors, depression, sleep deprivation</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient energy; tiredness; nonrestorative sleep pattern</para>
<para>Impaired ability to maintain usual physical activity/routines; ineffective role performance</para>
<para>Increase in physical complaints</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fatigue: Disruptive Effect</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report improved sense of energy.</para>
<para>Perform activities of daily living (ADLs) and participate in desired activities at level of ability.</para>
<para>Participate in recommended treatment program.</para>
</note>
<note role="none" id="ch0006s0204note0504">
<table frame="top" id="ch0006s0204ta0286"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Energy Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determine if client is experiencing fatigue and ascertain client&rsquo;s belief about what is causing the fatigue and its impact on quality of life.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fatigue is a common problem for client with hepatitis, whether it is brought on directly by liver disease, insomnia, depression, nutritional deficits, or side effect of treatments (e.g., interferon). Studies have found that 61% to 82% of people with HepC report some level of fatigue, often being a debilitating factor in daily life (Blahd, 2016; Daniel, 2017; Zalai et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage bedrest and chair (recliner) rest during toxic state and frequent rest periods during recovery.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Available energy can be used for healing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide quiet environment and limit visitors as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Allows for extended periods of uninterrupted rest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client to note daily energy patterns (i.e., peaks and valleys) and to plan activities accordingly.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because fatigue may be profound at times over a long period of time with chronic hepatitis, client may need to learn to pace self. This may be accomplished by doing essential activities first and then other tasks as energy level allows.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify energy-conserving techniques, such as sitting to shower and brush teeth, planning steps of activity so that all needed materials are at hand, and scheduling rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps minimize fatigue, allowing client to accomplish more and feel better about self.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Progress activity as tolerated. Demonstrate and perform range-of-motion (ROM) exercises if unable to participate in other activities. Encourage daily exercise as time goes by.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prolonged disease process can be debilitating and body is further weakened by inactivity. This can be offset by limited activity alternating with rest periods, progressing to short walks and beyond. Daily exercise (no matter how limited) can improve energy and mood.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and instruct in stress management techniques, such as progressive relaxation, visualization, and guided imagery, as desired. Discuss appropriate diversional activities, such as music, Internet surfing and/or games, TV, and reading.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes relaxation and conserves energy, redirects attention, and may enhance coping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend avoidance of alcohol/other drugs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alcohol/other drugs are not only dangerous for the liver but also can exacerbate fatigue.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend small, more frequent meals of nutritious foods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>While anorexia is common, eating small amounts frequently may improve energy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Collaborate in treatment of hepatitis infection and other underlying conditions (e.g., anemia, thyroid disease).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fatigue will usually lessen significantly if client can achieve a sustained virologic response (SVR) defined as &ldquo;no evidence of the particular hepatitis virus in the blood after receiving hepatitis treatment&rdquo; (Daniel, 2017). Also managing other common conditions associated with fatigue can improve client&rsquo;s energy and coping abilities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refer to physical therapist, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be helpful in providing or instructing in mobility and strengthening exercises, as well as energy-saving techniques.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer medications, as indicated, for example, sedatives and antianxiety agents.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be given to assist in managing insomnia and promoting required rest. <emphasis>Note:</emphasis> Because the liver is responsible for breaking down drugs in the body, any benefit from medication must be weighed against possible risks of damaging the liver.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to community resources, as indicated (e.g., obtaining mobility aids, handicapped parking, Meals on Wheels, homemaker and housekeeper services).</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Promotes problem-solving of most pressing needs of individual and family.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0505">
<title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inability to ingest food&mdash;anorexia, nausea, vomiting</para>
<para>Inability to digest food/absorb nutrients&mdash;reduced peristalsis, bile stasis</para>
<para>[Increased caloric demands]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Food aversion; insufficient interest in food; food intake less than recommended daily allowance; alteration in taste sensation</para>
<para>Abdominal pain/cramping</para>
<para>Loss of weight, insufficient muscle tone</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Weight Maintenance Behavior</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Initiate behaviors and lifestyle changes to regain or maintain appropriate weight.</para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate progressive weight gain toward goal with normalization of laboratory values and no signs of malnutrition.</para>
</note>
<note role="none" id="ch0006s0204note0506">
<table frame="top" id="ch0006s0204ta0287"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Weight Gain Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note reports of/presence of anorexia, nausea and vomiting, diarrhea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be present because of the underlying disease or from side effects of certain treatments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor dietary intake and calorie count, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be required if client is severely anorexic, to assess deficits and needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide meals in several small feedings and offer largest meal at breakfast.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Large meals are difficult to manage when client is anorexic. Anorexia may also worsen during the day, making intake of food difficult later in the day.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Offer and make available snacks and calorie-dense fluids between meals and whenever client feels some appetite.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves total daily intake of nutrients, especially if client has access to foods that do not require cooking (e.g., liquid food supplements, single-package foods, snacks that don&rsquo;t require refrigeration).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage intake of plenty of fluids throughout the day (e.g., glass of water at beginning and end of day, ice chips or water bottle handy at all times).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some treatments (e.g., ribavirin) cause dehydration, dry mouth, and thick saliva, which can interfere with food intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Limit fluids at mealtime and/or carbonated sugar-containing beverages.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These can fill the stomach rapidly and interfere with appetite for food.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide bland foods and foods and fluids high in soluble fiber and electrolytes, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These may be helpful if client has diarrhea associated with disease process or treatments.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage mouth care before meals and after-dinner mints, chewing gum, etc.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rinsing mouth with saline or soda water, tea, ginger ale before eating can help clear taste buds and eliminate unpleasant taste associated with disease condition or treatments. Lemon drops, zinc lozenges, mints, or gum can help get rid of bad or &ldquo;off&rdquo; tastes that linger after eating.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend eating in upright position.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces sensation of abdominal fullness and may enhance intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage intake of fruit juices or smoothies, milk shakes, iced tea, other noncarbonated beverages; saltines or animal crackers; hard candy throughout the day.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These supply extra calories and may be more easily digested and tolerated than other fluids and foods.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Consult with dietitian or nutritional support team to provide diet according to client&rsquo;s needs, with fat and protein intake as tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in formulating dietary program to meet individual needs. Fat metabolism varies according to bile production and excretion and may necessitate restriction of fat intake if diarrhea develops. If tolerated, a normal or increased protein intake helps with liver regeneration. Protein restriction may be indicated in severe disease, such as fulminating hepatitis, because the accumulation of the end products of protein metabolism can potentiate hepatic encephalopathy (Daniel, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor serum glucose, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyperglycemia or hypoglycemia may develop in chronic hepatitis, either as a direct result of liver dysfunction or as a side effect of certain medications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antiemetics (e.g., ondansetron [Zofran], metoclopramide [Reglan])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Given before meals, these drugs may reduce nausea and increase food tolerance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antiulcer agents and antacids, such as lansoprazole (Prevacid), esomeprazole (Nexium), and magnesium hydroxide/aluminum hydroxide (Maalox, Mylanta), as indicated</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Counteracts gastric acidity, reducing irritation and risk of bleeding.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vitamins, such as B complex, C, and other dietary supplements, as indicated</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corrects deficiencies and aids in the healing process.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide supplemental feedings, enteral or parenteral nutrition if needed.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be necessary to meet nutrient requirements if marked deficits are present and intestinal symptoms are prolonged.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0507">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for deficient Fluid Volume/Bleeding</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Excessive losses through normal routes&mdash;vomiting, diarrhea</para>
<para>Failure of regulatory mechanisms&mdash;third-space shift</para>
<para>Active fluid loss&mdash;altered clotting process</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate hydration, as evidenced by stable vital signs, good skin turgor, timely capillary refill, strong peripheral pulses, and individually appropriate urinary output.</para>
<para><emphasis role="strong">Blood Coagulation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of signs of hemorrhage with clotting times within normal limits (WNL).</para>
</note>
<note role="none" id="ch0006s0204note0508">
<table frame="top" id="ch0006s0204ta0288"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor intake and output (I&amp;O) and compare periodic weights. Note enteric losses, such as vomiting and diarrhea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about replacement needs and effects of therapy. <emphasis>Note:</emphasis> Diarrhea may be due to transient flulike response to acute viral infection or may represent a more serious problem in chronic hepatitis with damaged liver, causing vascular congestion in the gastrointestinal (GI) tract. Or, it may be the intended result of medication use, such as neomycin or lactulose, to decrease serum ammonia levels in the presence of hepatic encephalopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess vital signs, peripheral pulses, capillary refill, skin turgor, and mucous membranes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of circulating volume and perfusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Bleeding Precautions <emphasis role="strong"><inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Check for ascites and edema formation. Measure abdominal girth, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Useful in monitoring progression and resolution of fluid shifts associated with edema and ascites.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Use small-gauge needles for injections, applying pressure for longer than usual after venipuncture.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces possibility of bleeding into tissues.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Have client use cotton or sponge swabs and alcohol-free mouthwash instead of toothbrush.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoids trauma and bleeding of the gums. <emphasis>Note:</emphasis> Alcohol-based mouthwash may be irritating to dry mucosa.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for signs of bleeding&mdash;hematuria and melena, ecchymosis, and oozing from gums or puncture sites.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prothrombin levels are reduced and coagulation times prolonged when vitamin K absorption is altered in GI tract, and synthesis of prothrombin is decreased in affected liver.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor periodic laboratory values, such as Hgb/Hct, sodium, albumin, and clotting times.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reflects hydration status and identifies sodium retention and protein deficits, which may lead to edema formation. Deficits in clotting potentiate risk of bleeding.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer antidiarrheal agents, such as diphenoxylate with atropine (Lomotil).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces fluid and electrolyte loss from GI tract.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide intravenous (IV) fluids (usually glucose) and electrolytes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides fluid and electrolyte replacement in acute toxic state.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Bleeding Precautions</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vitamin K</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because absorption is altered, supplementation may prevent coagulation problems, which may occur if clotting factors are decreased.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antacids or H<subscript>2</subscript>-receptor antagonists, such as lansoprazole (Prevacid) and cimetidine (Tagamet)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Neutralizes or reduces gastric secretions to lower risk of gastric irritation and bleeding.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Infuse fresh-frozen plasma (FFP), as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be required to replace clotting factors in the presence of coagulation defects.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0509">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for situational low Self-Esteem</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Physical illness</para>
<para>Alteration in body image</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Esteem</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize feelings.</para>
<para>Identify methods for coping with negative perception of self.</para>
<para>Verbalize acceptance of self in situation, including length of recovery and need for isolation.</para>
<para>Acknowledge self as worthwhile; be responsible for self.</para>
</note>
<note role="none" id="ch0006s0204note0510">
<table frame="top" id="ch0006s0204ta0289"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Self-Esteem Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Contract with client regarding time for listening. Encourage discussion of feelings and concerns.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establishing time enhances trusting relationship. Providing opportunity to express feelings allows client to feel more in control of the situation. Verbalization can decrease anxiety and depression and facilitate positive coping behaviors. Client may need to express feelings about being ill, length and cost of illness, possibility of infecting others, and (in severe illness) fear of death. May have concerns regarding the stigma of the disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoid making moral judgments regarding lifestyle, such as alcohol use, drug abuse, and sexual practices.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may already feel upset or angry and condemn self; judgments from others will further damage self-esteem.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss recovery expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recovery period may be prolonged (months), potentiating family and situational stress and necessitating need for planning, support, and follow-up.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess effect of illness on economic factors of client and significant other (SO).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Financial problems may exist because of loss of client&rsquo;s role functioning in the family and prolonged recovery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Offer diversional activities based on energy level.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enables client to use time and energy in constructive ways that enhance self-esteem and minimize anxiety and depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest client wear bright reds or blues and blacks instead of yellows or greens.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances appearance because yellow skin tones are intensified by yellow and green colors. <emphasis>Note:</emphasis> Jaundice usually peaks within 1 to 2 weeks, then gradually resolves over 2 to 4 weeks.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Make appropriate referrals for help as needed, such as community case manager, social services, and other community agencies.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can facilitate problem-solving and help involved individuals cope more effectively with situation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to counseling, support group, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May need additional assistance to deal with emotional issues of illness and effect on own life and family to prevent progression to chronic self-esteem issues.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0511">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection [secondary/spread]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Leukopenia, suppressed inflammatory response, immunosuppression</para>
<para>Malnutrition</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of individual causative and risk factor(s).</para>
<para>Demonstrate techniques and initiate lifestyle changes to avoid reinfection and transmission to others.</para>
</note>
<note role="none" id="ch0006s0204note0512">
<table frame="top" id="ch0006s0204ta0290"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">For client in healthcare facility:</emphasis></para>
<para>Establish isolation techniques if indicated according to facility infection guidelines and policy for handling body fluids and wastes, as well as contaminated objects. Model and emphasize need for effective hand hygiene, including handwashing and use of alcohol-based hand sanitizers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Healthcare-associated HAV occurs infrequently. HAV is spread by the fecal-oral route, and transmission to healthcare personnel usually occurs when the source client has unrecognized hepatitis and is fecally incontinent or has diarrhea. Types A, B, C, and D are transmitted by contaminated blood or blood products, needle punctures, open wounds, and contact with saliva, urine, stool, and semen. Incidence of both HBV and HCV has increased among healthcare providers (primarily through contaminated needles/other sharp instruments). <emphasis>Note:</emphasis> Toxic and alcoholic types of hepatitis are not communicable and do not require special measures or isolation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize need to monitor and restrict visitors, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client exposure to infectious processes, especially respiratory, potentiates risk of secondary complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explain isolation procedures to client and SO.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding reasons for safeguarding themselves and others can lessen feelings of isolation and stigmatization. Isolation may last 2 to 3 weeks from onset of illness, depending on type and duration of symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer anti-infective medications, as appropriate.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Used to treat or limit secondary infections.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0513">
<title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information; insufficient interest in learning; misinformation presented by others</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Chronic Illness Care</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process, prognosis, and potential complications.</para>
<para>Identify relationship of signs and symptoms to the disease and correlate symptoms with causative factors.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
</note>
<note role="none" id="ch0006s0204note0514">
<table frame="top" id="ch0006s0204ta0291"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess level of understanding of the disease process, prognosis, and possible treatment options.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies areas of lack of knowledge or misinformation and provides opportunity to give additional information as necessary.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss the importance of participating in entire treatment regimen (e.g., take mediations every day, exactly as prescribed; don&rsquo;t skip doses; get blood tests done on time; attend all follow-up visits with healthcare providers).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is known that sustained remission is rare in the absence of/or completion of treatment. Much of the time, treatment is 12 weeks long (but may be as short as 8 weeks or as long as over a year), which can become a burden to some clients, raising the risk that they fail to complete treatment and relapse.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide specific information regarding prevention and transmission of disease: for example, contacts may require gamma globulin, personal items should not be shared, and observe strict handwashing and sanitizing of clothes, dishes, and toilet facilities while liver enzymes are elevated. Avoid intimate contact, such as kissing and sexual contact, and exposure to infections, especially respiratory infections.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Needs vary with type of hepatitis, causative agent, and individual situation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Plan resumption of activity, as tolerated, with adequate periods of rest.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It is not necessary to wait until serum bilirubin levels or viral loads return to normal to resume activity. However, client needs to understand the importance of continued adequate rest in preventing relapse or recurrence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Help client identify appropriate diversional activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enjoyable activities promote rest and help client avoid focusing on prolonged convalescence.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage continuation of balanced diet.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes general well-being and enhances energy for healing process and tissue regeneration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify ways to maintain usual bowel function, such as adequate intake of fluids and dietary roughage and moderate exercise to tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased level of activity, changes in food and fluid intake, and slowed bowel motility may result in constipation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss the side effects and dangers of taking OTC and certain prescribed drugs that are known to have adverse effects on the liver. Advise client to notify pharmacists and all future healthcare providers of diagnosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Some drugs are toxic to the liver; many others are metabolized by the liver and should be avoided in severe liver diseases because they may cause cumulative toxic effects or chronic hepatitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss restrictions on donating blood.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Most state laws prevent accepting as donors those who have a history of any type of hepatitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of follow-up physical examination and laboratory evaluation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Disease process may take several months to resolve. If symptoms persist longer than 6 months, liver biopsy may be required to verify presence of chronic hepatitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss need for immunizations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recovery from hepatitis A and B results in protective antibodies in the client, so he or she will not get those strains again. There is currently no vaccine available against HCV. However, people should be vaccinated against HAV and HBV. Guidelines include immunizing everyone under the age of 18 years, individuals exposed to blood and body fluids or sharing a household with an infected person, screening all pregnant women for HBsAg, and providing immunoprophylaxis to infants of HBV-infected women, people traveling to areas where infection rates are known to be high, men who have sex with men, illicit injection drug users, and persons receiving hemodialysis or who have clotting disorders or liver disease (CDC, 2018).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Give information regarding availability of gamma globulin, immune serum globulin (ISG), hepatitis immune globulin (H-BIG), HBV vaccine (Recombivax HB, Engerix-B) through health department or family physician.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Immune globulins may be effective in preventing viral hepatitis in those who have been exposed, depending on type of hepatitis and period of incubation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review necessity of avoidance of alcohol, illicit drugs, and tobacco.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These substances increase hepatic irritation and interfere with recovery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to community resources and drug and alcohol treatment program, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May need additional assistance to withdraw from substance and maintain abstinence to avoid further liver damage.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0204note0515">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;altered body chemistry, malnutrition, stress, depression</para></listitem>
<listitem><para><emphasis role="bi">impaired Home Maintenance</emphasis>&mdash;illness, insufficient finances, inadequate support systems, unfamiliarity with neighborhood resources</para></listitem>
<listitem><para><emphasis role="bi">imbalanced Nutrition: less than body requirements</emphasis>&mdash;inability to ingest/digest food (anorexia, nausea, vomiting); inability to absorb nutrients; [increased metabolic demands]</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;inadequate secondary defenses; malnutrition</para></listitem>
<listitem><para><emphasis role="bi">risk for impaired Liver Function</emphasis>&mdash;viral infection, coinfections, substance abuse</para></listitem>
<listitem><para><emphasis role="bi">risk for ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, family patterns of healthcare, perceived barriers, social support deficit</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0209"><title><emphasis role="strong">CIRRHOSIS OF THE LIVER</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>All chronic liver diseases that progress to cirrhosis have in common the histologic features of hepatic fibrosis and nodular regeneration. However, signs and symptoms may vary, depending on the underlying etiology of the disease. For example, a person with end-stage liver disease caused by hepatitis C may develop profound muscle wasting, marked ascites, and severe hepatic encephalopathy, with only mild jaundice. In contrast, a person with end-stage primary biliary cirrhosis may be deeply jaundiced, with no evidence of muscle wasting or portal hypertension.</para></listitem>
<listitem><para>Altered liver structure and degenerative changes are the result of the buildup of diffuse bands of fibrotic connective tissue causing widespread destruction of hepatic cells, impairing liver function, and impeding blood flow through the liver.</para></listitem>
<listitem><para>Compensated cirrhosis: Liver function may continue for some time, even with significant scarring, but metabolic abnormalities can occur, such as coagulation defects and malnutrition.</para></listitem>
<listitem><para>Decompensated cirrhosis: Progression of failure with significant complications, such as portal hypertension with bleeding varices, spontaneous bacterial infections (SPBs), ascites, hepatorenal syndrome, and encephalopathy.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Rate of progression of fibrosis to cirrhosis varies for unknown reasons.</para></listitem>
<listitem><para>Multiple causation (Fagerstrom &amp; Frisman, 2017; Wolf, 2017)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Hepatitis C (26%)</para></listitem>
<listitem><para>Alcoholic liver disease (21%); HepC plus alcoholic liver disease (15%)</para></listitem>
<listitem><para>HepB, along with HepD (15%)</para></listitem>
<listitem><para>Cryptogenic causes (no readily identifiable cause) (18%): including nonalcoholic fatter liver disease (NAFLD). <emphasis>Note:</emphasis> The development of NAFLD is closely associated with obesity and metabolic syndrome, a proinflammatory state that perpetuates metabolic abnormalities and fatty deposits in the liver (Dietrich &amp; Hellerbrand, 2014; Wisocky &amp; Paul, 2017).</para></listitem>
<listitem><para>Miscellaneous liver disorders (about 5%) include autoimmune hepatitis, Wilson&rsquo;s disease, alpha<subscript>1</subscript>-antitrypsin deficiency, drug-induced liver disease (e.g., NSAIDs, acetaminophen; aminoglycoside antibiotics, methotrexate; statins, phenytoin; methamphetamine [not a complete list]) (Lee, 2016), chronic right-sided heart failure, hemochromatosis, and toxins (e.g., arsenic, environmental toxins).</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Treatment</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Goals are to (1) slow the progression of the disease (if the cause can be treated) and manage developing complications (e.g., esophageal varices, hepatic encephalopathy, hepatocellular carcinoma [HCC]) and (2) alleviate distressing symptoms (e.g., anorexia, anemia, ascites, pruritus, pain).</para></listitem>
<listitem><para>Liver transplantation is currently the only life-saving procedure for end-stage disease.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: According to a study published in 2015, the prevalence of cirrhosis in the United States was approximately 0.27%, corresponding to 633,323 adults (Scaglione et al, 2015). As of December 2015, approximately 14,046 individuals were listed on the waiting list for liver transplant (Kim et al, 2015).</para></listitem>
<listitem><para>Mortality: In 2014, cirrhosis (and other liver disorders) were listed as the 12th leading cause of death in the United States (approximately 38,000 a year) (Centers for Disease Control and Prevention [CDC], 2016b).</para></listitem>
<listitem><para>According to a study published in 2011, the national cost for treatment of cirrhosis in 2008 ranged from $14 million to $2 billion, depending on disease etiology. <emphasis>Note:</emphasis> This burden is expected to rise over the next 20 years, given that the percentage of patients with HCV-related cirrhosis is predicted to almost double (Neff et al, 2011).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0209note0516"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Ascites: </emphasis>Buildup of excessive fluid within the peritoneal cavity, can be a complication of either hepatic or nonhepatic disease. The four most common causes of ascites in North America and Europe are cirrhosis, neoplasm, congestive heart failure, and tuberculous peritonitis (Wolf, 2017).</para>
<para><emphasis role="strong">Asterixis: </emphasis>Involuntary jerking movements of hands and feet associated with hepatic encephalopathy.</para>
<para><emphasis role="strong">Ecchymosis: </emphasis>Skin discoloration consisting of a large, irregularly formed hemorrhagic area with colors changing from blue-black to greenish-brown or yellow; commonly referred to as a bruise.</para>
<para><emphasis role="strong">Fetor hepaticus: </emphasis>Particularly foul-smelling breath, which frequently precedes hepatic coma.</para>
<para><emphasis role="strong">Hematemesis: </emphasis>Bloody vomitus.</para>
<para><emphasis role="strong">Hepatic encephalopathy: </emphasis>Brain dysfunction directly due to liver dysfunction seen in advanced cirrhosis, resulting in disturbances of consciousness and progressing to coma.</para>
<para><emphasis role="strong">Hepatomegaly: </emphasis>Enlarged liver.</para>
<para><emphasis role="strong">Hepatorenal syndrome: </emphasis>Represents a continuum of kidney dysfunction observed in individuals with cirrhosis caused by the vasoconstriction of large and small renal arteries.</para>
<para><emphasis role="strong">Jaundice: </emphasis>Yellow staining of the skin and sclera (and sometimes other tissues and body fluids) because of abnormally high blood levels of bilirubin.</para>
<para><emphasis role="strong">Melena: </emphasis>Bloody stools.</para>
<para><emphasis role="strong">Palmar erythema: </emphasis>Redness of the palms of the hands caused by dilation and congestion of capillaries.</para>
<para><emphasis role="strong">Peritoneovenous shunt: </emphasis>Surgically implanted device for continuous draining of ascitic fluid into the venous system. Fluid is removed via a pressure-sensitive one-way valve. It is connected to a tube under the subcutaneous tissue of the chest wall to the neck, where it enters the internal jugular vein and terminates in the superior vena cava.</para>
<para><emphasis role="strong">Petechiae: </emphasis>Tiny red dots on the skin caused by minute hemorrhage, indicating low platelet count or other blood disorder.</para>
<para><emphasis role="strong">Spider angiomas: </emphasis>Abnormal collection of blood vessels near the surface of the skin; can occur anywhere but are most common on the face and trunk.</para>
<para><emphasis role="strong">Splenomegaly: </emphasis>Enlarged spleen.</para>
<para><emphasis role="strong">Steatorrhea: </emphasis>Pale, bulky, and malodorous stools as a result of fat malabsorption.</para>
<para><emphasis role="strong">Telangiectasia: </emphasis>Visibly dilated blood vessel on the skin or mucosal surface.</para>
<para><emphasis role="strong">Venous thromboembolism (VTE): </emphasis>A venous thrombus is a blood clot that forms within a vein. A common type of venous thrombosis is a deep vein thrombosis (DVT), a blood clot in the deep veins of the leg. If the thrombus breaks off and flows toward the lungs, it can become a pulmonary embolism (PE), a blood clot in the lungs.</para>
</note>
<sect2 id="ch0006s0210"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client may be hospitalized on a medical unit during initial or recurrent acute episodes with potentially life-threatening complications. Otherwise, this condition is managed at the community, outpatient level.</para>
</sect2>
<sect2 id="ch0006s0211"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0008s0244">Acute renal injury (acute renal failure)</link></para>
<para><link linkend="ch0014s0360">Alcohol: acute withdrawal</link></para>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0005s0164">Peritonitis</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0008s0254">Renal dialysis&mdash;general considerations</link></para>
<para><link linkend="ch0014s0365">Substance use disorders</link></para>
<para><link linkend="ch0006s0219">Total nutritional support: parenteral/enteral feeding</link></para>
<para><link linkend="ch0005s0144">Upper gastrointestinal bleeding</link></para>
<para><link linkend="ch0002s0064">Venous thromboembolism (VTE) disease including deep vein thrombosis (DVT) and pulmonary embolism (PE)</link></para>
<table frame="top" id="ch0006s0209ta0292"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Data depend on underlying cause of the condition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weakness</para></listitem>
<listitem><para>Fatigue, exhaustion</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased muscle mass and tone</para></listitem>
<listitem><para>Lethargy, malaise</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of or recent onset of hepatitis, heart failure (HF), pericarditis, rheumatic heart disease, or cancer, causing liver impairment leading to failure</para></listitem>
<listitem><para>Easy bruising, nosebleeds, bleeding gums</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hypertension or hypotension (fluid shifts)</para></listitem>
<listitem><para>Dysrhythmias, extra heart sounds&mdash;S<subscript>3</subscript>, S<subscript>4</subscript></para></listitem>
<listitem><para>Jugular vein distention (JVD), distended abdominal veins, spider angiomas, collateral circulation</para></listitem>
<listitem><para>Ecchymosis, petechiae</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Gradual abdominal enlargement</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal distention (hepatomegaly, splenomegaly, ascites)</para></listitem>
<listitem><para>Hemorrhoidal or esophageal varices</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Diarrhea or constipation</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased or absent bowel sounds</para></listitem>
<listitem><para>Clay-colored stools, melena</para></listitem>
<listitem><para>Dark, concentrated urine; oliguria (hepatorenal syndrome, failure)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Anorexia</para></listitem>
<listitem><para>Food intolerance, ingestion</para></listitem>
<listitem><para>Nausea, vomiting</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Weight loss (actual) or gain (fluid)</para></listitem>
<listitem><para>Tissue wasting</para></listitem>
<listitem><para>Hematemesis</para></listitem>
<listitem><para>Halitosis or fetor hepaticus, bleeding gums</para></listitem>
<listitem><para>Dry skin, poor turgor</para></listitem>
<listitem><para>Edema generalized in tissues</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Significant other (SO)/family may report personality changes, depressed mentation</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Changes in mentation, confusion</para></listitem>
<listitem><para>Slowed, slurred speech</para></listitem>
<listitem><para>Hallucinations</para></listitem>
<listitem><para>Confusion progressing to delirium and coma (hepatic encephalopathy)</para></listitem>
<listitem><para>Asterixis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal tenderness and right upper quadrant (RUQ) pain</para></listitem>
<listitem><para>Pins-and-needles sensation, burning pain in extremities (peripheral neuropathy)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Guarding or distraction behaviors</para></listitem>
<listitem><para>Self-focus</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachypnea, dyspnea, shallow respiration, adventitious breath sounds</para></listitem>
<listitem><para>Hypoxia</para></listitem>
<listitem><para>Limited thoracic expansion because of ascites</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Itching, dryness of the skin (pruritus)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever&mdash;more common in alcoholic cirrhosis</para></listitem>
<listitem><para>Jaundiced skin and sclera</para></listitem>
<listitem><para>Spider angiomas, telangiectasias</para></listitem>
<listitem><para>Palmar erythema</para></listitem>
<listitem><para>Delayed wound healing</para></listitem>
<listitem><para>Unsteady or shaky, jerking movements (risk for falls)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Menstrual disorders (women)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Impotence (men)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Testicular atrophy, gynecomastia, loss of hair&mdash;chest, underarm, pubic</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of long-term alcohol or injection drug use, alcoholic liver disease, use of drugs affecting liver function</para></listitem>
<listitem><para>History of biliary system disease, hepatitis, exposure to toxins, liver trauma</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May need assistance with self-care and other activities of daily living (ADLs), homemaking and maintenance tasks, or placement in care facility</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0209ta0293"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Liver enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), alkaline phosphatase (ALP):</emphasis> Assess liver functioning and detect liver damage.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Liver enzyme levels are elevated because of cellular damage and release of enzymes. Which enzymes are elevated and how much they are elevated varies depending on the cause(s) for liver disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum bilirubin (total and indirect unconjugated):</emphasis> Bilirubin results from the breakdown of hemoglobin.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated because of cellular disruption or biliary obstruction, causing jaundice.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum albumin:</emphasis> Protein of the highest concentration in plasma. Transports substances, such as bilirubin, calcium, progesterone, and drugs, and regulates osmotic pressure of blood, keeping fluid from leaking out into the tissues.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because albumin is made by the liver, decreased serum albumin may result from liver disease and affect bleeding/clotting and nutrition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Immunoglobulin (Ig) A, G, and M:</emphasis> Proteins found in blood or other bodily fluids used by the immune system to identify and neutralize foreign objects, such as bacteria and viruses.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Levels are increased.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests, which typically includes hemoglobin (Hgb); hematocrit (Hct); red blood cell (RBC) count, morphology, indices, and distribution width index; platelet count and size; white blood cell (WBC) count and differential.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hb, Hct, and RBCs may be decreased because of bleeding and RBC destruction. Anemia is seen with hypersplenism and iron deficiency. Leukopenia may be present as a result of hypersplenism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Bleeding studies</emphasis> (e.g., platelets, coagulation factors [Factor II, V, VII, X, or XII deficiencies]; prothrombin time, fibrinogen, vitamin K [not a complete list])</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In severe liver disease, there is both a risk for bleeding and risk for clotting, which may be concurrent.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Clotting studies</emphasis> (e.g., protein C, antithrombin, aPTT, anti-Xa, INR [not a complete list])</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN):</emphasis> Urea is the end product of protein metabolism formed in the liver from amino acids and from ammonia compounds.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevation indicates breakdown of blood proteins and possible kidney dysfunction because of diuretic use in treatment of ascites.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum ammonia:</emphasis> Product of breakdown of protein, which is normally converted to urea and excreted.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated because of inability to convert ammonia to urea. Elevated levels will cause hepatic encephalopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum glucose:</emphasis> One of the simple sugars in the blood, which serves as primary energy source for cells.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low blood glucose (hypoglycemia) suggests impaired synthesis of glycogen from glucose (glycogenesis).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrolytes:</emphasis> Substances that dissociate into ions in solution and acquire the capacity to conduct electricity. Common electrolytes include sodium, potassium, chloride, calcium, and phosphate.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Low potassium (hypokalemia) may reflect increased aldosterone, although various imbalances may occur. Low calcium (hypocalcemia) may occur because of impaired absorption of vitamin D.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Abdominal ultrasonography with Doppler:</emphasis> Diagnostic technique that uses sound waves to produce an image of internal body structures.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be first assessment performed in individual with suspected liver disease to detect ascites and enlarged liver and spleen. In advanced disease, the liver appears small and multinodular, ascites may be detected, and Doppler flow can be significantly decreased in the portal circulation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Liver biopsy:</emphasis> Biopsy can be performed via percutaneous, transjugular, laparoscopic, open operative, or computed tomography (CT)-guided fine-needle approaches. Samples are obtained for microscopic evaluation.</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Definitive test for cirrhosis, revealing hepatic tissue destruction and fibrosis.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0212"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Maintain adequate nutrition.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Enhance self-concept and acceptance of situation.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, potential complications, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0213"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Nutritional intake adequate for individual needs.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Deals effectively with current reality.</para></listitem>
<listitem><para>Disease process, prognosis, potential complications, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0209note0517">
<title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inability to ingest food (e.g., anorexia, nausea, vomiting, indigestion)</para>
<para>Inability to digest food</para>
<para>Abdominal cramping</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Body weight 20% or more below ideal weight range [recent weight loss; decreased subcutaneous fat or muscle mass]; poor muscle tone</para>
<para>Insufficient interest in food; food aversion; food intake less than recommended daily allowances; satiety immediately after ingesting food</para>
<para>Hyperactive bowel sounds; diarrhea, steatorrhea</para>
<para>Abnormal laboratory studies (e.g., decreased albumin)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate progressive weight gain toward goal.</para>
<para>Experience no further signs of malnutrition.</para>
<para><emphasis role="strong">Nutritional Status: Biochemical Measures</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display appropriate normalization of laboratory values.</para>
</note>
<note role="none" id="ch0006s0209note0518">
<table frame="top" id="ch0006s0209ta0294"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Nutrition Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note client reports of inability to eat. Assess for presence of conditions that can interfere with food intake.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with cirrhosis may have been sick for quite a while with nausea and/or vomiting and have no appetite or may have abdominal ascites, which causes early satiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate client&rsquo;s risk for malnutrition, noting such things as emaciated appearance, muscle wasting, obvious lack of interest in food, expressed aversion to eating, etc.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Malnutrition, weight loss, and muscle wasting occur in more than 50% of persons with cirrhosis (Cheung et al, 2012). Client may have malabsorption syndrome due to inability to process or digest nutrients, anorexia, nausea or vomiting, indigestion, or early satiety associated with ascites. Deficiencies in water-soluble vitamins are common in alcoholic cirrhosis, while deficiencies in fat-soluble vitamins are more common in cholestatic liver disease. In more advanced stages, both fat-soluble and water-soluble vitamin deficiencies occur (O&rsquo;Brien &amp; Williams, 2008).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine ability to chew, swallow, and taste. Discuss usual eating habits, including food preferences, intolerances, or aversions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Factors that affect ingestion and digestion of nutrients.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate total daily food intake, using food diary if needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information about intake, needs, and deficiencies. <emphasis>Note:</emphasis> Dietary protein restriction is not advised for the management of mild hepatic encephalopathy since loss of skeletal muscle, which metabolizes ammonia, can lead to worsening hepatic encephalopathy (Cordoba et al, 2004; Liou, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh, as indicated. Consider fluid status and recent weight history.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>It may not be reasonable to use weight as a direct indicator of nutritional status in view of edema and ascites.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist or encourage client to eat; explain reasons for the types of diet. Feed client if tiring easily, or have SO assist client. Consider preferences in food choices.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improved nutrition is vital to recovery. Client may eat better if family is involved and preferred foods are included as much as possible. Client and family must understand protein intake limitations and how best to meet needs and desires within limitations.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend or provide small, frequent meals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Poor tolerance to larger meals may be due to increased intra-abdominal pressure or ascites.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Offer and make available snack and calorie-dense foods between meals and whenever client feels some appetite.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Improves total daily intake of nutrients especially if client has access to foods that do not require cooking (e.g., liquid supplements, single-package low-salt foods, snacks that don&rsquo;t require refrigeration).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend sitting in upright position to eat.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces discomfort from abdominal distention and may enhance intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage intake of plenty of fluids throughout the day (e.g., glass of water at beginning and end of day, ice chips or water bottle handy at all times).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps in hydrating for metabolic functions but also can counteract effects of some treatments (e.g., ribavirin, diuretics used for ascites/edema), which can cause dehydration, dry mouth, and thick saliva interfering with food intake.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Limit fluids at mealtime and/or carbonated sugar-containing beverages.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These can fill stomach rapidly and interfere with appetite for foods.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Limit such high-salt foods as canned soups and vegetables, processed meats, and condiments. Provide salt substitutes if allowed, avoiding those containing ammonia.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Salt limitations can help manage fluid complications in cirrhosis, including ascites or tissue edema. Salt substitutes enhance the flavor of food and aid in increasing appetite; ammonia potentiates risk of encephalopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage or provide frequent mouth care, especially before meals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client is prone to sore and bleeding gums and bad taste in mouth, which contributes to anorexia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide assistance with activities as needed. Promote undisturbed rest periods, especially before meals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Conserving energy reduces metabolic demands on the liver and promotes cellular regeneration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies (e.g., glucose, prealbumin or albumin, total proteins, and ammonia).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Glucose may be decreased because of impaired glycogenesis, depleted glycogen stores, or inadequate intake. Protein may be low because of impaired metabolism, decreased hepatic synthesis, or loss into peritoneal cavity (ascites). Elevation of ammonia level may require restriction of protein intake to prevent serious complications in person with severe cirrhosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain nothing by mouth (NPO) status, when indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gastrointestinal (GI) rest may be required in acutely ill clients to reduce demands on the liver and production of ammonia and urea in the GI tract. When this is the case, nutrition must be supplied by another method&mdash;enteral or parenteral feedings.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate with nutritional team to provide diet individualized to client&rsquo;s needs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The client needs and food tolerance vary greatly from day to day, because they are dependent on multiple factors, such as the status of client&rsquo;s gastrointestinal system, but also response to treatments and cognitive and emotional state.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide enteral tube feedings or total parenteral nutrition (TPN), if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be required to supplement diet or to provide nutrients when client is too nauseated or anorexic to eat or when esophageal varices interfere with oral intake. (Refer to CP: <link linkend="ch0006s0219">Total Nutritional Support: Parenteral/Enteral Feedings</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vitamin supplements (especially fat-soluble vitamins A, D, E, K) and B vitamins (thiamine, iron, folic acid)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replacement required because of the inability of the liver to process or store vitamins.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Antiemetics, such as ondansetron (Zofran) and promethazine (Phenergan)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Used to reduce nausea and vomiting or to enhance oral intake (when taken before meals).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0519">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for excess Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Compromised regulatory mechanism&mdash;decreased plasma proteins</para>
<para>Excess sodium and fluid intake</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stabilized fluid volume, with balanced intake and output (I&amp;O), stable weight, vital signs within client&rsquo;s normal range, and free of edema.</para>
</note>
<note role="none" id="ch0006s0209note0520">
<table frame="top" id="ch0006s0209ta0295"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure I&amp;O, noting positive balance&mdash;intake in excess of output. Weigh daily, and note trends.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reflects circulating volume status, developing or resolving fluid shifts, and response to therapy. Positive fluid balance and weight gain often reflect continuing fluid retention. <emphasis>Note:</emphasis> Decreased circulating volume and fluid shifts can directly affect renal function and urine output, resulting in hepatorenal syndrome.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily or as prescribed and document changes, noting both gains and losses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitoring is needed to help direct therapy, as weight may increase, decrease, or fluctuate. For example, steady weight gain may reflect continuing fluid retention (renal impairment) or development of ascites. Or adjustments in dosage may be required in client losing more than a pound a day while on diuretic therapy for ascites.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor BP and CVP, if available. Note JVD and abdominal vein distention.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>BP elevations are usually associated with fluid volume excess but may not occur because of fluid shifts out of the vascular space. JVD and presence of distended abdominal veins are associated with vascular congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess respiratory status, noting increased respiratory rate and dyspnea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicative of pulmonary congestion or edema.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate lungs, noting diminished or absent breath sounds and developing adventitious sounds&mdash;crackles.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increasing pulmonary congestion may result in consolidation, impaired gas exchange, and complications, such as pulmonary edema.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor for cardiac dysrhythmias. Auscultate heart sounds, noting development of S<subscript>3</subscript>/S<subscript>4</subscript> gallop rhythm.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be caused by HF, decreased coronary arterial perfusion, or electrolyte imbalance.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess degree of peripheral and dependent edema.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluids shift into tissues as a result of sodium and water retention, decreased albumin, and increased antidiuretic hormone (ADH).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Measure abdominal girth.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reflects accumulation of fluid or ascites resulting from loss of plasma proteins and fluid into peritoneal space. <emphasis>Note: </emphasis>Ascites is one of the most frequent complications of late-stage cirrhosis (60%&ndash;75%) (Cesario et al, 2013; Shah &amp; Fields, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide frequent mouth care and occasional ice chips, particularly if NPO; schedule fluid intake around the clock.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases sensation of thirst, especially when fluid intake is restricted.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor serum albumin and electrolytes, particularly potassium and sodium.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased serum albumin affects plasma colloid osmotic pressure, resulting in edema formation. Reduced renal blood flow, accompanied by elevated ADH and aldosterone levels and the use of diuretics to reduce total body water, may cause various electrolyte shifts and imbalances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor serial chest x-rays.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vascular congestion, pulmonary edema, and pleural effusions frequently occur.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Restrict sodium and fluids, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sodium may be restricted to minimize fluid retention in extravascular spaces. Fluid restriction may be necessary to correct dilutional hyponatremia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer salt-free albumin and plasma expanders, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Albumin may be given to increase the colloid osmotic pressure in the vascular compartment, thereby increasing effective circulating volume and decreasing formation of ascites. <emphasis>Note:</emphasis> In client with tense ascites in whom other complications are absent or have been resolved, a total paracentesis (i.e., removal of the maximal amount of ascites) may be an initial treatment for ascites along with albumin infusion followed by the administration of diuretics (Shah &amp; Fields, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretics, such as spironolactone (Aldactone) given alone or in combination with furosemide (Lasix)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Spironolactone is the diuretic of choice to control edema and ascites, block effect of aldosterone, and increase water excretion while sparing potassium. Diuretics given in conjunction with albumin may enhance fluid removal.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potassium</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum and cellular potassium are usually depleted because of liver disease and urinary losses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Positive inotropic drugs and arterial vasodilators</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Given to increase cardiac output and improve renal blood flow and function, thereby reducing excess fluid.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for/assist with procedures as indicated in client with ascites unresponsive to medical therapies, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Paracentesis, either single or serial</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Therapeutic paracentesis may be performed in client who requires rapid symptomatic relief for refractory ascites. The removal of 5 L of fluid or more is considered large-volume paracentesis (LVP) (Shah &amp; Fields, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Peritoneovenous shunting (PVS)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This surgically placed shunt creates a passage between the peritoneum and the jugular vein to return ascitic fluid to the central venous system. The procedure is an alternative to LVP and may be used in client with diuretic-resistant ascites, who is not a candidate for transplant or other shunting procedures (Shah &amp; Fields, 2016).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Transjugular intrahepatic portosystemic shunt (TIPS)</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>This procedure places a stent between the right jugular vein and the hepatic vein, creating a connection between the portal and systemic circulations. TIPS is gradually becoming the standard of care in patients with diuretic-refractory ascites (Shah &amp; Fields, 2016).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0521">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Stasis of body fluid</para>
<para>Chronic illness; immunosuppression; invasive procedure</para>
<para>Malnutrition</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of fever and abdominal pain.</para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Acknowledge individual risk factors for infection.</para>
<para>Engage in actions to reduce risk of infection.</para>
<para>Be free of preventable complications.</para>
</note>
<note role="none" id="ch0006s0209note0522">
<table frame="top" id="ch0006s0209ta0296"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify client at risk (i.e., presence of cirrhosis and ascites, immunocompromised state, malnutrition, invasive lines and procedures).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This client is at risk for any healthcare-related infection (e.g., pneumonia, urinary tract infection, skin/wound infections) and especially blood-borne infections resulting in sepsis. Hospitalized client with cirrhosis plus ascites is at significant risk (10% to 30%) for spontaneous bacterial peritonitis (SBP) (Bonnel et al, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note client reports of new-onset abdominal pain or change in usual level of abdominal discomfort. Determine intensity using 0 to 10 or similar coded scale.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client with chronic cirrhosis does not always have abdominal pain and may characterize it as discomfort, depending on presence/degree of ascites. Thus, if client is reporting new-onset or unusual abdominal pain, interventions should be geared toward finding the cause, not just relieving pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor vital signs, noting onset of fever.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever usually accompanies bacterial infections but is not always present in immunocompromised client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate body systems (e.g., respiratory, skin, urinary tract for signs of infection).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Infection may be anywhere in the body. If not found in most likely places, client must be evaluated for more unusual infectious causes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Promote safe healthcare environment:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>First-line defense against healthcare-associated infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize and practice proper handwashing before and after direct contact. Wear gloves when appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>This is important for staff, clients, and visitors to reduce the cross-contamination, especially for immunocompromised clients.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain sterile technique for all invasive procedures (e.g., IV, urinary catheter, pulmonary suctioning).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of device-related infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Change surgical or other wound dressings, as indicated, using proper technique for changing/disposing of contaminated materials.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Dressing changes maintain dry, clean wound area to promote healing. Proper disposal of contaminated material reduces risk of spread of infection to others.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage deep breathing and coughing, position changes, and early ambulation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To limit complications associated with stasis of respiratory secretions and shallow breathing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain adequate hydration; encourage regular voiding or maintain urinary catheter as indicated. Provide/assist with pericare.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents infections associated with urinary stasis and/or presence of catheter, which can be associated with ascending urinary tract infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for/assist with medical procedures (e.g., paracentesis).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be performed to obtain specimen of ascitic fluid for analysis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review laboratory test results (e.g., WBCs with differential, urinalysis, ascitic fluid and/or blood cultures).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps reveal source of infection. Additional tests may be done on ascites fluid (e.g., total protein, LDH, glucose) to help differentiate secondary bacterial peritonitis from spontaneous bacterial peritonitis when other sources of infection (e.g., pneumonia, perforated gut, or abdominal abscess) have been ruled out (Roy Lu et al, 2017).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer antibiotics, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Therapy will be determined by the site and type of infection found. Broad-spectrum therapy is used in client with suspected ascitic fluid infection until the results of susceptibility testing are available. Cefotaxime or a similar third-generation cephalosporin appears to be the treatment of choice for suspected SBP.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0523">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Skin Integrity</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Impaired circulation</para>
<para>Inadequate nutrition; alteration in metabolism</para>
<para>Chemical injury agents&mdash;accumulation of bile salts in skin</para>
<para>Changes in skin turgor, skeletal prominence, changes in fluid status (e.g., edema, ascites)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain skin integrity.</para>
<para>Identify individual risk factors and demonstrate behaviors or techniques to prevent skin breakdown.</para>
</note>
<note role="none" id="ch0006s0209note0524">
<table frame="top" id="ch0006s0209ta0297"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Skin Surveillance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin surfaces and pressure points routinely. Use emollient lotions and limit use of soap for bathing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Edematous tissues are more prone to breakdown and to the formation of decubitus ulcers. Ascites may stretch the skin to the point of tearing in severe cirrhosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage and assist with repositioning on a regular schedule, while in bed or chair, and active or passive range-of-motion (ROM) exercises, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Repositioning reduces pressure on edematous tissues to improve circulation. Exercises enhance circulation and improve or maintain joint mobility.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend elevating lower extremities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances venous return and reduces edema formation in extremities, which reduces risk of skin irritation and breakdown.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep linens dry and free of wrinkles.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Moisture aggravates pruritus and increases risk of skin breakdown.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss itching with client, addressing areas involved and time of day when client is most uncomfortable.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Approximately 55% to 60% of patients with primary biliary cirrhosis present with pruritus, and almost all develop pruritus at some point during the course of their disease (Butler, 2017; Pyrsopoulos &amp; Reddy, 2016). The itching often worsens during the evening and improves during the day. It typically begins in the palms and soles and then spreads to the rest of the body. Prolonged, repeated scratching can result in excoriations and thickening and darkening of the skin.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Offer comfort measures (e.g., cold applications, colloidal oatmeal or baking soda baths, OTC creams, lotions or ointments for itching).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be soothing and provide relief of itching.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggest clipping fingernails short and provide mittens or gloves, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents client from inadvertently injuring the skin, especially while sleeping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage, or provide, perineal care following urination and bowel movement.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents skin excoriation breakdown from gastrointestinal or urinary excretions or bile salts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use pressure-relieving devices such as alternating-pressure mattress, waterbed, overlays such as egg-crate or foam mattress, or gel-filled pad when up in chair, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces dermal pressure, increases circulation, and diminishes risk of tissue ischemia and breakdown.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer medications, such as cholestyramine (Questran), rifampin (Rimactane), ondansetron (Zofran), colestipol (Colestid), hydroxyzine (Atarax), and dronabinol (Marinol), if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Although the cause of pruritus is unknown, it may respond to these treatments (Pyrsopoulos &amp; Reddy, 2016; Butler, 2017).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0525">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for ineffective Breathing Pattern</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Hypoventilation [ascites with decreased lung expansion]</para>
<para>Fatigue</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Ventilation</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain effective respiratory pattern and be free of dyspnea and cyanosis, with arterial blood gases (ABGs) and vital capacity within acceptable range.</para>
</note>
<note role="none" id="ch0006s0209note0526">
<table frame="top" id="ch0006s0209ta0298"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor respiratory rate, depth, and effort.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rapid, shallow respirations or dyspnea may be present because of hypoxia or fluid accumulation in abdomen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds, noting crackles, wheezes, and rhonchi.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicates developing complications&mdash;presence of adventitious sounds reflects accumulation of fluid while diminished sounds suggest atelectasis&mdash;increasing risk of pulmonary infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate changes in level of consciousness (LOC).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes in mentation may reflect hypoxemia and respiratory failure, which often accompany hepatic coma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep head of bed elevated. Position client on side.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Facilitates breathing by reducing pressure on the diaphragm and minimizes risk of aspiration of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage frequent repositioning, deep-breathing exercises, and coughing, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in lung expansion and mobilizing secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor temperature. Note presence of chills, increased coughing, and changes in color or character of sputum.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicative of onset of infection, such as pneumonia. <emphasis>Note: </emphasis>Severely ill client is immunocompromised and may not be able to mount a febrile response to infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor serial ABGs, pulse oximetry, vital capacity measurements, and chest x-rays.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reveals changes in respiratory status and developing pulmonary complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Ventilation Assistance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide supplemental oxygen (O<subscript>2</subscript>) as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be necessary to treat or prevent hypoxia. If respirations or oxygenation are inadequate, mechanical ventilation may be required.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Demonstrate and assist with respiratory adjuncts, such as incentive spirometer.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces incidence of atelectasis and enhances mobilization of secretions.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for/assist with acute care procedures, such as paracentesis.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Occasionally may be done to remove ascites fluid to relieve abdominal pressure when respiratory embarrassment is not corrected by other measures.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0527">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Bleeding/Venous Thromboembolism</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Impaired liver function</para>
<para>Significant medical comorbidity</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Liver Function</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain homeostasis with absence of bleeding/venous thromboembolism.</para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate behaviors to reduce risk of bleeding and thrombosis.</para>
</note>
<note role="none" id="ch0006s0209note0528">
<table frame="top" id="ch0006s0209ta0299"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Bleeding Precautions</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be aware of client&rsquo;s risk in current condition, either <emphasis role="bi">bleeding </emphasis>(e.g., late-stage cirrhosis with portal hypertension/risk for variceal bleeding) or <emphasis role="bi">thromboembolic phenomena.</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Although the risk for bleeding has long been associated with liver dysfunction, recent research has enlarged the view of coagulation issues with cirrhosis. The current understanding is that in liver disease, the hemostatic balance remains as in normal individuals but is reset, with equally reduced levels of both coagulant and anticoagulant proteins. Thus, it is fragile and easily disturbed, resulting in either bleeding (e.g., varices) or thrombosis (e.g., peripheral or systemic), depending on the initial stimulus. Recent data of the literature support this hypothesis, as portal vein thrombosis and peripheral thrombosis are frequent features of cirrhosis (Ahmed &amp; Hunt, 2016; Tripodi et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>For bleeding complications:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for signs and symptoms of GI bleeding; for instance, check all secretions for frank or occult blood. Observe color and consistency of stools, nasogastric (NG) drainage, or vomitus.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The GI tract&mdash;especially esophagus and rectum&mdash;is the most usual source of bleeding because of its mucosal fragility and alterations in homeostasis associated with cirrhosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for presence of petechiae, ecchymosis, and bleeding from one or more sites.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Subacute disseminated intravascular coagulation (DIC) may develop secondary to altered clotting factors.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor pulse, BP, and CVP, if available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An increased pulse with decreased BP and CVP may indicate loss of circulating blood volume, requiring further evaluation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note changes in mentation and LOC.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes may indicate decreased cerebral perfusion secondary to hypovolemia or hypoxemia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Avoid rectal temperature; be gentle with GI tube insertions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Rectal and esophageal vessels are most vulnerable to rupture.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage use of soft toothbrush and electric razor, avoiding straining for stool, forceful nose blowing, and so forth.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In the presence of clotting factor disturbances, minimal trauma can cause mucosal bleeding.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Use small needles for injections. Apply pressure to small bleeding or venipuncture sites for longer than usual.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes damage to tissues, reducing risk of bleeding and hematoma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Embolus Precautions</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine presence of factors associated with thrombus or emboli (e.g., inflammatory diseases such as hepatitis; long periods of immobility, dehydration, presence of central venous catheters).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To identify client at higher risk for venous stasis, vessel wall injury, and hypercoagulability.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess presence, location, and degree of swelling or edema formation. Measure circumference of extremities, noting difference in size, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can help to identify developing DVT and monitoring course of edema in extremities (but may not be readily apparent in severely emaciated or dehydrated client).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine presence and quality of peripheral pulses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To evaluate distribution and quality of blood flow.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Document and report client&rsquo;s complaints of extremity discomfort or pain, or reports of chest pain accompanied by dyspnea and changes in pulse oximetry.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These symptoms often accompany VTE, especially deep vein thrombosis (DVT) or pulmonary embolus (PE).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to CP: <link linkend="ch0002s0064">Venous thromboembolism (VTE) disease including deep vein thrombosis (DVT) and pulmonary embolism (PE)</link> for related assessments and interventions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To provide interventions to promote systemic and peripheral circulation, and limit complications associated with venous stasis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies favoring <emphasis role="bi">risk for bleeding</emphasis> (e.g., platelets, reduced coagulation factors [e.g., II, V, VII, X, or XII], fibrinogen, vitamin K deficiency [not a complete list]) and studies favoring <emphasis role="bi">risk for thrombotic events</emphasis> (e.g., protein C, antithrombin, aPTT, anti-Xa, INR [not a complete list]).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduced production of procoagulant factors and platelets is balanced by concomitant decreased levels of anticoagulants, thus placing the client at risk both for bleeding and for venous thromboembolism (VTE). Research is still new in this area but seems to support that some individuals with advanced liver disease have a loss of balance toward the clotting side, and others are clearly more prone to bleeding (Aggarwal et al, 2014; Ha &amp; Regal, 2016; Northup &amp; Caldwell, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with treatment of underlying condition (cirrhosis and comorbidities) and with supportive measures including fluids, electrolytes, medications, nutrients, and oxygen, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To maximize systemic circulation, improve tissue perfusion and organ function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, to reduce risk of bleeding, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Supplemental vitamins, such as vitamins K, D, and C, as indicated</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes prothrombin synthesis and coagulation, if liver is functional. Vitamin C deficiencies increase susceptibility of GI system to irritation and bleeding.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide gastric lavage with cool saline solution or water, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In presence of acute bleeding, evacuation of blood from GI tract may reduce ammonia production and risk of hepatic encephalopathy. (Refer to CP: <link linkend="ch0005s0144">Upper Gastrointestinal Bleeding</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for procedures, such as direct ligation or banding of varices, esophagogastric resection, transjugular intra-hepatic portosystemic shunt (TIPS), and splenorenal-portacaval anastomosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be needed to control active hemorrhage or to decrease portal and collateral blood vessel pressure to minimize risk of recurrence of bleeding. TIPS is an interventional radiological procedure involving stent placement from the right jugular vein to the hepatic vein, thereby creating a connection between the portal and systemic circulations to relieve portal hypertension and decompress varices.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer anticoagulants, such as low-molecular-weight heparins (e.g., enoxaparin [Lovenox]) and, ardeparin (Indeparin), as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Thromboprophylaxis against VTE should be considered and implemented (with caution) in the at-risk client.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0529">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for acute Confusion</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Liver impairment [inability to remove toxins]; altered metabolic functioning</para>
<para>Substance abuse [alcohol/other drugs]; pharmaceutical agent</para>
<para>Alteration in cognitive functioning</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Cognition</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Regain and maintain usual level of mentation and reality orientation.</para>
<para><emphasis role="strong">Alcohol/Drug Abuse Cessation Behavior</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Initiate behaviors or lifestyle changes to prevent or minimize recurrence of problem.</para>
</note>
<note role="none" id="ch0006s0209note0530">
<table frame="top" id="ch0006s0209ta0300"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Substance Use Treatment: Alcohol/Drug Withdrawal</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify client at risk for hepatic encephalopathy in current situation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client at risk is typically in end-stage liver disease. Among the precipitating factors for hepatic encephalopathy, common categories include (1) increased nitrogen load (e.g., gastrointestinal bleed, infection, excess dietary protein), (2) decreased toxin clearance (e.g., hypovolemia, renal failure, constipation, portosystemic shunt, medication noncompliance, acute-on-chronic liver failure), and (3) altered neurotransmission (e.g., sedating medication, alcohol, hypoxia, hypoglycemia) (Liou, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for changes in behavior and mentation: lethargy, confusion, drowsiness, slowing or slurring of speech, and irritability. Arouse client at intervals, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ongoing assessment of behavior and mental status is important because of fluctuating nature of hepatic encephalopathy or impending hepatic coma. <emphasis>Note:</emphasis> Subtle signs of hepatic encephalopathy are observed in nearly 70% of patients with cirrhosis (Wolf, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review current medication regimen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adverse drug reactions or interactions may potentiate or exacerbate confusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Evaluate sleep and rest schedule.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Difficulty falling asleep or staying asleep leads to sleep deprivation, exacerbating cognition problems and fatigue.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note development or presence of asterixis, fetor hepaticus, and seizure activity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggests elevating serum ammonia levels and increased risk of progression to encephalopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Consult with SO about client&rsquo;s usual behavior and mentation.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides baseline for comparison of current status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Have client write name periodically and keep this record for comparison. Report deterioration of ability. Have client do simple arithmetic computations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Easy test of neurological status and muscle coordination.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reorient to time, place, person, and situation, as needed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assists in maintaining reality orientation, reducing confusion and anxiety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain a pleasant, quiet environment and approach in a slow, calm manner. Encourage uninterrupted rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces excessive stimulation and sensory overload, promotes relaxation, and may enhance coping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide continuity of care. If possible, assign same nurse over a period of time.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Familiarity provides reassurance, aids in reducing anxiety, and provides a more accurate documentation of subtle changes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Reduce provocative stimuli and confrontation. Refrain from forcing activities. Assess potential for violent behavior.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Avoids triggering agitated, violent responses; promotes client safety.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Discuss current situation and future expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client and SO may be reassured that intellectual as well as emotional function may improve as liver involvement resolves.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain bedrest and assist with self-care activities.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces metabolic demands on liver, prevents fatigue, and promotes healing, lowering risk of ammonia buildup.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Identify and provide for safety needs, such as supervision during smoking, bed in low position, side rails up and padded, if necessary. Provide close supervision.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of injury when confusion, seizures, or violent behavior occurs. <emphasis>Note:</emphasis> Falls and fall-related injuries are common in chronic liver diseases. One study reported a 40% fall incidence in patients with cirrhosis and the cognitive dysfunction associated with hepatic encephalopathy compared to 6% in those without it (Soriano et al, 2012; Yildirim, 2017).</para>
<para>This may be due to loss of balance control, longer reaction time, slowed motor function, loss of muscle strength (and other factors) associated with multiple body system disorders.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate temperature elevations. Monitor for signs of infection.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Clients with cirrhosis are immunocompromised and susceptible to infections. Also, infection can precipitate hepatic encephalopathy caused by tissue catabolism and release of nitrogen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Recommend avoidance of narcotics or sedatives, antianxiety agents, and limiting or restricting use of medications metabolized by the liver.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Certain drugs are toxic to the liver, whereas other drugs may not be metabolized because of cirrhosis, causing cumulative effects that alter mentation, mask signs of developing encephalopathy, or precipitate coma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with treatment of underlying condition(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Approximately 70% to 80% of patients with overt hepatic encephalopathy improve after correction of precipitating factors (Wolf, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as ammonia, electrolytes, pH, blood urea nitrogen (BUN), glucose, and CBC with differential.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevated ammonia levels, hypokalemia, metabolic alkalosis, hypoglycemia, anemia, and infection can precipitate or potentiate development of hepatic coma.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Eliminate or restrict protein in diet if indicated in severe liver dysfunction. Provide glucose supplements and adequate hydration.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ammonia is responsible for mental changes in hepatic encephalopathy. Dietary changes may result in constipation, which also increases bacterial action and formation of ammonia. Glucose provides a source of energy, reducing need for protein catabolism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Beta-galactosidofructose (Lactulose) orally, via nasogastric tube or enema</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lactulose appears to inhibit intestinal ammonia production and also works as a cathartic, reducing colonic bacterial load. <emphasis>Note:</emphasis> Long-term use of lactulose may be required for clients with hepatic encephalopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aminoglycoside antibiotics (e.g., neomycin, paromomycin [Humatin]); other broad-spectrum antibiotics (e.g., metronidazole [Flacyl], vancomycin [Vancocin], rifaximin [Rifampin], and oral quinolone ciprofloxacin [Cipro])</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Destroys protein-degrading intestinal bacteria and production of ammonia to prevent/limit effects of encephalopathy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Electrolytes</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corrects imbalances and may improve cerebral function and metabolism of ammonia.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer supplemental O<subscript>2</subscript>.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Mentation is affected by O<subscript>2</subscript> concentration and utilization in the brain.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist with procedures as indicated, such as dialysis, plasmapheresis, or extracorporeal liver perfusion.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be used to reduce serum ammonia levels if encephalopathy develops or other measures are not successful.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0531">
<title><emphasis role="strong">NURSING DIAGNOSIS: disturbed Body Image</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Alteration in self-perception</para>
<para>Alteration in body function</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alteration in view of one&rsquo;s body; negative feeling about body</para>
<para>Change in social involvement; fear of reaction by others</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Body Image</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of changes and acceptance of self in the present situation.</para>
<para>Identify feelings and methods for coping with negative perception of self.</para>
</note>
<note role="none" id="ch0006s0209note0532">
<table frame="top" id="ch0006s0209ta0301"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Body Image Enhancement</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss situation and encourage verbalization of fears and concerns. Explain relationship between nature of disease and symptoms.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client is very sensitive to body changes and may also experience feelings of guilt when cause is related to alcohol or other drug use.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Support and encourage client; provide care with a positive, friendly attitude.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Caregivers sometimes allow judgmental feelings to affect the care of client and need to make every effort to help client feel valued as a person.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage family/SO to verbalize feelings, visit freely, and participate in care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Family/SO may feel guilty about client&rsquo;s condition and may be fearful of impending death. They need nonjudgmental emotional support and free access to client. Participation in care helps them feel useful and promotes trust between staff, client, and family/SO.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client/SO to cope with change in appearance; suggest clothing that does not emphasize altered appearance, such as use of red, blue, or black clothing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may present unattractive appearance as a result of jaundice, ascites, and ecchymotic areas. Providing support can enhance self-esteem and promote client&rsquo;s sense of control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to support services, such as counselors, psychiatric resources, social service, clergy, and alcohol treatment program.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Increased vulnerability and concerns associated with this illness may require services of additional professional resources.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0533">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of therapeutic regimen; insufficient knowledge</para>
<para>Perceived seriousness of condition, susceptibility, benefit, or barrier; decisional conflicts</para>
<para>Excessive demands; insufficient social support</para>
<para>Economically disadvantaged</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Difficulty with prescribed regimen</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>Failure to take action to reduce risk factors</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Self-Management: Chronic Disease</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of disease process, prognosis, and potential complications.</para>
<para>Correlate symptoms with causative factors.</para>
<para>Identify and initiate necessary lifestyle changes.</para>
<para>Actively participate in care.</para>
</note>
<note role="none" id="ch0006s0209note0534">
<table frame="top" id="ch0006s0209ta0302"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Be aware of client&rsquo;s living situation when preparing for postdischarge teaching or community care. Make every effort to provide useful, appropriate teaching and referrals.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The complexities of treating advanced liver disease are often compounded by poverty, limited/absent family and social support systems. For example, a national survey of homeless veterans (2011) revealed that over 20% had been hospitalized (one to three times) in the past year, 76% reported a substance abuse habit, 14% had a diagnosis of hepatitis C, and over 9% of those reported liver disease (Marie Curie Palliative Care Research Unit, 2011; Veterans Affairs [VA], 2011). Whatever the living circumstances, the client may have limited insight into his or her condition and is frequently unwilling to accept services offering treatment. Therefore, attempts to encourage client to seek help must be tempered by respect for personal autonomy and rights of individual choice.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review disease process and future expectations.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base from which client can make informed choices.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize importance of avoiding alcohol and illegal drugs (e.g., heroin, inhalants, performance-enhancing steroids). Give information about medical and community services available to aid in substance use rehabilitation, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alcohol is one of the leading causes for the development of cirrhosis and can be deadly when combined with other substances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inform client of altered effects of medications with cirrhosis and the importance of using only drugs prescribed or cleared by a healthcare provider who is familiar with client&rsquo;s history.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Many over-the-counter and prescription drugs are hepatotoxic (may be dose dependent). Examples in this category include acetaminophen (Tylenol), NSAIDs, certain antibiotics, anticonvulsants, cough suppressants (antitussives), analgesic pain relievers, and certain types of muscle relaxants (not a complete list). In addition, the damaged liver has a reduced ability to metabolize all drugs, potentiating cumulative effect and exacerbating liver-related complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assist client with identifying support person(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Because of length of recovery, potential for relapses, and slow convalescence, support systems are extremely important in maintaining behavior modifications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize the importance of good nutrition. Provide written dietary instructions of diet prescriptions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Can assist in remission of symptoms and help prevent further liver damage. Written instructions are helpful for client to refer to at home.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss sodium and salt substitute restrictions and necessity of reading labels on food, OTC drugs, and herbal agents, if client has ascites.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Minimizes ascites and edema formation. Overuse of substitutes may result in other electrolyte imbalances. Food, OTC medications, and personal care products, including antacids and some mouthwashes, may contain sodium or alcohol and may be toxic to the liver or be primarily metabolized by the liver.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage scheduling activities with adequate rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Adequate rest decreases metabolic demands on the body and increases energy available for tissue regeneration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promote diversional activities that are enjoyable to client.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents boredom, facilitates rest, and minimizes anxiety and depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend avoidance of persons with infections, especially upper respiratory infections.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased resistance, altered nutritional status, and impaired immune responses potentiate risk of infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stress necessity of follow-up care and adherence to therapeutic regimen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Chronic nature of disease has potential for life-threatening complications. Provides opportunity for evaluation of effectiveness of regimen, including patency of shunt if used.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client and SO of signs and symptoms that warrant notification of healthcare provider, such as increased abdominal girth, rapid weight loss or gain, increased peripheral edema, increased dyspnea, fever, blood in stool or urine, excess bleeding of any kind, and jaundice.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prompt reporting of symptoms provides opportunity to treat complications before they become life-threatening. <emphasis>Note: </emphasis>Client may be evaluated for additional medical or surgical interventions, including liver transplantation.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Instruct SO to notify healthcare providers of any confusion, untidiness, night wandering, tremors, or personality change.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Changes reflecting deterioration in mental status may be apparent to SO, although insidious changes may be noted by others with less frequent contact with client.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0209note0535">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease state, malnutrition, poor physical condition, negative life events, altered body chemistry (e.g., alcohol withdrawal, changes in liver function, effect on target organs)</para></listitem>
<listitem><para><emphasis role="bi">imbalanced Nutrition: less than body requirements</emphasis>&mdash;inability to ingest food (anorexia, nausea and vomiting, indigestion), inability to digest food/absorb nutrients</para></listitem>
<listitem><para><emphasis role="bi">risk for ineffective Health</emphasis>&nbsp;<emphasis role="bi">Management</emphasis>&mdash;perceived benefit, social support deficit, complexity of therapeutic regimen, economic difficulties</para></listitem>
<listitem><para><emphasis role="bi">dysfunctional Family Processes</emphasis>&mdash;substance abuse, resistance to treatment, inadequate coping and/or lack of problem-solving skills</para></listitem>
<listitem><para><emphasis role="bi">risk for caregiver Role Strain</emphasis>&mdash;illness severity of care receiver, substance abuse codependency; family dysfunction before caregiving situation; presence of situational stressors that normally affect families (e.g., economic vulnerability)</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0214"><title><emphasis role="strong">PANCREATITIS</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Inflammation of pancreas with premature activation of pancreatic enzymes resulting in localized damage to the pancreas, autodigestion, and fibrosis of the pancreas</para></listitem>
<listitem><para>Leads to wide range of metabolic consequences and life-threatening complications, such as hypovolemia, shock, acute renal failure, diabetes, acute respiratory distress syndrome (ARDS), and multiorgan failure</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Types</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Acute pancreatitis (AP)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Sudden inflammation occurs over a short period of time.</para></listitem>
<listitem><para>Severity ranges from mild abdominal discomfort to a life-threatening illness.</para></listitem>
<listitem><para>Can result in bleeding into the gland, serious tissue damage, infection, and cyst formation</para></listitem>
<listitem><para>Release of enzymes and toxins into bloodstream can damage other vital organs, including the heart, lungs, and kidneys.</para></listitem>
<listitem><para>Classified as early or late and mild or severe (Banks et al, 2013; Bell et al, 2014)</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Severe is further classified as mild, moderate, and severe.</para></listitem>
<listitem><para>Mild acute pancreatitis is the most common form, has no local or systemic complications, and resolves quickly.</para></listitem>
<listitem><para>Moderately severe acute pancreatitis is demonstrated by transient organ (pancreas) dysfunction and local complications.</para></listitem>
<listitem><para>Severe acute pancreatitis: organ failure longer than 48 hours, local complications (e.g., peripancreatic fluid collection, abscess, pseudocyst, necrosis)</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para>Chronic pancreatitis (CP) (Huffman et al, 2016)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Commonly defined as continuing, chronic, inflammatory process of the pancreas with irreversible structural changes. Chronic inflammation can lead to chronic abdominal pain and/or impairment of endocrine and exocrine functions of the pancreas.</para></listitem>
<listitem><para>Development may be delayed, as in long-term alcohol abuse.</para>
</listitem></orderedlist></listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Acute</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Biliary tract disease, such as obstruction by gallstones, is most common cause&mdash;about 35% to 40% (Vege, 2017)</para></listitem>
<listitem><para>Longstanding alcohol abuse, particularly binge drinking&mdash;approximately 30% (Bell et al, 2014; Yang et al, 2008)</para></listitem>
<listitem><para>Trauma: blunt or penetrating</para></listitem>
<listitem><para>Procedures: endoscopic or surgical</para></listitem>
<listitem><para>Viral infections: mumps, coxsackievirus, hepatitis A and B, cytomegalovirus, herpes simplex, HIV, mononucleosis, varicella</para></listitem>
<listitem><para>Bacterial infections: <emphasis>Mycoplasma pneumoniae, </emphasis>salmonellosis, tuberculosis</para></listitem>
<listitem><para>Drugs: Drug-associated pancreatitis is rare (0.3% to 1.4%) (Spanier et al, 2011), but many drugs may be implicated, including sulfonamides, glucocorticoids, thiazide diuretics, combination cancer chemotherapy drugs (especially asparaginase), 5-aminosalicylic acid compounds, nonsteroidal anti-inflammatory drugs (NSAIDs)</para></listitem>
<listitem><para>Very high serum triglycerides (greater than 1000 mg/dL) as may occur in obesity, diabetes mellitus, hypothyroidism, nephrotic syndrome, pregnancy</para></listitem>
<listitem><para>Unknown cause&mdash;about 15% to 20% of cases. <emphasis>Note: </emphasis>Biliary sludge (tiny gallstones) is commonly found in 20% to 40% of patients with acute pancreatitis with no obvious cause (Vege, 2017). Also, with the advent of molecular medicine, research is revealing various genetic abnormalities associated with pancreatitis (Tang &amp; Markus, 2017).</para></listitem></orderedlist>
</listitem>
<listitem><para>Chronic (Huffman et al, 2016)</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Intraductal obstruction: alcohol abuse, stones, or tumors</para></listitem>
<listitem><para>Alcohol abuse&mdash;about 60% to 70% of cases</para></listitem>
<listitem><para>Direct toxins and toxic metabolites</para></listitem>
<listitem><para>Recurrent acute pancreatitis that heals with fibrosis</para></listitem>
<listitem><para>Ischemia from obstruction and fibrosis exacerbates or perpetuates disease rather than initiates disease.</para></listitem>
<listitem><para>Autoimmune pancreatitis: diffuse enlargement of gland, irregular narrowing of main pancreatic duct, increased circulating levels of gamma globulin, presence of autoantibodies, and a possible association with other autoimmune diseases</para></listitem></orderedlist>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Statistics</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Morbidity: Acute pancreatitis (AP) caused approximately 275,000 hospitalizations in 2009 and was the single most frequent gastrointestinal cause of hospital admissions in the United States. The annual incidence of AP ranges from 13 to 45/100,000 persons and chronic pancreatitis (CP) from 5 to 12/100,000 (Dhiraj &amp; Lowenfels, 2013).</para></listitem>
<listitem><para>Mortality: Mild AP has an overall mortality of approximately 0% to 5% (Stevens, 2014). The risk of death increases with age, comorbidities, and the severity of pancreatic disease (e.g., 30% for infected necrotic pancreatitis with persistent organ failure) (Stevens, 2014). Patients with CP have shorter survival times than the general population, but most die from comorbidities (Dhiraj &amp; Lowenfels, 2013).</para></listitem>
<listitem><para>Cost: In 2009, AP was the most common gastroenterology discharge diagnosis in the United States, with a cost of $2.6 billion (Peery et al, 2012).</para>
</listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0214note0536"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Cullen&rsquo;s sign: </emphasis>Blue-black bruising around the umbilicus area, indicative of intraperitoneal hemorrhage.</para>
<para><emphasis role="strong">Endocrine function: </emphasis>Pertains to hormones and the glands that make and secrete them into the bloodstream where they travel to distant organs. The islets of Langerhans produce and secrete insulin.</para>
<para><emphasis role="strong">Exocrine function: </emphasis>Refers to glands that secrete their products into ducts. Pancreatic enzymes are produced in the pancreas, accumulate in the intralobular ducts, and empty into the main pancreatic duct, which drains into the duodenum when needed for digestion.</para>
<para><emphasis role="strong">Hemorrhagic pancreatitis: </emphasis>Hemorrhage caused by digestion of vessel walls by pancreatic enzymes.</para>
<para><emphasis role="strong">Ileus: </emphasis>Partial or complete blockage of the small and/or large intestine.</para>
<para><emphasis role="strong">Interstitial edema: </emphasis>Abnormally large fluid volume in tissues between the body&rsquo;s cells (interstitial spaces).</para>
<para><emphasis role="strong">Pancreas: </emphasis>Gland located in the upper, posterior abdomen responsible for insulin production and the manufacture and secretion of digestive enzymes leading to carbohydrate, fat, and protein metabolism.</para>
<para><emphasis role="strong">Pancreatic pseudocyst: </emphasis>Collection of tissue, fluid, debris, pancreatic enzymes, and blood. The fluid is usually pancreatic juice that has leaked out of a damaged pancreatic duct.</para>
<para><emphasis role="strong">Secondary diabetes</emphasis>: A small minority of diabetes cases (about 2%) arise as the consequence of some other well-defined disease or predisposing factor such as pancreatitis with damage to the exocrine pancreas. Pancreatic diabetes results in loss of both insulin and pancreatic glucagon, but some residual function is often present, which means that diabetic ketoacidosis rarely occurs. Lack of glucagon means that client is extrasensitive to the action of insulin, and hypoglycemia may be a problem (Diapedia, n.d.)</para>
<para><emphasis role="strong">Steatorrhea: </emphasis>Symptom in which fecal matter is frothy or foul-smelling and floats because of a high fat content.</para>
<para><emphasis role="strong">Systemic inflammatory response syndrome (SIRS): </emphasis>Inflammation of the whole body (the &ldquo;system&rdquo;) without a proven source of infection. It is a medical emergency.</para>
</note>
<sect2 id="ch0006s0215"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>The client is treated in an inpatient acute medical unit or intensive care unit (ICU) for initial incident or exacerbations with serious complications; otherwise, condition is managed at the community level.</para>
</sect2>
<sect2 id="ch0006s0216"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0008s0244">Acute renal injury (acute renal failure)</link></para>
<para><link linkend="ch0014s0360">Alcohol: acute withdrawal</link></para>
<para><link linkend="ch0006s0194">Diabetes mellitus and diabetic ketoacidosis</link></para>
<para><link linkend="ch0005s0164">Peritonitis</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0013s0318">Sepsis/septic shock</link></para>
<para><link linkend="ch0014s0365">Substance use disorders</link></para>
<para><link linkend="ch0006s0219">Total nutritional support: parenteral/enteral feeding</link></para>
<para><link linkend="ch0005s0144">Upper gastrointestinal bleeding</link></para>
<table frame="top" id="ch0006s0214ta0303"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Malaise, fatigue</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Agitation, restlessness, apprehension</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hypertension (acute pain)</para></listitem>
<listitem><para>Tachycardia (65%)</para></listitem>
<listitem><para>Hypotension and tachycardia accompany hypovolemic shock or sepsis or SIRS (see <link linkend="ch0006s0214note0536">Glossary</link>)</para></listitem>
<listitem><para>Generalized edema</para></listitem>
<listitem><para>Ascites</para></listitem>
<listitem><para>Skin pale, mottled areas</para></listitem>
<listitem><para>Flushing may be present in acute stage from systemic inflammation</para></listitem>
<listitem><para>Jaundice (28%) (inflammation or obstruction of common duct)</para></listitem>
<listitem><para>Bluish discoloration (Cullen&rsquo;s sign) around umbilicus (severe necrotizing pancreatitis)</para></listitem>
<listitem><para>Reddish-brown discoloration between upper abdomen and back (flanks) (severe necrotizing pancreatitis)</para></listitem>
<listitem><para><emphasis role="bi">In severe acute pancreatitis:</emphasis> There may be evidence of systemic organ failure (e.g., systolic blood pressure below 90 mm Hg, arterial partial pressure of oxygen [PaO<subscript>2</subscript>] 60 mm Hg or lower, serum creatinine level 2 mg/dL or higher, and GI bleeding) (Banks et al, 2013).</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal bloating</para></listitem>
<listitem><para>Absence of bowel movements</para></listitem>
<listitem><para>Diarrhea</para></listitem>
<listitem><para>Dark and decreased urine</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Bowel sounds may be decreased or absent&mdash;reduced peristalsis or ileus</para></listitem>
<listitem><para>Diarrhea</para></listitem>
<listitem><para>Steatorrhea</para></listitem>
<listitem><para>Dark amber or brown, foamy urine (bile)</para></listitem>
<listitem><para>Scanty urine (oliguria) progressing to absence of urine (anuria), which may be a compensatory response to hypovolemia</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Nausea and frequent or persistent vomiting; retching, dry heaves</para></listitem>
<listitem><para>Food intolerance, loss of appetite</para></listitem>
<listitem><para>Weight loss</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Hypoactive bowel sounds</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Confusion, agitation</para></listitem>
<listitem><para>Coarse tremors of extremities from hypocalcemia</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Unrelenting, severe, deep abdominal pain (primary symptom), usually located in the epigastrium and periumbilical regions, but may radiate to the back (acute pancreatitis)</para></listitem>
<listitem><para>Onset may be sudden and may follow an episode of heavy drinking or a large meal</para></listitem>
<listitem><para>Radiation to chest and back</para></listitem>
<listitem><para>May increase in supine position</para></listitem>
<listitem><para>Poorly localized, dull, cramping, burning, deep, or aching (long-term or chronic pancreatitis)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Abdominal tenderness (68%) and guarding (65% in acute pancreatitis) (Tang &amp; Markus, 2017)</para></listitem>
<listitem><para>Diffuse abdominal tenderness to palpation</para></listitem>
<listitem><para>Abdominal rigidity, distention</para></listitem>
<listitem><para>May curl up on left side with both arms over abdomen and knees and hips flexed</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Difficulty breathing; shortness of breath</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachypnea with or without dyspnea</para></listitem>
<listitem><para>Decreased depth of respiration with splinting or guarding actions</para></listitem>
<listitem><para>Bibasilar crackles&mdash;associated with pleural effusion</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fever (76% in acute pancreatitis) (Tang &amp; Markus, 2017)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Current pregnancy (third trimester) with shifting of abdominal contents and compression of biliary tract</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Family history of pancreatitis</para></listitem>
<listitem><para>Signs and symptoms of hyperglycemic crisis</para></listitem>
<listitem><para>History of cholelithiasis with partial or complete common bile duct obstruction</para></listitem>
<listitem><para>Gastritis, duodenal ulcer, duodenitis, diverticulitis, Crohn&rsquo;s disease</para></listitem>
<listitem><para>Recent abdominal surgery (such as procedures on the pancreas, biliary tract, stomach, or duodenum)</para></listitem>
<listitem><para>External abdominal trauma</para></listitem>
<listitem><para>Binge alcohol intake (90% of cases)</para></listitem>
<listitem><para>Use of medications&mdash;salicylates, pentamidine, antihypertensives, opiates, thiazides, steroids, some antibiotics, estrogens</para></listitem>
<listitem><para>Infectious diseases&mdash;mumps, hepatitis B, Coxsackie viral infection</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with dietary program and activities of daily living (ADLs) at home</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0214ta0304"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum amylase:</emphasis> Common biochemical marker for acute pancreatitis.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased because of obstruction of normal outflow of pancreatic enzymes. May be five or more times the normal level in acute pancreatitis and then fall back within normal ranges because serum half-life is short. Levels are elevated in chronic pancreatitis, but not as high as in acute phase, and may return to near-normal levels in late stage of chronic disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum lipase:</emphasis> More specific to the pancreas than amylase and has a longer half-life.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevates along with amylase but stays elevated longer. Levels are elevated to a lesser degree in chronic pancreatitis and return to normal levels in late stage of chronic disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Alanine aminotransferase (ALT):</emphasis> An enzyme found mainly in the liver but also in smaller amounts in the kidneys, heart, and pancreas.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An increased ALT can be indicative of gallstones, which is commonly associated with pancreatitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum bilirubin:</emphasis> Substance formed when red blood cells (RBCs) break down and are excreted by the liver.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Elevation is common (may be caused by alcoholic liver disease or compression of common bile duct). Excessive bilirubin causes jaundice and may be excreted in urine and stools.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Alkaline phosphatase:</emphasis> Enzyme concentrated in liver and biliary tract.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Usually elevated if pancreatitis is accompanied by biliary disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">C-reactive protein (CRP):</emphasis> An acute-phase reactant protein produced in the liver.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Level greater than 10 mg/dL strongly indicates severe pancreatitis. Higher levels have been shown to correlate with a propensity toward organ failure (Tang &amp; Markus, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum albumin:</emphasis> Most abundant plasma protein transports substances such as bilirubin, calcium, progesterone, and drugs and creates oncotic pressure to keep fluid from leaking out into the tissues.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be decreased because of increased capillary permeability and movement of fluid into extracellular space.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum calcium:</emphasis> Chemical element necessary for the normal function of the heart, nerves, and bones.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypocalcemia occurs early on because of the release of fatty acids combining with calcium, rendering it unusable to the body. May be decreased because of increased capillary permeability and movement of fluid into extracellular space. Hypoalbuminemia and marked elevations of LDH (lactic dehydrogenase) are associated with an increased mortality rate.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Potassium:</emphasis> Electrolyte needed to regulate water balance, levels of acidity, and blood pressure.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypokalemia may occur because of gastric losses; hyperkalemia may develop secondary to tissue necrosis, acidosis, and renal insufficiency.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnesium:</emphasis> Essential mineral needed for protein, bone, and fatty acid formation, making new cells, activating B vitamins, relaxing muscles, clotting of blood, and producing and using insulin.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Diuretic therapy, chronic alcoholism, cirrhosis, and pancreatitis can all cause excessive magnesium loss, as can losses from the gastrointestinal (GI) tract through nasogastric suctioning, fistula drainage, and diarrhea (Astle, 2005).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Triglycerides:</emphasis> One of the many fats formed by the union of glycerol and fatty acids and may indicate cause of condition.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>High triglyceride levels are often indicative of high levels of insulin. Levels may exceed 1700 mg/dL and may be causative agent in acute pancreatitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Complete blood count (CBC):</emphasis> Battery of screening tests that typically includes hemoglobin (Hgb); hematocrit (Hct); RBC count, morphology, indices, and distribution width index; platelet count and size; white blood cell (WBC) count and differential.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>WBC count of 10,000 to 25,000 is present in 80% of clients with acute pancreatitis. Hgb may be lower because of bleeding. Hct may be elevated because of hemoconcentration associated with vomiting, hypovolemia, or from effusion of fluid into pancreas or retroperitoneal area.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum glucose:</emphasis> One of the simple sugars in the blood.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Transient elevations of more than 200 mg/dL are common, especially during initial or acute attacks. Sustained hyperglycemia reflects widespread pancreatic cell damage and necrosis and is a poor prognostic sign.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Blood urea nitrogen (BUN)</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>An elevated BUN has been associated with severe acute pancreatitis, possibly due to hemoconcentration and intravascular depletion (Tang &amp; Markus, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">OTHER DIAGNOSTIC TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Ultrasound of abdomen:</emphasis> Technique that uses sound waves to produce an image of internal body structures.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Most useful initial test to determine etiology of pancreatitis and to identify pancreatic inflammation, abscesses, pseudocysts, or obstruction of biliary tract by gallstones.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Endoscopic ultrasound (EUS):</emphasis> Combines endoscopy (to provide direct visualization of digestive tract) and ultrasound (uses high-frequency sound waves to produce images of the organs and structures).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Computed tomography (CT) scan:</emphasis> X-ray procedure that uses a computer to produce a detailed picture of a cross section of the body to look for complications of pancreatitis and determine treatment options.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicated in client with severe acute pancreatitis and is the imaging study of choice for assessing complications, such as fluid around the pancreas, abscess, or pancreatic pseudocyst.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Endoscopic retrograde cholangiopancreatography (ERCP):</emphasis> Test that combines endoscopy with x-rays to provide an accurate view of the pancreatic and bile ducts.</para></listitem></itemizedlist>
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enables accurate visualization of the pancreatic ductal system and is regarded as the criterion standard for diagnosing chronic pancreatitis (Huffman et al, 2016). Should not be used as a first-line diagnostic tool in acute pancreatitis (Tang &amp; Markus, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Magnetic resonance cholangiopancreatography (MRCP): </emphasis>Type of MRI that uses computer software to focus on the pancreas, bile ducts, gallbladder, and liver.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Not as sensitive as ERCP but safer and noninvasive. No nuclear contrast medium is required because fluid naturally present in the ducts serves as contrast.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ASSOCIATED TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Fecal tests</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Because malabsorption does not occur until more than 90% of the pancreas has been destroyed, steatorrhea is a manifestation of advanced chronic pancreatitis (Huffman et al, 2016).</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0217"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Control pain and promote comfort.</para></listitem>
<listitem><para>Prevent and treat fluid and electrolyte imbalance.</para></listitem>
<listitem><para>Reduce pancreatic stimulation while maintaining adequate nutrition.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Provide information about disease process, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0218"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Pain relieved or controlled.</para></listitem>
<listitem><para>Hemodynamically stable.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Disease process, prognosis, potential complications, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0214note0537">
<title><emphasis role="strong">NURSING DIAGNOSIS: acute Pain</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Physical agent&mdash;obstruction of pancreatic/biliary ducts</para>
<para>Chemical agent&mdash;contamination of peritoneal surfaces by pancreatic exudate, autodigestion of pancreas, extension of inflammation to the retroperitoneal nerve plexus</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Self-report of pain intensity and characteristics</para>
<para>Guarding behavior&mdash;positioning to avoid pain</para>
<para>Expressive behavior (e.g., grimacing)</para>
<para>Self-focused</para>
<para>Changes in physiological parameter (e.g., blood pressure, heart rate, respiratory rate)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Pain Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Report pain is relieved or controlled.</para>
<para><emphasis role="strong">Pain Self-Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Follow prescribed therapeutic regimen.</para>
<para>Demonstrate use of methods that provide relief.</para>
</note>
<note role="none" id="ch0006s0214note0538">
<table frame="top" id="ch0006s0214ta0305"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Pain Management: Acute</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Investigate verbal reports of pain, noting specific location and intensity (e.g., 0 to 10 scale). Note factors that aggravate and relieve pain.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pain is often diffuse, severe, and unrelenting in acute or hemorrhagic pancreatitis. Severe pain is often the major symptom in client with chronic pancreatitis. Isolated pain in the right upper quadrant (RUQ) reflects involvement of the head of the pancreas. Pain in the left upper quadrant (LUQ) suggests involvement of the pancreatic tail. Localized abdominal pain may indicate development of pseudocysts or abscesses.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain bedrest during severe, acute attack and provide quiet, restful environment.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases stimulation of pancreatic secretions, thereby reducing pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Promote position of comfort, such as on one side with knees flexed or sitting up and leaning forward.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces abdominal pressure and tension, providing some measure of comfort and pain relief. <emphasis>Note:</emphasis> Supine position often increases pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide alternative comfort measures, including repositioning and back rub, and quiet diversional activities such as TV or radio. Encourage relaxation techniques, such as guided imagery and visualization.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes relaxation and enables client to refocus attention; may enhance coping.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Keep environment free of food odors.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Sensory stimulation can activate pancreatic enzymes, increasing pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer intravenous (IV) analgesics in timely manner and in smaller, more frequent doses, during acute episode. Consider use of patient-controlled analgesia (PCA), if appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Severe or prolonged pain can aggravate shock and is more difficult to relieve, requiring larger doses of medication, which can mask underlying problems and complications and may contribute to respiratory depression.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain meticulous skin care, especially in presence of draining abdominal wall fistulas.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Pancreatic enzymes can digest the skin and tissues of the abdominal wall, creating abscesses and ulceration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medication, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Opioid analgesics, such as meperidine (Demerol), morphine sulfate, hydrocodone (Vicodin), and tramadol (Ultram)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Meperidine is usually effective in relieving pain and may be preferred over morphine, which may have a side effect of biliary-pancreatic spasms. <emphasis>Note:</emphasis> Pain in clients who have recurrent or chronic pancreatitis may be more difficult to manage because they can develop tolerance to normal doses of the opioids given for pain control.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Histamine blockers, such as lansoprazole (Prevacid), cimetidine (Tagamet), ranitidine (Zantac), and famotidine (Pepcid)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreasing production of hydrochloric acid inhibits pancreatic enzyme activity and associated pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Withhold food and fluid, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client should be kept on nothing by mouth (NPO) status until pain and nausea subside to limit or reduce release of pancreatic enzymes and resultant pain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain gastric suction when used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nasogastric (NG) tube may be used for client with ileus or protracted vomiting to prevent accumulation of gastric secretions and pancreatic enzyme activity.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgical intervention, if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Surgical exploration may be required in presence of intractable pain or complications involving the biliary tract, such as gallstones blocking duct, pancreatic abscess, or pseudocyst. <emphasis>Note:</emphasis> Surgery is not performed during acute stage, unless it would actually cure the problem, such as removing stone causing biliary tract obstruction.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0539">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for deficient Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Active fluid volume loss; excessive losses through normal routes&mdash;vomiting, gastric suctioning</para>
<para>Fluid loss through abnormal routes: compromised regulatory mechanisms (e.g., third-space fluid transudation, ascites formation, vasodilatation, alteration of clotting process)</para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate hydration as evidenced by stable vital signs, good skin turgor, prompt capillary refill, strong peripheral pulses, and individually appropriate urinary output.</para>
</note>
<note role="none" id="ch0006s0214note0540">
<table frame="top" id="ch0006s0214ta0306"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Fluid/Electrolyte Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate heart sounds; note rate and rhythm. Monitor and document rhythm and changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cardiac changes and dysrhythmias may reflect hypovolemia or electrolyte imbalance, commonly hypokalemia and hypocalcemia. Hyperkalemia may occur related to tissue necrosis, acidosis, and renal insufficiency and may precipitate lethal dysrhythmias if uncorrected. <emphasis>Note:</emphasis> Cardiovascular complications are common in severe pancreatitis and include myocardial infarction (MI), pericarditis, and pericardial effusion with or without tamponade.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor blood pressure (BP), noting trends. Measure central venous pressure (CVP), if available.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fluid sequestration with shifts into third space, bleeding, and release of vasodilators (kinins) and cardiac depressant factor triggered by pancreatic ischemia may result in profound hypotension. Reduced cardiac output and poor organ perfusion can precipitate widespread systemic complications. Systemic infection (septic shock) is also possible, exacerbating hypovolemic status.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate changes in sensorium: confusion and slowed responses.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Changes may be related to hypovolemia, hypoxia, electrolyte imbalance, or impending delirium tremens (in client with acute pancreatitis secondary to excessive alcohol intake). Severe pancreatic disease may cause toxic psychosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measure intake and output (I&amp;O), including vomiting or gastric aspirate and diarrhea. Calculate 24-hour fluid balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of replacement needs and effectiveness of therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note decrease in urine output (less than 400 mL/24 hr).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Oliguria may occur, signaling renal impairment or acute tubular necrosis (ATN), related to increase in renal vascular resistance or altered renal blood flow.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Record color and character of gastric drainage, measure pH, and note presence of occult blood.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Risk of gastric hemorrhage is high because of esophageal varices or erosion of other large vessels. (Refer to CP: <link linkend="ch0005s0144">Upper Gastrointestinal Bleeding</link>, if indicated.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weigh, as indicated; correlate with calculated fluid balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Weight loss may suggest hypovolemia; however, edema, fluid retention, and ascites or hemorrhage into the peritoneal cavity may be reflected by increased weight or stable weight in the presence of muscle wasting.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note poor skin turgor, dry skin and mucous membranes, or reports of thirst.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Further physiological indicators of dehydration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe and record peripheral and dependent edema. Measure abdominal girth if ascites present.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Edema and fluid shifts occur as a result of increased vascular permeability, sodium retention, and decreased colloid osmotic pressure in the intravascular compartment.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect skin for petechiae, hematomas, and unusual wound or venipuncture bleeding. Note hematuria, mucous membrane bleeding, and bloody gastric contents.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Disseminated intravascular coagulation (DIC) may be initiated by release of active pancreatic proteases into the circulation. The most frequently affected organs are the kidneys, skin, and lungs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Observe and report coarse muscle tremors, twitching, and positive Chvostek&rsquo;s sign.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These are symptoms of calcium imbalance. Calcium binds with free fats in the intestine and is lost by excretion in the stool. <emphasis>Note:</emphasis> Chvostek&rsquo;s sign is evaluated by tapping the cheek over the facial nerve and then observing for the development of a lip twitch or facial spasm, which is indicative of muscular irritability.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer fluid replacement, as indicated, such as saline solutions, albumin, blood and blood products, and dextran.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Choice of replacement solution may be less important than rapidity and adequacy of volume restoration. Saline solutions and albumin may be used to promote mobilization of fluid back into vascular space. Low-molecular-weight dextran is sometimes used to reduce risk of renal dysfunction and pulmonary edema associated with pancreatitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor laboratory studies&mdash;Hgb/Hct, protein, albumin, electrolytes, blood urea nitrogen (BUN), creatinine, urine osmolality, sodium and potassium, and coagulation studies.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies deficits, replacement needs, and developing complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replace electrolytes&mdash;sodium, potassium, chloride, and calcium, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreased oral intake and excessive losses greatly affect electrolyte and acid-base balance, which is necessary to maintain optimal cellular and organ function.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prepare for and assist with peritoneal lavage or peritoneal dialysis.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>While uncommon, peritoneal dialysis is an approach to treat necrotizing acute pancreatitis as it removes dialyzable toxins and rapidly reduces severe metabolic disturbances (Li et al, 2016). (Refer to CP: <link linkend="ch0008s0259">Peritoneal Dialysis (PD)</link> for related assessments and interventions, as needed.)</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0541">
<title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inability to ingest food (e.g., anorexia, nausea, vomiting, indigestion)</para>
<para>Inability to digest food</para>
<para>Abdominal cramping [severe pain with food ingestion]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient interest in food; food aversion; food intake less than recommended daily allowances; satiety immediately after ingesting food</para>
<para>Hyperactive bowel sounds; diarrhea, steatorrhea</para>
<para>Abnormal laboratory studies (e.g., decreased albumin)</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stable weight with normalization of laboratory values, including blood glucose.</para>
<para>Be free of signs of malnutrition and nutritional deficiencies.</para>
<para><emphasis role="strong">Knowledge: Prescribed Diet</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate behaviors or lifestyle changes to avoid causing acute episode of pancreatitis, and maintain appropriate weight.</para>
</note>
<note role="none" id="ch0006s0214note0542">
<table frame="top" id="ch0006s0214ta0307"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Nutrition Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine likelihood of serious nutritional issues in client&rsquo;s current situation. Note reason for pancreatitis (e.g., acute incident associated with gallstones or binge drinking, or long-term chronic alcoholic with nutritional deficits and acute-on-chronic pancreatitis).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nutrition needs and feeding depend on the type and stage of the disease. The severity of malnutrition is correlated with two major factors: (1) malabsorption and depletion of nutrients (e.g., from alcoholism and pain) cause impaired nutritional status, and (2) increased metabolic activity is present (in correlation with disease type and stage). However, in CP, uncontrolled exocrine pancreatic insufficiency (EPI) can have serious ramifications, resulting in nutrient malabsorption, weight loss, bloating, abdominal pain, and even chronic malnutrition, if left untreated (Grant, 2011; Rasmussen et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Perform brief nutrition screening upon admission to care. Refer for in-depth testing as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nutrition status is part of the admission assessment and can be evaluated quickly in four basic areas (i.e., recent weight loss, recent food intake, current weight and BMI, and estimate of current disease severity) to predict risk of malnutrition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess abdomen, noting presence and character of bowel sounds, abdominal distention, and reports of nausea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Gastric distention and intestinal atony are frequently present, resulting in reduced or absent bowel sounds. Return of bowel sounds and relief of symptoms signal readiness for discontinuation of NG tube.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide frequent oral care.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreases vomiting stimulus and soothes inflamed, dry mucous membranes associated with dehydration and mouth breathing when NG tube is in place.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assist client in selecting food and fluids that meet nutritional needs and restrictions when diet is resumed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Previous dietary habits may be unsatisfactory in meeting current needs for tissue regeneration and healing. Use of gastric stimulants, such as caffeine, alcohol, cigarettes, or gas-producing foods, or ingestion of large meals may result in excessive stimulation of the pancreas and recurrence of symptoms.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe color, consistency, and amount of stools. Note frothy consistency and foul odor.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Steatorrhea may develop in chronic pancreatitis from incomplete digestion of fats.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain NPO status and gastric suctioning during acute phase.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents stimulation and release of pancreatic enzymes (secretin) when chyme and hydrochloric acid enter the duodenum.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Resume oral intake as appropriate in frequent small meals (four to eight times a day).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>In mild AP, oral feedings can be started immediately if there is no nausea and vomiting, and abdominal pain has resolved. Studies support that initiation of feeding with a low-fat solid diet appears as safe as a clear liquid diet; however, oral feedings given too early in the course of AP may exacerbate symptoms (Tenner et al, 2013). Dietary management in CP includes a diet of lean meat and vegetable proteins, as well as low-fat and nutrient-dense foods. Fried or greasy foods are to be avoided to help prevent pain. Carbohydrate intake might be limited when overt diabetes mellitus is present (Rasmussen et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to nutritionist for full nutritional evaluation of client&rsquo;s needs, especially noting dietary deficiencies (e.g., when client has replaced food with alcohol or stopped eating because of pain) <emphasis role="bi">and</emphasis> current presence of hypermetabolic state (e.g., fever, sepsis, hemodynamic shock state).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>To help identify needs and influence interventions. For example, dietary recommendations usually begin with total abstinence from alcohol. In addition, an adequate number of calories should be taken. Estimation (or measurement) of resting energy expenditure (REE) is essential to calculate adequate caloric intake. The carbohydrate intake might be limited when overt diabetes mellitus is present. Data on measured REE in CP are very limited but have shown that weight loss is accompanied by hypermetabolism and that between 30% and 50% of patients with CP have increased REE (Rasmussen et al, 2013).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate in treatment regimen.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Treatment should be multidisciplinary and support that the mainstay of treatment is abstinence from alcohol, pain treatment, dietary modifications, and pancreatic enzyme supplementation (where needed). <emphasis>Note:</emphasis> About 80% of patients can be managed by a combination of analgesics, dietary recommendations, and pancreatic enzyme supplements, while 10% to 15% need oral nutritional supplements, 5% need enteral tube feeding, and around 1% require parenteral nutrition (Meier et al, 2006; Plauth et al, 2009).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer enteral or parenteral feedings, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nutritional support can have a significant beneficial impact in a hypermetabolic and hypercatabolic state. Enteral feeding is preferred via nasogastric or jejunostomy tube to stabilize gut bacteria, which can help to limit/prevent infection. However, parenteral nutrition (PN) should be instituted if enteral feedings can&rsquo;t meet nutritional needs or client can&rsquo;t tolerate enteral feeding (Grant, 2011; Krenzer, 2016; Tenner et al, 2013). (Refer to CP: <link linkend="ch0006s0219">Total Nutritional Support: Parenteral/Enteral Feedings</link>.)</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Vitamins, such as A, D, E, and K</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Replacement required because fat metabolism is altered, reducing absorption and storage of fat-soluble vitamins. A deficiency in vitamins A, D, E, and K correlates with the severity of steatorrhea in patients with CP but may be caused by several different mechanisms, including (and not limited to) suboptimal dietary intakes, increased nutrient and vitamin losses occurring simultaneously with increased requirements, and impaired binding of nutrients.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Replacement enzymes, such as delayed-release varied enzyme combination drugs (e.g., pancrelipase [Creon, Zenep, Pancrease V, Viokase, Zenpep])</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Used in chronic pancreatitis to correct deficiencies and to promote digestion and absorption of nutrients. <emphasis>Note:</emphasis> Use of delayed-release pancreatic enzymes has improved client outcomes for dosage and timing of meals.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0543">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for unstable Blood Glucose Level</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Dietary intake; [pancreas dysfunction with decreased insulin production, increased glucagon release]</para>
<para>Physical health status, stress</para>
<para>Insufficient knowledge of, or adherence to management plan</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Blood Glucose Level</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain glucose in satisfactory range.</para>
</note>
<note role="none" id="ch0006s0214note0544">
<table frame="top" id="ch0006s0214ta0308"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Hyperglycemia Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note signs of increased thirst and urination or changes in mentation and visual acuity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May warn of developing hyperglycemia associated with increased release of glucagon (damage to alpha cells) or decreased release of insulin (damage to beta-cells). <emphasis>Note:</emphasis> When the insulin-producing cells (beta-cells) have been damaged, diabetes may develop. Diabetes as a consequence of pancreatitis is known as secondary diabetes (see <link linkend="ch0006s0214note0536">Glossary</link>) and may require insulin injections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Perform and monitor results of bedside fingerstick glucose testing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection of inadequate glucose utilization may prevent development of hyperglycemic crisis. IV insulin may be required to control serum glucose within normal ranges.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor serum glucose, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicator of insulin needs because hyperglycemia is frequently present, although not usually in levels high enough to produce ketoacidosis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide insulin, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Corrects persistent hyperglycemia caused by injury to beta-cells and the increased release of glucocorticoids. Insulin therapy is usually short term unless permanent damage to pancreas occurs.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Advance diet as tolerated and based on specific nutritional needs.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Loss of pancreatic function or reduced insulin production may require initiation of a permanent diabetic diet.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0545">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection [sepsis]</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Stasis of body fluids; alteration in peristalsis; malnutrition</para>
<para>Chronic illness; alteration in pH of secretions; alteration in tissue integrity; immunosuppression</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of signs of infection.</para>
<para>Be afebrile.</para>
<para><emphasis role="strong">Risk Control: Infectious Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Participate in activities to reduce risk of infection.</para>
</note>
<note role="none" id="ch0006s0214note0546">
<table frame="top" id="ch0006s0214ta0309"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Use strict aseptic technique when changing surgical dressings or working with IV lines, indwelling catheters, tubes, or drains. Change soiled dressings promptly.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Limits sources of infection, which can lead to sepsis in a compromised client.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Model and emphasize importance of good hand hygiene.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of cross-contamination.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe rate and characteristics of respirations and breath sounds. Note occurrence of cough and sputum production.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Potential pulmonary complications of pancreatitis can include atelectasis, pleural effusion, pneumonia, and acute respiratory distress syndrome (ARDS). Fluid accumulation and limited mobility predispose client to respiratory infections and atelectasis. Accumulation of ascites fluid may cause elevated diaphragm and shallow abdominal breathing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Encourage frequent position changes, deep breathing, and coughing. Assist with ambulation as soon as stable.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances ventilation of all lung segments and promotes mobilization of secretions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe for signs of infection, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fever and respiratory distress in conjunction with jaundice</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cholestatic jaundice and decreased pulmonary function may be first sign of sepsis or ARDS.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased abdominal pain, rigidity and rebound tenderness, diminished or absent bowel sounds</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggestive of peritonitis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increased abdominal pain and tenderness, recurrent fever (higher than 101&deg;F [38.3&deg;C]), leukocytosis, hypotension, tachycardia, and chills</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Abscesses can occur 2 weeks or more after the onset of pancreatitis and should be suspected whenever client is deteriorating despite supportive measures.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Obtain culture specimens, such as blood, wound, urine, sputum, or pancreatic aspirate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identifies presence of infection and causative organism.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer anti-infective therapies as indicated, such as imipenem/cilastatin (Primaxin), metronidazole (Flagyl), and levofloxacin (Levaquin); cephalosporins, such as ceftriaxone (Rocephin); and aminoglycosides, such as gentamicin (Garamycin) and tobramycin (Nebcin).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Antibiotics are not given routinely for fever, especially early in the disease course, because this symptom is almost universally secondary to the inflammatory response and typically does not reflect an infectious process. However, broad-spectrum anti-infectives are generally recommended for acute pancreatitis sepsis, while long-term therapy will be based on the specific organisms cultured (Tang &amp; Markus, 2017).</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare for surgical intervention, as necessary.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Abscesses may be surgically drained with resection of necrotic tissue. Sump tubes may be inserted for antibiotic irrigation and drainage of pancreatic debris. Pseudocysts (persisting for several weeks) may be drained because of the risk and incidence of infection and rupture.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0547">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for impaired Gas Exchange</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Alveolar-capillary membrane changes&mdash;interstitial edema, pulmonary congestion</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain adequate ventilation with respiratory rate and rhythm normal for client, breath sounds clear, and free of dyspnea or shortness of breath.</para>
<para>Display arterial blood gases (ABGs) within client&rsquo;s normal range.</para>
</note>
<note role="none" id="ch0006s0214note0548">
<table frame="top" id="ch0006s0214ta0310"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Respiratory Monitoring</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Evaluate respiratory rate and depth. Note respiratory effort, for example, presence of dyspnea, use of accessory muscles, and nasal flaring.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client responses are variable. Rate and effort may be increased by pain, accumulation of secretions, or abdominal distention. Respiratory depression can occur with use of opioid analgesics. Early recognition and treatment of abnormal ventilation may prevent complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Auscultate breath sounds. Note areas of diminished or absent breath sounds and presence of adventitious sounds, such as rhonchi or crackles.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Loss of active breath sounds in an area of previous ventilation may reflect atelectasis. Crackles or rhonchi may be indicative of fluid accumulation due to interstitial edema, pulmonary congestion, or infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage client participation and responsibility for deep-breathing exercises, use of adjuncts, and coughing, as indicated. Reposition frequently.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Stimulates respiratory function and lung expansion. Effective in preventing and resolving pulmonary congestion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reinforce splinting of abdomen with pillows during deep breathing or coughing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May enhance effectiveness of cough effort.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Note increasing restlessness, confusion, and lethargy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May indicate impaired gas exchange and possible ARDS, requiring prompt evaluation and intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and graph serial ABGs and pulse oximetry, and review chest x-ray reports.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Decreasing oxygen level or saturation and increasing PaCO<subscript>2</subscript> and changes in chest x-rays suggest developing complications requiring further evaluation and treatment.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer supplemental oxygen (O<subscript>2</subscript>), if indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Increases available O<subscript>2</subscript> for tissue and organ function. <emphasis>Note: </emphasis>Inability to maintain adequate oxygenation indicates need for more aggressive therapy or mechanical ventilation. (Refer to CP: <link linkend="ch0003s0094">Respiratory Failure/Ventilatory Assistance</link>.)</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0549">
<title><emphasis role="strong">NURSING DIAGNOSIS: ineffective Health Management</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Complexity of therapeutic regimen; insufficient knowledge of healthcare regimen</para>
<para>Perceived seriousness of condition, susceptibility, benefit or barriers; decisional conflicts</para>
<para>Economically disadvantaged</para>
<para>Insufficient social support</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Reports difficulty with prescribed regimen</para>
<para>Failure to include treatment regimen in daily living or to take action to reduce risk factors</para>
<para>Ineffective choices in daily living for meeting health goals</para>
<para>Unexpected acceleration of illness symptoms</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Acute Illness/Chronic Disease Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition, disease process, and potential complications.</para>
<para>Verbalize understanding of therapeutic needs.</para>
<para>Correctly perform necessary procedures and explain reasons for the actions.</para>
<para>Initiate necessary lifestyle changes and participate in treatment regimen.</para>
<para>Identify and use available resources.</para>
</note>
<note role="none" id="ch0006s0214note0550">
<table frame="top" id="ch0006s0214ta0311"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Teaching: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review specific cause of current episode and prognosis.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides knowledge base on which client can make informed choices.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss other causative and associated factors such as excessive alcohol intake, gallbladder disease, duodenal ulcer, and some drugs&mdash;oral contraceptives, thiazide diuretics, glucocorticoids, and sulfonamides.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client may or may not be able to impact risk, but avoidance of certain substances and drugs may help limit damage and prevent development of a chronic condition.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Explore availability of treatment programs for chemical dependency, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alcohol abuse is currently the most common cause of recurrence of chronic pancreatitis. Usage of other drugs, whether prescribed or illicit, is increasing as a factor. <emphasis>Note: </emphasis>Pain of pancreatitis can be severe and prolonged and may lead to narcotic dependence. Client may benefit from referral to a pain clinic.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize the importance of follow-up care, and review symptoms that need to be reported immediately to physician, such as recurrence of abdominal pain, persistent fever, nausea and vomiting, abdominal distention, frothy or foul-smelling stools, and general intolerance of food.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prolonged recovery period requires close monitoring to prevent or limit recurrence and complications, such as infection and pancreatic pseudocysts.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review importance of initially continuing bland, low-fat diet with frequent small feedings within individual tolerance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Understanding the purpose of the diet in maximizing the use of available enzymes while avoiding overstimulation of the pancreas may enhance client involvement in self-monitoring of dietary needs and responses to foods.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct in use of pancreatic enzyme replacements as indicated, avoiding concomitant ingestion of hot foods or fluids.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>If permanent damage to the pancreas has occurred, exocrine deficiencies will occur, requiring long-term replacement. Hot foods or fluids can inactivate enzymes.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend cessation of smoking. Refer for medical and support interventions, if client desires.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nicotine stimulates gastric secretions and unnecessary pancreatic activity.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss signs and symptoms of diabetes mellitus: polydipsia, polyuria, weakness, and weight loss.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Damage to the beta-cells may result in a temporary or permanent alteration of insulin production.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Provide information about available resources, such as home healthcare, nutritionist, alcohol treatment program, financial assistance, diabetes care, transplant information, etc.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client/SO may benefit assistance from multiple community assistance programs. Aid may be possible for many clients if they are assisted in accessing resources.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0214note0551">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">imbalanced Nutrition: less than body requirements</emphasis>&mdash;inability to ingest food (prescribed dietary restrictions, persistent nausea and vomiting), inability to digest food/absorb nutrients (imbalances in digestive enzymes)</para></listitem>
<listitem><para><emphasis role="bi">risk for unstable Blood Glucose Level</emphasis>&mdash;lack of acceptance of diagnosis; deficient knowledge of diabetes management; medication management</para></listitem>
<listitem><para><emphasis role="bi">acute/chronic Pain</emphasis>&mdash;chemical agents (e.g., irritation of peritoneal surfaces by pancreatic enzymes, general inflammatory process), physical agent (e.g., spasms of biliary ducts)</para></listitem>
<listitem><para><emphasis role="bi">dysfunctional Family Processes</emphasis>&mdash;alcohol abuse, family history of resistance to treatment, inadequate coping, lack of problemsolving skills</para></listitem>
<listitem><para><emphasis role="bi">ineffective Health Management</emphasis>&mdash;complexity of therapeutic regimen, economic difficulties, perceived benefit, social support deficits</para></listitem></itemizedlist>
</note>
</sect2></sect1>
<sect1 id="ch0006s0219"><title><emphasis role="strong">TOTAL NUTRITIONAL SUPPORT: PARENTERAL/ENTERAL FEEDING</emphasis></title>
<orderedlist numeration="upperroman" inheritnum="ignore" continuation="restarts">
<listitem><para><emphasis role="strong">Pathophysiology</emphasis>&mdash;Malnutrition is a disorder of body composition in which nutritional intake is less than required and results in reduced organ function, abnormalities in blood chemistry, reduced body mass, and worsened clinical outcomes.</para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>According to the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), malnutrition can be classified as either being illness related (secondary to another disease of injury) or non&ndash;illness related (attributable to environmental/behavioral causes) or a combination of the two (Mehta et al, 2013).</para></listitem>
<listitem><para>Nutritional status is affected by multiple factors, including eating behaviors, disease states, age, economics, and environment.</para></listitem>
<listitem><para>In the acutely or chronically ill client, the impact of malnutrition includes muscle mass loss, progressive weakness, reduced immune competence, increased infectious complications, poor skin integrity and delayed wound healing, a higher rate of systemic complications, and prolonged length of stay.</para></listitem>
<listitem><para>When oral intake is inadequate or not possible, specifically designed nutritional therapy can be administered via an enteral or a parenteral route to prevent or correct protein-calorie malnutrition.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Clinical Indication for Feeding</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Preexisting nutritional deprivation; unplanned or unexplained loss of 10% in body weight</para></listitem>
<listitem><para>Anticipated or actual inadequate energy intake by mouth, such as inability to consume food or drink orally for 7 days or more, based on individual nutritional status</para></listitem>
<listitem><para>Critically ill individuals, because of their increased metabolic demands and limited nutritional reserve, commonly require nutritional support.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Etiology of Malnutrition</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Can exist in persons who are underfed or overfed, occurring in both extremely thin and obese individuals</para></listitem>
<listitem><para>May result from an inadequate or unbalanced diet, digestive difficulties, absorption problems, or other medical conditions</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Acute conditions, such as surgery, severe burns, infections, and trauma, that drastically increase short-term nutritional requirements</para></listitem>
<listitem><para>Chronic diseases associated with nutrient loss, nutrient demand, and malabsorption, such as celiac disease, cystic fibrosis, pancreatic insufficiency, pernicious anemia</para></listitem>
<listitem><para>Conditions and treatments associated with malnutrition through decreased intake, such as depressed appetite, difficulty swallowing, and nausea associated with both cancer and chemotherapy, as well as with HIV/AIDS and its drug therapies</para>
</listitem></orderedlist></listitem>
<listitem><para>Certain age groups, such as elderly clients, require fewer calories but continue to require adequate nutritional support because they are often less able to absorb nutrients, due in part to decreased stomach acid production, and are more likely to have one or more chronic ailments that may affect their nutritional status.</para>
</listitem></orderedlist></listitem>
<listitem><para><emphasis role="strong">Routes for Feeding</emphasis></para>
<orderedlist numeration="loweralpha" inheritnum="ignore" continuation="restarts">
<listitem><para>Enteral nutrition</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>Gastrointestinal (GI) intubation is preferred for clients with a functional GI tract but who are unable to consume an adequate nutritional intake or for whom oral intake is contraindicated or impossible.</para></listitem>
<listitem><para>Feeding may be done via flexible catheter (such as nasogastric [NG], orogastric tube) or enterostomy (such as gastrostomy, duodenostomy, or jejunostomy) tube.</para></listitem>
<listitem><para>Feeding may be short term for supplementation of oral intake or long term to provide for all of client&rsquo;s nutrition.</para></listitem>
<listitem><para>Formulas can be manufactured to meet certain needs for the body (e.g., <emphasis>polymeric</emphasis> is a standard formula, and <emphasis>elemental</emphasis> is for those with malabsorptive guts), but also there are special formulas for diabetes, acute and chronic renal failure, immune system enhancement, and hepatic encephalopathy.</para>
</listitem></orderedlist></listitem>
<listitem><para>Parenteral nutrition</para>
<orderedlist numeration="lowerroman" inheritnum="ignore" continuation="restarts">
<listitem><para>May be chosen because of altered metabolic states or when mechanical or functional abnormalities of the GI tract prevent enteral feeding</para></listitem>
<listitem><para>Goals are to improve the client&rsquo;s nutritional status, establish and maintain a positive nitrogen balance, improve or maintain muscle strength and mass, promote weight gain, and encourage the healing process through infusion of amino acids, fat, carbohydrates, trace elements, vitamins, and electrolytes, as indicated.</para></listitem>
<listitem><para>The average adult requires approximately 1500 calories per day in order to maintain energy stores before illness is factored in.</para></listitem>
<listitem><para>Parenteral nutrition (PN) is provided via an intravenous (IV) route, either centrally or peripherally.</para>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Central: Formula is concentrated hyperosmolar and must be infused via a large vein in the chest, neck, or arm. Commonly used central lines are peripherally inserted central catheter (PICC) lines and Hickman and Groshong catheters. The nutrition supplied in this manner is called total parenteral nutrition (TPN) because it supplies all the nutrition the client receives.</para></listitem>
<listitem><para>Peripheral PN (also called PPN) formulas are similar to (but less concentrated than) centrally infused formulas and are infused via a peripheral vein. <emphasis>Note:</emphasis> A.S.P.E.N. guidelines suggest that PN with an osmolarity of up to 900 mOsm/L can be safely infused peripherally (Boullata et al, 2014). PPN treatment is typically short term and may be given to supplement other methods of nutrition the client receives.</para>
</listitem></orderedlist></listitem></orderedlist></listitem></orderedlist></listitem></orderedlist>
<note id="ch0006s0219note0552"><title><emphasis role="strong">GLOSSARY</emphasis></title>
<para><emphasis role="strong">Basal metabolic rate (BMR): </emphasis>Number of calories the body burns at rest to maintain normal body functions.</para>
<para><emphasis role="strong">Cachexia: </emphasis>Profound and marked state of general ill health and malnutrition.</para>
<para><emphasis role="strong">Catabolism: </emphasis>Metabolic breakdown of complex molecules into simpler ones, often resulting in a release of energy.</para>
<para><emphasis role="strong">Harris-Benedict equation: </emphasis>Formula that uses BMR and then applies an activity factor to determine total daily energy expenditure (calories).</para>
<para><emphasis role="strong">Ideal body weight (IBW): </emphasis>Calculation for men: 106 lbs for first 5 feet plus 6 lbs for each additional inch of height. Women: 100 lbs for first 5 feet plus 5 lbs for each additional inch of height.</para>
<para><emphasis role="strong">Indirect calorimetry: </emphasis>Estimation of energy expenditure via the measurement of oxygen consumption and carbon dioxide production.</para>
<para><emphasis role="strong">Lipids: </emphasis>Lipids are fat emulsion of 10% to 20%. It contains triglycerides, egg phospholipids, glycerol, and water. If lipids are needed with TPN, they are given intermittently or mixed in with the TPN solution.</para>
<para><emphasis role="strong">Malabsorption: </emphasis>Inability of the body to use one or more available nutrients.</para>
<para><emphasis role="strong">Partial parenteral nutrition (PPN): </emphasis>Normally prescribed for clients who can tolerate some oral feedings but cannot ingest adequate amounts of food to meet their nutritional needs. It is usually administered through a peripheral intravenous catheter. A time frame of less than 14 days is recommended. Two types of solutions are commonly used in a number of combinations for PPN: lipid emulsions and amino acid&ndash;dextrose solutions.</para>
<para><emphasis role="strong">Protein calorie malnutrition (PCM), also called protein energy malnutrition (PEM): </emphasis>Severe deficiency of protein plus inadequate caloric intake to meet energy needs.</para>
<para><emphasis role="strong">Total energy expenditure (TEE): </emphasis>Amount of energy spent, on average, in a typical day measured in calories (k/day).</para>
<para><emphasis role="strong">Total parenteral nutrition (TPN): </emphasis>IV full nutrition support using a formulation of amino acids, carbohydrates, lipids, electrolytes, multiple vitamins, minerals, and supplemental medications (e.g., insulin or H2 blockers). It is recommended for a minimum of 7 days for improvement in patient outcome to occur.</para>
<para><emphasis role="strong">TPN IV access: </emphasis>Central access lines for TPN may include a triple lumen catheter (TLC), a peripherally inserted central line (PICC), tunneled central venous catheters (e.g., Broviac, Groshong, or Hickman), and implanted central venous catheter (e.g., Port-A-Cath). The first two categories are likely to be used in shorter-term parenteral therapy, while the latter two categories may be reserved for long-term and permanent therapy.</para>
</note>
<sect2 id="ch0006s0220"><title><emphasis role="strong">CARE SETTING</emphasis></title>
<para>Client may be treated in any setting, including acute care (often ICU), community care, or home care.</para>
<para><emphasis role="bi">***NOTE:</emphasis><emphasis role="strong"> This plan of care addresses only enteral or parenteral feedings and does not deal with transitional feedings or caring for the client with difficulties chewing and swallowing that may require additional interventions in order to ingest food by mouth.</emphasis></para>
</sect2>
<sect2 id="ch0006s0221"><title><emphasis role="strong">RELATED CONCERNS</emphasis></title>
<para><link linkend="ch0003s0089">Acute lung injury/acute respiratory distress syndrome</link></para>
<para><link linkend="ch0013s0328">Acquired immunodeficiency syndrome (AIDS)</link></para>
<para><link linkend="ch0007s0224">Anemias</link></para>
<para><link linkend="ch0006s0189">Bariatric surgery</link></para>
<para><link linkend="ch0012s0308">Burns: thermal, chemical, and electrical&mdash;acute and convalescent phases</link></para>
<para><link linkend="ch0014s0370">Cancer</link></para>
<para><link linkend="ch0004s0114">Cerebrovascular accident (CVA)/stroke</link></para>
<para><link linkend="ch0004s0107">Craniocerebral trauma&mdash;acute rehabilitative phase</link></para>
<para><link linkend="ch0003s0069">Chronic obstructive pulmonary disease (COPD) and asthma</link></para>
<para><link linkend="ch0006s0209">Cirrhosis of the liver</link></para>
<para><link linkend="ch0006s0194">Diabetes mellitus and diabetic ketoacidosis</link></para>
<para><link linkend="ch0006s0179">Eating disorders: anorexia nervosa/bulimia nervosa</link></para>
<para><link linkend="ch0006s0184">Obesity</link></para>
<para>Fluid and electrolyte imbalances (see Davis<emphasis>Plus</emphasis>)</para>
<para><link linkend="ch0011s0293">Fractures</link></para>
<para><link linkend="ch0005s0149">Inflammatory bowel disease</link></para>
<para><link linkend="ch0004s0134">Multiple sclerosis (MS)</link></para>
<para><link linkend="ch0006s0214">Pancreatitis</link></para>
<para><link linkend="ch0004s0139">Parkinson&rsquo;s disease (PD)</link></para>
<para><link linkend="ch0014s0338">Psychosocial aspects of care</link></para>
<para><link linkend="ch0008s0249">Renal failure: chronic</link></para>
<para><link linkend="ch0003s0094">Respiratory failure/ventilatory assistance</link></para>
<para><link linkend="ch0014s0348">Surgical intervention</link></para>
<table frame="top" id="ch0006s0219ta0312"><title><emphasis role="strong">CLIENT ASSESSMENT DATABASE</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Clinical signs listed here depend on the degree and duration of malnutrition and include observations indicative of vitamin, mineral, protein, and calorie deficiencies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DIAGNOSTIC DIVISION<?lb?>MAY REPORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">MAY EXHIBIT</emphasis></para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ACTIVITY/REST</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Fatigue</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Decreased activity tolerance</para></listitem>
<listitem><para>Muscle wasting&mdash;temporal, intercostal, gastrocnemius, dorsum of hand</para></listitem>
<listitem><para>Flaccid muscles</para></listitem>
<listitem><para>Thin extremities</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">CIRCULATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Tachycardia, bradycardia</para></listitem>
<listitem><para>Pallor, cyanosis</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">ELIMINATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Diarrhea or constipation, flatulence associated with food intake</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Stools may be loose, hard-formed, fatty, or clay-colored</para></listitem>
<listitem><para>Abdominal distention, increased girth, ascites</para></listitem>
<listitem><para>Abdominal tenderness on palpation</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">FOOD/FLUID</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Recent weight loss or weight loss of 10% or more of body weight within previous 6 months</para></listitem>
<listitem><para>Unplanned weight loss of more than 20 lb in the last 3 months</para></listitem>
<listitem><para>Inadequate oral intake (nothing by mouth [NPO]) status for 7 to 10 days</para></listitem>
<listitem><para>Anorexia</para></listitem>
<listitem><para>Nausea, vomiting</para></listitem>
<listitem><para>Problems with chewing, swallowing</para></listitem>
<listitem><para>Sore mouth and gums</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Actual measured weight as compared with usual, or weight is less than 90% of IBW for height, sex, and age</para></listitem>
<listitem><para>Actual weight equal to or greater than 120% of IBW</para></listitem>
<listitem><para>Subcutaneous fat loss</para></listitem>
<listitem><para>Bowel sounds diminished, hyperactive, or absent</para></listitem>
<listitem><para>Lips and mucous membranes dry, cracked, red, swollen</para></listitem>
<listitem><para>Edema, generalized or dependent (e.g., feet/ankles; periorbital, abdominal)</para></listitem>
<listitem><para>Dentition may be poor, such as lack of teeth, multiple cavities, denture problems</para></listitem>
<listitem><para>Tongue may be smooth, pale, slick, coated; color often magenta, beefy red; lingual papillae atrophy or swelling</para></listitem>
<listitem><para>Gums swollen, bleeding</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">NEUROSENSORY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History of neurological conditions (e.g., brain injury, stroke, multiple sclerosis, Parkinson&rsquo;s disease) affecting eating abilities</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Lethargy, apathy, listlessness, irritability, disorientation</para></listitem>
<listitem><para>Loss of balance and coordination</para></listitem>
<listitem><para>Decreased cognitive function</para></listitem>
<listitem><para>Gag and swallow reflex may be decreased or absent</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">PAIN/DISCOMFORT</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Headache</para></listitem>
<listitem><para>Various pains dependent on underlying conditions</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">RESPIRATION</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Shortness of breath; difficulty breathing</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Increased respiratory rate; respiratory distress</para></listitem>
<listitem><para>Breath sounds, crackles (protein deficiency-related fluid shifts)</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SAFETY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Allergies</para></listitem>
<listitem><para>Exposure to infectious diseases</para></listitem>
<listitem><para>Altered immune system</para></listitem>
<listitem><para>Delayed healing</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Skin dry, scaly, tented; &ldquo;flaky paint&rdquo; dermatosis; edematous</para></listitem>
<listitem><para>Nails may be brittle, thin, flattened, ridged, spoon-shaped</para></listitem>
<listitem><para>Draining or unhealed wounds; pressure sores</para></listitem>
<listitem><para>Ecchymosis; perifollicular petechiae</para></listitem></itemizedlist></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">SEXUALITY</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Loss of libido</para></listitem>
<listitem><para>Amenorrhea</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">TEACHING/LEARNING</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>History or presence of conditions causing protracted protein and caloric losses&mdash;malabsorption or short-gut syndrome, diarrhea, acute pancreatitis, renal dialysis, fistulas, draining wounds, thermal injuries, problems with chewing or swallowing (such as due to stroke or Parkinson&rsquo;s disease)</para></listitem>
<listitem><para>Presence of factors known to alter nutritional requirements and increase energy demands&mdash;single or multiorgan failure, sepsis, fever, AIDS, cancer, trauma (especially traumatic brain injury [TBI]), extensive burns, pressure ulcers, use of steroids, antitumor agents, immunosuppressants</para></listitem>
<listitem><para>Use of treatments that greatly alter intake and medications that cause untoward drug and nutrient interactions&mdash;laxatives, anticonvulsants, diuretics, antacids, opioids, immunosuppressants, radiation, high-dose chemotherapy</para></listitem>
<listitem><para>Illness of psychiatric origin&mdash;anorexia nervosa or bulimia</para></listitem>
<listitem><para>Educational and social factors&mdash;lack of nutrition knowledge or kitchen facilities, reduced or limited financial resources</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">DISCHARGE PLAN CONSIDERATIONS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>May require assistance with solution preparation, therapy supplies, and maintenance of feeding device for home nutritional care</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para><inlinemediaobject><imageobject><imagedata fileref="pa.jpg"/></imageobject></inlinemediaobject> Refer to section at end of plan for postdischarge considerations.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry></row></tbody></tgroup></table>
<table frame="top" id="ch0006s0219ta0313"><title><emphasis role="strong">DIAGNOSTIC STUDIES</emphasis></title>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">TEST</emphasis><?lb?><emphasis role="strong">WHY IT IS DONE</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">WHAT IT TELLS ME</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">ANTHROPOMETRICS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para>Techniques that deal with the measurement of the size, weight, and proportions of the human body, including:</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Ideal body weight (IBW):</emphasis> What people are expected to weigh based on age, gender, and height.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A malnourished person could weigh less or more than their IBW. Weight may be inaccurate because of factors such as edema or ascites.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Body mass index (BMI):</emphasis> Calculates body composition.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Measures ratios of lean-to-fat body weight. Classifications include underweight (less than 18.5), normal weight (18.5 to 24.9), overweight (25 to 29.9), and obese (greater than 30).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Skinfold measurement:</emphasis> Estimates subcutaneous body fat by measuring skinfold thickness using calipers. Measurements can use from three to nine different standard anatomical sites around the body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Fat reserves less than in the 10th percentile suggest advanced depletion; levels less than the 30th percentile suggest mild-to-moderate depletion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">BLOOD TESTS</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Visceral proteins:</emphasis> Nonmuscular proteins useful in monitoring nutritional status, including:</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Deficits suggest malnutrition. Protein is an essential nutrient that functions to promote tissue growth, repair, and wound healing.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum albumin:</emphasis> Protein deficiency results in decreased synthesis of albumin.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Albumin is not a definitive measure of visceral protein status but reflects the complex relationship between protein synthesis, degradation, and distribution. Depletion is considered at &lt;3.5 g/dL. However, overhydration and dehydration affect albumin concentration, and its long half-life makes it unreliable in acute depletion or repletion. It is more accurate in chronic protein deficiency states (Dawodu et al, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Serum transferrin:</emphasis> An iron-transport protein.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Transferrin is more sensitive to changes in visceral protein stores than albumin; also, its shorter half-life and smaller blood pool make it a more accurate early marker for protein-energy malnutrition (PEM). Level of less than 150 mg/dL is considered severe depletion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Prealbumin (PAB), also called transthyretin and thyroxine transport protein,</emphasis> carries thyroxine (the main thyroid hormone) and vitamin A throughout the body.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>PAB has a very short half-life and levels respond quickly to nutritional therapy, making it a more sensitive indicator of improvement and change in protein status. Depletion is considered severe at &lt;11 mg/dL (Dawodu et al, 2015). <emphasis>Note:</emphasis> Although some healthcare practitioners still use the test (especially to monitor client receiving TPN), there is controversy because changes in prealbumin may actually reflect other conditions such as inflammation, infection, or trauma (Lab Tests Online, 2015).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Nitrogen balance studies:</emphasis> Nitrogen excretion via urine, stool, and insensible losses often exceeds nitrogen intake in the acutely ill, reflecting catabolic response to stress and use of endogenous protein stores for energy production (gluconeogenesis).</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blood urea nitrogen (BUN) may be severely decreased because of chronic malnutrition and depletion of skeletal protein stores.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Glucose:</emphasis> Carbohydrates provide energy and spare body protein.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>During the critical phase of illness or injury, or in states of malnutrition, carbohydrate metabolism is radically altered. Hyperglycemia is a hallmark of stress and is frequently a side effect of nutritional support. Blood sugars are usually checked every 6 hours during therapy and treated, as needed, using a sliding-scale insulin regimen.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Retinol-binding protein (RBP):</emphasis> Carrier protein of vitamin A.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Concentration falls during protein and calorie deprivation and rises rapidly with supplementation.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">C-reactive protein (CRP):</emphasis> Acute inflammation phase protein.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Increases dramatically during systemic inflammation and catabolism, while visceral proteins fall. CRP values return to normal once the body starts to synthesize proteins, such as PAB.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Total lymphocyte count:</emphasis> Indicator of the status of the immune system.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Less than 1500 cells/mm<superscript>3</superscript> indicates leukopenia and results from decreased generation of T cells, which are very sensitive to malnutrition. Less than 800 cells/mm<superscript>3</superscript> indicates severe depletion. Levels are also altered by severe stress, renal failure, cancer, infection, and administration of corticosteroids.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Tests of micronutrients:</emphasis> Trace elements and electrolytes required for body to produce enzymes, hormones, and substances required for growth and development, as well as numerous body regulations, functions, and balance.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Deficiency occurs with inadequate intake and with loss of electrolyte-containing fluids&mdash;urine, diarrhea, vomiting, fistula drainage, and continuous NG suctioning. Imbalances occur also when excessive or deficient amounts of electrolytes and other micronutrients are supplied in TPN for the daily allowance for nutrition. Protocols should be in place for laboratory studies.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">OTHER DIAGNOSTIC STUDIES</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">24-hour creatinine (Cr) excretion:</emphasis> Because Cr is concentrated in muscle mass, there is a correlation between lean body mass and 24-hour Cr excretion. Actual values are compared with ideal values based on height and weight times 100.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Cr height index (CHI) of 60% to 80% indicates moderate depletion; less than 60% indicates severe depletion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Chest x-ray:</emphasis> Procedure used to evaluate organs and structures within the chest for symptoms of disease.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be normal or show evidence of pleural effusion; small heart silhouette in severely malnourished individual. <emphasis>Note:</emphasis> Chest x-ray will also be done after central line is inserted prior to beginning TPN to determine it is a location safe for infusion of hyperosmolar solutions. Also recommended to verify position of NG/Dobhoff tube prior to beginning enteral feedings.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Electrocardiogram (ECG):</emphasis> A record of the electrical activity of the heart that provides important information concerning the spread of electricity to the different parts of the heart.</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be normal or demonstrate low voltage, dysrhythmias, and patterns reflective of electrolyte imbalances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<itemizedlist mark="&bull;"><listitem><para><emphasis role="bi">Monitoring tests once client is on TPN:</emphasis></para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Guides changes in TPN formula.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Basic metabolic panel, C-reactive protein (CRP), magnesium (Mg), and phosphorus (Phos)</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be done on days 1 and 2 and prn. <emphasis>Note:</emphasis> Blood glucose may be checked every 6 hours for first 72 hours.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Liver function studies, prealbumin, and triglycerides</para></listitem></itemizedlist></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May be checked weekly and prn.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<itemizedlist mark="&bull;"><listitem><para>Resting energy expenditure (REE): Measures body&rsquo;s energy at rest using a heat process called calorimetry (via a portable cart available at point of care)</para></listitem></itemizedlist></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be done every 2 weeks.</para></entry></row></tbody></tgroup></table>
</sect2>
<sect2 id="ch0006s0222"><title><emphasis role="strong">NURSING PRIORITIES</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Promote consistent intake of adequate calorie and protein requirements.</para></listitem>
<listitem><para>Prevent complications.</para></listitem>
<listitem><para>Minimize energy losses and needs.</para></listitem>
<listitem><para>Provide information about condition, prognosis, and treatment needs.</para></listitem></orderedlist>
</sect2>
<sect2 id="ch0006s0223"><title><emphasis role="strong">DISCHARGE GOALS</emphasis></title>
<orderedlist numeration="arabic" inheritnum="ignore" continuation="restarts">
<listitem><para>Nutritional intake adequate for individual needs.</para></listitem>
<listitem><para>Complications prevented or minimized.</para></listitem>
<listitem><para>Fatigue alleviated.</para></listitem>
<listitem><para>Condition, prognosis, and therapeutic regimen understood.</para></listitem>
<listitem><para>Plan in place to meet needs after discharge.</para></listitem></orderedlist>
<note id="ch0006s0219note0553">
<title><emphasis role="strong">NURSING DIAGNOSIS: imbalanced Nutrition: less than body requirements</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Inability to ingest/digest food (e.g., cancer and associated treatments, anorexia, surgical procedures, dysphagia, decreased level of consciousness, hypermetabolic states)</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Body weight 20% or more under ideal; [decreased subcutaneous fat or muscle mass]; loss of weight with adequate food intake</para>
<para>Insufficient interest in food; food aversion; perceived inability to ingest food; food intake less than recommended daily allowances</para>
<para>Abdominal pain, cramping</para>
<para>Weakness of muscles required for mastication or swallowing; insufficient muscle tone</para>
<para>Hyperactive bowel sounds; diarrhea; steatorrhea</para>
<para>[Abnormal laboratory studies]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Nutritional Status</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Demonstrate stable weight or progressive weight gain toward goal, with normalization of laboratory values and no signs of malnutrition.</para>
</note>
<note role="none" id="ch0006s0219note0554">
<table frame="top" id="ch0006s0219ta0314"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Nutrition Therapy</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">General Interventions</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess nutritional status continually during daily nursing care, noting energy level; condition of skin, nails, hair, oral cavity; and desire to eat.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides the opportunity to observe deviations from normal client baseline and influences choice of interventions.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily (or as prescribed) and compare with admission weight.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Establishes baseline, aids in monitoring effectiveness of therapeutic regimen, and alerts nurse to inappropriate trends in weight loss or gain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Refer to nutritional team and registered dietitian.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aids in identification of nutrient deficits and specific need for parenteral or enteral nutritional intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine nutritional and caloric needs, using appropriate method, such as TEE, BMI, Harris-Benedict equation, and indirect calorimetry test, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Several methods are available to provide an estimation of calorie and protein needs. TEE is based on resting and activity energy expenditure and thermic effect of food. BMI estimates caloric needs according to energy requirements per kilogram of body weight. The Harris-Benedict equation provides a reasonable estimate of resting energy expenditure in kilocalories per day. Indirect calorimetry test measures oxygen (O<subscript>2</subscript>) consumption at basal or resting metabolic rate to aid in estimating calorie and protein requirements. <emphasis>Note:</emphasis> Although any of these tests may accurately determine individual needs, a standard formula for projecting energy requirements in the ill client is to provide 30 kcal/kg for weight maintenance, 25 kcal/kg for weight loss, or 35 kcal/kg for weight gain.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies: serum glucose, electrolytes, transferrin, prealbumin, albumin, total protein, phosphate, BUN/Cr, liver enzymes, complete blood count (CBC), and arterial blood gases (ABGs).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum chemistries, blood counts, and lipid profiles are performed before initiation of therapy, providing a baseline for comparison with repeat studies to determine therapy needs and monitor for complications. <emphasis>Note:</emphasis> Untoward metabolic effects of TPN include hypokalemia, hyponatremia and fluid retention, hyperglycemia, hypophosphatemia, increased CO<subscript>2</subscript> production resulting in respiratory compromise, elevation of liver function tests, and renal dysfunction.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">For Client Receiving Enteral Therapy</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Enteral Tube Feeding</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine presence and type of feeding tube, and document that tube is functional before starting nutrition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tube placement will be verified at insertion. However, bedside affirmation of tube tip placement (e.g., in stomach [prepyloric] or small bowel [postpyloric]) and tube function (e.g., free flowing or clogged) is advised on a regular basis (e.g., before bolus feedings; before and after administration of medications).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Elevate head of bed (HOB) 30 to 45 degrees, unless contraindicated by client&rsquo;s medical condition(s).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes digestion and helps reduce risk of aspiration of stomach contents (risk factor for pneumonia).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Confirm accuracy of prescribed enteral solution.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Nutritional support prescriptions are based on individually estimated caloric and protein (and micronutrient) requirements. Various medical nutrition products are formulated to target specific needs (e.g., pulmonary conditions, pressure ulcers, wound healing, burns, protein malnutrition, impaired GI function, chronic liver disease) (Elke et al, 2014; McClave &amp; Heyland, 2009; Medtrition, 2015-2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare equipment and continually monitor function of equipment used for feeding administration. Make certain label clearly states &ldquo;For Enteral Use Only&mdash;Not for IV Use.&rdquo;</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Use of properly functioning pump prevents/limits complications associated with enteral feeding rates. Labeling helps prevent misconnection errors (e.g., tube feeding inadvertently connected to an IV line).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain patency of enteral feeding tubes by flushing with at least 15 to 20 mL sterile/purified water before and after each feeding and as indicated (e.g., between doses of each medication or when checking gastric residuals).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tube occlusion is a frequently occurring problem (20%&ndash;45%) often requiring replacement (Guenter &amp; Boullata, 2013). Enteral formulas contain protein that can clog feeding tubes (more likely with small-bore or silicone than with polyurethane tubes), necessitating removal or replacement of tube. Other reasons the enteral tube may become clogged are inadequate water flushing, frequent medication delivery, and use of the tube to check residual volumes (Guenter &amp; Boullata, 2013; Wilkinson et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note date and time of feeding bag set change.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Bags should be changed every 24 hours or according to facility protocol.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Auscultate for bowel sounds before each feeding (if bolus) or every 4 to 8 hours or facility protocol (continuous feeding). Check for abdominal bloating/distention, nausea, vomiting, or diarrhea.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Symptoms may indicate intolerance of feeding or impaired GI motility, placing client at risk for complications (e.g., reflux, aspiration) (Houston, 2017; Wilkinson et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Collaborate with insertion and confirmation of proper placement of specified feeding tube.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>X-ray confirmation of tube placement is carried out prior to starting feedings to eliminate possibility of misplacement and to prevent administration of formula into the lungs. Alternately, tube position may be confirmed by aspiration of green gastric fluid or golden small bowel contents from feeding tube, before administration of solutions <emphasis>Note: </emphasis>Placement of feeding tube is dependent on client&rsquo;s specific needs. For example, although nasogastric (NG) feeding is safe for most patents, small bowel feeding may be best for those at risk for aspiration or GI intolerance. A.S.P.E.N. guidelines recommend that enteral feeding route should be based on patient-specific factors (e.g., patient with persistent dysphagia should be considered for a long-term enteral device [e.g., percutaneous endoscopic or surgically placed gastrostomy tube]) (Boullata et al, 2014; Kreymann et al, 2006; McClave &amp; Heyland, 2009).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications as indicated, such as:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Diphenoxylate with atropine (Lomotil), camphorated tincture of opium (paregoric), and metoclopramide (Reglan)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>GI side effects of enteral feeding may need to be controlled with antidiarrheal agents (Lomotil/paregoric) or peristaltic stimulants (Reglan) if more conservative measures such as alteration of rate or strength or type of formula are not successful. <emphasis>Note:</emphasis> Diarrhea may be a side effect of administered medications, especially those high in sorbitol (which can be found in premade liquid drugs such as potassium chloride, acetaminophen, theophylline) (Houston, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">For Client Receiving Parenteral Therapy</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Total Parenteral Nutrition (TPN) Administration</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess client&rsquo;s nutrition status and needs ongoing (e.g., daily weight, lab results, intake and output [I&amp;O]).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client receiving PN has complex nutritional needs (and medical conditions) requiring constant assessment and intervention, especially during imitation of therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Determine the type, location, and characteristics of PN access catheters (e.g., Hickman; Broviac; PICC; triplelumen, double-lumen, or single-lumen catheters; and ports)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Parenteral nutrition access options include central venous <emphasis role="bi">short-term</emphasis> catheters (put in place in the hospital and generally removed prior to discharge) and <emphasis role="bi">long-term</emphasis> options such as (1) tunneled Hickman catheter located in the upper chest, (2) peripherally inserted central catheter (PICC) located in the upper arm), and (3) ports implanted under the skin, usually in the upper chest wall. Many catheters are available in multilumen versions to allow for simultaneous infusion of multiple fluids and/or medications. Central venous catheters are commonly used for patients requiring weeks, months, or years of therapy (Kirby &amp; Parisian, 2011).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Check prescriber&rsquo;s orders for type and concentration of additives in each PN solution container and for rate of infusion. Notify physician and document problems (e.g., deviation from prescribed infusion over 24 hours; catheter complication requiring discontinuation of PN).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps prevent errors and complications and allows for early intervention where needed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Prepare and continually monitor function of equipment used for PN administration. Monitor pump alarms (e.g., occlusion may be from clogged filter or kinked tubing) and keep alarms on at all times.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Helps prevent errors and complications associated with inaccurate rate of infusion.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Observe appropriate &ldquo;hang&rdquo; time of parenteral solutions per facility protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Solutions in general appear to be stable in the usual facility 24-hour hang time. In one study (2011), many vitamins were stable in the formulation during the 3 days of study when stored at 4&deg;C (39&deg;F) (Ribeiro et al, 2011). <emphasis>Note:</emphasis> In literature, parenteral solution hang times are primarily concerned with intravenous lipid emulsions (IVLEs) and their correlation with catheter-related infections. In general, IVLEs given alone in their original manufacturer&rsquo;s container should be infused within 12 hours. IVLEs administered in an alternative container should be infused within 6 hours. IVLEs administered as a component of 3-in-1 and accompanying administration set should be terminated within 24 hours of infusion (Ayers et al, 2014; Perry, 2003; Sacks &amp; Driscoll, 2002).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor fingerstick glucose per protocol (such as every 6 hours) during initiation of therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Blood glucose levels may be elevated if PN contains too much carbohydrate in the form of dextrose, when the infusion rate is too high, as a side effect of the infection process or of medications (e.g., steroids) used for treatment of medical conditions. Hypoglycemia can also occur (although less common), precipitated by suddenly stopping concentrated dextrose infusions (Thomas, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Be familiar with electrolyte content of nutritional solutions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Metabolic complications of nutritional support often result from a lack of appreciation of changes that can occur because of refeeding&mdash;hyperglycemia, hyperosmolar nonketotic coma (HHNC), and electrolyte imbalances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer parenteral solution(s) as prescribed (e.g., dextrose-electrolyte or dextrose&ndash;amino acid and lipid emulsions [3-in-1] solutions) or premixed solutions, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>PN solutions provide calories, essential amino acids, and micronutrients and are modified to meet specific needs, such as lower protein in renal and liver failure or higher fat in respiratory failure. 3-in-1 solution bags are larger (2 to 3 L) and can infuse over a 24-hour period, eliminating the need for frequent bag changes and reducing line manipulation and risk of contamination. <emphasis>Note:</emphasis> Premixed PN solutions may have a number of advantages over compounded PN (e.g., decreased costs and compounding time, reduced chance for error, and reduced incidence of bloodstream infections) (Hall, 2015). However, it remains unclear if premixed solutions should be used in all cases. Comparison studies found that while calories and protein were remarkably similar, dextrose, lipid, and electrolytes differed. It has been suggested that premixed solutions be used in stable non&ndash;critically ill patients (Beattie et al, 2016).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Coinfuse lipid emulsions if 3-in-1 solutions are not used.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Lipid emulsions are often added to supply essential fatty acids and triglycerides with 20% to 30% of total calories supplied as lipids. <emphasis>Note:</emphasis> Lipid solutions may be contraindicated in clients with alterations in fat metabolism or in the presence of pancreatitis, liver damage, anemia, coagulation disorders, or pulmonary disease.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Administer medications, as indicated, for example:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Multivitamin preparations</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Water-soluble vitamins are added to parenteral solutions. Other vitamins may be given for identified deficiencies.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Insulin</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>High glucose content of solutions may require exogenous insulin for metabolism, especially in the presence of pancreatic insufficiency or disease. <emphasis>Note:</emphasis> Now insulin is usually added directly to parenteral solution.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0219note0555">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Infection</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Malnutrition; stasis of body fluids: chronic illness; immunosuppression</para>
<para>[Environmental exposure: invasive procedures&mdash;insertion of venous catheter, surgically placed gastrostomy or jejunostomy feeding tube, access devices in place for extended periods; improper preparation and handling or contamination of the feeding solution]</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Infection Severity</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Experience no fever or chills.</para>
<para>Demonstrate clean catheter insertion sites, free of drainage and erythema or edema.</para>
</note>
<note role="none" id="ch0006s0219note0556">
<table frame="top" id="ch0006s0219ta0315"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Emphasize and model proper handwashing technique.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of cross-contamination.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain sterile technique for invasive procedures. Provide routine site care, as appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Prevents entry of bacteria, reducing risk of nosocomial infections.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage frequent position changes and being out of bed or ambulation, as tolerated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Limits stasis of body fluids, promotes optimal functioning of organ systems and GI tract.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Screen visitors and care providers for infectious processes, especially upper respiratory infection (URI).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of transmission of viruses that are difficult to treat.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor and assist with respiratory exercises and use of adjuncts, such as incentive spirometer. Auscultate lungs for adventitious sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes deep breathing to clear airways and reduce risk of pneumonia. Presence of wheezes suggests retained secretions and potential complications requiring intervention.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess vital signs, including temperature, per protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A rise in pulse and temperature may provide warning of infectious process unless client&rsquo;s immune system is too compromised to respond.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Total Parenteral Nutrition (TPN) Administration</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain an optimal aseptic environment during bedside insertion of central venous catheters and during changes of TPN bottles and administration tubing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Catheter-related sepsis may result from entry of pathogenic microorganisms through skin insertion tract or from touch contamination during manipulations of TPN system.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Secure external portion of catheter and administration tubing to dressing with tape. Note intactness of skin suture.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Manipulation of catheter in and out of insertion site can result in tissue trauma or coring and potentiate entry of skin organisms into catheter tract.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain a sterile occlusive dressing over catheter insertion site. Perform central or peripheral venous catheter dressing care per protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Protects catheter insertion sites from potential sources of contamination. <emphasis>Note:</emphasis> Central venous catheter sites can easily become contaminated from tracheotomy or endotracheal secretions or from wounds of the head, neck, and chest.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect insertion site of catheter for erythema, induration, drainage, and tenderness.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>The catheter is a potential irritant to the surrounding skin and subcutaneous skin tract, and extended use may result in insertion site irritation and infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refrigerate premixed solutions before use; observe a 24-hour hang time for amino acid or total nutrient admixtures solutions and a 12-hour hang time for IV fat emulsions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>TPN solutions and fat emulsions have been shown to support the growth of a variety of pathogenic organisms once contaminated.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor temperature and serum glucose levels.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>A rise in temperature or loss of glucose tolerance (glycosuria, hyperglycemia) is an early indication of possible catheter-related sepsis.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Enteral Tube Feeding</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep manipulations of enteral feeding system to a minimum and wash hands before opening system. Handle the system as little as possible.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Touch contamination of formula is caused by caregiver administration technique.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Alternate nares for tube placement in long-term NG feedings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of trauma and infection of paranasal tissue, especially important in facial trauma or burns.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide daily and as needed site care to abdominally placed feeding tubes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>GI secretions leaking through or around gastrostomy or jejunostomy tube tracts can cause skin breakdown severe enough to require removal of the feeding tube.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Refrigerate reconstituted enteral formulas before use; observe a hang time of 4 to 8 hours; discard unused formula after 24 hours.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enteral formulas easily support bacterial growth due to high concentration of glucose and lipids and can be contaminated from several sources, including when preparation is mixed or poured or via frequent aspiration of gastric or small bowel contents, use of open system, and use of blue dye.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Infection Protection</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aseptically prepare parenteral solutions or enteral formulas for administration. When possible, use prepackaged sterile enteral feeding formula.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>TPN solutions should be prepared under a laminar flow hood in the pharmacy. Enteral formulas should be mixed in a clean environment in the dietary or pharmacy department. <emphasis>Note:</emphasis> Additives to TPN solutions, as a rule, should not be made on the unit because of the potential for contamination and drug incompatibilities.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Notify physician if signs of infection are present. Follow protocol for obtaining appropriate culture specimens of blood and solutions, and change bottle and tubing, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Necessary to identify source of infection and initiate appropriate therapy. May require removal of TPN line and culture of catheter tip.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Administer antibiotics, as indicated.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>May be given prophylactically or for specifically identified organism.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0219note0557">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Injury</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>[Physical (e.g., catheter-related complications; effects of therapy, drug interactions)]</para>
<para>Impaired primary defense mechanisms; malnutrition; abnormal blood profile; immune dysfunction</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Risk Control</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Be free of complications associated with nutritional support.</para>
<para>Modify environment and correct hazards to enhance safety for in-home therapy.</para>
</note>
<note role="none" id="ch0006s0219note0558">
<table frame="top" id="ch0006s0219ta0316"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Surveillance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Parenteral</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain a closed central IV system using Luer-Lock (or similar) connections.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inadvertent disconnection of central IV system can result in lethal air emboli.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Administer appropriate TPN solution via peripheral or central venous route, including peripherally inserted central catheter (PICC) lines and tunneled catheters.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Solutions containing high concentrations of dextrose more than 10% must be delivered via a central vein because they result in chemical phlebitis when delivered through small peripheral veins.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Monitor for potential drug and nutrient interactions.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Various interactions are possible, such as digoxin in conjunction with diuretic therapy, which can cause hypomagnesemia; hypokalemia may result from chronic use of laxatives, mineralocorticoid steroids, diuretics, or amphotericin.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess catheter for signs of displacement out of central venous position: extended length of catheter on skin surface, leaking of IV solution onto dressing, client complaints of neck/arm pain, tenderness at catheter site, or swelling of extremity on side of catheter insertion.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These measures are necessary for preventing catheter-associated issues (e.g., pulmonary or vascular complications, extravasation of solution(s) into tissue, and infection).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inspect peripheral TPN catheter site routinely and change sites at least every other day or per protocol.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Peripheral TPN solutions, although less hyperosmolar, can still irritate small veins and cause phlebitis. Peripheral venous access is often limited in malnourished clients, but site should still be changed if signs of irritation develop.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Investigate reports of severe chest pain or coughing in clients with central line. Turn client to left side in Trendelenburg position, if indicated, and notify physician.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Suggests presence of air embolus requiring immediate intervention to displace air into apex of heart away from the pulmonary artery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Maintain an occlusive dressing on catheter insertion sites for 24 hours after subclavian catheter is removed.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Extended catheter use may result in development of catheter skin tract. Once the catheter is removed, air embolus is still a potential risk until skin tract has sealed.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Enteral</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess gastrostomy or jejunostomy tube sites for evidence of malposition.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indwelling and mushroom catheters are still used for feeding tubes inserted via the abdomen. Migration of the catheter balloon can result in duodenal or jejunal obstruction. Improperly sutured gastrostomy tubes may easily fall out.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review chest x-ray, as indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Central parenteral line placement is routinely confirmed by x-ray.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Consult with pharmacist in regard to site and time of delivery of drugs that might have action adversely affected by enteral formula.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Absorption of vitamin D is impaired by administration of mineral oil, which inhibits micelle formation of bile salts, and by neomycin, which inactivates bile salts. Aluminum-containing antacids bind with the phosphorus in the feeding solution, potentiating hypophosphatemia. Other medications (e.g., levothyroxine, alendronate, phenytoin, carbamazepine, carbidopa levodopa) need to be given on an empty stomach, requiring interruption of gastric feeding for 1 to 2 hours before and after administration (Houston, 2017).</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0219note0559">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for Aspiration</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Presence of gastrointestinal tube, enteral tube feedings</para>
<para>Delayed gastric emptying; increase in gastric residual</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Respiratory Status: Airway Patency</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Maintain clear airway, free of signs of aspiration.</para>
</note>
<note role="none" id="ch0006s0219note0560">
<table frame="top" id="ch0006s0219ta0317"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Aspiration Precautions</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Enteral</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Confirm placement of enteral feeding tubes. Determine feeding tube position in stomach by x-ray, confirm pH of 0 to 5 for the gastric fluid withdrawn through tube, or auscultate injected air before intermittent feedings. Observe for ability to speak and cough.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Malplacement of feeding tubes may result in aspiration of enteral formula. Clients at particular risk include those who are intubated, obtunded/comatose, and those who have had a neurological injury (e.g., stroke, MS, Guillain-Barr&eacute;) or surgery of the head, neck, and upper GI system. <emphasis>Note:</emphasis> The reliability of the pH method is reduced if antacids or certain other medications have been given orally or via NG in the past 4 hours. In addition, when using auscultatory method to assess tube placement, air sounds can be transmitted to the epigastrium even if the tube is malpositioned in lung or proximal jejunum.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Maintain aspiration precautions during enteral feedings, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Keep head of bed elevated at 30 to 45 degrees during feeding and for at least 1 hour after feeding. Interrupt continuous feeding when client is in prone position for repositioning or transport.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of regurgitation or gastric reflux.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Inflate tracheostomy cuff during and for 1 hour after intermittent feeding.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Aspiration of enteral formulas is highly irritating to the lung parenchyma and may result in pneumonia and respiratory compromise.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor gastric residual volumes (GRVs) between or before bolus feedings (as previously noted in ND: imbalanced Nutrition: less than body requirements) and high bolus feeding volumes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of large gastric residuals may potentiate an incompetent esophageal sphincter, leading to vomiting and aspiration. In addition, fast feeding rates with volumes exceeding 1500 mL/d are at higher risk of aspiration (Houston, 2017).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note characteristics of sputum and tracheal aspirate. Investigate development of dyspnea, cough, tachypnea, and cyanosis. Auscultate breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Presence of formula in tracheal secretions or signs and symptoms reflecting respiratory distress suggest aspiration.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note indicators of NG tube intolerance, such as absence of gag reflex, high risk of aspiration, and frequent removal of NG feeding tubes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May require consideration of surgically placed feeding tube, percutaneous endoscopic gastrostomy (PEG), or jejunostomy (J tube) for client safety and consistency of enteral formula delivery.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Review abdominal x-ray if performed.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Confirmation of placement of gastric feeding tube should be obtained by x-ray.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0219note0561">
<title><emphasis role="strong">NURSING DIAGNOSIS: risk for imbalanced Fluid Volume</emphasis></title>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Treatment regimen; [complications of nutrition therapy&mdash;high-glucose solutions, hyperglycemia; overhydration or dehydration]</para>
<para>Failure of regulatory mechanisms specific to underlying disease process or trauma Inability to obtain or ingest fluids</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client Will</emphasis></para>
<para><emphasis role="strong">Fluid Balance</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Display moist skin, moist mucous membranes, stable vital signs, and adequate urinary output; be free of edema and excessive weight loss or inappropriate gain.</para>
</note>
<note role="none" id="ch0006s0219note0562">
<table frame="top" id="ch0006s0219ta0318"><title/>
<tgroup colsep="0" rowsep="0" cols="3">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<colspec colnum="3" colname="3" align="left" colsep="0"/>
<spanspec spanname="1-2" namest="1" nameend="2"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom" spanname="1-2">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="strong">Fluid Management</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note presence of conditions (e.g., diabetes, intestinal obstruction, burns, sepsis, kidney or liver failure).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These underlying conditions associated with fluid imbalances may be present in the client receiving nutritional therapy. Both the conditions and nutritional therapies have fluid imbalance implications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Note current treatment modalities (e.g., mechanical ventilation, surgery, major invasive procedures and devices).</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>These can cause/exacerbate fluid imbalances.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Assess for clinical signs of <emphasis role="bi">dehydration</emphasis> such as thirst, dry skin and mucous membranes, hypotension, or <emphasis role="bi">fluid excess,</emphasis> including peripheral edema, tachycardia, and adventitious breath sounds.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early detection and intervention may prevent occurrence of excessive fluctuation in fluid balance. <emphasis>Note:</emphasis> Severely malnourished clients have an increased risk of developing <emphasis role="bi">refeeding syndrome</emphasis> (life-threatening fluid overload, intracellular electrolyte shifts, and cardiac strain occurring during initial 3 to 5 days of therapy). This potentially catastrophic complication can usually be prevented by starting feedings at low rates and advancing them slowly over several days (Mehler et al, 2010).</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Incorporate knowledge of caloric density of enteral formulas into assessment of fluid balance.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enteric solutions are usually concentrated and do not meet free water needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Provide additional free water via feeding tube or at bedside (if client can drink) and via feeding tube flushing tubing.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>With higher calorie formula, additional water is needed to prevent dehydration or hyperglycemic complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Record intake and output (I&amp;O), calculate 24-hour fluid balance, and measure urine-specific gravity.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Indicators of fluid balance. Specific gravity is an indicator of hydration and renal function.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Weigh daily, or as indicated; evaluate changes.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides for early detection and intervention as needed. <emphasis>Note:</emphasis> Rapid weight gain reflecting fluid retention can predispose or potentiate heart failure (HF) or pulmonary edema. Gain of more than 0.5 lb/d indicates fluid retention and not deposition of lean body mass.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para><emphasis role="bi">Collaborative</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Monitor laboratory studies, such as the following:</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Serum potassium and phosphorus</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypokalemia and phosphatemia can occur because of intracellular shifts during initial refeeding and may compromise cardiac function if not corrected.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Hematocrit (Hct)</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reflects hydration and circulating volume.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top" spanname="1-2">
<para>Serum albumin</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hypoalbuminemia and decreased colloidal osmotic pressure lead to third spacing of fluid and edema.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Serum transferrin</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reacts quickly to changes in protein status.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
</entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Prealbumin</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Sensitive to low levels of protein.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0219note0563">
<title><emphasis role="strong">NURSING DIAGNOSIS: deficient Knowledge regarding condition, prognosis, treatment, self-care, and discharge needs</emphasis></title>
<para><emphasis role="strong">May Be Related To</emphasis></para>
<para>Insufficient information; insufficient knowledge of resources or interest in learning</para>
<para>Alteration in cognitive functioning or memory</para>
<para>[Information misinterpretation]</para>
<para><emphasis role="strong">Possibly Evidenced By</emphasis></para>
<para>Insufficient knowledge</para>
<para>Inaccurate follow-through of instructions</para>
<para>Development of preventable complications</para>
<para><emphasis role="strong">Desired Outcomes/Evaluation Criteria&mdash;Client/Caregiver Will</emphasis></para>
<para><emphasis role="strong">Knowledge: Disease Process</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Verbalize understanding of condition or the disease process and individual nutritional needs.</para>
<para>Participate in learning process of treatment regimen.</para>
<para>Be free of preventable complications.</para>
<para><emphasis role="strong">Knowledge: Treatment Procedure</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnoc.jpg"/></imageobject></inlinemediaobject></para>
<para>Perform necessary procedures correctly, and explain reasons for the actions.</para>
</note>
<note role="none" id="ch0006s0219note0564">
<table frame="top" id="ch0006s0219ta0319"><title/>
<tgroup colsep="0" rowsep="0" cols="2">
<colspec colnum="1" colname="1" align="left" colsep="0"/>
<colspec colnum="2" colname="2" align="left" colsep="0"/>
<thead>
<row rowsep="1" valign="bottom">
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">ACTIONS/INTERVENTIONS</emphasis></para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="bottom">
<para><emphasis role="strong">RATIONALE</emphasis></para></entry></row></thead>
<tbody>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="strong">Enteral Tube Feeding/Total Parenteral Nutrition (TPN) Administration</emphasis>&nbsp;<inlinemediaobject><imageobject><imagedata fileref="pnic.jpg"/></imageobject></inlinemediaobject></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para><emphasis role="bi">Independent</emphasis></para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
</entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Assess client&rsquo;s and significant other&rsquo;s (SO&rsquo;s) knowledge of nutritional state.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Determines content matter to be presented.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review individual situation, signs and symptoms of malnutrition, future expectations, and transitional feeding needs.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides information from which client and SO can make informed choices. Knowledge of the interaction between malnutrition and illness is helpful in understanding need for special therapy.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss reasons for use of nutrition support.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>May experience anxiety regarding inability to eat and may not comprehend the nutritional value of the prescribed TPN or tube feedings.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provide adequate time for teaching client and SO when client is going home on enteral or parenteral feedings. Document client&rsquo;s and SO&rsquo;s understanding, ability, and competence to deliver safe home therapy.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Generally, 3 to 4 days is sufficient for client and SO to become proficient with tube feedings. Parenteral therapy is more complex, and client and SO may require a week or longer to feel ready for home management; follow-up in the home is required.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss proper handling, storage, and preparation of nutritional solutions; also discuss aseptic or clean techniques for care of insertion sites and use of dressings.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Reduces risk of formula or solution-related problems, metabolic complications, and infection.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review use and proper care of nutritional delivery devices.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Client understanding and cooperation are key to the safe insertion and maintenance of nutritional support access devices and prevention of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Review specific precautions (depending on type of feeding), such as checking placement of tube, sitting upright for enteral feeding, maintaining patency of tube, anchoring of tubing, and adequate length of tubing for nighttime feeding.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Promotes safe self-care and reduces risk of complications.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss and demonstrate reinsertion of enterostomal feeding tube, if appropriate.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Tube may be changed routinely or inserted only for feedings. Intermittent feedings enhance client mobility and aid in transition to regular feeding pattern.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Identify signs and symptoms requiring medical evaluation&mdash;nausea and vomiting, abdominal cramping or bloating, diarrhea, rapid weight changes, erythema, drainage, foul odor at tube insertion site, fever and chills, coughing and choking, or difficulty breathing during enteral feeding.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Early evaluation and treatment of problems such as feeding intolerance, infection, and aspiration may prevent progression to complications that are more serious.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Instruct client and SO in glucose monitoring, if indicated.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Timely recognition of changes in blood glucose levels reduces risk of hyperglycemic or hypoglycemic reactions in client on TPN.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Discuss signs, symptoms, and treatment of hyperglycemia and hypoglycemia.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Hyperglycemia is more common for clients receiving parenteral feedings and those who have pancreas or liver disease or are taking large doses of corticosteroids. Rebound hypoglycemia can occur when feedings are intentionally or accidentally discontinued.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Encourage use of diary for recording test results, physical feelings and any reactions, activity level, oral intake if any, I&amp;O, and weekly weight. Report trends to appropriate healthcare providers.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides resource for review by healthcare providers for optimal management of individual situation. <emphasis>Note: </emphasis>Journaling (by client or caregiver) about intake may be especially important when efforts are being made to transition from enteral or parenteral feeding to oral feeding. <emphasis>Note:</emphasis> The client with conditions interfering with oral intake (e.g., stroke or Parkinson&rsquo;s disease; brain injury; facial trauma, burns) may require additional referrals and interventions by healthcare providers to manage nutrition needs.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Recommend daily exercise and activity to tolerance, scheduling of adequate rest periods.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Enhances gastric motility for enteral transition feedings, promotes feelings of general well-being, and prevents undue fatigue.</para></entry></row>
<row rowsep="0" valign="top">
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Ascertain that all supplies are in place in the home before discharge; make arrangements as needed with suppliers, such as hospital, pharmacy, medical equipment company, and laboratory.</para></entry>
<entry rowsep="0" morerows="0" colsep="0" valign="top">
<para>Provides for successful, smooth transition from acute care setting to home and competent home therapy.</para></entry></row>
<row rowsep="1" valign="top">
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Refer to nutritional support team, home healthcare agency, and counseling resources. Provide with immediate-access phone numbers.</para></entry>
<entry rowsep="1" morerows="0" colsep="0" valign="top">
<para>Client and SO need readily available support persons to assist with nutrition therapy, equipment problems, and emotional adjustments in long-term or home-based therapy.</para></entry></row></tbody></tgroup></table></note>
<note id="ch0006s0219note0565">
<para><emphasis role="strong">POTENTIAL CONSIDERATIONS </emphasis>following acute hospitalization (dependent on client&rsquo;s age, physical condition and presence of complications, personal resources, and life responsibilities)</para>
<itemizedlist mark="&bull;">
<listitem><para><emphasis role="bi">Fatigue</emphasis>&mdash;disease states; malnutrition; stress; altered body chemistry (e.g., medications, chemotherapy)</para></listitem>
<listitem><para><emphasis role="bi">risk for Injury</emphasis>&mdash;physical (e.g., catheter-related complications&mdash;catheter breaks, dislodgement, occlusion air emboli, septic thrombophlebitis); malnutrition; effects of therapy, drug interactions</para></listitem>
<listitem><para><emphasis role="bi">risk for Infection</emphasis>&mdash;invasive tubes, environmental exposure, malnutrition, chronic disease</para></listitem>
<listitem><para><emphasis role="bi">interrupted Family Processes</emphasis>&mdash;situational crises; shift of health status of a family member; shift in family roles</para></listitem></itemizedlist>
</note>
</sect2></sect1></chapter>
